
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Pathobiology and Regulation of Eosinophils, Mast Cells, and Basophils in Allergic Asthma - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="68F7E02980953CA300E02900064F119A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12001016/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Immunological Reviews">
<meta name="citation_title" content="Pathobiology and Regulation of Eosinophils, Mast Cells, and Basophils in Allergic Asthma">
<meta name="citation_author" content="Christiane E Whetstone">
<meta name="citation_author_institution" content="Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada">
<meta name="citation_author" content="Rand Amer">
<meta name="citation_author_institution" content="Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada">
<meta name="citation_author" content="Samarah Maqbool">
<meta name="citation_author_institution" content="Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada">
<meta name="citation_author" content="Tooba Javed">
<meta name="citation_author_institution" content="Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada">
<meta name="citation_author" content="Gail M Gauvreau">
<meta name="citation_author_institution" content="Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada">
<meta name="citation_publication_date" content="2025 Apr 16">
<meta name="citation_volume" content="331">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="e70018">
<meta name="citation_doi" content="10.1111/imr.70018">
<meta name="citation_pmid" content="40235366">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12001016/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12001016/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12001016/pdf/IMR-331-0.pdf">
<meta name="description" content="Eosinophilia is a hallmark of allergic disorders, including asthma, allergic rhinitis, and atopic dermatitis. The onset and maintenance of allergic inflammation in atopic adults involves the activation of selective hemopoietic processes and the ...">
<meta name="og:title" content="Pathobiology and Regulation of Eosinophils, Mast Cells, and Basophils in Allergic Asthma">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Eosinophilia is a hallmark of allergic disorders, including asthma, allergic rhinitis, and atopic dermatitis. The onset and maintenance of allergic inflammation in atopic adults involves the activation of selective hemopoietic processes and the ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12001016/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12001016">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/imr.70018"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/IMR-331-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12001016%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12001016/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12001016/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12001016/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/imr.70018" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Immunol Rev</button></div>. 2025 Apr 16;331(1):e70018. doi: <a href="https://doi.org/10.1111/imr.70018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/imr.70018</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Immunol%20Rev%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Immunol%20Rev%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Immunol%20Rev%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Immunol%20Rev%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Pathobiology and Regulation of Eosinophils, Mast Cells, and Basophils in Allergic Asthma</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Whetstone%20CE%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Christiane E Whetstone</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Christiane E Whetstone</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Whetstone%20CE%22%5BAuthor%5D" class="usa-link"><span class="name western">Christiane E Whetstone</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Amer%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Rand Amer</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Rand Amer</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Amer%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rand Amer</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maqbool%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Samarah Maqbool</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Samarah Maqbool</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maqbool%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Samarah Maqbool</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Javed%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Tooba Javed</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Tooba Javed</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Javed%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tooba Javed</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gauvreau%20GM%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Gail M Gauvreau</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Gail M Gauvreau</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gauvreau%20GM%22%5BAuthor%5D" class="usa-link"><span class="name western">Gail M Gauvreau</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="imr70018-aff-0001">
<sup>
<sup>1</sup>
</sup>Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Gail M. Gauvreau (<span>gauvreau@mcmaster.ca</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Feb 19; Received 2025 Feb 10; Accepted 2025 Feb 28; Issue date 2025 May.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Immunological Reviews</em> published by John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12001016  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40235366/" class="usa-link">40235366</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>Eosinophilia is a hallmark of allergic disorders, including asthma, allergic rhinitis, and atopic dermatitis. The onset and maintenance of allergic inflammation in atopic adults involves the activation of selective hemopoietic processes and the migration of mature and immature eosinophils to allergic tissue, where these cells release mediators of inflammation that participate in the regulation of inflammation. Eosinophils function in close cooperation with basophils and mast cells in allergic tissue, where crosstalk between these central effector cells regulates the inflammatory process. This chapter will review the cellular events leading to the accumulation of eosinophils and their progenitors in the airways in allergic asthma, with a particular focus on models of allergen‐induced allergic inflammation. Inhaled allergen challenges in allergic asthmatics have advanced understanding of the pathogenesis of allergen exposure leading to early and late asthmatic responses and the associated airway hyperresponsiveness and type 2 airway inflammation. This chapter will also discuss the mechanisms of commonly used asthma therapies on allergen‐induced eosinophilia and compare the effects of novel therapies targeting specific immune pathways for a better understanding of how to regulate airway eosinophil levels in patients with asthma.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> allergen‐challenge, allergic asthma, basophils, eosinophil progenitors, eosinophils, mast cells</p></section></section><section id="imr70018-sec-0001"><h2 class="pmc_sec_title">1. Eosinophils, Basophils, and Mast Cells in Allergic Disease</h2>
<p>Eosinophils, basophils, and mast cells are integral to the body's response to allergens and play critical roles in innate and adaptive immune responses. Derived from a common hematopoietic progenitor stem cell, these cells are closely linked by their shared lineage, overlapping receptor expression, and responsiveness to similar growth factors. This shared origin and developmental pathway highlight the interconnected nature of their functions in inflammation. Through complex signaling and crosstalk, eosinophils, basophils, and mast cells work in unison to release a variety of mediators that activate neighboring eosinophils/basophils/mast cells, recruit additional immune cells, and propagate the immune response to pathogens. The synchronized actions of these cells are vital in mounting a robust type 1 hypersensitivity reaction to pathogens, a hallmark of allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis.</p>
<section id="imr70018-sec-0002"><h3 class="pmc_sec_title">1.1. Cellular Differentiation and Maturation</h3>
<p>Eosinophils, basophils, and mast cells originate from uncommitted hemopoietic progenitor stem cells that give rise to all bone marrow and peripheral blood cell types [<a href="#imr70018-bib-0001" class="usa-link" aria-describedby="imr70018-bib-0001">1</a>]. Hemopoietic stem cells differentiate into multipotent progenitors and then into the common myeloid progenitor. These CD34+ hemopoietic progenitors reside in the blood and bone marrow at different stages of lineage commitment, responding to environmental signals, such as hematopoietic cytokines, to be directed to differentiate along specific pathways. In the case of eosinophils and basophils, the common myeloid progenitors differentiate into a common granulocyte/monocyte progenitor, which further develops into an eosinophil/basophil colony‐forming unit in response to T‐helper type 2 (Th2) cell cytokines granulocyte‐macrophage colony‐stimulating factor (GM‐CSF), interleukin (IL)‐3, IL‐5, and GATA‐1 transcription expression [<a href="#imr70018-bib-0002" class="usa-link" aria-describedby="imr70018-bib-0002">2</a>, <a href="#imr70018-bib-0003" class="usa-link" aria-describedby="imr70018-bib-0003">3</a>]. Mast cells differentiate directly from these common myeloid progenitors in response to the stroma‐cell‐derived cytokine stem cell factor, also termed c‐kit ligand or mast cell growth factor, to produce a separate cell lineage of mast cell precursor cells [<a href="#imr70018-bib-0004" class="usa-link" aria-describedby="imr70018-bib-0004">4</a>, <a href="#imr70018-bib-0005" class="usa-link" aria-describedby="imr70018-bib-0005">5</a>]. The stem cell factor is unique for differentiating and activating human mast cells [<a href="#imr70018-bib-0006" class="usa-link" aria-describedby="imr70018-bib-0006">6</a>, <a href="#imr70018-bib-0007" class="usa-link" aria-describedby="imr70018-bib-0007">7</a>].</p>
<p>The common CD34+ hemopoietic progenitor stem cell contributes to eosinophil and basophil recruitment in tissues during allergic inflammation [<a href="#imr70018-bib-0008" class="usa-link" aria-describedby="imr70018-bib-0008">8</a>]. Since eosinophils and basophils differentiate from a shared CD34+ hemopoietic progenitor cell, similar Th2 cytokines are responsible for the growth and maturation of both cells. The increased prevalence of CD34+ cells in the blood and bone marrow of atopic asthmatics is correlated with disease severity and level of airflow obstruction [<a href="#imr70018-bib-0009" class="usa-link" aria-describedby="imr70018-bib-0009">9</a>, <a href="#imr70018-bib-0010" class="usa-link" aria-describedby="imr70018-bib-0010">10</a>]. The Th2 cytokines GM‐CSF, IL‐3, and IL‐5 highly regulate the migration and accumulation of eosinophils, basophils, and mast cells, all of which signal through a specific high‐affinity common β chain receptor [<a href="#imr70018-bib-0003" class="usa-link" aria-describedby="imr70018-bib-0003">3</a>, <a href="#imr70018-bib-0011" class="usa-link" aria-describedby="imr70018-bib-0011">11</a>]. Mast cells are also known to produce IL‐5, which induces the expression of the membrane‐bound IL‐5 receptor subunit α (IL‐5Rα) on CD34+ bone marrow cells, promoting further response to IL‐5 and lineage skewing of CD34+ cells within the bone marrow and the subsequent development of blood and tissue eosinophils [<a href="#imr70018-bib-0012" class="usa-link" aria-describedby="imr70018-bib-0012">12</a>, <a href="#imr70018-bib-0013" class="usa-link" aria-describedby="imr70018-bib-0013">13</a>]. IL‐5 is often considered a critical growth factor for eosinophil differentiation and trafficking from the bone marrow to the airways, as airway, nasal, and blood eosinophilia is completely inhibited through neutralizing IL‐5 [<a href="#imr70018-bib-0014" class="usa-link" aria-describedby="imr70018-bib-0014">14</a>] or deletion of the gene encoding IL‐5 [<a href="#imr70018-bib-0015" class="usa-link" aria-describedby="imr70018-bib-0015">15</a>]. In a similar context to IL‐5 being crucial for eosinophil differentiation, IL‐3 plays a pivotal role in the growth and differentiation of basophils from the shared CD34+ hemopoietic progenitor cells [<a href="#imr70018-bib-0016" class="usa-link" aria-describedby="imr70018-bib-0016">16</a>]. Although IL‐3 is a key regulator of basophil development and functional effect, it is only one component of a larger network of cytokines that mediate basophil differentiation and proliferation [<a href="#imr70018-bib-0017" class="usa-link" aria-describedby="imr70018-bib-0017">17</a>]. Recently, TSLP has also been shown to promote basophil differentiation at levels comparable to IL‐3 [<a href="#imr70018-bib-0018" class="usa-link" aria-describedby="imr70018-bib-0018">18</a>], and these IL‐3‐independent TSLP‐elicited basophils produce more IL‐4 and IL‐13 than IL‐3‐elicited basophils [<a href="#imr70018-bib-0019" class="usa-link" aria-describedby="imr70018-bib-0019">19</a>].</p>
<p>Traditionally, eosinophils were thought to mature and terminally differentiate in the bone marrow before entering the circulation. However, it is now apparent that both CD34+ hemopoietic progenitors and CD34 + IL‐5Rα + eosinophil progenitors are found in the bronchial mucosa [<a href="#imr70018-bib-0020" class="usa-link" aria-describedby="imr70018-bib-0020">20</a>], nasal polyps [<a href="#imr70018-bib-0021" class="usa-link" aria-describedby="imr70018-bib-0021">21</a>] and atopic dermatitis lesions [<a href="#imr70018-bib-0022" class="usa-link" aria-describedby="imr70018-bib-0022">22</a>], and these cells can differentiate and mature in these tissues in response to local IL‐5 [<a href="#imr70018-bib-0020" class="usa-link" aria-describedby="imr70018-bib-0020">20</a>, <a href="#imr70018-bib-0023" class="usa-link" aria-describedby="imr70018-bib-0023">23</a>]. Compared to healthy controls, there are increased numbers of double‐positive cells for CD34 and IL‐5Rα mRNA in nasal and lung biopsies of allergic asthmatic subjects [<a href="#imr70018-bib-0020" class="usa-link" aria-describedby="imr70018-bib-0020">20</a>, <a href="#imr70018-bib-0023" class="usa-link" aria-describedby="imr70018-bib-0023">23</a>]. In these allergic asthmatics, IL‐5‐dependent differentiation of eosinophil progenitors can be stimulated by allergen provocation in the nasal mucosa to decrease CD34+IL‐5Rα+mRNA cells and increase major basic protein (MBP) positive cells [<a href="#imr70018-bib-0023" class="usa-link" aria-describedby="imr70018-bib-0023">23</a>]. Additionally, human airway smooth muscle cells have been shown to trigger eosinophil differentiation [<a href="#imr70018-bib-0024" class="usa-link" aria-describedby="imr70018-bib-0024">24</a>]. Furthermore, inhalation of IL‐5 by allergic asthmatics leads to the development of peripheral blood and sputum eosinophilia [<a href="#imr70018-bib-0025" class="usa-link" aria-describedby="imr70018-bib-0025">25</a>], which is accompanied by increased airway hyperresponsiveness [<a href="#imr70018-bib-0026" class="usa-link" aria-describedby="imr70018-bib-0026">26</a>]. In contrast, successive studies show IL‐5 alone was not robust enough to increase eosinophilia and airway hyperresponsiveness [<a href="#imr70018-bib-0027" class="usa-link" aria-describedby="imr70018-bib-0027">27</a>, <a href="#imr70018-bib-0028" class="usa-link" aria-describedby="imr70018-bib-0028">28</a>, <a href="#imr70018-bib-0029" class="usa-link" aria-describedby="imr70018-bib-0029">29</a>]. IL‐5 can induce chemokinesis of bone marrow eosinophils, but the mobilization of mature eosinophils involves multiple chemoattractants, including eotaxin [<a href="#imr70018-bib-0030" class="usa-link" aria-describedby="imr70018-bib-0030">30</a>]. Basophils complete their differentiation in the bone marrow and enter the circulation after maturation, homing to sites of inflammation in response to chemoattractants [<a href="#imr70018-bib-0018" class="usa-link" aria-describedby="imr70018-bib-0018">18</a>]. Interestingly, one report showed that when a precursor to basophil and mast cells migrates to the spleen without differentiating, it maintains the capacity to return to the bone marrow and further develop into a basophil [<a href="#imr70018-bib-0018" class="usa-link" aria-describedby="imr70018-bib-0018">18</a>]. In contrast, mast cell precursor cells undergo differentiation and maturation in extramedullary organs [<a href="#imr70018-bib-0031" class="usa-link" aria-describedby="imr70018-bib-0031">31</a>].</p>
<p>Under baseline conditions, only a small number of eosinophils are released from the bone marrow and localize in the thymus, gastrointestinal tract, uterus, and mammary glands, contributing to homeostatic functions [<a href="#imr70018-bib-0032" class="usa-link" aria-describedby="imr70018-bib-0032">32</a>]. During allergic inflammation, eosinophil differentiation and maturation, a process called eosinophilopoiesis, dramatically increases as eosinophil and eosinophil progenitor cells infiltrate the tissues. Eosinophil progenitors can mature within the bone marrow or be trafficked directly to sites of inflammation, where they are found alongside mature eosinophils [<a href="#imr70018-bib-0033" class="usa-link" aria-describedby="imr70018-bib-0033">33</a>] and undergo in situ <em>hematopoiesis</em>, contributing to the development of immunity at mucosal sites [<a href="#imr70018-bib-0034" class="usa-link" aria-describedby="imr70018-bib-0034">34</a>]. Eosinophil progenitors express the IL‐33 receptor (ST2) and the TSLP receptor (TSLPR), which can upregulate IL‐5Rα expression and regulate eosinophil progenitor homing and hematopoietic decisions [<a href="#imr70018-bib-0035" class="usa-link" aria-describedby="imr70018-bib-0035">35</a>, <a href="#imr70018-bib-0036" class="usa-link" aria-describedby="imr70018-bib-0036">36</a>].</p></section><section id="imr70018-sec-0003"><h3 class="pmc_sec_title">1.2. Central Effector Cells in Allergic Disease</h3>
<p>Eosinophils, basophils, and mast cells are central effector cells in allergic diseases, with an overlap in their regulation and effector functions (Figure <a href="#imr70018-fig-0001" class="usa-link">1</a>). Since eosinophil and basophil development is so closely linked based on similar developmental pathways and responses to cytokines and chemoattractants, eosinophils and basophils are often found in proximity in the tissues [<a href="#imr70018-bib-0037" class="usa-link" aria-describedby="imr70018-bib-0037">37</a>]. In addition to eosinophils and basophils shared expression of GM‐CSFRα, IL‐3Rα, IL‐5Rα, and CCR3, eosinophils and basophils share markers CD63 and CD69. CD34+ hemopoietic progenitor cells express CCR3, and this receptor expression is carried throughout basophil differentiation as it is expressed on the surface of mature basophils [<a href="#imr70018-bib-0038" class="usa-link" aria-describedby="imr70018-bib-0038">38</a>]. Like eosinophils, basophils express many C‐C motif receptors, with CCR3 being the most prominent [<a href="#imr70018-bib-0038" class="usa-link" aria-describedby="imr70018-bib-0038">38</a>, <a href="#imr70018-bib-0039" class="usa-link" aria-describedby="imr70018-bib-0039">39</a>], and eotaxin is a potent inducer of eosinophils and basophils influx into the airways [<a href="#imr70018-bib-0038" class="usa-link" aria-describedby="imr70018-bib-0038">38</a>, <a href="#imr70018-bib-0040" class="usa-link" aria-describedby="imr70018-bib-0040">40</a>].</p>
<figure class="fig xbox font-sm" id="imr70018-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eab/12001016/084c33144204/IMR-331-0-g009.jpg" loading="lazy" id="jats-graphic-1" height="637" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/imr70018-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Cell mediators and their receptors expressed by eosinophils, basophils, and mast cells in allergic airways, illustrating redundancy of cytokine expression and broad expression of their cognate receptors contributing to bidirectional regulation of cellular effector functions.</p></figcaption></figure><p>Mast cells are often the first to react in IgE‐dependent immediate hypersensitivity reactions, releasing histamine and other mediators that initiate the allergic cascade. Antigen‐presenting cells, such as dendritic cells, present allergens to Th2 cells, causing the release of IL‐4 and IL‐13, which induces isotype switching in B cells to produce IgE. IgE binds to mast cells, cross‐linking with FcεRI to activate mast cells [<a href="#imr70018-bib-0041" class="usa-link" aria-describedby="imr70018-bib-0041">41</a>]. Similarly to mast cells, FcεRI and IgE‐mediated crosslinking induce basophils to produce histamine, leukotrienes, IL‐4, and IL‐13 [<a href="#imr70018-bib-0042" class="usa-link" aria-describedby="imr70018-bib-0042">42</a>, <a href="#imr70018-bib-0043" class="usa-link" aria-describedby="imr70018-bib-0043">43</a>]. In contrast, eosinophil expression of FcεRI is minimal and not associated with eosinophil activation, and it is unclear if there is a functional significance. Unlike mast cells and basophils, which activate and degranulate in response to IgE, only activated eosinophils have FcεRIα. However, IgE was found to directly promote eosinophil migration by upregulating CCR3 expression [<a href="#imr70018-bib-0044" class="usa-link" aria-describedby="imr70018-bib-0044">44</a>]. Activated mast cells release performed mediators including histamine, serotonin, and serine proteases (tryptase and chymase), as well as lipid mediators, including prostaglandins and leukotrienes. Activated mast cells release a plethora of cytokines and chemokines, including tumor necrosis factor (TNF)‐α, transforming growth factor (TGF)‐β, macrophage inflammatory protein 1a (MIP‐1a), monocyte chemoattractant protein (MCP)‐1, VEGF, IFN‐α/β/γ, GM‐CSF, IL‐1α/β, IL‐2, IL‐3, IL‐4, IL‐5, IL‐6, IL‐8, IL‐9, IL‐10, IL‐11, IL‐12, IL‐13, IL‐15, IL‐16, IL‐18, IL25, and more [<a href="#imr70018-bib-0045" class="usa-link" aria-describedby="imr70018-bib-0045">45</a>]. GM‐CSF, prostaglandin (PG) D<sub>2</sub>, and leukotriene (LT) E<sub>4</sub> released from mast cells directly recruit and activate eosinophils and basophils [<a href="#imr70018-bib-0046" class="usa-link" aria-describedby="imr70018-bib-0046">46</a>, <a href="#imr70018-bib-0047" class="usa-link" aria-describedby="imr70018-bib-0047">47</a>, <a href="#imr70018-bib-0048" class="usa-link" aria-describedby="imr70018-bib-0048">48</a>]. Tryptase induces eosinophil influx and the release of EPO, IL‐6, and IL‐8 from eosinophils [<a href="#imr70018-bib-0049" class="usa-link" aria-describedby="imr70018-bib-0049">49</a>, <a href="#imr70018-bib-0050" class="usa-link" aria-describedby="imr70018-bib-0050">50</a>, <a href="#imr70018-bib-0051" class="usa-link" aria-describedby="imr70018-bib-0051">51</a>]. Mast cells also promote eosinophil migration and activation through the release of histamine, PGD<sub>2</sub>, and eotaxin via the H<sub>4</sub> receptor, the chemoattractant receptor‐homologous molecule on Th2 (CRTH<sub>2</sub>), and CCR3, respectively [<a href="#imr70018-bib-0052" class="usa-link" aria-describedby="imr70018-bib-0052">52</a>, <a href="#imr70018-bib-0053" class="usa-link" aria-describedby="imr70018-bib-0053">53</a>, <a href="#imr70018-bib-0054" class="usa-link" aria-describedby="imr70018-bib-0054">54</a>, <a href="#imr70018-bib-0055" class="usa-link" aria-describedby="imr70018-bib-0055">55</a>]. TNF‐α, IL‐4, and IL‐13 are released from the mast and help to modulate the differentiation of naïve T cells to Th1 and Th2 subsets, indirectly recruiting and activating eosinophils and basophils through the release of GM‐CSF, IL‐4, and IL‐5 from Th2 cells [<a href="#imr70018-bib-0056" class="usa-link" aria-describedby="imr70018-bib-0056">56</a>]. However, eosinophils also activate mast cells by releasing major basic protein (MBP) and eosinophil peroxidase (EPO), causing mast cells to release histamine [<a href="#imr70018-bib-0057" class="usa-link" aria-describedby="imr70018-bib-0057">57</a>, <a href="#imr70018-bib-0058" class="usa-link" aria-describedby="imr70018-bib-0058">58</a>]. Due to their resemblance to mast cells, basophils have often been considered insignificant and function as a surrogate for tissue‐dwelling mast cells. However, the infiltration of basophils and not mast cells during the late‐phase allergic response is pivotal for the continuation and sustained severity of the inflammatory response. At this phase, most histamine‐positive cells are found to be basophils, and there is a noted absence of mediators exclusively secreted by mast cells, such as tryptase [<a href="#imr70018-bib-0059" class="usa-link" aria-describedby="imr70018-bib-0059">59</a>]. Additionally, the release of IL‐4 and IL‐13 by basophils can regulate the infiltration of eosinophils, as described in a basophil‐deficient mice [<a href="#imr70018-bib-0060" class="usa-link" aria-describedby="imr70018-bib-0060">60</a>]. Basophils can further promote eosinophil influx by releasing various chemoattractants, including IL‐8 [<a href="#imr70018-bib-0061" class="usa-link" aria-describedby="imr70018-bib-0061">61</a>] and CCL5 (RANTES) [<a href="#imr70018-bib-0062" class="usa-link" aria-describedby="imr70018-bib-0062">62</a>].</p>
<p>Not only do mast cells and eosinophils release mediators to activate each other in the initial stages of inflammation, but eosinophils and mast cells coexist abundantly in inflamed tissues during the late and chronic phases of inflammation, engaging in physical and soluble crosstalk in a bidirectional manner. This bidirectional interaction between mast cells and eosinophils has been termed “the allergic effector unit” [<a href="#imr70018-bib-0063" class="usa-link" aria-describedby="imr70018-bib-0063">63</a>]. Cell‐to‐cell contact is mediated through cell surface receptors such as the CD2‐family molecule CD48 and its high‐affinity ligand 2B4, the adhesion molecules DNAM‐1 and Nectin‐2 [<a href="#imr70018-bib-0063" class="usa-link" aria-describedby="imr70018-bib-0063">63</a>, <a href="#imr70018-bib-0064" class="usa-link" aria-describedby="imr70018-bib-0064">64</a>, <a href="#imr70018-bib-0065" class="usa-link" aria-describedby="imr70018-bib-0065">65</a>, <a href="#imr70018-bib-0066" class="usa-link" aria-describedby="imr70018-bib-0066">66</a>], which convey stimulatory signals through their respective ligands and through the release of specific granular mediators, arachidonic acid metabolites, cytokines, and chemokines [<a href="#imr70018-bib-0063" class="usa-link" aria-describedby="imr70018-bib-0063">63</a>, <a href="#imr70018-bib-0067" class="usa-link" aria-describedby="imr70018-bib-0067">67</a>]. The activating receptor CD48 on mast cells engages CD244/2B4 on eosinophils, activating both cells to produce important mediators, including SCF, IL‐3, IL‐5, TNF‐α, PGD<sub>2</sub>, and tryptase, further enhancing the activation status of both cells [<a href="#imr70018-bib-0063" class="usa-link" aria-describedby="imr70018-bib-0063">63</a>, <a href="#imr70018-bib-0068" class="usa-link" aria-describedby="imr70018-bib-0068">68</a>].</p>
<p>The “allergic effector unit” interaction results in short‐ and long‐term proinflammatory effects on eosinophils and mast cells. This crosstalk induces the release of tryptase, β‐hexosaminidase from mast cells, and Lyn and Syk phosphorylation within 1–2 h after eosinophil‐mast cell engagement [<a href="#imr70018-bib-0069" class="usa-link" aria-describedby="imr70018-bib-0069">69</a>]. Additionally, this causes eosinophils to release eosinophil peroxidase, increase expression of LAMP‐1, and chemotaxis within 1–3 h after engagement [<a href="#imr70018-bib-0069" class="usa-link" aria-describedby="imr70018-bib-0069">69</a>]. This interaction causes both eosinophils and mast cells to markedly increase the release of TNF‐α and GM‐CSF and the prolonged survival of both cells 1–7 days after the initial engagement [<a href="#imr70018-bib-0069" class="usa-link" aria-describedby="imr70018-bib-0069">69</a>, <a href="#imr70018-bib-0070" class="usa-link" aria-describedby="imr70018-bib-0070">70</a>]. This eosinophil and mast cell interaction may also involve immunoregulatory receptors Siglec 7 and Siglec 8 with CD300a as inhibitory receptors on both cells [<a href="#imr70018-bib-0070" class="usa-link" aria-describedby="imr70018-bib-0070">70</a>, <a href="#imr70018-bib-0071" class="usa-link" aria-describedby="imr70018-bib-0071">71</a>, <a href="#imr70018-bib-0072" class="usa-link" aria-describedby="imr70018-bib-0072">72</a>, <a href="#imr70018-bib-0073" class="usa-link" aria-describedby="imr70018-bib-0073">73</a>]. The novelty of this physical and soluble communication may be a process for the prolonged survival of both eosinophils and mast cells in tissues and their continuation of chronic inflammation.</p></section></section><section id="imr70018-sec-0004"><h2 class="pmc_sec_title">2. Accumulation of Eosinophils and Basophils in Airways</h2>
<p>The appearance of eosinophils in the circulation involves processes in the bone marrow leading to the efflux of both mature and immature eosinophil populations into the circulation, with differentiation and proliferation of the latter eosinophil lineage‐committed hemopoietic progenitors at tissue sites. The accumulation of eosinophils within the airway tissue occurs as a response to locally generated signals, which induce the production of eosinophils in the bone marrow, continued migration of eosinophils and their progenitors, and increased survival and effector functions of these cells. Eosinophils are found in the bronchial submucosa and intraepithelial in the airways of asthmatics, together with a thickened basement membrane and hypertrophy of the underlying airway smooth muscle (Figure <a href="#imr70018-fig-0002" class="usa-link">2</a>).</p>
<figure class="fig xbox font-sm" id="imr70018-fig-0002"><h3 class="obj_head">FIGURE 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eab/12001016/d1673a543b6c/IMR-331-0-g006.jpg" loading="lazy" id="jats-graphic-3" height="241" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/imr70018-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Bronchial tissue of allergic asthmatic stained with hematoxylin and eosin (left panel) highlighting (A) intraepithelial and submucosal eosinophilic infiltrate (black arrow), (B) thickened basement membrane (black arrow), (C) smooth muscle hypertrophy (black arrow), and (D) intraepithelial and submucosal eosinophilic infiltrate (black arrows) and goblet cell hyperplasia in the epithelium (red arrows).</p></figcaption></figure><section id="imr70018-sec-0005"><h3 class="pmc_sec_title">2.1. Hemopoietic Activity in Allergic Asthma</h3>
<p>Accumulation of eosinophils in airways occurs in response to signals generated by local cells that can induce various outcomes including the expansion of eosinophil populations in the bone marrow and in the local microenvironment, migration of eosinophils and their progenitors from the bone marrow, and enhanced survival and effector functions of these cells at the site of inflammation. Hemopoietic progenitor cells can be found in the circulation under steady state and disease conditions, and in the bone marrow, they are present at various stages of lineage commitment. In the bone marrow, progenitor cells differentiate into specific lineages based on signals received in response to ambient stimuli such as growth factors and occur under the influence of stromal cells and microvascular endothelial cells. In the tissue, progenitor cells can differentiate in response to cytokines released from epithelial cells. These resident cell populations respond to triggers, thereby changing the transcription and translation rates of hemopoietic growth factors and/or cytokines to accelerate the production of eosinophils for release into the circulation or to augment local tissue eosinophilic inflammation [<a href="#imr70018-bib-0074" class="usa-link" aria-describedby="imr70018-bib-0074">74</a>, <a href="#imr70018-bib-0075" class="usa-link" aria-describedby="imr70018-bib-0075">75</a>].</p>
<section id="imr70018-sec-0006"><h4 class="pmc_sec_title">2.1.1. Colony‐Forming Units</h4>
<p>Eosinophils and basophils are hematopoietic cells that differentiate from CD34+ multipotential myeloid progenitors in the bone marrow. These myeloid progenitors can develop into cells that express transcription factors and receptors to growth factors necessary for the development of specific cell lineages [<a href="#imr70018-bib-0076" class="usa-link" aria-describedby="imr70018-bib-0076">76</a>, <a href="#imr70018-bib-0077" class="usa-link" aria-describedby="imr70018-bib-0077">77</a>]. The CD34+IL‐5Rα+ progenitor cells are eosinophil‐committed and undergo further development in response to growth factors IL‐3, GM‐CSF, and IL‐5, which are the most lineage‐specific of the cytokines involved in eosinophil hematopoiesis [<a href="#imr70018-bib-0076" class="usa-link" aria-describedby="imr70018-bib-0076">76</a>, <a href="#imr70018-bib-0078" class="usa-link" aria-describedby="imr70018-bib-0078">78</a>].</p>
<p>Non‐adherent mononuclear cells or purified CD34+ cell populations from blood or bone marrow that are seeded and grown together with hemopoietic growth factors result in the formation of clusters of immature cells derived from a single progenitor. Progenitor cell colonies grown in cultures indicate the potential for hemopoietic cell differentiation and provide a functional measure of viable clonogenic cell numbers. The earliest techniques used to assess the role of hemopoietic processes in allergic inflammation were colony‐forming assays performed by plating non‐adherent mononuclear cells or purified CD34+ cell populations from blood or bone marrow liquid culture for 14 days. In these clonogenic assays, the progenitor cells are defined as colony‐forming units (CFUs) because of their ability to generate clonally derived aggregates of daughter cells in vitro. These CFUs can be classified by light microscopy based on distinct morphological features and categorized as either eosinophil and basophil (Eo/B)CFU or as granulocyte‐macrophage (GM)CFU [<a href="#imr70018-bib-0079" class="usa-link" aria-describedby="imr70018-bib-0079">79</a>, <a href="#imr70018-bib-0080" class="usa-link" aria-describedby="imr70018-bib-0080">80</a>].</p>
<p>Eo/B CFU are nascent eosinophils and basophils derived from single progenitors [<a href="#imr70018-bib-0079" class="usa-link" aria-describedby="imr70018-bib-0079">79</a>, <a href="#imr70018-bib-0081" class="usa-link" aria-describedby="imr70018-bib-0081">81</a>, <a href="#imr70018-bib-0082" class="usa-link" aria-describedby="imr70018-bib-0082">82</a>]. Morphologically, these clusters revealed the existence of distinct colony types, some containing predominantly eosinophils, others consisting of all basophils, and another type containing mixtures of basophils and eosinophils, as shown by the presence of histamine, Charcot–Leyden crystal protein, and major basic protein [<a href="#imr70018-bib-0082" class="usa-link" aria-describedby="imr70018-bib-0082">82</a>] (Figure <a href="#imr70018-fig-0003" class="usa-link">3</a>).</p>
<figure class="fig xbox font-sm" id="imr70018-fig-0003"><h5 class="obj_head">FIGURE 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eab/12001016/824278fb8e5e/IMR-331-0-g005.jpg" loading="lazy" id="jats-graphic-5" height="574" width="661" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/imr70018-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Image of eosinophil and basophil colony forming units (Eo/B CFU) grown from peripheral blood mononuclear cells (PBMC) and enumerated after 14 days of culturing in methylcellulose under the influence of growth factors IL‐5, GM‐CSF, and IL‐3. Eo/B CFU are identified as tight, granular clusters of ≥ 40 cells under inverted light microscopy.</p></figcaption></figure><p>The presence of immature eosinophils and basophils found in the same colony indicates there is a common precursor and shared pathway of differentiation for both cell types [<a href="#imr70018-bib-0082" class="usa-link" aria-describedby="imr70018-bib-0082">82</a>]. The commitment of progenitor cells to the Eo/B lineage is regulated by a group of growth factors, including IL‐3, IL‐5, and GM‐CSF [<a href="#imr70018-bib-0083" class="usa-link" aria-describedby="imr70018-bib-0083">83</a>, <a href="#imr70018-bib-0084" class="usa-link" aria-describedby="imr70018-bib-0084">84</a>, <a href="#imr70018-bib-0085" class="usa-link" aria-describedby="imr70018-bib-0085">85</a>] which are present in the mixture of pro‐inflammatory cytokines in the airways of asthmatic patients [<a href="#imr70018-bib-0086" class="usa-link" aria-describedby="imr70018-bib-0086">86</a>, <a href="#imr70018-bib-0087" class="usa-link" aria-describedby="imr70018-bib-0087">87</a>, <a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>, <a href="#imr70018-bib-0089" class="usa-link" aria-describedby="imr70018-bib-0089">89</a>]. IL‐5 acts on the myeloid‐committed progenitor to induce specific differentiation along the Eo/B lineage, in contrast to IL‐3 and GM‐CSF, which have been shown to grow populations of more primitive progenitor cells [<a href="#imr70018-bib-0085" class="usa-link" aria-describedby="imr70018-bib-0085">85</a>, <a href="#imr70018-bib-0090" class="usa-link" aria-describedby="imr70018-bib-0090">90</a>].</p>
<p>Patients with various allergic airway disorders, including asthma, allergic rhinitis, and nasal polyposis, have significantly higher numbers of Eo/B CFU in circulation [<a href="#imr70018-bib-0091" class="usa-link" aria-describedby="imr70018-bib-0091">91</a>] and these numbers of circulating progenitors can be shown to exhibit fluctuations during an allergen pollen season in association with an increase in tissue eosinophils [<a href="#imr70018-bib-0092" class="usa-link" aria-describedby="imr70018-bib-0092">92</a>, <a href="#imr70018-bib-0093" class="usa-link" aria-describedby="imr70018-bib-0093">93</a>]. The kinetics of circulating progenitors are dependent on the length of exposure, with an initial increase in circulating Eo/B CFU occurring at the beginning of seasonal allergen exposure followed by a significant decline at the peak of the season. The reduction in circulating Eo/B CFU is coincident with the onset of symptoms and inflammation, suggesting a migration of progenitor cells from the blood to the inflamed tissue where they differentiate in situ and contribute to the accumulation of effector cells [<a href="#imr70018-bib-0092" class="usa-link" aria-describedby="imr70018-bib-0092">92</a>, <a href="#imr70018-bib-0093" class="usa-link" aria-describedby="imr70018-bib-0093">93</a>, <a href="#imr70018-bib-0094" class="usa-link" aria-describedby="imr70018-bib-0094">94</a>].</p>
<p>When comparing patients with asthma, by flow cytometry we have shown there are greater numbers of CD34+ cells detected in the blood and bone marrow of atopic compared with non‐atopic patients. These CD34+ cell numbers are positively related to higher numbers of Eo/B CFU grown from the blood and marrow of these subjects [<a href="#imr70018-bib-0009" class="usa-link" aria-describedby="imr70018-bib-0009">9</a>], suggesting that increases in the number of CD34+ cells indeed reflect viable colonogenic cell numbers. Hence, the higher levels of CD34+ cells and IL‐5‐responsive Eo/B CFU in atopic subjects indicate a functional role for Eo/B progenitors in allergic diseases, such as asthma.</p>
<p>The growth of Eo/B CFU in vitro is influenced by exposure to specific antigen in vivo. Exposure to inhaled allergen in patients with allergic asthma initiates a cascade of events leading to a stimulatory effect on the bone marrow to produce and release newly formed inflammatory cells [<a href="#imr70018-bib-0095" class="usa-link" aria-describedby="imr70018-bib-0095">95</a>, <a href="#imr70018-bib-0096" class="usa-link" aria-describedby="imr70018-bib-0096">96</a>, <a href="#imr70018-bib-0097" class="usa-link" aria-describedby="imr70018-bib-0097">97</a>]. This increase in Eo/B CFU has also been demonstrated in the blood of patients after asthma exacerbation [<a href="#imr70018-bib-0098" class="usa-link" aria-describedby="imr70018-bib-0098">98</a>, <a href="#imr70018-bib-0099" class="usa-link" aria-describedby="imr70018-bib-0099">99</a>], leading to further investigations finding higher numbers of bone marrow [<a href="#imr70018-bib-0095" class="usa-link" aria-describedby="imr70018-bib-0095">95</a>] and circulating [<a href="#imr70018-bib-0100" class="usa-link" aria-describedby="imr70018-bib-0100">100</a>] Eo/B CFU measured at 24 h after inhaled allergen challenge in patients with allergic asthma. Using bromodeoxyuridine, a marker of proliferating cells, experiments have been conducted in animal models of allergic asthma to investigate the trafficking of cells from bone marrow. These studies have reported that inhaled allergen challenges cause an increase in proliferating cells that traffic through the circulation into the lungs, thereby confirming that allergen‐induced airway inflammation is associated with increased numbers of newly formed cells in the blood and airways [<a href="#imr70018-bib-0101" class="usa-link" aria-describedby="imr70018-bib-0101">101</a>, <a href="#imr70018-bib-0102" class="usa-link" aria-describedby="imr70018-bib-0102">102</a>]. Hemopoietic processes contributing to eosinophilic airway inflammation occur rapidly after allergen challenge. In mouse models of allergic rhinitis and/or asthma, we observe changes in bone marrow eosinophilopoiesis as early as 2 h after airway allergen challenges accompanied by elevations in growth factors and chemokines including IL‐5, GM‐CSF, and eotaxin in airways and blood [<a href="#imr70018-bib-0103" class="usa-link" aria-describedby="imr70018-bib-0103">103</a>, <a href="#imr70018-bib-0104" class="usa-link" aria-describedby="imr70018-bib-0104">104</a>, <a href="#imr70018-bib-0105" class="usa-link" aria-describedby="imr70018-bib-0105">105</a>, <a href="#imr70018-bib-0106" class="usa-link" aria-describedby="imr70018-bib-0106">106</a>, <a href="#imr70018-bib-0107" class="usa-link" aria-describedby="imr70018-bib-0107">107</a>].</p>
<p>Studies assessing changes in cytokine levels in the bone marrow of allergic asthmatic patients following inhaled allergen challenge have shown increases in IL‐5 levels, and the timing of this IL‐5 expression is consistent with the kinetics of eosinophil‐lineage commitment [<a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>, <a href="#imr70018-bib-0089" class="usa-link" aria-describedby="imr70018-bib-0089">89</a>, <a href="#imr70018-bib-0096" class="usa-link" aria-describedby="imr70018-bib-0096">96</a>, <a href="#imr70018-bib-0097" class="usa-link" aria-describedby="imr70018-bib-0097">97</a>, <a href="#imr70018-bib-0108" class="usa-link" aria-describedby="imr70018-bib-0108">108</a>]. Bone marrow progenitor cells collected after allergen challenge from allergic asthmatic patients that have developed allergen‐induced late‐phase responses and associated airway eosinophilia were shown to be more responsive to IL‐5 than cells from subjects without these allergen‐induced responses [<a href="#imr70018-bib-0012" class="usa-link" aria-describedby="imr70018-bib-0012">12</a>]. Subsequently, it was demonstrated that in these patients there is a time‐dependent change in the levels of growth factors and cytokines in the bone marrow, whereby patients having elevated levels of airway and circulating eosinophils post‐challenge also had increased numbers of IL‐5‐responsive progenitors that were coincident with increased IL‐5 levels in the bone marrow [<a href="#imr70018-bib-0096" class="usa-link" aria-describedby="imr70018-bib-0096">96</a>]. These studies highlight the relationship between bone marrow IL‐5 levels and regulation of eosinophil production from bone marrow progenitor cells. Furthermore, our data provide evidence for the involvement of activated T cells that may migrate from the airways to the bone marrow and release cytokines such as IL‐5, thereby contributing to the hemopoietic events during an allergic inflammatory response [<a href="#imr70018-bib-0015" class="usa-link" aria-describedby="imr70018-bib-0015">15</a>, <a href="#imr70018-bib-0097" class="usa-link" aria-describedby="imr70018-bib-0097">97</a>, <a href="#imr70018-bib-0109" class="usa-link" aria-describedby="imr70018-bib-0109">109</a>].</p></section><section id="imr70018-sec-0007"><h4 class="pmc_sec_title">2.1.2. 
CD34+ Eosinophil and Basophil Progenitors in Allergic Asthma</h4>
<p>Sputum levels of EoP are increased in asthmatics after inhaled allergen challenge [<a href="#imr70018-bib-0110" class="usa-link" aria-describedby="imr70018-bib-0110">110</a>] suggesting an exaggerated eosinophilopoietic environment in the asthmatic airways. Accurate estimates of EoP and HPC numbers can be determined by fluorescence activating cell sorting using multi‐parametric gating analyses of cell‐specific surface markers. Hemopoietic progenitors express the cell stage‐specific antigen, CD34, a cell surface glycoprotein that is now widely recognized as a marker of hematopoietic progenitor cells. As such, CD34 is present at the highest levels on early hemopoietic myeloid progenitors, and during terminal differentiation, this receptor is progressively lost [<a href="#imr70018-bib-0024" class="usa-link" aria-describedby="imr70018-bib-0024">24</a>]. We have applied methodology to stain for surface expression of CD34 in combination with sorting for small size and low granularity determinants to accurately count HPC in samples of cord blood, peripheral blood, bone marrow, and expectorated sputum [<a href="#imr70018-bib-0009" class="usa-link" aria-describedby="imr70018-bib-0009">9</a>, <a href="#imr70018-bib-0012" class="usa-link" aria-describedby="imr70018-bib-0012">12</a>, <a href="#imr70018-bib-0036" class="usa-link" aria-describedby="imr70018-bib-0036">36</a>, <a href="#imr70018-bib-0111" class="usa-link" aria-describedby="imr70018-bib-0111">111</a>] (Figure <a href="#imr70018-fig-0004" class="usa-link">4</a>).</p>
<figure class="fig xbox font-sm" id="imr70018-fig-0004"><h5 class="obj_head">FIGURE 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eab/12001016/cb3a4265f86a/IMR-331-0-g002.jpg" loading="lazy" id="jats-graphic-7" height="368" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/imr70018-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Flow cytometry gating of eosinophil progenitor cells (EoP). Cells were gated as singlets, live, CD45+ cells. Hematopoietic progenitor cells (HPC) were gated as CD34+SSC<sup>low</sup>, CD45<sup>dim</sup>, and FSC<sup>low</sup> SSC<sup>low</sup>. Eosinophil progenitor cells (EoP) were gated as CD34+SSC<sup>low</sup>, CD45<sup>dim</sup>, and FSC<sup>low</sup>SSC<sup>low</sup>, CD125+.</p></figcaption></figure><p>Using this flow cytometry analysis to study patients with allergic diseases, including asthma, we and others have provided evidence that CD34+ hemopoietic progenitor cells contribute to the ongoing recruitment of eosinophils and basophils to sites of allergen challenge. The number of CD34+ cells, as well as immature eosinophils and mature eosinophils, has shown to be significantly higher in the blood and bone marrow of atopic subjects compared with non‐atopic controls [<a href="#imr70018-bib-0009" class="usa-link" aria-describedby="imr70018-bib-0009">9</a>, <a href="#imr70018-bib-0112" class="usa-link" aria-describedby="imr70018-bib-0112">112</a>], suggesting that the mechanism for eosinophilia in atopic individuals is driven by elevated CD34+ cells. Important findings demonstrated that patients with severe asthma have higher levels of circulating CD34+ cells than those with milder disease and that CD34+ cells negatively correlate with the level of airflow obstruction [<a href="#imr70018-bib-0010" class="usa-link" aria-describedby="imr70018-bib-0010">10</a>]. These observations led to further experiments examining the regulation and efflux of eosinophil progenitor cells from bone marrow into circulatory and airway compartments in allergic asthma.</p></section><section id="imr70018-sec-0008"><h4 class="pmc_sec_title">2.1.3. 
IL‐5 Differentiates Eosinophil Progenitors in Allergic Asthma</h4>
<p>During the course of allergic inflammatory responses, it has been shown that CD34+ cells and T cells are sources of IL‐5 cytokine production within the bone marrow [<a href="#imr70018-bib-0015" class="usa-link" aria-describedby="imr70018-bib-0015">15</a>, <a href="#imr70018-bib-0097" class="usa-link" aria-describedby="imr70018-bib-0097">97</a>, <a href="#imr70018-bib-0109" class="usa-link" aria-describedby="imr70018-bib-0109">109</a>, <a href="#imr70018-bib-0113" class="usa-link" aria-describedby="imr70018-bib-0113">113</a>, <a href="#imr70018-bib-0114" class="usa-link" aria-describedby="imr70018-bib-0114">114</a>]. Several groups have been investigating autocrine sources of growth factors.</p>
<p>Furthermore, in vitro stimulation of CD34+ cells from blood and bone marrow with calcium ionophore and phorbol‐12‐myristate‐13‐acetate stimulation induces the release of IL‐5 at a higher per cell amount compared to CD3<sup>+</sup> T‐lymphocytes [<a href="#imr70018-bib-0115" class="usa-link" aria-describedby="imr70018-bib-0115">115</a>], demonstrating the potential of progenitor cells to produce an autocrine source of growth factor in the bone marrow compartment. To explore the potential of autocrine growth factors in circulation, we examined the expression of IL‐5 and GM‐CSF in differentiating Eo/B colony cells grown from peripheral blood NAMC of normal and atopic individuals, and atopic asthmatics before and after allergen‐inhalation challenge [<a href="#imr70018-bib-0100" class="usa-link" aria-describedby="imr70018-bib-0100">100</a>]. In this study, we found a significantly higher percentage of differentiating eosinophils were immunopositive for GM‐CSF in atopic individuals versus normal controls, and in mild allergic asthmatics after inhaled allergen versus pre‐challenge, and these observations were confirmed in carbocol chromotrope 2R+ cells through combined in situ reverse transcription‐polymerase chain reaction for GM‐CSF mRNA and cytochemistry. We did not observe a shift in IL‐5 expression suggesting that differentiating eosinophils in blood provide an autocrine source of GM‐CSF but not IL‐5. Our early work investigating CD34+ cells from sputum samples of mild allergic asthmatics shows that these cells also contain IL‐5, with numbers increasing after inhaled allergen challenge [<a href="#imr70018-bib-0114" class="usa-link" aria-describedby="imr70018-bib-0114">114</a>]. In the airways of asthmatic patients, the level of IL‐5 is elevated compared to non‐asthmatic controls [<a href="#imr70018-bib-0116" class="usa-link" aria-describedby="imr70018-bib-0116">116</a>, <a href="#imr70018-bib-0117" class="usa-link" aria-describedby="imr70018-bib-0117">117</a>]. Our work has shown that IL‐5 levels are driven higher in the airways post‐allergen challenge as measured in sputum fluid phase [<a href="#imr70018-bib-0089" class="usa-link" aria-describedby="imr70018-bib-0089">89</a>] and sputum immunopositive cells [<a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>]. These observations suggest that IL‐5 in asthmatic airways, including autocrine expression in progenitor cells, could support the observed eosinophilia.</p>
<p>It has been reported that CD34 + IL‐5Rα + cells circulate at higher levels in patients with asthma compared to controls and correlate with asthma severity [<a href="#imr70018-bib-0010" class="usa-link" aria-describedby="imr70018-bib-0010">10</a>]. Furthermore, the observed upregulation of IL‐5Rα on CD34+ cells from the bone marrow of atopic asthmatics indicates the cells are primed and ready to respond to IL‐5 [<a href="#imr70018-bib-0010" class="usa-link" aria-describedby="imr70018-bib-0010">10</a>, <a href="#imr70018-bib-0118" class="usa-link" aria-describedby="imr70018-bib-0118">118</a>]. Sehmi et al. [<a href="#imr70018-bib-0012" class="usa-link" aria-describedby="imr70018-bib-0012">12</a>] reported that while inhaled allergen challenge in patients with mild allergic asthma had no effect on the number of CD34+ cells in bone marrow, there was a significant increase in CD34 + IL‐5Rα + eosinophil progenitor cells obtained from bone marrow aspirates collected 24 h after challenge, as assessed by in situ hybridization of IL‐5Rα mRNA colocalization in cells immunopositive for CD34 + IL‐5Rα+. Collectively, these data suggest an upregulation of IL‐5Rα on CD34+ cells occurring following allergen challenge, and the higher number of eosinophil progenitor cells contributes to the corresponding robust eosinophilia observed in the blood and airways post‐challenge. Eosinophil growth and maturation is dependent on IL‐5 signaling through IL‐5Rα; after inhaled allergen challenge, we also observe a significant increase in IL‐5 mRNA on bone marrow CD3+ cells [<a href="#imr70018-bib-0097" class="usa-link" aria-describedby="imr70018-bib-0097">97</a>], providing a mechanism whereby T lymphocytes that are activated in airways traffick to the bone marrow where they release IL‐5 to induce differentiation of CD34 + IL‐5Rα + eosinophil progenitor cells.</p>
<p>In addition to the expansion of mature and immature cells in bone marrow, the mobilization of hemopoietic progenitor cells from the bone marrow is a feature of inflammatory asthmatic responses. This includes increases in levels of chemotaxins and cell responsiveness to them, to facilitate the egress of cells from bone marrow to the peripheral circulation. The CCR3 receptor is critically important for the chemotaxis of eosinophils and basophils to the potent chemoattractant eotaxin. The CCR3 receptor is expressed not only on mature eosinophils and basophils but also on CD34+ progenitor cells [<a href="#imr70018-bib-0119" class="usa-link" aria-describedby="imr70018-bib-0119">119</a>] where the level is upregulated by Th2 cytokines [<a href="#imr70018-bib-0120" class="usa-link" aria-describedby="imr70018-bib-0120">120</a>]. This regulation by inflammatory cytokines can explain the elevated expression of CCR3 on mature and immature bone marrow eosinophils in allergic asthmatic patients after inhaled allergen challenge [<a href="#imr70018-bib-0119" class="usa-link" aria-describedby="imr70018-bib-0119">119</a>, <a href="#imr70018-bib-0121" class="usa-link" aria-describedby="imr70018-bib-0121">121</a>, <a href="#imr70018-bib-0122" class="usa-link" aria-describedby="imr70018-bib-0122">122</a>]. Together with the allergen‐induced increase of eotaxin in the airways [<a href="#imr70018-bib-0089" class="usa-link" aria-describedby="imr70018-bib-0089">89</a>], CCR3 expression provides a coordinated mechanism to enhance the migration of CCR3+ eosinophils and CCR3+ eosinophil/basophil progenitors from bone marrow to the site of inflammation [<a href="#imr70018-bib-0030" class="usa-link" aria-describedby="imr70018-bib-0030">30</a>, <a href="#imr70018-bib-0119" class="usa-link" aria-describedby="imr70018-bib-0119">119</a>]. We have also observed alterations to factors that tether cells in the bone marrow after inhaled allergen challenges. At 24 h post‐challenge, there is a significant decrease in the expression of the beta1‐integrin, very late antigen (VLA) 4, on bone marrow CD34+IL‐5Rα+ eosinophil progenitor cells, and this reduced expression was accompanied by functional changes observed by a reduced adhesion to fibronectin [<a href="#imr70018-bib-0123" class="usa-link" aria-describedby="imr70018-bib-0123">123</a>]. That there was no change in the expression of beta‐2 integrin suggests a preferential downregulation of beta‐1 integrins. We have also reported downregulation in the expression of CXCR4 on bone marrow CD34+ progenitor cells after allergen challenge in addition to a reduced level of its ligand, SDF‐1α, in bone marrow [<a href="#imr70018-bib-0122" class="usa-link" aria-describedby="imr70018-bib-0122">122</a>] which together may reduce progenitor cell retention in bone marrow stroma, thereby facilitating the egress of progenitor cells to the circulation.</p></section><section id="imr70018-sec-0009"><h4 class="pmc_sec_title">2.1.4. Role of T2 and Alarmin Cytokines in Eosinophil and Basophil Differentiation</h4>
<p>IL‐5 is not the only growth factor that can initiate eosinophil differentiation. Eotaxin may play a role in the migration and differentiation of CD34+ cells since these cells are found to express the eotaxin receptor C‐C chemokine receptor 3 (CCR3), possibly allowing for progenitor cells to differentiate into eosinophils in a pathway that is independent of GM‐CSF, IL‐3, and IL‐5 [<a href="#imr70018-bib-0119" class="usa-link" aria-describedby="imr70018-bib-0119">119</a>, <a href="#imr70018-bib-0120" class="usa-link" aria-describedby="imr70018-bib-0120">120</a>, <a href="#imr70018-bib-0121" class="usa-link" aria-describedby="imr70018-bib-0121">121</a>]. IL‐9 has also been shown to play a supportive role in both mast cell and Eo/B differentiation [<a href="#imr70018-bib-0074" class="usa-link" aria-describedby="imr70018-bib-0074">74</a>, <a href="#imr70018-bib-0124" class="usa-link" aria-describedby="imr70018-bib-0124">124</a>].</p>
<p>TSLP, IL‐25, and IL‐33 are alarmin cytokines that are released from epithelial cells, thereby providing a local source of these cytokines in the airways of patients with severe asthma [<a href="#imr70018-bib-0125" class="usa-link" aria-describedby="imr70018-bib-0125">125</a>, <a href="#imr70018-bib-0126" class="usa-link" aria-describedby="imr70018-bib-0126">126</a>]. These cytokines are found at higher concentrations in the airways of asthmatic patients, and the concentrations of TSLP, IL‐25, and IL‐33 have each been shown to correlate positively with disease severity in patients with asthma [<a href="#imr70018-bib-0127" class="usa-link" aria-describedby="imr70018-bib-0127">127</a>, <a href="#imr70018-bib-0128" class="usa-link" aria-describedby="imr70018-bib-0128">128</a>]. Levels of these alarmins are further elevated after inhaled allergen challenge [<a href="#imr70018-bib-0129" class="usa-link" aria-describedby="imr70018-bib-0129">129</a>, <a href="#imr70018-bib-0130" class="usa-link" aria-describedby="imr70018-bib-0130">130</a>, <a href="#imr70018-bib-0131" class="usa-link" aria-describedby="imr70018-bib-0131">131</a>], in association with increased airway eosinophil levels, suggesting they may play a role in driving eosinophilia. In mature eosinophils, IL‐33 stimulation upregulates the expression of its own receptor, ST2, as well as increases the intracellular expression of IL‐5 [<a href="#imr70018-bib-0130" class="usa-link" aria-describedby="imr70018-bib-0130">130</a>]. Mature eosinophils, basophils, and mast cells express receptors for alarmin cytokines and demonstrate a higher level of activation after stimulation [<a href="#imr70018-bib-0130" class="usa-link" aria-describedby="imr70018-bib-0130">130</a>, <a href="#imr70018-bib-0132" class="usa-link" aria-describedby="imr70018-bib-0132">132</a>, <a href="#imr70018-bib-0133" class="usa-link" aria-describedby="imr70018-bib-0133">133</a>, <a href="#imr70018-bib-0134" class="usa-link" aria-describedby="imr70018-bib-0134">134</a>, <a href="#imr70018-bib-0135" class="usa-link" aria-describedby="imr70018-bib-0135">135</a>]. CD34+ progenitor cells have also been shown to express receptors for TSLP and IL‐33 that can be upregulated in airway progenitor cells following inhaled allergen challenges [<a href="#imr70018-bib-0036" class="usa-link" aria-describedby="imr70018-bib-0036">36</a>, <a href="#imr70018-bib-0114" class="usa-link" aria-describedby="imr70018-bib-0114">114</a>]. Stimulation with alarmin cytokines activates CD34+ progenitor cells through mechanisms involving lineage commitment and by promotion of eosinophilopoiesis/basophilopoiesis [<a href="#imr70018-bib-0114" class="usa-link" aria-describedby="imr70018-bib-0114">114</a>, <a href="#imr70018-bib-0136" class="usa-link" aria-describedby="imr70018-bib-0136">136</a>, <a href="#imr70018-bib-0137" class="usa-link" aria-describedby="imr70018-bib-0137">137</a>, <a href="#imr70018-bib-0138" class="usa-link" aria-describedby="imr70018-bib-0138">138</a>]. Interestingly, TSLP and IL‐33 have now been shown to act directly on CD34+ HPCs to stimulate basophilopoiesis in mice [<a href="#imr70018-bib-0136" class="usa-link" aria-describedby="imr70018-bib-0136">136</a>] and lineage commitment [<a href="#imr70018-bib-0137" class="usa-link" aria-describedby="imr70018-bib-0137">137</a>]. Collaborators at McMaster University have demonstrated the outgrowth of eosinophil/basophil colony‐forming units cultured from enriched human CD34+ HPCs was enhanced when TSLP was added to the growth factor IL‐3 [<a href="#imr70018-bib-0138" class="usa-link" aria-describedby="imr70018-bib-0138">138</a>], and histochemical analysis of these colonies revealed increases in cells with eosinophilic granular cytoplasm or metachromatic granules, morphologically consistent with eosinophils and basophils, respectively. We repeated these experiments in methylcellulose cultures of blood‐derived non‐adherent mononuclear cells that were incubated together with IL‐5 plus primary bronchial epithelial cell culture supernatants from healthy and asthmatic patients [<a href="#imr70018-bib-0139" class="usa-link" aria-describedby="imr70018-bib-0139">139</a>]. The results of these experiments demonstrated higher levels of Eo/B‐CFU outgrowth when cells were co‐cultured with the supernatants from asthmatic donors, with significant attenuation by TSLPR‐blockade. In contrast, ST2 blockade had no effect on colony growth, suggesting that the expansion of Eo/B CFU was mediated through TSLP but not IL‐33. Collectively, these findings demonstrate that factors released by BEC, such as TSLP, in addition to IL‐5 [<a href="#imr70018-bib-0140" class="usa-link" aria-describedby="imr70018-bib-0140">140</a>] can promote eosinophil‐lineage commitment and differentiation. Interestingly, we also demonstrated that stimulation of HPCs with TSLP and IL‐33 significantly increased their production of IL‐5 [<a href="#imr70018-bib-0036" class="usa-link" aria-describedby="imr70018-bib-0036">36</a>], thereby enhancing the autocrine source of a key growth factor required for eosinophil differentiation.</p>
<p>We have reported a significant increase in the expression of the TSLP receptor subunits TSLPR and CD127, as well as the IL‐33 receptor, ST2, on sputum HPC but not EoP after allergen inhalation challenge in patients with mild allergic asthma [<a href="#imr70018-bib-0036" class="usa-link" aria-describedby="imr70018-bib-0036">36</a>]. These observations suggest that undifferentiated HPCs become more responsive to alarmin cytokines post‐challenge.</p>
<p>To understand the functional role of alarmin cytokines on HPC, subsequent in vitro experiments demonstrated that preincubation of HPC with TSLP and IL‐33 primed their migration to SDF‐1 [<a href="#imr70018-bib-0036" class="usa-link" aria-describedby="imr70018-bib-0036">36</a>], a potent progenitor cell chemoattractant that is highly expressed by endothelial cells, macrophages, and T lymphocytes in bronchia mucosa of asthmatic patients [<a href="#imr70018-bib-0129" class="usa-link" aria-describedby="imr70018-bib-0129">129</a>, <a href="#imr70018-bib-0130" class="usa-link" aria-describedby="imr70018-bib-0130">130</a>, <a href="#imr70018-bib-0131" class="usa-link" aria-describedby="imr70018-bib-0131">131</a>], and this effect was mediated through HPC production of IL‐13. Taken together, these data suggest that alarmin cytokines contribute to local eosinophilia by promoting the migration of HPCs to the site of inflammation in airways in asthmatic patients, where these cells can undergo differentiation into mature cells as directed by signals from the local microenvironment.</p></section><section id="imr70018-sec-0010"><h4 class="pmc_sec_title">2.1.5. Role of Tissue EoP as Effector Cells</h4>
<p>Hemopoietic progenitor cell differentiation and maturation are traditionally understood to take place in the microenvironment of the bone marrow. More recently, it has been shown that hemopoietic progenitor cells are present in tissue. These may be recruited from bone marrow to mucosal tissues to become part of a regenerative and/or inflammatory process at the site of disease. Within the tissue, the fate of these hemopoietic progenitor cells is determined by locally elaborated growth factors that permit a process termed “in situ hemopoiesis.”</p>
<p>Our understanding of the processes involved in the amplification of eosinophilic inflammation through progenitor differentiation in local tissue has evolved through the work of Denburg and others. Localized differentiation of hemopoietic progenitors is reasoned from experiments showing that in vitro IL‐5 stimulation of CD34+ cells extracted from human nasal polyp tissue undergo proliferation and differentiation into Eo/B‐CFU [<a href="#imr70018-bib-0021" class="usa-link" aria-describedby="imr70018-bib-0021">21</a>]. These findings were supported by experiments in nasal explant tissue from allergic rhinitics showing increases in mature major basic protein‐positive eosinophils in conjunction with reduced progenitor CD34+IL‐5Rα<sup>+</sup> mRNA cells after antigen challenge and after exposure to IL‐5 ex vivo, thereby indicating a local maturation process was occurring [<a href="#imr70018-bib-0023" class="usa-link" aria-describedby="imr70018-bib-0023">23</a>]. Cells examined from Eo/B CFU also have been shown to constitute autocrine sources of IL‐5 and GM‐CSF [<a href="#imr70018-bib-0100" class="usa-link" aria-describedby="imr70018-bib-0100">100</a>, <a href="#imr70018-bib-0141" class="usa-link" aria-describedby="imr70018-bib-0141">141</a>], which could further amplify the process of differentiation and proliferation.</p>
<p>In vivo, we have documented the presence of CD34 + IL‐5Rα+ progenitor cells entering the airway lumen through measurements of induced sputum and describe significantly higher levels in those with more severe asthma [<a href="#imr70018-bib-0142" class="usa-link" aria-describedby="imr70018-bib-0142">142</a>]. Interestingly, these progenitor cells found in sputum also stain intracellularly for cytokines crucial for the differentiation and survival of eosinophils and basophils. This was first reported by Allakhverdi et al. from experiments showing that circulating CD34+ cells could be stimulated to rapidly release high levels of proinflammatory cytokines and chemokines, and that CD34+ cells containing IL‐5 and IL‐13 could be detected in the sputum of individuals with allergic asthma [<a href="#imr70018-bib-0114" class="usa-link" aria-describedby="imr70018-bib-0114">114</a>]. The notion of CD34+ effector cells was further described in experiments demonstrating that severe asthmatics have higher numbers of blood and sputum eosinophil progenitors expressing IL‐5 and IL‐13 [<a href="#imr70018-bib-0142" class="usa-link" aria-describedby="imr70018-bib-0142">142</a>]. We also reported that the number of eosinophil progenitor cells increasing in asthmatic airways after allergen challenge coincides with higher concentrations of IL‐5 [<a href="#imr70018-bib-0110" class="usa-link" aria-describedby="imr70018-bib-0110">110</a>], with similar kinetics suggesting EoP may be an important source of IL‐5 release into airways. Further evidence supporting a role for in situ eosinophilopoiesis in asthma includes our work showing the presence of eosinophil‐committed CD34 + IL‐5Rα+ progenitor cells present in the airway submucosa of patients with mild allergic asthma at approximately 30 cells/mm<sup>2</sup> (unpublished data). These eosinophil progenitor cells have also been reported in airway tissue from nonallergic asthma, nasal polyposis, and in the skin of patients with atopic dermatitis [<a href="#imr70018-bib-0020" class="usa-link" aria-describedby="imr70018-bib-0020">20</a>, <a href="#imr70018-bib-0021" class="usa-link" aria-describedby="imr70018-bib-0021">21</a>, <a href="#imr70018-bib-0022" class="usa-link" aria-describedby="imr70018-bib-0022">22</a>, <a href="#imr70018-bib-0115" class="usa-link" aria-describedby="imr70018-bib-0115">115</a>, <a href="#imr70018-bib-0143" class="usa-link" aria-describedby="imr70018-bib-0143">143</a>, <a href="#imr70018-bib-0144" class="usa-link" aria-describedby="imr70018-bib-0144">144</a>, <a href="#imr70018-bib-0145" class="usa-link" aria-describedby="imr70018-bib-0145">145</a>, <a href="#imr70018-bib-0146" class="usa-link" aria-describedby="imr70018-bib-0146">146</a>], indicating the potential for in situ expansion of eosinophils is not limited to the lower airways of asthmatic patients.</p></section></section><section id="imr70018-sec-0011"><h3 class="pmc_sec_title">2.2. Chemotaxis</h3>
<p>Eotaxin is a potent eosinophil‐specific chemoattractant [<a href="#imr70018-bib-0147" class="usa-link" aria-describedby="imr70018-bib-0147">147</a>, <a href="#imr70018-bib-0148" class="usa-link" aria-describedby="imr70018-bib-0148">148</a>, <a href="#imr70018-bib-0149" class="usa-link" aria-describedby="imr70018-bib-0149">149</a>] that is released from structural lung cells, trafficking eosinophils to the lung and increasing after allergen provocation [<a href="#imr70018-bib-0150" class="usa-link" aria-describedby="imr70018-bib-0150">150</a>]. In a mouse model, eotaxin‐1 and eotaxin‐2 were shown to induce migration for CD34 + CCR3+ cells from the bone marrow and blood [<a href="#imr70018-bib-0151" class="usa-link" aria-describedby="imr70018-bib-0151">151</a>], and the receptor for eotaxin, CCR3, is upregulated on CD34+ cells after allergen challenge [<a href="#imr70018-bib-0119" class="usa-link" aria-describedby="imr70018-bib-0119">119</a>, <a href="#imr70018-bib-0122" class="usa-link" aria-describedby="imr70018-bib-0122">122</a>]. Altogether, this suggests that the eotaxin/CCR3 pathway facilitates progenitor cell mobilization from the bone marrow to the peripheral blood as the first step toward the accumulation of eosinophil progenitor cells in tissue and subsequent eosinophilia.</p>
<p>In addition to IL‐5 and eotaxin, there are other pro‐inflammatory mediators that have been shown to induce chemotactic responses in both mature eosinophils and Eo/B progenitors. Other chemoattractants for mature eosinophils and basophils include bioactive lipids such as PAF, prostaglandin D2, and LTE<sub>4</sub> [<a href="#imr70018-bib-0152" class="usa-link" aria-describedby="imr70018-bib-0152">152</a>, <a href="#imr70018-bib-0153" class="usa-link" aria-describedby="imr70018-bib-0153">153</a>, <a href="#imr70018-bib-0154" class="usa-link" aria-describedby="imr70018-bib-0154">154</a>, <a href="#imr70018-bib-0155" class="usa-link" aria-describedby="imr70018-bib-0155">155</a>] which are generated in allergic tissues from the metabolism of polyunsaturated fatty acids. These bioactive lipids are found at elevated levels in the airways of asthmatic individuals and are further enhanced by inhaled allergen [<a href="#imr70018-bib-0156" class="usa-link" aria-describedby="imr70018-bib-0156">156</a>, <a href="#imr70018-bib-0157" class="usa-link" aria-describedby="imr70018-bib-0157">157</a>].</p>
<p>To address the potential role of cysteinyl leukotrienes in eosinophil accumulation into airways, we conducted experiments administering inhaled LTD<sub>4</sub> and LTE<sub>4</sub> to allergic asthmatics and found that airway eosinophil levels increased only following LTE<sub>4</sub> inhalation, thereby demonstrating the potency of LTE<sub>4</sub> on airway eosinophils [<a href="#imr70018-bib-0158" class="usa-link" aria-describedby="imr70018-bib-0158">158</a>]. We have also demonstrated a role of the cysteinyl leukotrienes in the differentiation of Eo/B CFU in experiments [<a href="#imr70018-bib-0153" class="usa-link" aria-describedby="imr70018-bib-0153">153</a>]. Others have described a role for LTD<sub>4</sub> in the induction of chemotaxis and in vitro transendothelial migration of Eo/B progenitors [<a href="#imr70018-bib-0159" class="usa-link" aria-describedby="imr70018-bib-0159">159</a>]. We examined the effect of blocking LTD<sub>4</sub> signaling by administering the cysLT1 inhibitor pranlukast to asthmatics undergoing inhaled allergen challenges. Compared to placebo, treatment with pranlukast significantly attenuated the allergen‐induced number of bone marrow Eo/B CFU, reduced the number of bone marrow CD34+ cells expressing CCR3, in addition to reduced sputum eosinophil counts and reduced frequency of sputum cells immunopositive for EG2, eotaxin, IL‐5, and RANTES [<a href="#imr70018-bib-0160" class="usa-link" aria-describedby="imr70018-bib-0160">160</a>]. Together, this body of work illustrates the supportive role of cysteinyl leukotrienes in the accumulation of eosinophils and basophils in allergic airway tissue.</p>
<p>Mature eosinophils are terminally differentiated leukocytes that accumulate in tissues as effector cells in inflammatory processes including allergic diseases [<a href="#imr70018-bib-0161" class="usa-link" aria-describedby="imr70018-bib-0161">161</a>]. Movement of these cells from bone marrow to inflamed tissue is regulated by chemokines and cytokines through binding to their cell surface receptors, as well as through upregulated expression of adhesion molecules [<a href="#imr70018-bib-0162" class="usa-link" aria-describedby="imr70018-bib-0162">162</a>]. Cytokines that drive and support eosinophilia are largely Th2 cell products. Interleukin (IL)‐3, IL‐5, and GM‐CSF signal through specific high‐affinity cell surface receptor subunits that are linked to a common β‐chain. Each of these cytokines behaves as an eosinophil growth factor to stimulate the development of Eo/BCFU that can be found in functional assays [<a href="#imr70018-bib-0003" class="usa-link" aria-describedby="imr70018-bib-0003">3</a>, <a href="#imr70018-bib-0096" class="usa-link" aria-describedby="imr70018-bib-0096">96</a>, <a href="#imr70018-bib-0100" class="usa-link" aria-describedby="imr70018-bib-0100">100</a>]. The common β‐chain is especially important for Eo/B proliferation, production of cytokines from eosinophils, and eosinophil migration to effector sites [<a href="#imr70018-bib-0163" class="usa-link" aria-describedby="imr70018-bib-0163">163</a>, <a href="#imr70018-bib-0164" class="usa-link" aria-describedby="imr70018-bib-0164">164</a>]. IL‐5 is essential for the mobilization of eosinophil progenitors from the bone marrow as well as their terminal differentiation [<a href="#imr70018-bib-0165" class="usa-link" aria-describedby="imr70018-bib-0165">165</a>]. Aside from these growth factors, other T2 cytokines found to be elevated in allergic diseases, such as IL‐4 and IL‐13, indirectly regulate the transmigration of eosinophils and basophils from the vasculature into the tissue through the upregulating expression of adhesion molecules on the endothelium [<a href="#imr70018-bib-0166" class="usa-link" aria-describedby="imr70018-bib-0166">166</a>], and by inducing the release of the potent chemokines eotaxin and RANTES from immune and structural cells in the airways [<a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>, <a href="#imr70018-bib-0167" class="usa-link" aria-describedby="imr70018-bib-0167">167</a>, <a href="#imr70018-bib-0168" class="usa-link" aria-describedby="imr70018-bib-0168">168</a>, <a href="#imr70018-bib-0169" class="usa-link" aria-describedby="imr70018-bib-0169">169</a>].</p>
<p>Progenitors are also responsive to the eosinophil chemoattractants CRTH2 [<a href="#imr70018-bib-0170" class="usa-link" aria-describedby="imr70018-bib-0170">170</a>] and PPARγ [<a href="#imr70018-bib-0171" class="usa-link" aria-describedby="imr70018-bib-0171">171</a>]. We demonstrated that low concentrations of the PPAR agonist rosiglitazone increased chemokinesis of eosinophils as well as SDF‐1<em>α</em>‐induced migration of immature eosinophils, and this effect on eosinophil migration and chemokinesis appears to be through modification of calcium signaling, alluding to a novel PPAR‐mediated mechanism to modulate eosinophil function [<a href="#imr70018-bib-0171" class="usa-link" aria-describedby="imr70018-bib-0171">171</a>]. In the allergen challenge model, we observe attenuation of SDF‐1α receptor expression on bone marrow CD34+ cells of mild asthmatic subjects, as well as a reduction in SDF‐1α levels in the bone marrow, demonstrating a mechanism whereby reduced retention of progenitors in the bone marrow permits egress of these cells into the blood [<a href="#imr70018-bib-0122" class="usa-link" aria-describedby="imr70018-bib-0122">122</a>].</p>
<p>Interleukin‐25 (IL‐25; IL‐17E) is a pro‐inflammatory alarmin cytokine that contributes to maintaining type 2 immune responses in airways [<a href="#imr70018-bib-0172" class="usa-link" aria-describedby="imr70018-bib-0172">172</a>]. IL‐25 has been shown to directly activate eosinophils through upregulation of ICAM‐1 and by stimulating the release of pro‐inflammatory chemokines and cytokines from eosinophils [<a href="#imr70018-bib-0173" class="usa-link" aria-describedby="imr70018-bib-0173">173</a>, <a href="#imr70018-bib-0174" class="usa-link" aria-describedby="imr70018-bib-0174">174</a>]. In asthmatics who developed allergen‐induced early and late asthmatic responses, we have demonstrated that in the presence of increased plasma IL‐25 levels, there was elevated expression of intracellular IL‐25 and membrane expression of IL‐17RB and IL‐17RA/B on mature eosinophils collected 24 h post‐challenge [<a href="#imr70018-bib-0175" class="usa-link" aria-describedby="imr70018-bib-0175">175</a>]. We also observed a significant increase in circulating EoP expressing the IL‐25 receptor, IL‐17RB, at 24 h after inhaled allergen inhalation challenge [<a href="#imr70018-bib-0135" class="usa-link" aria-describedby="imr70018-bib-0135">135</a>]. We then performed in vitro experiments to explore these findings and demonstrated that pre‐exposure of EoP to IL‐25 in vitro primed the migrational response of EoP to the chemoattractant, stromal cell‐derived factor 1α. This series of experiments suggests that upregulation of IL‐17B, together with exposure to IL‐25 in airways, contributes to allergen‐induced trafficking of EoP to the asthmatic airways. In separate experiments, we evaluated the effects of TSLP and IL‐33 on the migration of hematopoietic progenitors. HPC were assessed in transwell chambers for their response to the chemokine SDF‐1. Although TSLP and IL‐33 did not directly stimulate the migration of HPCs, we found that priming of these enriched CD34+ cells with TSLP and IL‐33 significantly enhanced their migratory response to SDF‐1 [<a href="#imr70018-bib-0036" class="usa-link" aria-describedby="imr70018-bib-0036">36</a>] but not to other chemoattractants, including eotaxin, RANTES, or MCP‐1.</p></section></section><section id="imr70018-sec-0012"><h2 class="pmc_sec_title">3. The Allergen Challenge Model</h2>
<p>Allergic asthma is the most common asthma phenotype of all asthmatic patients [<a href="#imr70018-bib-0176" class="usa-link" aria-describedby="imr70018-bib-0176">176</a>] and the weight of evidence strongly supports that the inhalation of environmental allergens plays an important role in the initiation and persistence of asthma in a majority of patients. Birth cohort studies have shown a significantly higher risk of diagnosed asthma and AHR in atopic children [<a href="#imr70018-bib-0177" class="usa-link" aria-describedby="imr70018-bib-0177">177</a>] especially when sensitized to allergens from cats and dogs and house dust mite (HDM) [<a href="#imr70018-bib-0178" class="usa-link" aria-describedby="imr70018-bib-0178">178</a>]. Seasonal asthma that is associated with specific plant pollen exposure is well described [<a href="#imr70018-bib-0179" class="usa-link" aria-describedby="imr70018-bib-0179">179</a>] and asthma morbidity and mortality have been associated with inhalation of allergens across different countries and continents [<a href="#imr70018-bib-0180" class="usa-link" aria-describedby="imr70018-bib-0180">180</a>, <a href="#imr70018-bib-0181" class="usa-link" aria-describedby="imr70018-bib-0181">181</a>, <a href="#imr70018-bib-0182" class="usa-link" aria-describedby="imr70018-bib-0182">182</a>]. Accordingly, avoidance of allergens can improve asthma control, reduce AHR, and lessen treatment requirements [<a href="#imr70018-bib-0183" class="usa-link" aria-describedby="imr70018-bib-0183">183</a>, <a href="#imr70018-bib-0184" class="usa-link" aria-describedby="imr70018-bib-0184">184</a>]. Occupational asthma caused by inhalation of allergens in the workplace can be cured by removal of the patient from this environment [<a href="#imr70018-bib-0185" class="usa-link" aria-describedby="imr70018-bib-0185">185</a>]. Collectively, these studies show that environmental allergens are an important cause of persistent asthma and asthma exacerbations and suggest that an improved understanding of the mechanisms and their regulation could lead to better management of asthma in patients with allergic asthma.</p>
<p>Controlled experimental allergen challenges are established models of allergic diseases in sensitized individuals that mimic short‐term high‐dose allergen exposure, or prolonged low‐dose allergen exposure. These models include challenges to upper or lower airways in individuals allergic rhinitis and asthma, respectfully [<a href="#imr70018-bib-0186" class="usa-link" aria-describedby="imr70018-bib-0186">186</a>, <a href="#imr70018-bib-0187" class="usa-link" aria-describedby="imr70018-bib-0187">187</a>], and lead to accumulation of eosinophils at the site of challenge [<a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>, <a href="#imr70018-bib-0188" class="usa-link" aria-describedby="imr70018-bib-0188">188</a>] (Figure <a href="#imr70018-fig-0005" class="usa-link">5</a>). Allergen exposures in non‐airway diseases such as intradermal challenges in skin of sensitized individuals also leads to an acute accumulation of eosinophils, basophils, and mast cells in the papillary dermis [<a href="#imr70018-bib-0111" class="usa-link" aria-describedby="imr70018-bib-0111">111</a>, <a href="#imr70018-bib-0189" class="usa-link" aria-describedby="imr70018-bib-0189">189</a>]. Asthma, allergic rhinitis, and atopic dermatitis are common disorders that can coexist and represent manifestations of the same (systemic) inflammatory process [<a href="#imr70018-bib-0190" class="usa-link" aria-describedby="imr70018-bib-0190">190</a>]. Having both asthma and allergic rhinitis is referred to as “one airway disease” within the context of the “united airways concept” [<a href="#imr70018-bib-0191" class="usa-link" aria-describedby="imr70018-bib-0191">191</a>]. In addition to the shared pathophysiology, there is evidence of crosstalk between these airway compartments whereby challenging one induces inflammatory responses both locally and within other compartments [<a href="#imr70018-bib-0191" class="usa-link" aria-describedby="imr70018-bib-0191">191</a>, <a href="#imr70018-bib-0192" class="usa-link" aria-describedby="imr70018-bib-0192">192</a>]. Allergen instillation into a lung segment of non‐asthmatics with AR has been shown to induce a local inflammatory response locally in the upper airway mucosa as well as systemically in the circulation [<a href="#imr70018-bib-0193" class="usa-link" aria-describedby="imr70018-bib-0193">193</a>] and nasal allergen challenges induce upregulation of inflammatory mechanisms and eosinophilia in both the upper and lower airways in non‐asthmatic subjects with seasonal allergic rhinitis (AR) [<a href="#imr70018-bib-0194" class="usa-link" aria-describedby="imr70018-bib-0194">194</a>, <a href="#imr70018-bib-0195" class="usa-link" aria-describedby="imr70018-bib-0195">195</a>].</p>
<figure class="fig xbox font-sm" id="imr70018-fig-0005"><h3 class="obj_head">FIGURE 5.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eab/12001016/f97b018472f8/IMR-331-0-g001.jpg" loading="lazy" id="jats-graphic-9" height="391" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/imr70018-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Bronchial tissue of allergic asthmatic stained with hematoxylin and eosin from biopsies collected (A) pre‐inhaled allergen challenge and (B) post‐inhaled allergen challenge showing increased submucosal eosinophilic infiltration (black arrows).</p></figcaption></figure><p>High‐dose allergen inhalation by allergic asthmatics results in many of the physiological and inflammatory manifestations of asthma, including reversible airflow obstruction and AHR in association with increased eosinophilic and basophilic airway inflammation [<a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>]. The first description of allergen‐induced bronchoconstrictor responses identified two distinct constrictor components, the early (EAR) and late asthmatic responses (LAR) [<a href="#imr70018-bib-0196" class="usa-link" aria-describedby="imr70018-bib-0196">196</a>]. The early bronchoconstriction response develops rapidly within 10–15 min after inhalation, reaches a maximum within 30 min, and generally resolves by 1–3 h. Some individuals go on to develop a late bronchoconstriction response that recurs after 3–4 h and reaches a maximum over 6–12 h [<a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>].</p>
<p>We and others have demonstrated that allergen‐induced airway responses are followed by an enhanced AHR to inhaled histamine or methacholine, which can last several days to weeks [<a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>, <a href="#imr70018-bib-0197" class="usa-link" aria-describedby="imr70018-bib-0197">197</a>] and which is greater in patients who develop allergen‐induced LAR compared to those who develop isolated early responses [<a href="#imr70018-bib-0198" class="usa-link" aria-describedby="imr70018-bib-0198">198</a>, <a href="#imr70018-bib-0199" class="usa-link" aria-describedby="imr70018-bib-0199">199</a>]. Inflammatory changes after upper or lower airway allergen challenge consistently demonstrate local increases in effector cells central to the pathophysiology of asthma. Inhaled allergen challenge of the lower airways elevates levels of eosinophils in the bronchial tissue compartment, as well as in BAL fluid and induced sputum sampled from the lumen of lower airways [<a href="#imr70018-bib-0087" class="usa-link" aria-describedby="imr70018-bib-0087">87</a>, <a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>, <a href="#imr70018-bib-0089" class="usa-link" aria-describedby="imr70018-bib-0089">89</a>, <a href="#imr70018-bib-0108" class="usa-link" aria-describedby="imr70018-bib-0108">108</a>]. Work from our laboratory and others describes the effect of allergen challenge to the upper airways, resulting in significant increases in eosinophils, basophils, and evidence of mast cell activation in post‐challenge samples from nasal lavage fluid [<a href="#imr70018-bib-0188" class="usa-link" aria-describedby="imr70018-bib-0188">188</a>, <a href="#imr70018-bib-0200" class="usa-link" aria-describedby="imr70018-bib-0200">200</a>, <a href="#imr70018-bib-0201" class="usa-link" aria-describedby="imr70018-bib-0201">201</a>], in conjunction with physiological changes such as reduced PNIF and increased symptoms. Intradermal allergen challenge causing late‐phase reaction in skin also results in the elevation of eosinophils, mast cells, and basophils [<a href="#imr70018-bib-0111" class="usa-link" aria-describedby="imr70018-bib-0111">111</a>, <a href="#imr70018-bib-0202" class="usa-link" aria-describedby="imr70018-bib-0202">202</a>, <a href="#imr70018-bib-0203" class="usa-link" aria-describedby="imr70018-bib-0203">203</a>], though in different proportions than the airway compartments [<a href="#imr70018-bib-0111" class="usa-link" aria-describedby="imr70018-bib-0111">111</a>, <a href="#imr70018-bib-0203" class="usa-link" aria-describedby="imr70018-bib-0203">203</a>].</p>
<p>These localized allergen exposures cause reproducible changes in early and late responses [<a href="#imr70018-bib-0188" class="usa-link" aria-describedby="imr70018-bib-0188">188</a>, <a href="#imr70018-bib-0204" class="usa-link" aria-describedby="imr70018-bib-0204">204</a>], AHR [<a href="#imr70018-bib-0205" class="usa-link" aria-describedby="imr70018-bib-0205">205</a>], and inflammation [<a href="#imr70018-bib-0188" class="usa-link" aria-describedby="imr70018-bib-0188">188</a>, <a href="#imr70018-bib-0206" class="usa-link" aria-describedby="imr70018-bib-0206">206</a>] that allow for the study of the pathobiology of allergic disease and therapeutic regulation of inflammatory mechanisms. Inhaled allergen challenges have been used as proof‐of‐concept studies to support larger clinical trials to evaluate the efficacy of novel therapeutics in patients with moderate‐to‐severe asthma, with the hypothesis that inhibition of allergic responses is a predictor of the clinical success of the drug. The LAR, due to its association with rapid and severe T2 airway inflammation, has been the most frequent endpoint of clinical trials evaluating anti‐inflammatory therapies, whereby inhibition of LAR demonstrates blockade of a critical pathway. Also, of value for drug development, investigational medications that do not inhibit the allergen‐induced late asthmatic response have never been subsequently proven to be effective in asthma treatment. As such, the model has an excellent negative predictive value [<a href="#imr70018-bib-0207" class="usa-link" aria-describedby="imr70018-bib-0207">207</a>].</p></section><section id="imr70018-sec-0013"><h2 class="pmc_sec_title">4. The Association Between Allergen‐Induced Physiology and Airway Inflammation</h2>
<p>The ability of purified human eosinophils to synthesize large quantities of bronchoconstrictive LTC<sub>4</sub> after stimulation with either the calcium‐ionophore A23187 or opsonized zymosan [<a href="#imr70018-bib-0208" class="usa-link" aria-describedby="imr70018-bib-0208">208</a>] provided early evidence to suggest that the eosinophil may play an active role in causing the late‐phase asthmatic reaction. Furthermore, the accumulation of eosinophils, basophils, and mast cells in airways is temporally associated with physiological changes in airways, including bronchoconstriction and AHR, leading us to believe causal relationships may exist.</p>
<p>The introduction of noninvasive sampling of airways by sputum induction facilitated experiments characterizing the kinetics of airway inflammation throughout the period of allergen‐induced increase in AHR. In allergic asthmatics selected to have early and late‐phase allergen‐induced bronchoconstriction, we measured eosinophils and mast cells/basophils (metachromatic cells) in sputum using chemical staining Diff Quik and toluidine blue, respectively. Sputum samples were collected before allergen challenges and at regular time intervals for 7 days afterward, and measures of sputum inflammatory cells were accompanied by AHR assessed by methacholine PC<sub>20</sub>. We reported peak allergen‐induced sputum eosinophil levels were reached within 24 h, and recovery approached pre‐challenge levels over a period of 1 week [<a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>] (Figure <a href="#imr70018-fig-0006" class="usa-link">6</a>). Similarly, the metachromatic cells peaked by 7 h post‐allergen with normalization toward pre‐allergen levels over the next 7 days. Allergen‐induced AHR persisted throughout the week post‐allergen, as described previously [<a href="#imr70018-bib-0197" class="usa-link" aria-describedby="imr70018-bib-0197">197</a>], and we discovered the reduction in methacholine PC<sub>20</sub> was significantly and negatively correlated with eosinophils (<em>r</em> = −0.41) and metachromatic cells (<em>r</em> = −0.38), demonstrating an association between these effector cells and worsening airway responsiveness. The results of this study also described the kinetics of elevated chemoattractants, eotaxin and RANTES, and of IL‐5‐positive cells in the airways which followed a pattern similar to eosinophils and metachromatic cells. In a recent pilot study, we examined the kinetics of eosinophil accumulation in the airways post‐challenge and found sputum eosinophils significantly increased already by 2 h after allergen inhalation, likely involving migration of eosinophils sequestered in extravascular sites for an initial and rapid response to allergic triggers. In addition to the accumulation of mature eosinophils in lower airways of allergic asthmatics after allergen inhalation, we also have shown corresponding increases of mature and immature eosinophils in bone marrow post‐allergen challenge, and eosinophil progenitors are found in higher numbers in blood, sputum, and bronchial mucosa [<a href="#imr70018-bib-0096" class="usa-link" aria-describedby="imr70018-bib-0096">96</a>, <a href="#imr70018-bib-0097" class="usa-link" aria-describedby="imr70018-bib-0097">97</a>, <a href="#imr70018-bib-0110" class="usa-link" aria-describedby="imr70018-bib-0110">110</a>] (Figure <a href="#imr70018-fig-0007" class="usa-link">7</a>). This composite summary of the shift in levels of immature and mature eosinophils across hemopoietic, systemic, and end organ compartments highlights the dynamic changes to eosinophil expansion and migration resulting from a single exposure to allergen in lower airways of allergic asthmatics.</p>
<figure class="fig xbox font-sm" id="imr70018-fig-0006"><h3 class="obj_head">FIGURE 6.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eab/12001016/df2184ee8f5e/IMR-331-0-g003.jpg" loading="lazy" id="jats-graphic-11" height="1055" width="707" alt="FIGURE 6"></p>
<div class="p text-right font-secondary"><a href="figure/imr70018-fig-0006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Response to inhaled allergen and diluent challenges in allergic asthmatics. (A) Airway hyperresponsiveness assessed by methacholine PC<sub>20</sub>, (B) sputum eosinophils, (C) and metachromatic cells (MCC) shown as number per milliliter (mL) of sputum were measured at baseline with repeated sampling until 7 days post‐challenge. (D) Forced expiratory volume in 1 s (FEV<sub>1</sub>). Adapted from reference [<a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>].</p></figcaption></figure><figure class="fig xbox font-sm" id="imr70018-fig-0007"><h3 class="obj_head">FIGURE 7.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eab/12001016/6e6b694f83d9/IMR-331-0-g004.jpg" loading="lazy" id="jats-graphic-13" height="376" width="709" alt="FIGURE 7"></p>
<div class="p text-right font-secondary"><a href="figure/imr70018-fig-0007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Allergen‐induced changes in mature and immature eosinophils measured in (A) bronchial tissue (B) airway lumen, (C) circulation, and (D) bone marrow before and after inhaled allergen challenge in allergic asthmatics. Adapted from reference [<a href="#imr70018-bib-0209" class="usa-link" aria-describedby="imr70018-bib-0209">209</a>].</p></figcaption></figure><p>Further characterization of the inhaled allergen challenge model consistently exhibited a positive relationship between the worsening of allergen‐induced LAR and AHR and increased airway eosinophils. The initial studies incorporating sputum eosinophil readouts examined the effect of regular treatment with the ICS budesonide on allergen‐induced airway inflammation and the association with changes in lung function. We demonstrated that budesonide treatment inhibited allergen‐induced eosinophils across many compartments including blood, bone marrow, and airways of allergic asthmatics [<a href="#imr70018-bib-0210" class="usa-link" aria-describedby="imr70018-bib-0210">210</a>, <a href="#imr70018-bib-0211" class="usa-link" aria-describedby="imr70018-bib-0211">211</a>] in addition to reducing the number of circulating eosinophil progenitors [<a href="#imr70018-bib-0141" class="usa-link" aria-describedby="imr70018-bib-0141">141</a>]. Sputum eosinophil levels post‐allergen were inhibited by approximately 50%, with a larger effect on activated eosinophils measured by immunostaining of the activated form of ECP. These changes in eosinophil levels were associated with a significant inhibition of the LAR and improvement in AHR. The post‐allergen level of metachromatic cells (basophils and mast cells) was reduced by 30% with budesonide treatment. The association between allergen‐induced airway eosinophil levels and inhibition of LAR and AHR was further explored in a clinical trial that evaluated these outcomes across a range of doses of the ICS mometasone furoate [<a href="#imr70018-bib-0212" class="usa-link" aria-describedby="imr70018-bib-0212">212</a>]. The results of this study demonstrated a clear association between the magnitude of effect on LAR and the 24 h post‐challenge eosinophil levels, as observed in a dose–response fashion (Figure <a href="#imr70018-fig-0008" class="usa-link">8</a>). The reduction in allergen‐induced eosinophilia by glucocorticoids can occur through several mechanisms including repression of IL‐5 transcription [<a href="#imr70018-bib-0213" class="usa-link" aria-describedby="imr70018-bib-0213">213</a>] leading to the inhibition of the terminal differentiation of eosinophil progenitors. Eosinophils could also be removed from circulation by induction of death through upregulation of pro‐apoptotic genes [<a href="#imr70018-bib-0214" class="usa-link" aria-describedby="imr70018-bib-0214">214</a>], or by induction of CXCR4‐regulated homing of peripheral eosinophils to the bone marrow [<a href="#imr70018-bib-0215" class="usa-link" aria-describedby="imr70018-bib-0215">215</a>]. Through its association with a reduction in eosinophils and to some extent metachromatic cells, it was hypothesized that these cells were at least partially responsible for the worsening of lung function post‐allergen challenge. This idea was further tested in a study that treated allergic asthmatics for 1 week with inhaled SABA (salbuterol/albuterol) at a dose of 200 mcg four times daily followed by inhaled allergen challenge [<a href="#imr70018-bib-0216" class="usa-link" aria-describedby="imr70018-bib-0216">216</a>]. In contrast to the ICS studies, SABA treatment significantly increased the LAR, and this heightened response to allergen was accompanied by higher levels of eosinophils measured during the LAR (Figure <a href="#imr70018-fig-0009" class="usa-link">9</a>). These studies demonstrated a clear association between therapeutic shifts in LAR and airway eosinophils, although mechanistically we have no evidence that eosinophils are the cause of LAR or increased AHR after allergen challenges. Collectively, however, these studies revealed that allergen‐induced LAR as an indication of lung function and sputum eosinophil levels as biomarkers of asthma severity could be used as proof of concept to evaluate new therapies for the management of asthma. Supporting data showing that steroid treatment reduces eosinophil, basophil, and mast cell markers after nasal and intradermal allergen challenges together with improvement in measures of PNIF and wheal size, respectively [<a href="#imr70018-bib-0188" class="usa-link" aria-describedby="imr70018-bib-0188">188</a>, <a href="#imr70018-bib-0217" class="usa-link" aria-describedby="imr70018-bib-0217">217</a>, <a href="#imr70018-bib-0218" class="usa-link" aria-describedby="imr70018-bib-0218">218</a>], suggest common inflammatory pathways at least in part contribute to the pathophysiology observed after allergen exposure in skin and airways.</p>
<figure class="fig xbox font-sm" id="imr70018-fig-0008"><h3 class="obj_head">FIGURE 8.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eab/12001016/927a63e53ed3/IMR-331-0-g007.jpg" loading="lazy" id="jats-graphic-15" height="780" width="661" alt="FIGURE 8"></p>
<div class="p text-right font-secondary"><a href="figure/imr70018-fig-0008/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Dose response to the inhaled corticosteroid mometasone furoate at doses of 50 μg BID, 100 μg BID, and 400 μg BID compared to placebo treatment shown by (A) allergen‐induced changes during the early and late asthmatic response maximum percent fall in forced expiratory volume in 1 s (FEV<sub>1</sub>), and (B) and sputum eosinophils levels pre‐ and post‐allergen challenge in allergic asthmatics. Adapted from reference [<a href="#imr70018-bib-0212" class="usa-link" aria-describedby="imr70018-bib-0212">212</a>].</p></figcaption></figure><figure class="fig xbox font-sm" id="imr70018-fig-0009"><h3 class="obj_head">FIGURE 9.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eab/12001016/3da31230fd1c/IMR-331-0-g010.jpg" loading="lazy" id="jats-graphic-17" height="778" width="661" alt="FIGURE 9"></p>
<div class="p text-right font-secondary"><a href="figure/imr70018-fig-0009/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Contrasting effects of inhaled corticosteroid and inhaled short‐acting beta2‐agonist on allergen‐induced responses in allergic asthmatics (A) forced expiratory volume in 1 s (FEV<sub>1</sub>) shown as percent change from pre‐allergen baseline, and (B) sputum eosinophils measured at baseline and 7 h post‐allergen challenge after treatment with placebo, budesonide 200 μg BID and salbutamol 200 μg QID.</p></figcaption></figure></section><section id="imr70018-sec-0014"><h2 class="pmc_sec_title">5. The IL‐5 Pathway in Allergen‐Induced Eosinophilia</h2>
<p>Early studies have demonstrated the importance of the IL‐5 pathway to the development of eosinophilia. Inhalation of IL‐5 in asthmatics has been shown to increase eosinophils in peripheral blood and sputum [<a href="#imr70018-bib-0025" class="usa-link" aria-describedby="imr70018-bib-0025">25</a>], and this eosinophilia was accompanied by increased airway responsiveness (AHR) [<a href="#imr70018-bib-0026" class="usa-link" aria-describedby="imr70018-bib-0026">26</a>], suggesting an effect of the eosinophil on airway smooth muscle. IL‐5 inhalation in allergic asthmatics has also been reported to reduce the number of CD34+/IL‐5Rα+ mRNA cells within the bronchial mucosa and the number of CD34+ CCR3+ cells in the bone marrow of atopic asthmatics [<a href="#imr70018-bib-0027" class="usa-link" aria-describedby="imr70018-bib-0027">27</a>, <a href="#imr70018-bib-0028" class="usa-link" aria-describedby="imr70018-bib-0028">28</a>, <a href="#imr70018-bib-0029" class="usa-link" aria-describedby="imr70018-bib-0029">29</a>], findings that can be explained by enhanced in situ eosinophil differentiation [<a href="#imr70018-bib-0023" class="usa-link" aria-describedby="imr70018-bib-0023">23</a>] and by work in our laboratory suggesting that lung‐derived IL‐5 induces a population of T lymphocytes to traffic to the bone marrow [<a href="#imr70018-bib-0097" class="usa-link" aria-describedby="imr70018-bib-0097">97</a>] where they can locally induce the efflux of CD34+/CCR3<sup>+</sup> cells from the bone marrow. Through their dependence on IL‐5 for terminal differentiation, eosinophil progenitors are also a relevant target of anti‐IL‐5/anti‐IL‐5Rα therapy. Progenitor cells from the bone marrow of allergic individuals have shown enhanced responsiveness to IL‐5 [<a href="#imr70018-bib-0009" class="usa-link" aria-describedby="imr70018-bib-0009">9</a>], likely due to increased levels of bone marrow CD34 + IL‐5Rα + cells, which appear to be a distinctive feature of allergic disease [<a href="#imr70018-bib-0112" class="usa-link" aria-describedby="imr70018-bib-0112">112</a>]. After inhaled allergen challenge in allergic asthmatics and the resultant elevated IL‐5 levels, CD34+ cells from the bone marrow synthesize mRNA transcripts and protein for IL‐5Rα [<a href="#imr70018-bib-0012" class="usa-link" aria-describedby="imr70018-bib-0012">12</a>], thereby enabling a heightened response to IL‐5. The higher proportion of CD34+IL‐5Rα+ in the bone marrow after allergen challenge is associated with airway eosinophilia as well as increased AHR [<a href="#imr70018-bib-0012" class="usa-link" aria-describedby="imr70018-bib-0012">12</a>, <a href="#imr70018-bib-0095" class="usa-link" aria-describedby="imr70018-bib-0095">95</a>], demonstrating a direct relationship between eosinophil lineage‐skewing of CD34+ cells in response to an allergic stimulus and the development of eosinophilia in airways. Enhanced production of Eo/B‐lineage committed progenitors in the bone marrow and the subsequent development of blood and tissue eosinophilia have been linked to the maintenance of allergic inflammation in allergic individuals [<a href="#imr70018-bib-0009" class="usa-link" aria-describedby="imr70018-bib-0009">9</a>] and to the regulation of baseline Eo/B CFU by anti‐inflammatory treatment [<a href="#imr70018-bib-0211" class="usa-link" aria-describedby="imr70018-bib-0211">211</a>]. Collectively, these studies provide evidence that eosinophilia is driven by the expansion of the eosinophil progenitor population in addition to the release of mature eosinophils into the circulation, both of which are dependent on IL‐5 signaling.</p>
<p>Other biologically important effector cells found in high numbers in allergic tissues express IL‐5Rα, including basophils [<a href="#imr70018-bib-0219" class="usa-link" aria-describedby="imr70018-bib-0219">219</a>] which are primed by low concentrations of IL‐5 to enhance their release of histamine and generation of LTC<sub>4</sub> in response to established basophil agonists. We have recently reported the expression of membrane‐bound IL‐5Rα on ILC2 in circulation and mast cells in the papillary dermis of patients with atopic dermatitis [<a href="#imr70018-bib-0111" class="usa-link" aria-describedby="imr70018-bib-0111">111</a>]. Hence, blockade of the IL‐5 pathway in allergic diseases may have beneficial effects in addition to those leading to inhibition of eosinophilia. Given the positive relationship between eosinophils and severity of asthma [<a href="#imr70018-bib-0220" class="usa-link" aria-describedby="imr70018-bib-0220">220</a>, <a href="#imr70018-bib-0221" class="usa-link" aria-describedby="imr70018-bib-0221">221</a>] and the importance of the IL‐5 pathway to eosinophil production, antibodies to IL‐5 or its receptor, IL‐5Rα, were developed as a novel asthma therapeutic.</p></section><section id="imr70018-sec-0015"><h2 class="pmc_sec_title">6. Inflammatory Pathways Contributing to Allergen‐Induced Airway Responses</h2>
<p>To improve our understanding of the mechanisms of cellular infiltration to airways and the role of these cells, we have carefully characterized the inflammatory events that occur during allergen challenges. Whether in the airways or skin, the acute response to allergen challenge is an IgE‐mediated inflammatory process initiated by the cross‐linking of antigen on allergen‐specific IgE molecules bound to high‐affinity IgE receptors on mast cells and basophils. Figure <a href="#imr70018-fig-0010" class="usa-link">10</a> depicts events occurring in airways following allergen inhalation by allergic asthmatic individuals. IgE‐mediated activation of mast cells and basophils causes the release of pro‐inflammatory mediators, including degranulation of the preformed mediators histamine and proteases, increases synthesis and release of arachidonic acid products that are rapidly metabolized to produce prostaglandins and leukotrienes [<a href="#imr70018-bib-0222" class="usa-link" aria-describedby="imr70018-bib-0222">222</a>, <a href="#imr70018-bib-0223" class="usa-link" aria-describedby="imr70018-bib-0223">223</a>, <a href="#imr70018-bib-0224" class="usa-link" aria-describedby="imr70018-bib-0224">224</a>]. These rapidly released mediators from mast cells and basophils cause acute changes to airways that characterize the early phase allergic response. In upper airways, we have reported a reduction in peak nasal inspiratory flow rate within minutes of nasal allergen challenge, and this response occurs in association with rapid activation of mast cells as indicated by concurrent tryptase release into nasal secretions [<a href="#imr70018-bib-0188" class="usa-link" aria-describedby="imr70018-bib-0188">188</a>]. We and others have shown that LTD<sub>4</sub> and LTE<sub>4</sub> cause maximal bronchoconstriction within 2–3 min of inhalation [<a href="#imr70018-bib-0158" class="usa-link" aria-describedby="imr70018-bib-0158">158</a>, <a href="#imr70018-bib-0225" class="usa-link" aria-describedby="imr70018-bib-0225">225</a>]. Furthermore, we demonstrated that inhalation of LTE<sub>4</sub> increases the number of eosinophils and basophils in the bronchial mucosa of asthmatics [<a href="#imr70018-bib-0158" class="usa-link" aria-describedby="imr70018-bib-0158">158</a>], providing a mechanism whereby cysteinyl leukotrienes play a role in eosinophil and basophil migration to airways. In our studies of asthmatic airways, we have also shown that allergen inhalation upregulates cytokine receptors for IL‐25 (IL‐17RB and IL‐17RA/B) and IL‐33 (ST2) on circulating eosinophils, which promotes their degranulation [<a href="#imr70018-bib-0175" class="usa-link" aria-describedby="imr70018-bib-0175">175</a>] and enhances the expression of T2 cytokines IL‐5 and IL‐13 [<a href="#imr70018-bib-0130" class="usa-link" aria-describedby="imr70018-bib-0130">130</a>, <a href="#imr70018-bib-0175" class="usa-link" aria-describedby="imr70018-bib-0175">175</a>]. Inhaled allergen expression also causes a significant increase in activation marker CD203c, higher intracellular levels of T2 cytokines IL‐4 and IL‐13, and upregulation of receptors for TSLP, IL‐3, and eotaxin in basophils found across several compartments including blood, bone marrow, and sputum [<a href="#imr70018-bib-0133" class="usa-link" aria-describedby="imr70018-bib-0133">133</a>]. These changes to basophils may result in priming and enhanced responsiveness of the effector function of these cells when exposed to the corresponding ligand.</p>
<figure class="fig xbox font-sm" id="imr70018-fig-0010"><h3 class="obj_head">FIGURE 10.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eab/12001016/62ddff9e9abe/IMR-331-0-g008.jpg" loading="lazy" id="jats-graphic-19" height="487" width="709" alt="FIGURE 10"></p>
<div class="p text-right font-secondary"><a href="figure/imr70018-fig-0010/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Immunopathogenesis of early and late‐phase asthmatic responses to inhaled allergen in the allergic asthmatic lung. Adapted from reference [<a href="#imr70018-bib-0226" class="usa-link" aria-describedby="imr70018-bib-0226">226</a>].</p></figcaption></figure><p>The late‐phase response is likely partially driven by events resulting from the IgE‐mediated early response, as suggested by the positive relationship between the fall in FEV<sub>1</sub> measured during the early and late asthmatic responses [<a href="#imr70018-bib-0227" class="usa-link" aria-describedby="imr70018-bib-0227">227</a>]. The development of the late‐phase airway response to a specific allergen begins when an inhaled allergen is presented by dendritic cells (DCs), the professional antigen‐presenting cells, to naïve T‐cells. In the presence of TSLP, naïve T‐cells are polarized to develop into Th2 cells, and ILC2 are activated [<a href="#imr70018-bib-0228" class="usa-link" aria-describedby="imr70018-bib-0228">228</a>], and both produce a variety of T2 cytokines, including IL‐4, IL‐5, IL‐9, and IL‐13, which are crucial for promoting the production of IgE, driving eosinophilopoiesis, mast cell development, and goblet cell hyperplasia and AHR, respectively.</p>
<p>The late‐phase response can also occur independently of the early response. The induction of the late asthmatic response has been demonstrated following the administration of allergen‐derived T‐cell peptide epitopes delivered by intradermal injection [<a href="#imr70018-bib-0229" class="usa-link" aria-describedby="imr70018-bib-0229">229</a>] or by inhalation [<a href="#imr70018-bib-0230" class="usa-link" aria-describedby="imr70018-bib-0230">230</a>], with a similar time course of onset and resolution as late‐phase responses induced by whole allergen extract. This illustrates the effect of direct activation of allergen‐specific airway T cells by peptide inhalation leading to increased AHR and elevated airway CD3+ and CD4+ cells and TARC; interestingly, in the absence of significant changes in eosinophils or basophil and mast cell products [<a href="#imr70018-bib-0231" class="usa-link" aria-describedby="imr70018-bib-0231">231</a>]. The results of these experiments align with clinical trials that show a dissociation between allergen‐induced eosinophilia and the development of LAR and AHR [<a href="#imr70018-bib-0089" class="usa-link" aria-describedby="imr70018-bib-0089">89</a>, <a href="#imr70018-bib-0232" class="usa-link" aria-describedby="imr70018-bib-0232">232</a>] and suggest that eosinophils and their products are unrelated to allergen‐induced changes in airway tone and responsiveness.</p></section><section id="imr70018-sec-0016"><h2 class="pmc_sec_title">7. Immunobiology of the Late Asthmatic Response</h2>
<p>The association of airway eosinophils, basophils, and mast cells with allergen‐induced LAR led to a series of studies examining the potential contribution of these cells to allergen‐induced airway pathophysiology in allergic asthma. Notably, while the development of LAR is a reproducible outcome of inhaled allergen challenges within individual allergic asthmatics, it is noted that a group of individuals routinely develop isolated early responses without the subsequent LAR sequelae [<a href="#imr70018-bib-0233" class="usa-link" aria-describedby="imr70018-bib-0233">233</a>]. The different responses to inhaled allergen were not explained by the type or concentration of inhaled allergen [<a href="#imr70018-bib-0234" class="usa-link" aria-describedby="imr70018-bib-0234">234</a>] or by baseline characteristics, including FEV<sub>1</sub> or baseline airway inflammation [<a href="#imr70018-bib-0235" class="usa-link" aria-describedby="imr70018-bib-0235">235</a>]. These naturally occurring groups with identical baseline characteristics present an opportunity to compare and contrast allergen‐induced changes to inflammatory pathways to evaluate differences that could be driving the more clinically relevant late‐phase response. The results of these comparisons reflected our earlier observation that eosinophils were positively related to LAR by showing that the LAR group had a higher eosinophilic response to inhaled allergen. Compared to isolated early responders, the LAR group had higher post‐allergen eosinophils and eosinophil progenitor levels in sputum [<a href="#imr70018-bib-0110" class="usa-link" aria-describedby="imr70018-bib-0110">110</a>, <a href="#imr70018-bib-0198" class="usa-link" aria-describedby="imr70018-bib-0198">198</a>]. These differences are in part driven by the bone marrow response to allergen because the LAR group also exhibited higher numbers of IL‐5 mRNA+ cells, IL‐5 mRNA+ CD3+ cells [<a href="#imr70018-bib-0097" class="usa-link" aria-describedby="imr70018-bib-0097">97</a>], higher IL‐3 and IL‐5‐responsive progenitors, and elevated IL‐5 levels [<a href="#imr70018-bib-0096" class="usa-link" aria-describedby="imr70018-bib-0096">96</a>] post‐allergen. Furthermore, Eo/B CFU grown from bone marrow collected post‐allergen were responsive to lower levels of IL‐5 [<a href="#imr70018-bib-0095" class="usa-link" aria-describedby="imr70018-bib-0095">95</a>], likely due to elevated expression of IL‐5Rα [<a href="#imr70018-bib-0012" class="usa-link" aria-describedby="imr70018-bib-0012">12</a>]. However, despite these consistent findings of an enhanced eosinophil pathway, treatment with mepolizumab or benralizumab to block IL‐5 function and deplete IL‐5Rα+ cells, respectively, was completely ineffective in reducing LAR or AHR in these allergic asthmatics [<a href="#imr70018-bib-0089" class="usa-link" aria-describedby="imr70018-bib-0089">89</a>, <a href="#imr70018-bib-0232" class="usa-link" aria-describedby="imr70018-bib-0232">232</a>]. It has been shown that mepolizumab and benralizumab treatment depletes circulating eosinophils, but a low level of these cells remains in the tissue [<a href="#imr70018-bib-0089" class="usa-link" aria-describedby="imr70018-bib-0089">89</a>, <a href="#imr70018-bib-0236" class="usa-link" aria-describedby="imr70018-bib-0236">236</a>, <a href="#imr70018-bib-0237" class="usa-link" aria-describedby="imr70018-bib-0237">237</a>]. As such, it is unknown whether these remaining eosinophils represent a subset of IL‐5 independent cells that contribute to pathophysiological responses post‐allergen inhalation or whether different cell populations, such as mast cells and/or basophils, that correlate more strongly with allergen‐induced LAR and AHR [<a href="#imr70018-bib-0198" class="usa-link" aria-describedby="imr70018-bib-0198">198</a>] are responsible for allergen‐induced pathophysiology.</p>
<p>Comparisons of isolated early and dual responders to inhaled allergen challenge also revealed differences in other cellular inflammation. Using antibodies specific for mast cells (tryptase) and basophils (2D7), we demonstrated that LAR was associated with an increase in sputum mast cells 7 and 24 h post‐allergen that was not present in those without LAR [<a href="#imr70018-bib-0198" class="usa-link" aria-describedby="imr70018-bib-0198">198</a>] and had a significant negative relationship with the magnitude of LAR. We also measured significantly higher levels of sputum basophils at 7 and 24 h post‐allergen in asthmatics with LAR, and the allergen‐induced shift in basophils showed a significant positive relationship with the shift in AHR. Basophils can produce histamine and cysteinyl leukotrienes which suggests that basophils are, at least in part, involved in causing the LAR. Collectively, the results of this study suggest that mediator release from airway mast cells and basophils activated by inhaled allergen contribute to the late‐phase fall in FEV<sub>1</sub> and to the development of AHR post‐challenge. These observations are supported by clinical trials showing that treatment with antihistamine plus anti‐leukotriene almost completely abolishes allergen‐induced LAR, AHR, and sputum eosinophils [<a href="#imr70018-bib-0238" class="usa-link" aria-describedby="imr70018-bib-0238">238</a>, <a href="#imr70018-bib-0239" class="usa-link" aria-describedby="imr70018-bib-0239">239</a>]. Other cellular pathways shown to be different between isolated early and dual responders include the T‐cell subpopulations. In dual responders, we have shown at 24 h post‐allergen challenge that the sputum CD4+ T cells significantly increase, with a corresponding decrease in Tregs that is proportional to the magnitude of the LAR, and this is in contrast to no changes in isolated early responders [<a href="#imr70018-bib-0240" class="usa-link" aria-describedby="imr70018-bib-0240">240</a>]. The lower ratio of sputum Treg: CD4+ [<a href="#imr70018-bib-0240" class="usa-link" aria-describedby="imr70018-bib-0240">240</a>] together with a lower frequency of blood IL‐10‐producing CD4+ and CD8+ T cells [<a href="#imr70018-bib-0240" class="usa-link" aria-describedby="imr70018-bib-0240">240</a>] measured post‐allergen in dual responder asthmatics suggests that dual responders may have a diminished regulatory response that impedes inhibition of allergen‐induced responses and a corresponding accumulation of central effector cells in airways.</p>
<p>Another mechanism important for allergic airway inflammation involves dendritic cells (DC), which are potent lung antigen‐presenting cells that initiate primary and secondary immune responses [<a href="#imr70018-bib-0095" class="usa-link" aria-describedby="imr70018-bib-0095">95</a>]. In humans, different types of DCs are distinguished by their different expression of cell surface antigens and function; plasmacytoid dendritic cells (pDC) derived from lymphoid precursors, and myeloid dendritic cells (mDC) are derived from myeloid precursors [<a href="#imr70018-bib-0241" class="usa-link" aria-describedby="imr70018-bib-0241">241</a>]. mDC consist of two subsets, mDC1s and mDC2s [<a href="#imr70018-bib-0242" class="usa-link" aria-describedby="imr70018-bib-0242">242</a>]. After allergen challenge in asthmatics, there is a rapid reduction in the numbers of circulating mDCs within 3 h [<a href="#imr70018-bib-0243" class="usa-link" aria-describedby="imr70018-bib-0243">243</a>], with trafficking of immature mDCs from blood into the airway [<a href="#imr70018-bib-0244" class="usa-link" aria-describedby="imr70018-bib-0244">244</a>], while trafficking of mDCs from the airways into the regional lymph nodes likely occurs through the lymphatic system. Allergen inhalation is also shown to increase the number of classical DCs in airway biopsy samples [<a href="#imr70018-bib-0245" class="usa-link" aria-describedby="imr70018-bib-0245">245</a>], which is reflected in sputum by higher levels of mDCs and pDCs 24 h after challenge [<a href="#imr70018-bib-0246" class="usa-link" aria-describedby="imr70018-bib-0246">246</a>]. We have also shown that inhaled allergen increased the number of classical DCs and plasmacytoid DCs in bone marrow aspirates 24 h after allergen [<a href="#imr70018-bib-0245" class="usa-link" aria-describedby="imr70018-bib-0245">245</a>]. The increase in mDC2s in the sputum suggests this subtype is involved in the regulation of allergen responses in the lung [<a href="#imr70018-bib-0247" class="usa-link" aria-describedby="imr70018-bib-0247">247</a>] and, through well‐described interactions with T cells, drives a type 2 response that supports the accumulation of eosinophils, basophils, and mast cells in the airways.</p></section><section id="imr70018-sec-0017"><h2 class="pmc_sec_title">8. Validation of Inhaled Allergen Challenge Model for Evaluation of Investigational Medications</h2>
<p>We sought to identify other inflammatory pathways that are activated by inhaled allergens to improve the identification of treatment targets for the regulation of allergen‐induced LAR and corresponding asthma pathophysiology. Although clinical trials blocking the IL‐5 pathway have suggested that the predominant population of eosinophils is not a major driver of allergen‐induced LAR and AHR [<a href="#imr70018-bib-0089" class="usa-link" aria-describedby="imr70018-bib-0089">89</a>, <a href="#imr70018-bib-0232" class="usa-link" aria-describedby="imr70018-bib-0232">232</a>], these therapeutics have been proven effective for reducing exacerbations in patients with severe eosinophilic asthma [<a href="#imr70018-bib-0248" class="usa-link" aria-describedby="imr70018-bib-0248">248</a>], thereby establishing the eosinophil as one of the relevant targets for drug development in asthma. Inhaled allergen challenges induce rapid and intense airway eosinophilia [<a href="#imr70018-bib-0187" class="usa-link" aria-describedby="imr70018-bib-0187">187</a>] that develops through established immune pathways [<a href="#imr70018-bib-0209" class="usa-link" aria-describedby="imr70018-bib-0209">209</a>, <a href="#imr70018-bib-0228" class="usa-link" aria-describedby="imr70018-bib-0228">228</a>]. Furthermore, we have shown that allergen‐induced eosinophilia serves as an excellent biomarker of airway pathophysiology [<a href="#imr70018-bib-0207" class="usa-link" aria-describedby="imr70018-bib-0207">207</a>, <a href="#imr70018-bib-0249" class="usa-link" aria-describedby="imr70018-bib-0249">249</a>], making the model useful for testing anti‐eosinophil and anti‐inflammatory therapies. Using the inhaled allergen challenge model, we have tested dozens of investigational medications in proof‐of‐concept studies. In most of these studies, asthmatics were being treated for the first time with these medications, and sputum eosinophil levels were assessed as secondary end points to support a primary analysis of the LAR. A comparison of the effects of experimental therapies on allergen‐induced eosinophil levels is shown in Table <a href="#imr70018-tbl-0001" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="imr70018-tbl-0001"><h3 class="obj_head">TABLE 1.</h3>
<div class="caption p"><p>Inhibition of allergen‐induced sputum eosinophilia measured 24 h post‐challenge.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Drug name</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Drug class</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">% inhibition</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Reference</th>
</tr></thead>
<tbody valign="top">
<tr><td align="left" colspan="4" valign="top" rowspan="1">Eosinophil targeted biologic</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Benralizumab</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐IL‐5Rα mAb</td>
<td align="center" valign="top" rowspan="1" colspan="1">85.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0089" class="usa-link" aria-describedby="imr70018-bib-0089">89</a>]</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Non‐eosinophil targeted biologic</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Efalizumab</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐CD11a mAb</td>
<td align="center" valign="top" rowspan="1" colspan="1">86.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0277" class="usa-link" aria-describedby="imr70018-bib-0277">277</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">AMG 157</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐TSLP mAb</td>
<td align="center" valign="top" rowspan="1" colspan="1">75.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0251" class="usa-link" aria-describedby="imr70018-bib-0251">251</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Eculizumab</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐C5a mAb</td>
<td align="center" valign="top" rowspan="1" colspan="1">67.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0276" class="usa-link" aria-describedby="imr70018-bib-0276">276</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">IMA‐638</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐13 mAb (binding site of IL‐4Ra)</td>
<td align="center" valign="top" rowspan="1" colspan="1">55.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0278" class="usa-link" aria-describedby="imr70018-bib-0278">278</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Anti‐OX40L Mab</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐Ox40L mAb</td>
<td align="center" valign="top" rowspan="1" colspan="1">55.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0295" class="usa-link" aria-describedby="imr70018-bib-0295">295</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Ecleralimab</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐TSLP mAb</td>
<td align="center" valign="top" rowspan="1" colspan="1">51.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0255" class="usa-link" aria-describedby="imr70018-bib-0255">255</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Quilizumab</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti M1‐prime mAb</td>
<td align="center" valign="top" rowspan="1" colspan="1">12.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0287" class="usa-link" aria-describedby="imr70018-bib-0287">287</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">IMA‐025</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐IL‐13 mAb (binding site of IL‐13Ra1 and IL‐13Ra2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0278" class="usa-link" aria-describedby="imr70018-bib-0278">278</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Tocilizumab</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐IL‐6 mAb</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0291" class="usa-link" aria-describedby="imr70018-bib-0291">291</a>]</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Glucocorticoid receptor activation</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Budesonide</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhaled corticosteroid</td>
<td align="center" valign="top" rowspan="1" colspan="1">62.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0267" class="usa-link" aria-describedby="imr70018-bib-0267">267</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">AZD5423</td>
<td align="center" valign="top" rowspan="1" colspan="1">Glucocorticoid receptor agonist</td>
<td align="center" valign="top" rowspan="1" colspan="1">57.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0269" class="usa-link" aria-describedby="imr70018-bib-0269">269</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Budesonide</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhaled corticosteroid</td>
<td align="center" valign="top" rowspan="1" colspan="1">50.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0210" class="usa-link" aria-describedby="imr70018-bib-0210">210</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Ciclesonide 80 ug</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhaled corticosteroid</td>
<td align="center" valign="top" rowspan="1" colspan="1">40.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0268" class="usa-link" aria-describedby="imr70018-bib-0268">268</a>]</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Eosinophil recruitment</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Montekulast</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐leukotriene</td>
<td align="center" valign="top" rowspan="1" colspan="1">75.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0267" class="usa-link" aria-describedby="imr70018-bib-0267">267</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Montelukast + Desloratadine</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐leukotriene + Antihistamine</td>
<td align="center" valign="top" rowspan="1" colspan="1">72.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0238" class="usa-link" aria-describedby="imr70018-bib-0238">238</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Montekulast + Budesonide</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐leukotriene +Inhaled corticosteroid</td>
<td align="center" valign="top" rowspan="1" colspan="1">71.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0267" class="usa-link" aria-describedby="imr70018-bib-0267">267</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Montelukast</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐leukotriene</td>
<td align="center" valign="top" rowspan="1" colspan="1">61.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0238" class="usa-link" aria-describedby="imr70018-bib-0238">238</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ONO‐6950</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐leukotriene</td>
<td align="center" valign="top" rowspan="1" colspan="1">57.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0262" class="usa-link" aria-describedby="imr70018-bib-0262">262</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Montelukast</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐leukotriene</td>
<td align="center" valign="top" rowspan="1" colspan="1">44.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0262" class="usa-link" aria-describedby="imr70018-bib-0262">262</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Prankulast</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anti‐leukotriene</td>
<td align="center" valign="top" rowspan="1" colspan="1">38.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0160" class="usa-link" aria-describedby="imr70018-bib-0160">160</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">AXP1275</td>
<td align="center" valign="top" rowspan="1" colspan="1">CCR3 inhibitor</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0270" class="usa-link" aria-describedby="imr70018-bib-0270">270</a>]</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Nonspecific anti‐inflammatory</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">TPI ASM8 8 mg</td>
<td align="center" valign="top" rowspan="1" colspan="1">CCR3 + Common beta chain antisense</td>
<td align="center" valign="top" rowspan="1" colspan="1">64.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0261" class="usa-link" aria-describedby="imr70018-bib-0261">261</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Roflumilast</td>
<td align="center" valign="top" rowspan="1" colspan="1">PDE4 inhibitor</td>
<td align="center" valign="top" rowspan="1" colspan="1">47.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0293" class="usa-link" aria-describedby="imr70018-bib-0293">293</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CRTH2 inhibitor</td>
<td align="center" valign="top" rowspan="1" colspan="1">CRTH2 inhibitor</td>
<td align="center" valign="top" rowspan="1" colspan="1">46.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0266" class="usa-link" aria-describedby="imr70018-bib-0266">266</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Prostaglandin E2</td>
<td align="center" valign="top" rowspan="1" colspan="1">PGE2</td>
<td align="center" valign="top" rowspan="1" colspan="1">42.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0294" class="usa-link" aria-describedby="imr70018-bib-0294">294</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">IVX‐0142</td>
<td align="center" valign="top" rowspan="1" colspan="1">Heparin disulfide</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0264" class="usa-link" aria-describedby="imr70018-bib-0264">264</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">1018 ISS</td>
<td align="center" valign="top" rowspan="1" colspan="1">Immunostimulatory oligonucleotide</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0263" class="usa-link" aria-describedby="imr70018-bib-0263">263</a>]</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Desloratadine</td>
<td align="center" valign="top" rowspan="1" colspan="1">Antihistamine</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">[<a href="#imr70018-bib-0238" class="usa-link" aria-describedby="imr70018-bib-0238">238</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/imr70018-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Some of the earliest studies adding asthma therapies to inhaled allergen challenges examined the benefits of inhaled corticosteroids as a broad anti‐inflammatory treatment for the regulation of allergen‐induced outcomes, as discussed previously. These studies consistently demonstrated inhibition of early and late‐phase responses, lower levels of allergen‐induced eosinophils and metachromatic cells, and reduced the shift in AHR post‐challenge [<a href="#imr70018-bib-0210" class="usa-link" aria-describedby="imr70018-bib-0210">210</a>, <a href="#imr70018-bib-0211" class="usa-link" aria-describedby="imr70018-bib-0211">211</a>, <a href="#imr70018-bib-0212" class="usa-link" aria-describedby="imr70018-bib-0212">212</a>, <a href="#imr70018-bib-0258" class="usa-link" aria-describedby="imr70018-bib-0258">258</a>, <a href="#imr70018-bib-0267" class="usa-link" aria-describedby="imr70018-bib-0267">267</a>]. Newer iterations of ICS also have been tested. For example, ciclesonide, a nonhalogenated ICS that remains inactive until cleaved by esterases in the lung, attenuated the early and late asthmatic responses, sputum eosinophils, and serum eosinophil cationic protein measured at 24 h post‐challenge [<a href="#imr70018-bib-0268" class="usa-link" aria-describedby="imr70018-bib-0268">268</a>]. We also observed attenuation of allergen‐induced decrease in circulating IFN‐γ positive CD4+ lymphocytes and a correlation between CD4+ cells IFN‐γ/IL‐4 ratio and peripheral blood eosinophils, suggesting lymphocyte subsets are involved with the regulation of allergen‐induced eosinophilia [<a href="#imr70018-bib-0260" class="usa-link" aria-describedby="imr70018-bib-0260">260</a>]. Other approaches for broad anti‐inflammatory inhibition have been tested, including inhaled nonsteroidal glucocorticoid receptor agonists, which effectively reduced all allergen‐induced responses [<a href="#imr70018-bib-0269" class="usa-link" aria-describedby="imr70018-bib-0269">269</a>]. Interestingly, allergen‐induced sputum eosinophilia is significantly reduced by ICS/LABA combination treatment to a greater extent than by ICS alone, and measurements in airway biopsies suggested this effect on eosinophils could be attributed to a greater attenuation of allergen‐induced changes in myofibroblast numbers and smooth muscle area [<a href="#imr70018-bib-0259" class="usa-link" aria-describedby="imr70018-bib-0259">259</a>]. It is evident that eosinophilic airway inflammation is regulated by many different and sometimes opposing mechanistic pathways.</p></section><section id="imr70018-sec-0018"><h2 class="pmc_sec_title">9. Investigational Medications in the Allergen Challenge Model</h2>
<section id="imr70018-sec-0019"><h3 class="pmc_sec_title">9.1. Therapies Targeting Eosinophil Accumulation in Tissue</h3>
<p>Our studies with inhaled allergen challenge have explored direct mechanisms of eosinophil accumulation that were originally described in animal models and subsequently tested for their contribution to eosinophilia in this allergic model where several pro‐inflammatory pathways are activated by exposure to allergen. A number of investigational therapies have aimed to inhibit eosinophil and basophil chemotaxis by blocking the function of CCR3, the receptor for potent chemoattractants, eotaxin and RANTES. AXP1275, an oral, small‐molecule inhibitor of CCR3, significantly improved baseline AHR but had no effect on eosinophil levels in blood, sputum, or effects on LAR [<a href="#imr70018-bib-0270" class="usa-link" aria-describedby="imr70018-bib-0270">270</a>]. Taken together with the small non‐statistically significant improvement of EAR, this suggests there may be other cellular mechanisms mediated by CCR3, such as recruitment of basophils, that contribute to EAR through release of histamine and cysteinyl leukotrienes, and to airway hyperresponsiveness as supported by earlier associations between sputum basophils and AHR [<a href="#imr70018-bib-0198" class="usa-link" aria-describedby="imr70018-bib-0198">198</a>]. Our studies examining the effects of blocking cysteinyl leukotriene receptors demonstrate attenuation of EAR, LAR, and allergen‐induced sputum eosinophils, but no effect on shift in AHR [<a href="#imr70018-bib-0238" class="usa-link" aria-describedby="imr70018-bib-0238">238</a>, <a href="#imr70018-bib-0262" class="usa-link" aria-describedby="imr70018-bib-0262">262</a>], possibly indicating that cysLTs are not potent chemoattractants for cells, such as basophils, that might be contributing to AHR. Therapies with broader targets that inhibit activation and/or accumulation of eosinophils, basophils, and mast cells have demonstrated more complete inhibition of allergen‐induced responses. Treatment with TPI ASM8, a combination of antisense oligonucleotides that reduced post‐allergen levels of the beta subunit of the IL‐3, IL‐5, GM‐CSF receptors, and the chemokine receptor CCR3 [<a href="#imr70018-bib-0261" class="usa-link" aria-describedby="imr70018-bib-0261">261</a>], was shown to attenuate post‐allergen EAR, LAR, AHR, sputum eosinophils and eosinophil progenitors, and ECP with a &gt; 75% reduction in sputum basophils [<a href="#imr70018-bib-0271" class="usa-link" aria-describedby="imr70018-bib-0271">271</a>, <a href="#imr70018-bib-0272" class="usa-link" aria-describedby="imr70018-bib-0272">272</a>]. These results suggest that in addition to IL‐5 blockade, CCR3, IL‐3, and GM‐CSF are also important targets for the management of asthma through effects on central effector cells including basophils and mast cells. Other approaches for inhibiting activities of these effector cells, albeit with results that are difficult to interpret, include blockade of the complement factor C5 with eculizumab, to prevent the production of C5a, which is a potent chemoattractant of eosinophils and basophils, and causes degranulation of basophils and mast cells [<a href="#imr70018-bib-0273" class="usa-link" aria-describedby="imr70018-bib-0273">273</a>, <a href="#imr70018-bib-0274" class="usa-link" aria-describedby="imr70018-bib-0274">274</a>, <a href="#imr70018-bib-0275" class="usa-link" aria-describedby="imr70018-bib-0275">275</a>]. We demonstrated that a single dose of eculizumab had an unexpectedly prolonged effect in attenuating allergen‐induced airway responses, resulting in a significant period effect in the crossover study design [<a href="#imr70018-bib-0276" class="usa-link" aria-describedby="imr70018-bib-0276">276</a>]. Further broadening of target cells for the control of asthma can be achieved through blockade of common pathways, such as the adhesion molecule LFA‐1 expressed on cells including eosinophils, basophils, and T lymphocytes to enable adhesion to vascular epithelium during extravasation [<a href="#imr70018-bib-0252" class="usa-link" aria-describedby="imr70018-bib-0252">252</a>]. In the allergen challenge model, we reported that efalizumab, an antibody directed against CD11a (the LFA‐1 alpha chain), significantly reduced the allergen‐induced accumulation of airway eosinophils and metachromatic cells (mast cells and basophils) [<a href="#imr70018-bib-0277" class="usa-link" aria-describedby="imr70018-bib-0277">277</a>]. However, the effect of efalizumab on EAR, LAR, and AHR was not statistically significant, thereby providing another example of the dissociation between airway eosinophilia and allergen‐induced changes in pulmonary function.</p></section><section id="imr70018-sec-0020"><h3 class="pmc_sec_title">9.2. Therapies Targeting Key Allergic and Inflammatory Pathways</h3>
<p>There has also been significant progress made toward approaches that more broadly target airway inflammation for the treatment of asthma by inhibiting very specific pathways. IL‐13 is a pleiotropic cytokine produced by many cells found in asthmatic airways, including Th2 cells, mast cells, and basophils [<a href="#imr70018-bib-0250" class="usa-link" aria-describedby="imr70018-bib-0250">250</a>]. Animal models have shown that IL‐13 is potentially involved in many aspects of asthma pathobiology; however, finding the best target in humans has required testing of several mAbs. We conducted a series of clinical trials to evaluate IgG1mAbs blocking IL‐13. IMA‐638 is specific for the IL‐13 epitope that binds IL‐4Rα, and IMA‐026 is specific for the IL‐13 epitope that binds IL‐13Ra1 and IL‐13Ra2. The effects of these anti‐IL‐13 mAbs were modest and inconsistent, with neither having an effect on LAR or allergen‐induced AHR or sputum eosinophils [<a href="#imr70018-bib-0278" class="usa-link" aria-describedby="imr70018-bib-0278">278</a>]. Lebrikizumab, an IgG4 mAb that neutralizes IL‐13 by blocking its interaction with IL‐4Ra, had a modest effect on LAR, but in subsequent phase 3 clinical trials with moderate to severe asthmatics, the drug did not demonstrate consistent reduction in exacerbations [<a href="#imr70018-bib-0253" class="usa-link" aria-describedby="imr70018-bib-0253">253</a>]. Several other compounds directed against IL‐13, including tralokinumab, GSK679586, QAX576, and AMG317, failed to demonstrate clinical efficacy in early phase 2 clinical trials, providing consistent evidence that blocking IL‐13 is not an effective approach for asthma treatment. In contrast, dupilumab, an IgG4 mAb that targets the IL‐4R and blocks both IL‐4 and IL‐13 signaling, has been clinically effective for the reduction of asthma exacerbations and prednisone‐sparing [<a href="#imr70018-bib-0279" class="usa-link" aria-describedby="imr70018-bib-0279">279</a>, <a href="#imr70018-bib-0280" class="usa-link" aria-describedby="imr70018-bib-0280">280</a>]. To this end, pitrakinra, an IL‐4 variant that inhibits the binding of interleukin‐4 and interleukin‐13 to interleukin‐4Rα receptor complexes, demonstrated significant effects on allergen‐induced LAR [<a href="#imr70018-bib-0281" class="usa-link" aria-describedby="imr70018-bib-0281">281</a>]. As such, it is possible that due to redundancy in the pathobiology of asthma, IL‐13 blockade alone may be insufficient, and the additional effects of blocking IL‐4 and the associated reduction of airway eosinophils, as shown with dupilumab treatment [<a href="#imr70018-bib-0282" class="usa-link" aria-describedby="imr70018-bib-0282">282</a>], are required for asthma intervention to be effective.</p>
<p>Other approaches to broadly target airway inflammation have included blockade of pathways upstream of T2 inflammation, including blockade of IgE. The first mAb approved for treatment of asthma, Xolair, was initially tested in the allergen challenge model. These early studies demonstrated that systemic administration of this anti‐IgE monoclonal antibody, which inhibits binding of IgE to its receptor, effectively reduced serum IgE levels as well as significantly reduced the early and late‐phase responses to inhaled allergen challenge [<a href="#imr70018-bib-0283" class="usa-link" aria-describedby="imr70018-bib-0283">283</a>, <a href="#imr70018-bib-0284" class="usa-link" aria-describedby="imr70018-bib-0284">284</a>]. Subsequent studies demonstrated the effects of anti‐IgE treatment on airway inflammation. Inhibition of early and late asthmatic responses was paralleled by lower post‐allergen eosinophil levels in sputum and airway biopsies, together with a decline in airway tissue IgE‐bearing cells [<a href="#imr70018-bib-0285" class="usa-link" aria-describedby="imr70018-bib-0285">285</a>]. Our work evaluating a new formulation of anti‐IgE confirmed the previously reported inhibitory effects of IgE‐blockade on allergen‐induced early response, and we extended these findings to show dose‐dependent changes in basophil surface levels of IgE and FcεRI [<a href="#imr70018-bib-0286" class="usa-link" aria-describedby="imr70018-bib-0286">286</a>]. Collectively, these findings suggest that the benefits of anti‐IgE in asthma may be explained at least in part by a decrease in eosinophilic inflammation driven by reduced responsiveness of FcεRI‐bearing cells to IgE stimulation. Although we only measured surface levels of IgE and FcεRI on basophils in our study, downregulation on mast cells and dendritic cells would further explain reductions in eosinophils reported in other anti‐IgE studies. Other novel approaches to reduce IgE have included depletion of IgE‐switched B cells via the M1 prime segment of membrane‐bound IgE, with the mAb quilizumab. This treatment provided a prolonged reduction in total IgE and blocked the new production of allergen‐induced challenge‐specific IgE [<a href="#imr70018-bib-0287" class="usa-link" aria-describedby="imr70018-bib-0287">287</a>]. This was associated with a significant reduction of the allergen‐induced EAR; although the LAR and eosinophils in blood were reduced by quilizumab treatment, these differences were not statistically significant when compared with placebo. Notably, treatments blocking IgE had no effect on the allergen‐induced shift in AHR to methacholine [<a href="#imr70018-bib-0285" class="usa-link" aria-describedby="imr70018-bib-0285">285</a>, <a href="#imr70018-bib-0287" class="usa-link" aria-describedby="imr70018-bib-0287">287</a>].</p>
<p>A myriad of other inhibitors have been tested for their effects on allergen‐induced responses. Some have targeted very novel pathways that were previously demonstrated in animal models to drive allergic inflammation, including inhibition of the nicotinic acetylcholine α7 receptor (ASM024) [<a href="#imr70018-bib-0256" class="usa-link" aria-describedby="imr70018-bib-0256">256</a>], inhibition of inflammatory cell adhesion (AIM‐102), IL‐9 mAb [<a href="#imr70018-bib-0288" class="usa-link" aria-describedby="imr70018-bib-0288">288</a>, <a href="#imr70018-bib-0289" class="usa-link" aria-describedby="imr70018-bib-0289">289</a>], or for characterization of unique formulations such as antisense IL‐4Ra and a non‐steroidal glucocorticoid receptor antagonist [<a href="#imr70018-bib-0269" class="usa-link" aria-describedby="imr70018-bib-0269">269</a>, <a href="#imr70018-bib-0290" class="usa-link" aria-describedby="imr70018-bib-0290">290</a>]. Other investigational medications have been developed to target neutrophilic inflammation in addition to eosinophils and have been tested in the inhaled allergen challenge model, including IL‐6 blockade with tocilizumab, CXCR2 and CRTH2 antagonism, PGE<sub>2</sub> inhalation, PDE4 inhibition, and immunostimulatory sequences developed to activate TLR9 [<a href="#imr70018-bib-0257" class="usa-link" aria-describedby="imr70018-bib-0257">257</a>, <a href="#imr70018-bib-0263" class="usa-link" aria-describedby="imr70018-bib-0263">263</a>, <a href="#imr70018-bib-0264" class="usa-link" aria-describedby="imr70018-bib-0264">264</a>, <a href="#imr70018-bib-0266" class="usa-link" aria-describedby="imr70018-bib-0266">266</a>, <a href="#imr70018-bib-0291" class="usa-link" aria-describedby="imr70018-bib-0291">291</a>, <a href="#imr70018-bib-0292" class="usa-link" aria-describedby="imr70018-bib-0292">292</a>, <a href="#imr70018-bib-0293" class="usa-link" aria-describedby="imr70018-bib-0293">293</a>, <a href="#imr70018-bib-0294" class="usa-link" aria-describedby="imr70018-bib-0294">294</a>]. These investigational therapies have not been continued either due to a lack of effect on allergen‐induced responses or an unsatisfactory adverse event profile. A summary of the effects of these therapies on allergen‐induced sputum eosinophil levels is shown in Table <a href="#imr70018-tbl-0001" class="usa-link">1</a>.</p></section><section id="imr70018-sec-0021"><h3 class="pmc_sec_title">9.3. Therapies Targeting Dendritic Cell and Epithelium Interactions</h3>
<p>A more comprehensive understanding of airway inflammation regulation, including the role of dendritic cells and epithelial cell interactions on the immunopathobiology of asthma, has led to the development of drugs targeting key pathways upstream of T2 cytokines and IgE. Blockade of OX40L is one such approach that has been tested in recognition of the important role of its expression by dendritic cells polarizing naïve T cells to Th2 effector cells and its role in TSLP‐driven allergic inflammation [<a href="#imr70018-bib-0254" class="usa-link" aria-describedby="imr70018-bib-0254">254</a>, <a href="#imr70018-bib-0265" class="usa-link" aria-describedby="imr70018-bib-0265">265</a>]. OX40L blockade in the allergen challenge model had a small but significant effect on reducing total IgE, and by approximately 4 months after the initiation of treatment, there was a reduction in sputum eosinophils [<a href="#imr70018-bib-0295" class="usa-link" aria-describedby="imr70018-bib-0295">295</a>]. We saw no effect on any allergen‐induced outcomes, including EAR, LAR, and AHR, and redundancy in the regulation of Th2 inflammation may diminish the impact of targeting OX40 signaling alone. On the other hand, blocking TSLP, which is known to upregulate expression of OX40L on DCs in addition to directly activating a host of effector cells, including ILC2, mast cells, and basophils, has been shown to successfully inhibit all allergen‐induced responses. Studies using IV tezepelumab as well as the inhaled TSLP fragment, ecleralimab, resulted in the reduction of EAR, LAR, eosinophils in sputum, and FeNO levels [<a href="#imr70018-bib-0251" class="usa-link" aria-describedby="imr70018-bib-0251">251</a>, <a href="#imr70018-bib-0255" class="usa-link" aria-describedby="imr70018-bib-0255">255</a>]. The reduction in EAR, in particular, suggests that TSLP, through direct or indirect activation of mast cells and/or basophils, contributes to this acute bronchoconstriction response. We have shown that TSLP receptors, as well as receptors for other alarmin cytokines IL‐25 and IL‐33, increase on basophils post‐allergen inhalation and that TSLP stimulation activates basophils collected from allergic donors [<a href="#imr70018-bib-0133" class="usa-link" aria-describedby="imr70018-bib-0133">133</a>]. Systemic but not inhaled anti‐TSLP also inhibited blood eosinophils [<a href="#imr70018-bib-0251" class="usa-link" aria-describedby="imr70018-bib-0251">251</a>], as the inhaled formulation would not be expected to have any effect outside the airways. These inhaled allergen challenge studies have led us to understand the relevant impact of various allergic pathways on the recruitment of central effector cells to the airways and the corresponding effects on allergen‐induced pathophysiology. In these studies, inhibition of allergen‐induced airway eosinophils has emerged as an important biomarker for assessing the efficacy of new therapeutics.</p></section></section><section id="imr70018-sec-0022"><h2 class="pmc_sec_title">10. Eosinophil, Basophil, and Mast Cell Subsets in Asthma</h2>
<p>There is an increasing appreciation for the multifunctional role of effector cells. It has been well documented that mature cell populations are not structurally, functionally, or immunologically homogeneous, and they are characterized by their localization, expression of surface receptors, function, and hence contribution to the pathogenesis of diseases like asthma.</p>
<p>Human mast cells have traditionally been identified as tryptase‐positive cells and divided into two subtypes based on the presence (MC<sub>TC</sub>) or absence (MC<sub>T</sub>) of the protease granule chymase [<a href="#imr70018-bib-0296" class="usa-link" aria-describedby="imr70018-bib-0296">296</a>, <a href="#imr70018-bib-0297" class="usa-link" aria-describedby="imr70018-bib-0297">297</a>]. These mast cell subtypes are location‐specific, with those expressing both tryptase and chymase located mainly in the airway submucosa in contrast to mast cells that mainly express tryptase but not chymase located mainly in the airway mucosa. More recently, another population of mast cells, characterized by high expression of carboxypeptidase A3 but not chymase (MC<sub>T/CPA3</sub>) has been identified in the airway epithelium and lumen of asthmatics [<a href="#imr70018-bib-0298" class="usa-link" aria-describedby="imr70018-bib-0298">298</a>, <a href="#imr70018-bib-0299" class="usa-link" aria-describedby="imr70018-bib-0299">299</a>, <a href="#imr70018-bib-0300" class="usa-link" aria-describedby="imr70018-bib-0300">300</a>], and these intraepithelial mast cells have been associated with AHR and T2 airway inflammation [<a href="#imr70018-bib-0301" class="usa-link" aria-describedby="imr70018-bib-0301">301</a>]. With the introduction of biologics that target specific inflammatory pathways, we can begin to deplete subgroups of mast cells, for example, as observed by a significant reduction of IL‐5Rα positive mast cells in the skin of patients with AD following treatment with benralizumab [<a href="#imr70018-bib-0111" class="usa-link" aria-describedby="imr70018-bib-0111">111</a>]. Improved technology to measure a higher number of proteins has permitted the demonstration of considerable heterogeneity in basophil populations from healthy donors, with the identification of 4 unique subpopulations [<a href="#imr70018-bib-0302" class="usa-link" aria-describedby="imr70018-bib-0302">302</a>]. Interestingly, with this same methodology, there was minimal heterogeneity seen in eosinophils and neutrophils. Furthermore, we have shown that surface receptor expression of blood and sputum basophils is regulated by external stimuli such as inhaled allergens [<a href="#imr70018-bib-0303" class="usa-link" aria-describedby="imr70018-bib-0303">303</a>], possibly through upregulation of receptors for alarmin cytokines [<a href="#imr70018-bib-0133" class="usa-link" aria-describedby="imr70018-bib-0133">133</a>].</p>
<p>The literature examining eosinophil subsets has been growing rapidly, and generally adopted nomenclature developed from murine studies classifies eosinophils as resident (rEos) and inflammatory (iEos) eosinophils based on the expression of receptors for IL‐3 (CD123) and L‐selectin (CD62L) [<a href="#imr70018-bib-0304" class="usa-link" aria-describedby="imr70018-bib-0304">304</a>, <a href="#imr70018-bib-0305" class="usa-link" aria-describedby="imr70018-bib-0305">305</a>]. This seminal paper demonstrated higher expression of several proinflammatory genes in iEOS, whereas rEOS express several genes implicated in tissue homeostasis. Our work measuring differential expression of cell surface receptors, including IL‐5, Siglec 8, and CRTH2 on iEos and rEos in the blood of asthmatics supports the proposed functions of these eosinophil subsets (unpublished data). Furthermore, we have also shown that the frequency of iEos differs across respiratory diseases, across peripheral and airway compartments [<a href="#imr70018-bib-0306" class="usa-link" aria-describedby="imr70018-bib-0306">306</a>] and also shifts in response to exposure to inhaled allergens [<a href="#imr70018-bib-0307" class="usa-link" aria-describedby="imr70018-bib-0307">307</a>], further suggesting that eosinophil subsets may be fulfilling different functions. Evidence for allergen‐induced increases in activated eosinophils has been described by elevated EG2+ eosinophils in the sputum of asthmatics [<a href="#imr70018-bib-0088" class="usa-link" aria-describedby="imr70018-bib-0088">88</a>] and in the skin of patients with atopic dermatitis [<a href="#imr70018-bib-0111" class="usa-link" aria-describedby="imr70018-bib-0111">111</a>]. Furthermore, we have shown that benralizumab treatment significantly inhibits the allergen‐induced accumulation of EG2+ eosinophils in the skin of atopic dermatitis patients, but with no effect on MPB+ eosinophils [<a href="#imr70018-bib-0111" class="usa-link" aria-describedby="imr70018-bib-0111">111</a>], suggesting there is an IL‐5‐independent subset of eosinophils that remains in tissue even after circulating levels have been depleted by benralizumab. Studies examining the responsiveness of eosinophil subsets to therapy are ongoing, testing the hypothesis that central effector cells in allergic disease can be divided into subsets capable of responding differently to therapeutic intervention or to environmental stimuli. These studies will improve our current understanding of the immunopathogenesis of asthmatic responses to inhaled allergens [<a href="#imr70018-bib-0226" class="usa-link" aria-describedby="imr70018-bib-0226">226</a>].</p></section><section id="imr70018-sec-0023"><h2 class="pmc_sec_title">11. Summary and Conclusion</h2>
<p>Clinical trials evaluating the effects of novel anti‐inflammatory medications on allergen‐induced inflammation have demonstrated consistent associations with the corresponding airway responses, including bronchoconstriction and AHR. Although the role of mast cells and basophils in the immunopathobiology of asthma has been under investigation for many years, the introduction of novel medications that specifically deplete these cells will be required for a full appreciation of their respective roles. What is certain is that patients with severe eosinophilic asthma benefit from anti‐IL5/IL5Rα treatment, suggesting that IL‐5 dependent eosinophils, at least in part, drive the immunopathobiology of asthma exacerbation. The regulation of eosinophil accumulation into allergic airways continues to be a useful biomarker to gauge the anti‐inflammatory activity of investigational medications developed for the treatment of asthma. Additional studies into the function of eosinophil subsets will help to define the roles of these cells in disease.</p></section><section id="imr70018-sec-1015"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="imr70018-sec-0024" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This chapter would not have been possible without the unique and outstanding expertise of our colleagues and mentors at McMaster University, who conducted much of the seminal work and contributed to many of the studies described here.</p></section><section id="notes1"><section id="imr70018-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="imr70018-note-0001"><p>
<strong>Funding:</strong> The authors received no specific funding for this work.</p></div></div></section></section><section id="imr70018-sec-0026"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The authors have nothing to report.</p></section><section id="imr70018-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="imr70018-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="imr70018-bib-0001">
<span class="label">1.</span><cite>
Kitamura Y., Yokoyama M., Matsuda H., Ohno T., and Mori K., “Spleen Colony‐Forming Cell as Common Precursor for Tissue Mast Cells and Granulocytes,” Nature
291, no. 5811 (1981): 159–160.
</cite> [<a href="https://doi.org/10.1038/291159a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6112711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Spleen%20Colony%E2%80%90Forming%20Cell%20as%20Common%20Precursor%20for%20Tissue%20Mast%20Cells%20and%20Granulocytes&amp;author=Y.%20Kitamura&amp;author=M.%20Yokoyama&amp;author=H.%20Matsuda&amp;author=T.%20Ohno&amp;author=K.%20Mori&amp;volume=291&amp;issue=5811&amp;publication_year=1981&amp;pages=159-160&amp;pmid=6112711&amp;doi=10.1038/291159a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0002">
<span class="label">2.</span><cite>
Saito H., Hatake K., Dvorak A. M., et al., “Selective Differentiation and Proliferation of Hematopoietic Cells Induced by Recombinant Human Interleukins,” Proceedings National Academy of Sciences of the United States of America
85, no. 7 (1988): 2288–2292.</cite> [<a href="https://doi.org/10.1073/pnas.85.7.2288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC279976/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3258425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America&amp;title=Selective%20Differentiation%20and%20Proliferation%20of%20Hematopoietic%20Cells%20Induced%20by%20Recombinant%20Human%20Interleukins&amp;author=H.%20Saito&amp;author=K.%20Hatake&amp;author=A.%20M.%20Dvorak&amp;volume=85&amp;issue=7&amp;publication_year=1988&amp;pages=2288-2292&amp;pmid=3258425&amp;doi=10.1073/pnas.85.7.2288&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0003">
<span class="label">3.</span><cite>
Clutterbuck E. J. and Sanderson C. J., “Regulation of Human Eosinophil Precursor Production by Cytokines: A Comparison of Recombinant Human Interleukin‐1 (rhIL‐1), rhIL‐3, rhIL‐5, rhIL‐6, and rh Granulocyte‐Macrophage Colony‐Stimulating Factor,”
1990.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2184902/" class="usa-link">PubMed</a>]</li>
<li id="imr70018-bib-0004">
<span class="label">4.</span><cite>
Valent P., Spanblochl E., Sperr W. R., et al., “Induction of Differentiation of Human Mast Cells From Bone Marrow and Peripheral Blood Mononuclear Cells by Recombinant Human Stem Cell Factor/Kit‐Ligand in Long‐Term Culture,” Blood
80, no. 9 (1992): 2237–2245, 10.1182/blood.V80.9.2237.2237.
</cite> [<a href="https://doi.org/10.1182/blood.V80.9.2237.2237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1384799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Induction%20of%20Differentiation%20of%20Human%20Mast%20Cells%20From%20Bone%20Marrow%20and%20Peripheral%20Blood%20Mononuclear%20Cells%20by%20Recombinant%20Human%20Stem%20Cell%20Factor/Kit%E2%80%90Ligand%20in%20Long%E2%80%90Term%20Culture&amp;author=P.%20Valent&amp;author=E.%20Spanblochl&amp;author=W.%20R.%20Sperr&amp;volume=80&amp;issue=9&amp;publication_year=1992&amp;pages=2237-2245&amp;pmid=1384799&amp;doi=10.1182/blood.V80.9.2237.2237&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0005">
<span class="label">5.</span><cite>
Mitsui H., Furitsu T., Dvorak A. M., et al., “Development of Human Mast Cells From Umbilical Cord Blood Cells by Recombinant Human and Murine c‐Kit Ligand,” Proceedings of the National Academy of Sciences of the United States of America
90, no. 2 (1993): 735–739, 10.1073/pnas.90.2.735.
</cite> [<a href="https://doi.org/10.1073/pnas.90.2.735" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC45740/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7678463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America&amp;title=Development%20of%20Human%20Mast%20Cells%20From%20Umbilical%20Cord%20Blood%20Cells%20by%20Recombinant%20Human%20and%20Murine%20c%E2%80%90Kit%20Ligand&amp;author=H.%20Mitsui&amp;author=T.%20Furitsu&amp;author=A.%20M.%20Dvorak&amp;volume=90&amp;issue=2&amp;publication_year=1993&amp;pages=735-739&amp;pmid=7678463&amp;doi=10.1073/pnas.90.2.735&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0006">
<span class="label">6.</span><cite>
Columbo M., Horowitz E. M., Botana L. M., et al., “The Human Recombinant c‐Kit Receptor Ligand, rhSCF, Induces Mediator Release From Human Cutaneous Mast Cells and Enhances IgE‐Dependent Mediator Release From Both Skin Mast Cells and Peripheral Blood Basophils,” Journal of Immunology
149, no. 2 (1992): 599–608.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1378071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=The%20Human%20Recombinant%20c%E2%80%90Kit%20Receptor%20Ligand,%20rhSCF,%20Induces%20Mediator%20Release%20From%20Human%20Cutaneous%20Mast%20Cells%20and%20Enhances%20IgE%E2%80%90Dependent%20Mediator%20Release%20From%20Both%20Skin%20Mast%20Cells%20and%20Peripheral%20Blood%20Basophils&amp;author=M.%20Columbo&amp;author=E.%20M.%20Horowitz&amp;author=L.%20M.%20Botana&amp;volume=149&amp;issue=2&amp;publication_year=1992&amp;pages=599-608&amp;pmid=1378071&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0007">
<span class="label">7.</span><cite>
Sperr W., Czerwenka K., Mundigler G., et al., “Specific Activation of Human Mast Cells by the Ligand for c‐Kit: Comparison Between Lung, Uterus and Heart Mast Cells,” International Archives of Allergy and Immunology
102, no. 2 (1993): 170–175, 10.1159/000236568.
</cite> [<a href="https://doi.org/10.1159/000236568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7691300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Archives%20of%20Allergy%20and%20Immunology&amp;title=Specific%20Activation%20of%20Human%20Mast%20Cells%20by%20the%20Ligand%20for%20c%E2%80%90Kit:%20Comparison%20Between%20Lung,%20Uterus%20and%20Heart%20Mast%20Cells&amp;author=W.%20Sperr&amp;author=K.%20Czerwenka&amp;author=G.%20Mundigler&amp;volume=102&amp;issue=2&amp;publication_year=1993&amp;pages=170-175&amp;pmid=7691300&amp;doi=10.1159/000236568&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0008">
<span class="label">8.</span><cite>
Sergejeva S., Johansson A.‐K., Malmhäll C., and Lötvall J., “Allergen Exposure–Induced Differences in CD34+ Cell Phenotype: Relationship to Eosinophilopoietic Responses in Different Compartments,” Blood
103, no. 4 (2004): 1270–1277.
</cite> [<a href="https://doi.org/10.1182/blood-2003-05-1618" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14512324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Allergen%20Exposure%E2%80%93Induced%20Differences%20in%20CD34+%20Cell%20Phenotype:%20Relationship%20to%20Eosinophilopoietic%20Responses%20in%20Different%20Compartments&amp;author=S.%20Sergejeva&amp;author=A.%E2%80%90K.%20Johansson&amp;author=C.%20Malmh%C3%A4ll&amp;author=J.%20L%C3%B6tvall&amp;volume=103&amp;issue=4&amp;publication_year=2004&amp;pages=1270-1277&amp;pmid=14512324&amp;doi=10.1182/blood-2003-05-1618&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0009">
<span class="label">9.</span><cite>
Sehmi R., Howie K., Sutherland D. R., Schragge W., O'Byrne P. M., and Denburg J. A., “Increased Levels of CD34+ Hemopoietic Progenitor Cells in Atopic Subjects,” American Journal of Respiratory Cell and Molecular Biology
15, no. 5 (1996): 645–655.
</cite> [<a href="https://doi.org/10.1165/ajrcmb.15.5.8918371" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8918371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20Cell%20and%20Molecular%20Biology&amp;title=Increased%20Levels%20of%20CD34+%20Hemopoietic%20Progenitor%20Cells%20in%20Atopic%20Subjects&amp;author=R.%20Sehmi&amp;author=K.%20Howie&amp;author=D.%20R.%20Sutherland&amp;author=W.%20Schragge&amp;author=P.%20M.%20O'Byrne&amp;volume=15&amp;issue=5&amp;publication_year=1996&amp;pages=645-655&amp;pmid=8918371&amp;doi=10.1165/ajrcmb.15.5.8918371&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0010">
<span class="label">10.</span><cite>
Makowska J. S., Grzegorczyk J., Ciéslak M., Biénkiewicz B., and Kowalski M. L., “Recruitment of CD34+ Progenitor Cells Into Peripheral Blood and Asthma Severity,” Annals of Allergy, Asthma and Immunology
101, no. 4 (2008): 402–406.</cite> [<a href="https://doi.org/10.1016/S1081-1206(10)60317-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18939729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Allergy,%20Asthma%20and%20Immunology&amp;title=Recruitment%20of%20CD34+%20Progenitor%20Cells%20Into%20Peripheral%20Blood%20and%20Asthma%20Severity&amp;author=J.%20S.%20Makowska&amp;author=J.%20Grzegorczyk&amp;author=M.%20Ci%C3%A9slak&amp;author=B.%20Bi%C3%A9nkiewicz&amp;author=M.%20L.%20Kowalski&amp;volume=101&amp;issue=4&amp;publication_year=2008&amp;pages=402-406&amp;pmid=18939729&amp;doi=10.1016/S1081-1206(10)60317-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0011">
<span class="label">11.</span><cite>
Dahl C., Hoffmann H. J., Saito H., and Schiøtz P., “Human Mast Cells Express Receptors for IL‐3, IL‐5 and GM‐CSF; a Partial Map of Receptors on Human Mast Cells Cultured In Vitro,” Allergy
59, no. 10 (2004): 1087–1096.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2004.00606.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15355468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Human%20Mast%20Cells%20Express%20Receptors%20for%20IL%E2%80%903,%20IL%E2%80%905%20and%20GM%E2%80%90CSF;%20a%20Partial%20Map%20of%20Receptors%20on%20Human%20Mast%20Cells%20Cultured%20In%C2%A0Vitro&amp;author=C.%20Dahl&amp;author=H.%20J.%20Hoffmann&amp;author=H.%20Saito&amp;author=P.%20Schi%C3%B8tz&amp;volume=59&amp;issue=10&amp;publication_year=2004&amp;pages=1087-1096&amp;pmid=15355468&amp;doi=10.1111/j.1398-9995.2004.00606.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0012">
<span class="label">12.</span><cite>
Sehmi R., Wood L. J., Watson R., et al., “Allergen‐Induced Increases in IL‐5 Receptor Alpha‐Subunit Expression on Bone Marrow‐Derived CD34+ Cells From Asthmatic Subjects. A Novel Marker of Progenitor Cell Commitment Towards Eosinophilic Differentiation,” Journal of Clinical Investigation
100, no. 10 (1997): 2466–2475.
</cite> [<a href="https://doi.org/10.1172/JCI119789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC508447/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9366561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Allergen%E2%80%90Induced%20Increases%20in%20IL%E2%80%905%20Receptor%20Alpha%E2%80%90Subunit%20Expression%20on%20Bone%20Marrow%E2%80%90Derived%20CD34+%20Cells%20From%20Asthmatic%20Subjects.%20A%20Novel%20Marker%20of%20Progenitor%20Cell%20Commitment%20Towards%20Eosinophilic%20Differentiation&amp;author=R.%20Sehmi&amp;author=L.%20J.%20Wood&amp;author=R.%20Watson&amp;volume=100&amp;issue=10&amp;publication_year=1997&amp;pages=2466-2475&amp;pmid=9366561&amp;doi=10.1172/JCI119789&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0013">
<span class="label">13.</span><cite>
Tavernier J., Van der Heyden J., Verhee A., et al., “Interleukin 5 Regulates the Isoform Expression of Its Own Receptor α‐Subunit,” Blood
95, no. 5 (2000): 1600–1607.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10688814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Interleukin%205%20Regulates%20the%20Isoform%20Expression%20of%20Its%20Own%20Receptor%20%CE%B1%E2%80%90Subunit&amp;author=J.%20Tavernier&amp;author=J.%20Van%20der%20Heyden&amp;author=A.%20Verhee&amp;volume=95&amp;issue=5&amp;publication_year=2000&amp;pages=1600-1607&amp;pmid=10688814&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0014">
<span class="label">14.</span><cite>
Kopf M., Brombacher F., Hodgkin P. D., et al., “IL‐5‐Deficient Mice Have a Developmental Defect in CD5+ B‐1 Cells and Lack Eosinophilia but Have Normal Antibody and Cytotoxic T Cell Responses,” Immunity
4, no. 1 (1996): 15–24.
</cite> [<a href="https://doi.org/10.1016/s1074-7613(00)80294-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8574848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=IL%E2%80%905%E2%80%90Deficient%20Mice%20Have%20a%20Developmental%20Defect%20in%20CD5+%20B%E2%80%901%20Cells%20and%20Lack%20Eosinophilia%20but%20Have%20Normal%20Antibody%20and%20Cytotoxic%20T%20Cell%20Responses&amp;author=M.%20Kopf&amp;author=F.%20Brombacher&amp;author=P.%20D.%20Hodgkin&amp;volume=4&amp;issue=1&amp;publication_year=1996&amp;pages=15-24&amp;pmid=8574848&amp;doi=10.1016/s1074-7613(00)80294-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0015">
<span class="label">15.</span><cite>
Sitkauskiene B., Johansson A.‐K., Sergejeva S., Lundin S., Sjostrand M., and Lotvall J., “Regulation of Bone Marrow and Airway CD34+ Eosinophils by Interleukin‐5,” American Journal of Respiratory Cell and Molecular Biology
30, no. 3 (2004): 367–378.
</cite> [<a href="https://doi.org/10.1165/rcmb.2002-0311OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12920051/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20Cell%20and%20Molecular%20Biology&amp;title=Regulation%20of%20Bone%20Marrow%20and%20Airway%20CD34+%20Eosinophils%20by%20Interleukin%E2%80%905&amp;author=B.%20Sitkauskiene&amp;author=A.%E2%80%90K.%20Johansson&amp;author=S.%20Sergejeva&amp;author=S.%20Lundin&amp;author=M.%20Sjostrand&amp;volume=30&amp;issue=3&amp;publication_year=2004&amp;pages=367-378&amp;pmid=12920051&amp;doi=10.1165/rcmb.2002-0311OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0016">
<span class="label">16.</span><cite>
Kirshenbaum A., Goff J., Kessler S. W., Mican J., Zsebo K., and Metcalfe D., “Effect of IL‐3 and Stem Cell Factor on the Appearance of Human Basophils and Mast Cells From CD34+ Pluripotent Progenitor Cells,” Journal of Immunology
148, no. 3 (1992): 772–777.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1370517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Effect%20of%20IL%E2%80%903%20and%20Stem%20Cell%20Factor%20on%20the%20Appearance%20of%20Human%20Basophils%20and%20Mast%20Cells%20From%20CD34+%20Pluripotent%20Progenitor%20Cells&amp;author=A.%20Kirshenbaum&amp;author=J.%20Goff&amp;author=S.%20W.%20Kessler&amp;author=J.%20Mican&amp;author=K.%20Zsebo&amp;volume=148&amp;issue=3&amp;publication_year=1992&amp;pages=772-777&amp;pmid=1370517&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0017">
<span class="label">17.</span><cite>
Shen T., Kim S., Do J.‐s., et al., “T Cell‐Derived IL‐3 Plays Key Role in Parasite Infection‐Induced Basophil Production but Is Dispensable for In Vivo Basophil Survival,” International Immunology
20, no. 9 (2008): 1201–1209, 10.1093/intimm/dxn077.
</cite> [<a href="https://doi.org/10.1093/intimm/dxn077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18632726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Immunology&amp;title=T%20Cell%E2%80%90Derived%20IL%E2%80%903%20Plays%20Key%20Role%20in%20Parasite%20Infection%E2%80%90Induced%20Basophil%20Production%20but%20Is%20Dispensable%20for%20In%C2%A0Vivo%20Basophil%20Survival&amp;author=T.%20Shen&amp;author=S.%20Kim&amp;author=J.%E2%80%90s.%20Do&amp;volume=20&amp;issue=9&amp;publication_year=2008&amp;pages=1201-1209&amp;pmid=18632726&amp;doi=10.1093/intimm/dxn077&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0018">
<span class="label">18.</span><cite>
Siracusa M. C., Comeau M. R., and Artis D., “New Insights Into Basophil Biology: Initiators, Regulators, and Effectors of Type 2 Inflammation,” Annals of the New York Academy of Sciences
1217, no. 1 (2011): 166–177.
</cite> [<a href="https://doi.org/10.1111/j.1749-6632.2010.05918.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3076807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21276006/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&amp;title=New%20Insights%20Into%20Basophil%20Biology:%20Initiators,%20Regulators,%20and%20Effectors%20of%20Type%202%20Inflammation&amp;author=M.%20C.%20Siracusa&amp;author=M.%20R.%20Comeau&amp;author=D.%20Artis&amp;volume=1217&amp;issue=1&amp;publication_year=2011&amp;pages=166-177&amp;pmid=21276006&amp;doi=10.1111/j.1749-6632.2010.05918.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0019">
<span class="label">19.</span><cite>
Giacomin P. R., Siracusa M. C., Walsh K. P., et al., “Thymic Stromal Lymphopoietin‐Dependent Basophils Promote Th2 Cytokine Responses Following Intestinal Helminth Infection,” Journal of Immunology
189, no. 9 (2012): 4371–4378.</cite> [<a href="https://doi.org/10.4049/jimmunol.1200691" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3478488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23024277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Thymic%20Stromal%20Lymphopoietin%E2%80%90Dependent%20Basophils%20Promote%20Th2%20Cytokine%20Responses%20Following%20Intestinal%20Helminth%20Infection&amp;author=P.%20R.%20Giacomin&amp;author=M.%20C.%20Siracusa&amp;author=K.%20P.%20Walsh&amp;volume=189&amp;issue=9&amp;publication_year=2012&amp;pages=4371-4378&amp;pmid=23024277&amp;doi=10.4049/jimmunol.1200691&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0020">
<span class="label">20.</span><cite>
Robinson D. S., Damia R., Zeibecoglou K., et al., “CD34+/Interleukin‐5R α Messenger RNA+ Cells in the Bronchial Mucosa in Asthma: Potential Airway Eosinophil Progenitors,” American Journal of Respiratory Cell and Molecular Biology
20, no. 1 (1999): 9–13.
</cite> [<a href="https://doi.org/10.1165/ajrcmb.20.1.3449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9870912/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20Cell%20and%20Molecular%20Biology&amp;title=CD34+/Interleukin%E2%80%905R%20%CE%B1%20Messenger%20RNA+%20Cells%20in%20the%20Bronchial%20Mucosa%20in%20Asthma:%20Potential%20Airway%20Eosinophil%20Progenitors&amp;author=D.%20S.%20Robinson&amp;author=R.%20Damia&amp;author=K.%20Zeibecoglou&amp;volume=20&amp;issue=1&amp;publication_year=1999&amp;pages=9-13&amp;pmid=9870912&amp;doi=10.1165/ajrcmb.20.1.3449&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0021">
<span class="label">21.</span><cite>
Kim Y.‐K., Uno M., Hamilos D. L., et al., “Immunolocalization of CD34 in Nasal Polyposis: Effect of Topical Corticosteroids,” American Journal of Respiratory Cell and Molecular Biology
20, no. 3 (1999): 388–397.
</cite> [<a href="https://doi.org/10.1165/ajrcmb.20.3.3060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10030836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20Cell%20and%20Molecular%20Biology&amp;title=Immunolocalization%20of%20CD34%20in%20Nasal%20Polyposis:%20Effect%20of%20Topical%20Corticosteroids&amp;author=Y.%E2%80%90K.%20Kim&amp;author=M.%20Uno&amp;author=D.%20L.%20Hamilos&amp;volume=20&amp;issue=3&amp;publication_year=1999&amp;pages=388-397&amp;pmid=10030836&amp;doi=10.1165/ajrcmb.20.3.3060&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0022">
<span class="label">22.</span><cite>
Mastrandrea F., Cadario G., Nicotra M., and Natali P., “Hemopoietic Progenitor Cells in Atopic Dermatitis Skin Lesions,” Journal of Investigational Allergology and Clinical Immunology
9, no. 6 (1999): 386–391.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10664934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Investigational%20Allergology%20and%20Clinical%20Immunology&amp;title=Hemopoietic%20Progenitor%20Cells%20in%20Atopic%20Dermatitis%20Skin%20Lesions&amp;author=F.%20Mastrandrea&amp;author=G.%20Cadario&amp;author=M.%20Nicotra&amp;author=P.%20Natali&amp;volume=9&amp;issue=6&amp;publication_year=1999&amp;pages=386-391&amp;pmid=10664934&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0023">
<span class="label">23.</span><cite>
Cameron L., Christodoulopoulos P., Lavigne F., et al., “Evidence for Local Eosinophil Differentiation Within Allergic Nasal Mucosa: Inhibition With Soluble IL‐5 Receptor,” Journal of Immunology
164, no. 3 (2000): 1538–1545.</cite> [<a href="https://doi.org/10.4049/jimmunol.164.3.1538" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10640772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Evidence%20for%20Local%20Eosinophil%20Differentiation%20Within%20Allergic%20Nasal%20Mucosa:%20Inhibition%20With%20Soluble%20IL%E2%80%905%20Receptor&amp;author=L.%20Cameron&amp;author=P.%20Christodoulopoulos&amp;author=F.%20Lavigne&amp;volume=164&amp;issue=3&amp;publication_year=2000&amp;pages=1538-1545&amp;pmid=10640772&amp;doi=10.4049/jimmunol.164.3.1538&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0024">
<span class="label">24.</span><cite>
Fanat A., Thomson J., Radford K., Nair P., and Sehmi R., “Human Airway Smooth Muscle Promotes Eosinophil Differentiation,” Clinical and Experimental Allergy
39, no. 7 (2009): 1009–1017.
</cite> [<a href="https://doi.org/10.1111/j.1365-2222.2009.03246.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19438586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Human%20Airway%20Smooth%20Muscle%20Promotes%20Eosinophil%20Differentiation&amp;author=A.%20Fanat&amp;author=J.%20Thomson&amp;author=K.%20Radford&amp;author=P.%20Nair&amp;author=R.%20Sehmi&amp;volume=39&amp;issue=7&amp;publication_year=2009&amp;pages=1009-1017&amp;pmid=19438586&amp;doi=10.1111/j.1365-2222.2009.03246.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0025">
<span class="label">25.</span><cite>
Shi H.‐Z., Li C.‐Q., Qin S.‐M., Xie Z.‐F., and Liu Y., “Effect of Inhaled Interleukin‐5 on Number and Activity of Eosinophils in Circulation From Asthmatics,” Clinical Immunology
91, no. 2 (1999): 163–169.
</cite> [<a href="https://doi.org/10.1006/clim.1999.4699" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10227808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Immunology&amp;title=Effect%20of%20Inhaled%20Interleukin%E2%80%905%20on%20Number%20and%20Activity%20of%20Eosinophils%20in%20Circulation%20From%20Asthmatics&amp;author=H.%E2%80%90Z.%20Shi&amp;author=C.%E2%80%90Q.%20Li&amp;author=S.%E2%80%90M.%20Qin&amp;author=Z.%E2%80%90F.%20Xie&amp;author=Y.%20Liu&amp;volume=91&amp;issue=2&amp;publication_year=1999&amp;pages=163-169&amp;pmid=10227808&amp;doi=10.1006/clim.1999.4699&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0026">
<span class="label">26.</span><cite>
Shi H.‐Z., Xiao C.‐Q., Zhong D., et al., “Effect of Inhaled Interleukin‐5 on Airway Hyperreactivity and Eosinophilia in Asthmatics,” American Journal of Respiratory and Critical Care Medicine
157, no. 1 (1998): 204–209.
</cite> [<a href="https://doi.org/10.1164/ajrccm.157.1.9703027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9445301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Effect%20of%20Inhaled%20Interleukin%E2%80%905%20on%20Airway%20Hyperreactivity%20and%20Eosinophilia%20in%20Asthmatics&amp;author=H.%E2%80%90Z.%20Shi&amp;author=C.%E2%80%90Q.%20Xiao&amp;author=D.%20Zhong&amp;volume=157&amp;issue=1&amp;publication_year=1998&amp;pages=204-209&amp;pmid=9445301&amp;doi=10.1164/ajrccm.157.1.9703027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0027">
<span class="label">27.</span><cite>
Stirling R. G., Van Rensen E. L., Barnes P. J., and Fan Chung K., “Interleukin‐5 Induces CD34+ Eosinophil Progenitor Mobilization and Eosinophil CCR3 Expression in Asthma,” American Journal of Respiratory and Critical Care Medicine
164, no. 8 (2001): 1403–1409.
</cite> [<a href="https://doi.org/10.1164/ajrccm.164.8.2010002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11704586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Interleukin%E2%80%905%20Induces%20CD34+%20Eosinophil%20Progenitor%20Mobilization%20and%20Eosinophil%20CCR3%20Expression%20in%20Asthma&amp;author=R.%20G.%20Stirling&amp;author=E.%20L.%20Van%20Rensen&amp;author=P.%20J.%20Barnes&amp;author=K.%20Fan%20Chung&amp;volume=164&amp;issue=8&amp;publication_year=2001&amp;pages=1403-1409&amp;pmid=11704586&amp;doi=10.1164/ajrccm.164.8.2010002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0028">
<span class="label">28.</span><cite>
van Rensen E. L., Stirling R. G., Scheerens J., et al., “Evidence for Systemic Rather Than Pulmonary Effects of Interleukin‐5 Administration in Asthma,” Thorax
56, no. 12 (2001): 935–940, 10.1136/thorax.56.12.935.
</cite> [<a href="https://doi.org/10.1136/thorax.56.12.935" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1745987/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11713356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorax&amp;title=Evidence%20for%20Systemic%20Rather%20Than%20Pulmonary%20Effects%20of%20Interleukin%E2%80%905%20Administration%20in%20Asthma&amp;author=E.%20L.%20van%20Rensen&amp;author=R.%20G.%20Stirling&amp;author=J.%20Scheerens&amp;volume=56&amp;issue=12&amp;publication_year=2001&amp;pages=935-940&amp;pmid=11713356&amp;doi=10.1136/thorax.56.12.935&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0029">
<span class="label">29.</span><cite>
Menzies‐Gow A., Flood‐Page P., Robinson D., and Kay A., “Effect of Inhaled Interleukin‐5 on Eosinophil Progenitors in the Bronchi and Bone Marrow of Asthmatic and Non‐Asthmatic Volunteers,” Clinical and Experimental Allergy
37, no. 7 (2007): 1023–1032.
</cite> [<a href="https://doi.org/10.1111/j.1365-2222.2007.02735.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17581195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Effect%20of%20Inhaled%20Interleukin%E2%80%905%20on%20Eosinophil%20Progenitors%20in%20the%20Bronchi%20and%20Bone%20Marrow%20of%20Asthmatic%20and%20Non%E2%80%90Asthmatic%20Volunteers&amp;author=A.%20Menzies%E2%80%90Gow&amp;author=P.%20Flood%E2%80%90Page&amp;author=D.%20Robinson&amp;author=A.%20Kay&amp;volume=37&amp;issue=7&amp;publication_year=2007&amp;pages=1023-1032&amp;pmid=17581195&amp;doi=10.1111/j.1365-2222.2007.02735.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0030">
<span class="label">30.</span><cite>
Palframan R. T., Collins P. D., Williams T. J., and Rankin S. M., “Eotaxin Induces a Rapid Release of Eosinophils and Their Progenitors From the Bone Marrow,” Blood
91, no. 7 (1998): 2240–2248.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9516121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Eotaxin%20Induces%20a%20Rapid%20Release%20of%20Eosinophils%20and%20Their%20Progenitors%20From%20the%20Bone%20Marrow&amp;author=R.%20T.%20Palframan&amp;author=P.%20D.%20Collins&amp;author=T.%20J.%20Williams&amp;author=S.%20M.%20Rankin&amp;volume=91&amp;issue=7&amp;publication_year=1998&amp;pages=2240-2248&amp;pmid=9516121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0031">
<span class="label">31.</span><cite>
Galli S. J., “New Insights Into “the Riddle of the Mast Cells”: Microenvironmental Regulation of Mast Cell Development and Phenotypic Heterogeneity,” Pathology Reviews
1990 (1990): 49–77.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2404155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathology%20Reviews&amp;title=New%20Insights%20Into%20%E2%80%9Cthe%20Riddle%20of%20the%20Mast%20Cells%E2%80%9D:%20Microenvironmental%20Regulation%20of%20Mast%20Cell%20Development%20and%20Phenotypic%20Heterogeneity&amp;author=S.%20J.%20Galli&amp;volume=1990&amp;publication_year=1990&amp;pages=49-77&amp;pmid=2404155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0032">
<span class="label">32.</span><cite>
Marichal T., Mesnil C., and Bureau F., “Homeostatic Eosinophils: Characteristics and Functions,” Frontiers in Medicine
4 (2017): 101.
</cite> [<a href="https://doi.org/10.3389/fmed.2017.00101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5504169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28744457/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Medicine&amp;title=Homeostatic%20Eosinophils:%20Characteristics%20and%20Functions&amp;author=T.%20Marichal&amp;author=C.%20Mesnil&amp;author=F.%20Bureau&amp;volume=4&amp;publication_year=2017&amp;pages=101&amp;pmid=28744457&amp;doi=10.3389/fmed.2017.00101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0033">
<span class="label">33.</span><cite>
Chawla A., Nguyen K. D., and Goh Y. S., “Macrophage‐Mediated Inflammation in Metabolic Disease,” Nature Reviews Immunology
11, no. 11 (2011): 738–749.</cite> [<a href="https://doi.org/10.1038/nri3071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3383854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21984069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Immunology&amp;title=Macrophage%E2%80%90Mediated%20Inflammation%20in%20Metabolic%20Disease&amp;author=A.%20Chawla&amp;author=K.%20D.%20Nguyen&amp;author=Y.%20S.%20Goh&amp;volume=11&amp;issue=11&amp;publication_year=2011&amp;pages=738-749&amp;pmid=21984069&amp;doi=10.1038/nri3071&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0034">
<span class="label">34.</span><cite>
Hui C., McNagny K., Denburg J., and Siracusa M., “In Situ Hematopoiesis: A Regulator of TH2 Cytokine‐Mediated Immunity and Inflammation at Mucosal Surfaces,” Mucosal Immunology
8, no. 4 (2015): 701–711.
</cite> [<a href="https://doi.org/10.1038/mi.2015.17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25783967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mucosal%20Immunology&amp;title=In%20Situ%20Hematopoiesis:%20A%20Regulator%20of%20TH2%20Cytokine%E2%80%90Mediated%20Immunity%20and%20Inflammation%20at%20Mucosal%20Surfaces&amp;author=C.%20Hui&amp;author=K.%20McNagny&amp;author=J.%20Denburg&amp;author=M.%20Siracusa&amp;volume=8&amp;issue=4&amp;publication_year=2015&amp;pages=701-711&amp;pmid=25783967&amp;doi=10.1038/mi.2015.17&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0035">
<span class="label">35.</span><cite>
Johnston L. K., Hsu C.‐L., Krier‐Burris R. A., et al., “IL‐33 Precedes IL‐5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis,” Journal of Immunology
197, no. 9 (2016): 3445–3453.</cite> [<a href="https://doi.org/10.4049/jimmunol.1600611" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5101160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27683753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=IL%E2%80%9033%20Precedes%20IL%E2%80%905%20in%20Regulating%20Eosinophil%20Commitment%20and%20Is%20Required%20for%20Eosinophil%20Homeostasis&amp;author=L.%20K.%20Johnston&amp;author=C.%E2%80%90L.%20Hsu&amp;author=R.%20A.%20Krier%E2%80%90Burris&amp;volume=197&amp;issue=9&amp;publication_year=2016&amp;pages=3445-3453&amp;pmid=27683753&amp;doi=10.4049/jimmunol.1600611&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0036">
<span class="label">36.</span><cite>
Smith S. G., Gugilla A., Mukherjee M., et al., “Thymic Stromal Lymphopoietin and IL‐33 Modulate Migration of Hematopoietic Progenitor Cells in Patients With Allergic Asthma,” Journal of Allergy and Clinical Immunology
135, no. 6 (2015): 1594–1602.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2014.12.1918" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25656998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Thymic%20Stromal%20Lymphopoietin%20and%20IL%E2%80%9033%20Modulate%20Migration%20of%20Hematopoietic%20Progenitor%20Cells%20in%20Patients%20With%20Allergic%20Asthma&amp;author=S.%20G.%20Smith&amp;author=A.%20Gugilla&amp;author=M.%20Mukherjee&amp;volume=135&amp;issue=6&amp;publication_year=2015&amp;pages=1594-1602&amp;pmid=25656998&amp;doi=10.1016/j.jaci.2014.12.1918&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0037">
<span class="label">37.</span><cite>
Ito Y., Satoh T., Takayama K., Miyagishi C., Walls A., and Yokozeki H., “Basophil Recruitment and Activation in Inflammatory Skin Diseases,” Allergy
66, no. 8 (2011): 1107–1113.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2011.02570.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21371044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Basophil%20Recruitment%20and%20Activation%20in%20Inflammatory%20Skin%20Diseases&amp;author=Y.%20Ito&amp;author=T.%20Satoh&amp;author=K.%20Takayama&amp;author=C.%20Miyagishi&amp;author=A.%20Walls&amp;volume=66&amp;issue=8&amp;publication_year=2011&amp;pages=1107-1113&amp;pmid=21371044&amp;doi=10.1111/j.1398-9995.2011.02570.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0038">
<span class="label">38.</span><cite>
Uguccioni M., Mackay C. R., Ochensberger B., et al., “High Expression of the Chemokine Receptor CCR3 in Human Blood Basophils. Role in Activation by Eotaxin, MCP‐4, and Other Chemokines,” Journal of Clinical Investigation
100, no. 5 (1997): 1137–1143.
</cite> [<a href="https://doi.org/10.1172/JCI119624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC508288/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9276730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=High%20Expression%20of%20the%20Chemokine%20Receptor%20CCR3%20in%20Human%20Blood%20Basophils.%20Role%20in%20Activation%20by%20Eotaxin,%20MCP%E2%80%904,%20and%20Other%20Chemokines&amp;author=M.%20Uguccioni&amp;author=C.%20R.%20Mackay&amp;author=B.%20Ochensberger&amp;volume=100&amp;issue=5&amp;publication_year=1997&amp;pages=1137-1143&amp;pmid=9276730&amp;doi=10.1172/JCI119624&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0039">
<span class="label">39.</span><cite>
Iikura M., Ebisawa M., Yamaguchi M., et al., “Transendothelial Migration of Human Basophils,” Journal of Immunology
173, no. 8 (2004): 5189–5195.</cite> [<a href="https://doi.org/10.4049/jimmunol.173.8.5189" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15470064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Transendothelial%20Migration%20of%20Human%20Basophils&amp;author=M.%20Iikura&amp;author=M.%20Ebisawa&amp;author=M.%20Yamaguchi&amp;volume=173&amp;issue=8&amp;publication_year=2004&amp;pages=5189-5195&amp;pmid=15470064&amp;doi=10.4049/jimmunol.173.8.5189&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0040">
<span class="label">40.</span><cite>
Liu M. C., Hubbard W. C., Proud D., et al., “Immediate and Late Inflammatory Responses to Ragweed Antigen Challenge of the Peripheral Airways in Allergic Asthmatics: Cellular, Mediator, and Permeability Changes,” American Review of Respiratory Disease
144, no. 1 (1991): 51–58.
</cite> [<a href="https://doi.org/10.1164/ajrccm/144.1.51" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2064141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Review%20of%20Respiratory%20Disease&amp;title=Immediate%20and%20Late%20Inflammatory%20Responses%20to%20Ragweed%20Antigen%20Challenge%20of%20the%20Peripheral%20Airways%20in%20Allergic%20Asthmatics:%20Cellular,%20Mediator,%20and%20Permeability%20Changes&amp;author=M.%20C.%20Liu&amp;author=W.%20C.%20Hubbard&amp;author=D.%20Proud&amp;volume=144&amp;issue=1&amp;publication_year=1991&amp;pages=51-58&amp;pmid=2064141&amp;doi=10.1164/ajrccm/144.1.51&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0041">
<span class="label">41.</span><cite>
Metzger H., “The Receptor With High Affinity for IgE,” Immunological Reviews
125, no. 1 (1992): 37–48.
</cite> [<a href="https://doi.org/10.1111/j.1600-065x.1992.tb00624.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1532373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunological%20Reviews&amp;title=The%20Receptor%20With%20High%20Affinity%20for%20IgE&amp;author=H.%20Metzger&amp;volume=125&amp;issue=1&amp;publication_year=1992&amp;pages=37-48&amp;pmid=1532373&amp;doi=10.1111/j.1600-065x.1992.tb00624.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0042">
<span class="label">42.</span><cite>
Gibbs B. F., Haas H., Falcone F. H., et al., “Purified Human Peripheral Blood Basophils Release Interleukin‐13 and Preformed Interleukin‐4 Following Immunological Activation,” European Journal of Immunology
26, no. 10 (1996): 2493–2498.
</cite> [<a href="https://doi.org/10.1002/eji.1830261033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8898965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Immunology&amp;title=Purified%20Human%20Peripheral%20Blood%20Basophils%20Release%20Interleukin%E2%80%9013%20and%20Preformed%20Interleukin%E2%80%904%20Following%20Immunological%20Activation&amp;author=B.%20F.%20Gibbs&amp;author=H.%20Haas&amp;author=F.%20H.%20Falcone&amp;volume=26&amp;issue=10&amp;publication_year=1996&amp;pages=2493-2498&amp;pmid=8898965&amp;doi=10.1002/eji.1830261033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0043">
<span class="label">43.</span><cite>

D.
MacGlashan, Jr.
, White J. M., Huang S.‐K., Ono S. J., Schroeder J. T., and Lichtenstein L. M., “Secretion of IL‐4 From Human Basophils. The Relationship Between IL‐4 mRNA and Protein in Resting and Stimulated Basophils,” Journal of Immunology
152, no. 6 (1994): 3006–3016.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8144899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Secretion%20of%20IL%E2%80%904%20From%20Human%20Basophils.%20The%20Relationship%20Between%20IL%E2%80%904%20mRNA%20and%20Protein%20in%20Resting%20and%20Stimulated%20Basophils&amp;author=D.%20MacGlashan&amp;author=J.%20M.%20White&amp;author=S.%E2%80%90K.%20Huang&amp;author=S.%20J.%20Ono&amp;author=J.%20T.%20Schroeder&amp;volume=152&amp;issue=6&amp;publication_year=1994&amp;pages=3006-3016&amp;pmid=8144899&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0044">
<span class="label">44.</span><cite>
Yu J., Yan B., Shen S., et al., “IgE Directly Affects Eosinophil Migration in Chronic Rhinosinusitis With Nasal Polyps Through CCR3 and Predicts the Efficacy of Omalizumab,” Journal of Allergy and Clinical Immunology
153, no. 2 (2024): 447–460.e9.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2023.09.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37922997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=IgE%20Directly%20Affects%20Eosinophil%20Migration%20in%20Chronic%20Rhinosinusitis%20With%20Nasal%20Polyps%20Through%20CCR3%20and%20Predicts%20the%20Efficacy%20of%20Omalizumab&amp;author=J.%20Yu&amp;author=B.%20Yan&amp;author=S.%20Shen&amp;volume=153&amp;issue=2&amp;publication_year=2024&amp;pages=447-460&amp;pmid=37922997&amp;doi=10.1016/j.jaci.2023.09.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0045">
<span class="label">45.</span><cite>
Kawakami T., Ando T., Kimura M., Wilson B. S., and Kawakami Y., “Mast Cells in Atopic Dermatitis,” Current Opinion in Immunology
21, no. 6 (2009): 666–678.
</cite> [<a href="https://doi.org/10.1016/j.coi.2009.09.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2839879/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19828304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Immunology&amp;title=Mast%20Cells%20in%20Atopic%20Dermatitis&amp;author=T.%20Kawakami&amp;author=T.%20Ando&amp;author=M.%20Kimura&amp;author=B.%20S.%20Wilson&amp;author=Y.%20Kawakami&amp;volume=21&amp;issue=6&amp;publication_year=2009&amp;pages=666-678&amp;pmid=19828304&amp;doi=10.1016/j.coi.2009.09.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0046">
<span class="label">46.</span><cite>
McHale C., Mohammed Z., Deppen J., and Gomez G., “Interleukin‐6 Potentiates FcεRI‐Induced PGD2 Biosynthesis and Induces VEGF From Human In Situ‐Matured Skin Mast Cells,” Biochimica et Biophysica Acta
1862, no. 5 (2018): 1069–1078.
</cite> [<a href="https://doi.org/10.1016/j.bbagen.2018.01.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5866211/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29410184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochimica%20et%20Biophysica%20Acta&amp;title=Interleukin%E2%80%906%20Potentiates%20Fc%CE%B5RI%E2%80%90Induced%20PGD2%20Biosynthesis%20and%20Induces%20VEGF%20From%20Human%20In%C2%A0Situ%E2%80%90Matured%20Skin%20Mast%20Cells&amp;author=C.%20McHale&amp;author=Z.%20Mohammed&amp;author=J.%20Deppen&amp;author=G.%20Gomez&amp;volume=1862&amp;issue=5&amp;publication_year=2018&amp;pages=1069-1078&amp;pmid=29410184&amp;doi=10.1016/j.bbagen.2018.01.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0047">
<span class="label">47.</span><cite>
Reece P., Baatjes A. J., Cyr M. M., Sehmi R., and Denburg J. A., “Toll‐Like Receptor‐Mediated Eosinophil–Basophil Differentiation: Autocrine Signalling by Granulocyte–Macrophage Colony‐Stimulating Factor in Cord Blood Haematopoietic Progenitors,” Immunology
139, no. 2 (2013): 256–264.
</cite> [<a href="https://doi.org/10.1111/imm.12078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3647191/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23347362/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunology&amp;title=Toll%E2%80%90Like%20Receptor%E2%80%90Mediated%20Eosinophil%E2%80%93Basophil%20Differentiation:%20Autocrine%20Signalling%20by%20Granulocyte%E2%80%93Macrophage%20Colony%E2%80%90Stimulating%20Factor%20in%20Cord%20Blood%20Haematopoietic%20Progenitors&amp;author=P.%20Reece&amp;author=A.%20J.%20Baatjes&amp;author=M.%20M.%20Cyr&amp;author=R.%20Sehmi&amp;author=J.%20A.%20Denburg&amp;volume=139&amp;issue=2&amp;publication_year=2013&amp;pages=256-264&amp;pmid=23347362&amp;doi=10.1111/imm.12078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0048">
<span class="label">48.</span><cite>
Weller C. L., Collington S. J., Brown J. K., et al., “Leukotriene B4, an Activation Product of Mast Cells, Is a Chemoattractant for Their Progenitors,” Journal of Experimental Medicine
201, no. 12 (2005): 1961–1971, 10.1084/jem.20042407.
</cite> [<a href="https://doi.org/10.1084/jem.20042407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2212026/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15955837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Leukotriene%20B4,%20an%20Activation%20Product%20of%20Mast%20Cells,%20Is%20a%20Chemoattractant%20for%20Their%20Progenitors&amp;author=C.%20L.%20Weller&amp;author=S.%20J.%20Collington&amp;author=J.%20K.%20Brown&amp;volume=201&amp;issue=12&amp;publication_year=2005&amp;pages=1961-1971&amp;pmid=15955837&amp;doi=10.1084/jem.20042407&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0049">
<span class="label">49.</span><cite>
Bettiol J., Radermecker M., Sele J., Henquet M., Cataldo D., and Louis R., “Airway Mast‐Cell Activation in Asthmatics Is Associated With Selective Sputum Eosinophilia,” Allergy
54, no. 11 (1999): 1188–1193.
</cite> [<a href="https://doi.org/10.1034/j.1398-9995.1999.00177.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10604555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Airway%20Mast%E2%80%90Cell%20Activation%20in%20Asthmatics%20Is%20Associated%20With%20Selective%20Sputum%20Eosinophilia&amp;author=J.%20Bettiol&amp;author=M.%20Radermecker&amp;author=J.%20Sele&amp;author=M.%20Henquet&amp;author=D.%20Cataldo&amp;volume=54&amp;issue=11&amp;publication_year=1999&amp;pages=1188-1193&amp;pmid=10604555&amp;doi=10.1034/j.1398-9995.1999.00177.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0050">
<span class="label">50.</span><cite>
Temkin V., Kantor B., Weg V., Hartman M.‐L., and Levi‐Schaffer F., “Tryptase Activates the Mitogen‐Activated Protein Kinase/Activator Protein‐1 Pathway in Human Peripheral Blood Eosinophils, Causing Cytokine Production and Release,” Journal of Immunology
169, no. 5 (2002): 2662–2669.</cite> [<a href="https://doi.org/10.4049/jimmunol.169.5.2662" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12193739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Tryptase%20Activates%20the%20Mitogen%E2%80%90Activated%20Protein%20Kinase/Activator%20Protein%E2%80%901%20Pathway%20in%20Human%20Peripheral%20Blood%20Eosinophils,%20Causing%20Cytokine%20Production%20and%20Release&amp;author=V.%20Temkin&amp;author=B.%20Kantor&amp;author=V.%20Weg&amp;author=M.%E2%80%90L.%20Hartman&amp;author=F.%20Levi%E2%80%90Schaffer&amp;volume=169&amp;issue=5&amp;publication_year=2002&amp;pages=2662-2669&amp;pmid=12193739&amp;doi=10.4049/jimmunol.169.5.2662&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0051">
<span class="label">51.</span><cite>
Vliagoftis H., Lacy P., Luy B., et al., “Mast Cell Tryptase Activates Peripheral Blood Eosinophils to Release Granule‐Associated Enzymes,” International Archives of Allergy and Immunology
135, no. 3 (2004): 196–204.
</cite> [<a href="https://doi.org/10.1159/000081304" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15467372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Archives%20of%20Allergy%20and%20Immunology&amp;title=Mast%20Cell%20Tryptase%20Activates%20Peripheral%20Blood%20Eosinophils%20to%20Release%20Granule%E2%80%90Associated%20Enzymes&amp;author=H.%20Vliagoftis&amp;author=P.%20Lacy&amp;author=B.%20Luy&amp;volume=135&amp;issue=3&amp;publication_year=2004&amp;pages=196-204&amp;pmid=15467372&amp;doi=10.1159/000081304&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0052">
<span class="label">52.</span><cite>
Ling P., Ngo K., Nguyen S., et al., “Histamine H4 Receptor Mediates Eosinophil Chemotaxis With Cell Shape Change and Adhesion Molecule Upregulation,” British Journal of Pharmacology
142, no. 1 (2004): 161–171, 10.1038/sj.bjp.0705729.
</cite> [<a href="https://doi.org/10.1038/sj.bjp.0705729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1574921/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15131002/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Histamine%20H4%20Receptor%20Mediates%20Eosinophil%20Chemotaxis%20With%20Cell%20Shape%20Change%20and%20Adhesion%20Molecule%20Upregulation&amp;author=P.%20Ling&amp;author=K.%20Ngo&amp;author=S.%20Nguyen&amp;volume=142&amp;issue=1&amp;publication_year=2004&amp;pages=161-171&amp;pmid=15131002&amp;doi=10.1038/sj.bjp.0705729&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0053">
<span class="label">53.</span><cite>
Das A. M., Flower R. J., and Perretti M., “Resident Mast Cells Are Important for Eotaxin‐Induced Eosinophil Accumulation In Vivo,” Journal of Leukocyte Biology
64, no. 2 (1998): 156–162.
</cite> [<a href="https://doi.org/10.1002/jlb.64.2.156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9715253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Leukocyte%20Biology&amp;title=Resident%20Mast%20Cells%20Are%20Important%20for%20Eotaxin%E2%80%90Induced%20Eosinophil%20Accumulation%20In%C2%A0Vivo&amp;author=A.%20M.%20Das&amp;author=R.%20J.%20Flower&amp;author=M.%20Perretti&amp;volume=64&amp;issue=2&amp;publication_year=1998&amp;pages=156-162&amp;pmid=9715253&amp;doi=10.1002/jlb.64.2.156&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0054">
<span class="label">54.</span><cite>
Hirai H., Tanaka K., Yoshie O., et al., “Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven‐Transmembrane Receptor CRTH2,” Journal of Experimental Medicine
193, no. 2 (2001): 255–262.
</cite> [<a href="https://doi.org/10.1084/jem.193.2.255" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2193345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11208866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Prostaglandin%20D2%20Selectively%20Induces%20Chemotaxis%20in%20T%20Helper%20Type%202%20Cells,%20Eosinophils,%20and%20Basophils%20via%20Seven%E2%80%90Transmembrane%20Receptor%20CRTH2&amp;author=H.%20Hirai&amp;author=K.%20Tanaka&amp;author=O.%20Yoshie&amp;volume=193&amp;issue=2&amp;publication_year=2001&amp;pages=255-262&amp;pmid=11208866&amp;doi=10.1084/jem.193.2.255&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0055">
<span class="label">55.</span><cite>
Hogaboam C., Kunkel S. L., Strieter R. M., et al., “Novel Role of Transmembrane SCF for Mast Cell Activation and Eotaxin Production in Mast Cell‐Fibroblast Interactions,” Journal of Immunology
160, no. 12 (1998): 6166–6171.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9637535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Novel%20Role%20of%20Transmembrane%20SCF%20for%20Mast%20Cell%20Activation%20and%20Eotaxin%20Production%20in%20Mast%20Cell%E2%80%90Fibroblast%20Interactions&amp;author=C.%20Hogaboam&amp;author=S.%20L.%20Kunkel&amp;author=R.%20M.%20Strieter&amp;volume=160&amp;issue=12&amp;publication_year=1998&amp;pages=6166-6171&amp;pmid=9637535&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0056">
<span class="label">56.</span><cite>
Liu F.‐T., Goodarzi H., and Chen H.‐Y., “IgE, Mast Cells, and Eosinophils in Atopic Dermatitis,” Clinical Reviews in Allergy and Immunology
41 (2011): 298–310.
</cite> [<a href="https://doi.org/10.1007/s12016-011-8252-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21249468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Reviews%20in%20Allergy%20and%20Immunology&amp;title=IgE,%20Mast%20Cells,%20and%20Eosinophils%20in%20Atopic%20Dermatitis&amp;author=F.%E2%80%90T.%20Liu&amp;author=H.%20Goodarzi&amp;author=H.%E2%80%90Y.%20Chen&amp;volume=41&amp;publication_year=2011&amp;pages=298-310&amp;pmid=21249468&amp;doi=10.1007/s12016-011-8252-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0057">
<span class="label">57.</span><cite>
Piliponsky A. M., Gleich G. J., Nagler A., Bar I., and Levi‐Schaffer F., “Non‐IgE–Dependent Activation of Human Lung–and Cord Blood–Derived Mast Cells Is Induced by Eosinophil Major Basic Protein and Modulated by the Membrane Form of Stem Cell Factor,” Blood
101, no. 5 (2003): 1898–1904.
</cite> [<a href="https://doi.org/10.1182/blood-2002-05-1488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12393403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Non%E2%80%90IgE%E2%80%93Dependent%20Activation%20of%20Human%20Lung%E2%80%93and%20Cord%20Blood%E2%80%93Derived%20Mast%20Cells%20Is%20Induced%20by%20Eosinophil%20Major%20Basic%20Protein%20and%20Modulated%20by%20the%20Membrane%20Form%20of%20Stem%20Cell%20Factor&amp;author=A.%20M.%20Piliponsky&amp;author=G.%20J.%20Gleich&amp;author=A.%20Nagler&amp;author=I.%20Bar&amp;author=F.%20Levi%E2%80%90Schaffer&amp;volume=101&amp;issue=5&amp;publication_year=2003&amp;pages=1898-1904&amp;pmid=12393403&amp;doi=10.1182/blood-2002-05-1488&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0058">
<span class="label">58.</span><cite>
Ben‐Zimra M., Bachelet I., Seaf M., Gleich G., and Levi‐Schaffer F., “Eosinophil Major Basic Protein Activates Human Cord Blood Mast Cells Primed With Fibroblast Membranes by Integrin‐β1,” Allergy
68, no. 10 (2013): 1259–1268.
</cite> [<a href="https://doi.org/10.1111/all.12232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24112102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Eosinophil%20Major%20Basic%20Protein%20Activates%20Human%20Cord%20Blood%20Mast%20Cells%20Primed%20With%20Fibroblast%20Membranes%20by%20Integrin%E2%80%90%CE%B21&amp;author=M.%20Ben%E2%80%90Zimra&amp;author=I.%20Bachelet&amp;author=M.%20Seaf&amp;author=G.%20Gleich&amp;author=F.%20Levi%E2%80%90Schaffer&amp;volume=68&amp;issue=10&amp;publication_year=2013&amp;pages=1259-1268&amp;pmid=24112102&amp;doi=10.1111/all.12232&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0059">
<span class="label">59.</span><cite>
Guo C.‐B., Liu M. C., Galli S. J., Bochner B. S., Kagey‐Sobotka A., and Lichtenstein L. M., “Identification of IgE‐Bearing Cells in the Late‐Phase Response to Antigen in the Lung as Basophils,” American Journal of Respiratory Cell and Molecular Biology
10, no. 4 (1994): 384–390.
</cite> [<a href="https://doi.org/10.1165/ajrcmb.10.4.7510984" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7510984/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20Cell%20and%20Molecular%20Biology&amp;title=Identification%20of%20IgE%E2%80%90Bearing%20Cells%20in%20the%20Late%E2%80%90Phase%20Response%20to%20Antigen%20in%20the%20Lung%20as%20Basophils&amp;author=C.%E2%80%90B.%20Guo&amp;author=M.%20C.%20Liu&amp;author=S.%20J.%20Galli&amp;author=B.%20S.%20Bochner&amp;author=A.%20Kagey%E2%80%90Sobotka&amp;volume=10&amp;issue=4&amp;publication_year=1994&amp;pages=384-390&amp;pmid=7510984&amp;doi=10.1165/ajrcmb.10.4.7510984&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0060">
<span class="label">60.</span><cite>
Cheng L. E., Sullivan B. M., Retana L. E., Allen C. D., Liang H.‐E., and Locksley R. M., “IgE‐Activated Basophils Regulate Eosinophil Tissue Entry by Modulating Endothelial Function,” Journal of Experimental Medicine
212, no. 4 (2015): 513–524.
</cite> [<a href="https://doi.org/10.1084/jem.20141671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4387286/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25779634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=IgE%E2%80%90Activated%20Basophils%20Regulate%20Eosinophil%20Tissue%20Entry%20by%20Modulating%20Endothelial%20Function&amp;author=L.%20E.%20Cheng&amp;author=B.%20M.%20Sullivan&amp;author=L.%20E.%20Retana&amp;author=C.%20D.%20Allen&amp;author=H.%E2%80%90E.%20Liang&amp;volume=212&amp;issue=4&amp;publication_year=2015&amp;pages=513-524&amp;pmid=25779634&amp;doi=10.1084/jem.20141671&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0061">
<span class="label">61.</span><cite>
Iype J., Odermatt A., Bachmann S., Coeudevez M., and Fux M., “IL‐1β Promotes Immunoregulatory Responses in Human Blood Basophils,” Allergy
76, no. 7 (2021): 2017–2029.
</cite> [<a href="https://doi.org/10.1111/all.14760" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33544413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=IL%E2%80%901%CE%B2%20Promotes%20Immunoregulatory%20Responses%20in%20Human%20Blood%20Basophils&amp;author=J.%20Iype&amp;author=A.%20Odermatt&amp;author=S.%20Bachmann&amp;author=M.%20Coeudevez&amp;author=M.%20Fux&amp;volume=76&amp;issue=7&amp;publication_year=2021&amp;pages=2017-2029&amp;pmid=33544413&amp;doi=10.1111/all.14760&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0062">
<span class="label">62.</span><cite>
Nakashima C., Otsuka A., Kitoh A., et al., “Basophils Regulate the Recruitment of Eosinophils in a Murine Model of Irritant Contact Dermatitis,” Journal of Allergy and Clinical Immunology
134, no. 1 (2014): 100–107.e12.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2014.02.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24713170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Basophils%20Regulate%20the%20Recruitment%20of%20Eosinophils%20in%20a%20Murine%20Model%20of%20Irritant%20Contact%20Dermatitis&amp;author=C.%20Nakashima&amp;author=A.%20Otsuka&amp;author=A.%20Kitoh&amp;volume=134&amp;issue=1&amp;publication_year=2014&amp;pages=100-107&amp;pmid=24713170&amp;doi=10.1016/j.jaci.2014.02.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0063">
<span class="label">63.</span><cite>
Elishmereni M., Alenius H., Bradding P., et al., “Physical Interactions Between Mast Cells and Eosinophils: A Novel Mechanism Enhancing Eosinophil Survival In Vitro,” Allergy
66, no. 3 (2011): 376–385.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2010.02494.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20977491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Physical%20Interactions%20Between%20Mast%20Cells%20and%20Eosinophils:%20A%20Novel%20Mechanism%20Enhancing%20Eosinophil%20Survival%20In%C2%A0Vitro&amp;author=M.%20Elishmereni&amp;author=H.%20Alenius&amp;author=P.%20Bradding&amp;volume=66&amp;issue=3&amp;publication_year=2011&amp;pages=376-385&amp;pmid=20977491&amp;doi=10.1111/j.1398-9995.2010.02494.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0064">
<span class="label">64.</span><cite>
Bachelet I., Munitz A., Mankutad D., and Levi‐Schaffer F., “Mast Cell Costimulation by CD226/CD112 (DNAM‐1/Nectin‐2): A Novel Interface in the Allergic Process,” Journal of Biological Chemistry
281, no. 37 (2006): 27190–27196.
</cite> [<a href="https://doi.org/10.1074/jbc.M602359200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16831868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biological%20Chemistry&amp;title=Mast%20Cell%20Costimulation%20by%20CD226/CD112%20(DNAM%E2%80%901/Nectin%E2%80%902):%20A%20Novel%20Interface%20in%20the%20Allergic%20Process&amp;author=I.%20Bachelet&amp;author=A.%20Munitz&amp;author=D.%20Mankutad&amp;author=F.%20Levi%E2%80%90Schaffer&amp;volume=281&amp;issue=37&amp;publication_year=2006&amp;pages=27190-27196&amp;pmid=16831868&amp;doi=10.1074/jbc.M602359200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0065">
<span class="label">65.</span><cite>
Elishmereni M., Bachelet I., and Levi‐Schaffer F., “DNAM‐1: An Amplifier of Immune Responses as a Therapeutic Target in Various Disorders,” Current Opinion in Investigational Drugs
9, no. 5 (2008): 491–496.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/18465659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Investigational%20Drugs&amp;title=DNAM%E2%80%901:%20An%20Amplifier%20of%20Immune%20Responses%20as%20a%20Therapeutic%20Target%20in%20Various%20Disorders&amp;author=M.%20Elishmereni&amp;author=I.%20Bachelet&amp;author=F.%20Levi%E2%80%90Schaffer&amp;volume=9&amp;issue=5&amp;publication_year=2008&amp;pages=491-496&amp;pmid=18465659&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0066">
<span class="label">66.</span><cite>
Elishmereni M. and Levi‐Schaffer F., “CD48: A Co‐Stimulatory Receptor of Immunity,” International Journal of Biochemistry and Cell Biology
43, no. 1 (2011): 25–28.
</cite> [<a href="https://doi.org/10.1016/j.biocel.2010.09.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20833258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Biochemistry%20and%20Cell%20Biology&amp;title=CD48:%20A%20Co%E2%80%90Stimulatory%20Receptor%20of%20Immunity&amp;author=M.%20Elishmereni&amp;author=F.%20Levi%E2%80%90Schaffer&amp;volume=43&amp;issue=1&amp;publication_year=2011&amp;pages=25-28&amp;pmid=20833258&amp;doi=10.1016/j.biocel.2010.09.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0067">
<span class="label">67.</span><cite>
Minai‐Fleminger Y., Elishmereni M., Vita F., et al., “Ultrastructural Evidence for Human Mast Cell‐Eosinophil Interactions In Vitro,” Cell and Tissue Research
341 (2010): 405–415.
</cite> [<a href="https://doi.org/10.1007/s00441-010-1010-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20686785/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20and%20Tissue%20Research&amp;title=Ultrastructural%20Evidence%20for%20Human%20Mast%20Cell%E2%80%90Eosinophil%20Interactions%20In%C2%A0Vitro&amp;author=Y.%20Minai%E2%80%90Fleminger&amp;author=M.%20Elishmereni&amp;author=F.%20Vita&amp;volume=341&amp;publication_year=2010&amp;pages=405-415&amp;pmid=20686785&amp;doi=10.1007/s00441-010-1010-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0068">
<span class="label">68.</span><cite>
Robida P. A., Puzzovio P. G., Pahima H., Levi‐Schaffer F., and Bochner B. S., “Human Eosinophils and Mast Cells: Birds of a Feather Flock Together,” Immunological Reviews
282, no. 1 (2018): 151–167.
</cite> [<a href="https://doi.org/10.1111/imr.12638" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5812359/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29431215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunological%20Reviews&amp;title=Human%20Eosinophils%20and%20Mast%20Cells:%20Birds%20of%20a%20Feather%20Flock%20Together&amp;author=P.%20A.%20Robida&amp;author=P.%20G.%20Puzzovio&amp;author=H.%20Pahima&amp;author=F.%20Levi%E2%80%90Schaffer&amp;author=B.%20S.%20Bochner&amp;volume=282&amp;issue=1&amp;publication_year=2018&amp;pages=151-167&amp;pmid=29431215&amp;doi=10.1111/imr.12638&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0069">
<span class="label">69.</span><cite>
Elishmereni M., Bachelet I., Nissim Ben‐Efraim A., Mankuta D., and Levi‐Schaffer F., “Interacting Mast Cells and Eosinophils Acquire an Enhanced Activation State In Vitro,” Allergy
68, no. 2 (2013): 171–179.
</cite> [<a href="https://doi.org/10.1111/all.12059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23205534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Interacting%20Mast%20Cells%20and%20Eosinophils%20Acquire%20an%20Enhanced%20Activation%20State%20In%C2%A0Vitro&amp;author=M.%20Elishmereni&amp;author=I.%20Bachelet&amp;author=A.%20Nissim%20Ben%E2%80%90Efraim&amp;author=D.%20Mankuta&amp;author=F.%20Levi%E2%80%90Schaffer&amp;volume=68&amp;issue=2&amp;publication_year=2013&amp;pages=171-179&amp;pmid=23205534&amp;doi=10.1111/all.12059&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0070">
<span class="label">70.</span><cite>
Mizrahi S., Gibbs B. F., Karra L., Ben‐Zimra M., and Levi‐Schaffer F., “Siglec‐7 Is an Inhibitory Receptor on Human Mast Cells and Basophils,” Journal of Allergy and Clinical Immunology
134, no. 1 (2014): 230–233.e3.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2014.03.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24810846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Siglec%E2%80%907%20Is%20an%20Inhibitory%20Receptor%20on%20Human%20Mast%20Cells%20and%20Basophils&amp;author=S.%20Mizrahi&amp;author=B.%20F.%20Gibbs&amp;author=L.%20Karra&amp;author=M.%20Ben%E2%80%90Zimra&amp;author=F.%20Levi%E2%80%90Schaffer&amp;volume=134&amp;issue=1&amp;publication_year=2014&amp;pages=230-233&amp;pmid=24810846&amp;doi=10.1016/j.jaci.2014.03.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0071">
<span class="label">71.</span><cite>
Legrand F., Landolina N., Zaffran I., et al., “Siglec‐7 on Peripheral Blood Eosinophils: Surface Expression and Function,” Allergy
74, no. 7 (2019): 1257–1265.
</cite> [<a href="https://doi.org/10.1111/all.13730" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6661208/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30690753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Siglec%E2%80%907%20on%20Peripheral%20Blood%20Eosinophils:%20Surface%20Expression%20and%20Function&amp;author=F.%20Legrand&amp;author=N.%20Landolina&amp;author=I.%20Zaffran&amp;volume=74&amp;issue=7&amp;publication_year=2019&amp;pages=1257-1265&amp;pmid=30690753&amp;doi=10.1111/all.13730&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0072">
<span class="label">72.</span><cite>
Bochner B. S., “Siglec‐8 on Human Eosinophils and Mast Cells, and Siglec‐F on Murine Eosinophils, Are Functionally Related Inhibitory Receptors,” Clinical and Experimental Allergy
39, no. 3 (2009): 317–324.
</cite> [<a href="https://doi.org/10.1111/j.1365-2222.2008.03173.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2742622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19178537/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Siglec%E2%80%908%20on%20Human%20Eosinophils%20and%20Mast%20Cells,%20and%20Siglec%E2%80%90F%20on%20Murine%20Eosinophils,%20Are%20Functionally%20Related%20Inhibitory%20Receptors&amp;author=B.%20S.%20Bochner&amp;volume=39&amp;issue=3&amp;publication_year=2009&amp;pages=317-324&amp;pmid=19178537&amp;doi=10.1111/j.1365-2222.2008.03173.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0073">
<span class="label">73.</span><cite>
Zenarruzabeitia O., Vitallé J., Eguizabal C., Simhadri V. R., and Borrego F., “The Biology and Disease Relevance of CD300a, an Inhibitory Receptor for Phosphatidylserine and Phosphatidylethanolamine,” Journal of Immunology
194, no. 11 (2015): 5053–5060.</cite> [<a href="https://doi.org/10.4049/jimmunol.1500304" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25980030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=The%20Biology%20and%20Disease%20Relevance%20of%20CD300a,%20an%20Inhibitory%20Receptor%20for%20Phosphatidylserine%20and%20Phosphatidylethanolamine&amp;author=O.%20Zenarruzabeitia&amp;author=J.%20Vitall%C3%A9&amp;author=C.%20Eguizabal&amp;author=V.%20R.%20Simhadri&amp;author=F.%20Borrego&amp;volume=194&amp;issue=11&amp;publication_year=2015&amp;pages=5053-5060&amp;pmid=25980030&amp;doi=10.4049/jimmunol.1500304&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0074">
<span class="label">74.</span><cite>
Möhle R., Salemi P., Moore M. A., and Rafii S., “Expression of Interleukin‐5 by Human Bone Marrow Microvascular Endothelial Cells: Implications for the Regulation of Eosinophilopoiesis In Vivo,” British Journal of Haematology
99, no. 4 (1997): 732–738.
</cite> [<a href="https://doi.org/10.1046/j.1365-2141.1997.4713279.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9432015/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Haematology&amp;title=Expression%20of%20Interleukin%E2%80%905%20by%20Human%20Bone%20Marrow%20Microvascular%20Endothelial%20Cells:%20Implications%20for%20the%20Regulation%20of%20Eosinophilopoiesis%20In%C2%A0Vivo&amp;author=R.%20M%C3%B6hle&amp;author=P.%20Salemi&amp;author=M.%20A.%20Moore&amp;author=S.%20Rafii&amp;volume=99&amp;issue=4&amp;publication_year=1997&amp;pages=732-738&amp;pmid=9432015&amp;doi=10.1046/j.1365-2141.1997.4713279.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0075">
<span class="label">75.</span><cite>
Hogan M. B., Piktel D., and Landreth K. S., “IL‐5 Production by Bone Marrow Stromal Cells: Implications for Eosinophilia Associated With Asthma,” Journal of Allergy and Clinical Immunology
106, no. 2 (2000): 329–336.
</cite> [<a href="https://doi.org/10.1067/mai.2000.108309" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10932078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=IL%E2%80%905%20Production%20by%20Bone%20Marrow%20Stromal%20Cells:%20Implications%20for%20Eosinophilia%20Associated%20With%20Asthma&amp;author=M.%20B.%20Hogan&amp;author=D.%20Piktel&amp;author=K.%20S.%20Landreth&amp;volume=106&amp;issue=2&amp;publication_year=2000&amp;pages=329-336&amp;pmid=10932078&amp;doi=10.1067/mai.2000.108309&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0076">
<span class="label">76.</span><cite>
Mori Y., Iwasaki H., Kohno K., et al., “Identification of the Human Eosinophil Lineage‐Committed Progenitor: Revision of Phenotypic Definition of the Human Common Myeloid Progenitor,” Journal of Experimental Medicine
206 (2009): 183–193.
</cite> [<a href="https://doi.org/10.1084/jem.20081756" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2626675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19114669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Identification%20of%20the%20Human%20Eosinophil%20Lineage%E2%80%90Committed%20Progenitor:%20Revision%20of%20Phenotypic%20Definition%20of%20the%20Human%20Common%20Myeloid%20Progenitor&amp;author=Y.%20Mori&amp;author=H.%20Iwasaki&amp;author=K.%20Kohno&amp;volume=206&amp;publication_year=2009&amp;pages=183-193&amp;pmid=19114669&amp;doi=10.1084/jem.20081756&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0077">
<span class="label">77.</span><cite>
Iwasaki H., Mizuno S., Mayfield R., et al., “Identification of Eosinophil Lineage‐Committed Progenitors in the Murine Bone Marrow,” Journal of Experimental Medicine
201, no. 12 (2005): 1891–1897.
</cite> [<a href="https://doi.org/10.1084/jem.20050548" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2212039/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15955840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Identification%20of%20Eosinophil%20Lineage%E2%80%90Committed%20Progenitors%20in%20the%20Murine%20Bone%20Marrow&amp;author=H.%20Iwasaki&amp;author=S.%20Mizuno&amp;author=R.%20Mayfield&amp;volume=201&amp;issue=12&amp;publication_year=2005&amp;pages=1891-1897&amp;pmid=15955840&amp;doi=10.1084/jem.20050548&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0078">
<span class="label">78.</span><cite>
Rothenberg M. E. and Hogan S. P., “The Eosinophil,” Annual Review of Immunology
24, no. 1 (2006): 147–174.</cite> [<a href="https://doi.org/10.1146/annurev.immunol.24.021605.090720" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16551246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annual%20Review%20of%20Immunology&amp;title=The%20Eosinophil&amp;author=M.%20E.%20Rothenberg&amp;author=S.%20P.%20Hogan&amp;volume=24&amp;issue=1&amp;publication_year=2006&amp;pages=147-174&amp;pmid=16551246&amp;doi=10.1146/annurev.immunol.24.021605.090720&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0079">
<span class="label">79.</span><cite>
Denburg J., Richardson M., Telizyn S., and Bienenstock J., “Basophil/Mast Cell Precursors in Human Peripheral Blood,” Blood
61, no. 4 (1983): 775–780, 10.1182/blood.V61.4.775.775.
</cite> [<a href="https://doi.org/10.1182/blood.V61.4.775.775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6572535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Basophil/Mast%20Cell%20Precursors%20in%20Human%20Peripheral%20Blood&amp;author=J.%20Denburg&amp;author=M.%20Richardson&amp;author=S.%20Telizyn&amp;author=J.%20Bienenstock&amp;volume=61&amp;issue=4&amp;publication_year=1983&amp;pages=775-780&amp;pmid=6572535&amp;doi=10.1182/blood.V61.4.775.775&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0080">
<span class="label">80.</span><cite>
Watt S. and Visser J., “Recent Advances in the Growth and Isolation of Primitive Human Haemopoietic Progenitor Cells,” Cell Proliferation
25, no. 4 (1992): 263–297.
</cite> [<a href="https://doi.org/10.1111/j.1365-2184.1992.tb01440.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1643187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Proliferation&amp;title=Recent%20Advances%20in%20the%20Growth%20and%20Isolation%20of%20Primitive%20Human%20Haemopoietic%20Progenitor%20Cells&amp;author=S.%20Watt&amp;author=J.%20Visser&amp;volume=25&amp;issue=4&amp;publication_year=1992&amp;pages=263-297&amp;pmid=1643187&amp;doi=10.1111/j.1365-2184.1992.tb01440.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0081">
<span class="label">81.</span><cite>
Denburg J. A., Silver J. E., and Abrams J. S., “Interleukin‐5 Is a Human Basophilopoietin: Induction of Histamine Content and Basophilic Differentiation of HL‐60 Cells and of Peripheral Blood Basophil‐Eosinophil Progenitors,” Blood
77, no. 7 (1991): 1462–1468, 10.1182/blood.V77.7.1462.bloodjournal7771462.
</cite> [<a href="https://doi.org/10.1182/blood.V77.7.1462.bloodjournal7771462" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1706953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Interleukin%E2%80%905%20Is%20a%20Human%20Basophilopoietin:%20Induction%20of%20Histamine%20Content%20and%20Basophilic%20Differentiation%20of%20HL%E2%80%9060%20Cells%20and%20of%20Peripheral%20Blood%20Basophil%E2%80%90Eosinophil%20Progenitors&amp;author=J.%20A.%20Denburg&amp;author=J.%20E.%20Silver&amp;author=J.%20S.%20Abrams&amp;volume=77&amp;issue=7&amp;publication_year=1991&amp;pages=1462-1468&amp;pmid=1706953&amp;doi=10.1182/blood.V77.7.1462.bloodjournal7771462&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0082">
<span class="label">82.</span><cite>
Denburg J. A., Telizyn S., Messner H., et al., “Heterogeneity of Human Peripheral Blood Eosinophil‐Type Colonies: Evidence for a Common Basophil‐Eosinophil Progenitor,” Blood
66, no. 2 (1985): 312–318, 10.1182/blood.V66.2.312.bloodjournal662312.
</cite> [<a href="https://doi.org/10.1182/blood.V66.2.312.bloodjournal662312" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2410064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Heterogeneity%20of%20Human%20Peripheral%20Blood%20Eosinophil%E2%80%90Type%20Colonies:%20Evidence%20for%20a%20Common%20Basophil%E2%80%90Eosinophil%20Progenitor&amp;author=J.%20A.%20Denburg&amp;author=S.%20Telizyn&amp;author=H.%20Messner&amp;volume=66&amp;issue=2&amp;publication_year=1985&amp;pages=312-318&amp;pmid=2410064&amp;doi=10.1182/blood.V66.2.312.bloodjournal662312&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0083">
<span class="label">83.</span><cite>
Denburg J. A., “Cytokine‐Induced Human Basophil/Mast Cell Growth and Differentiation In Vitro,” Springer Seminars in Immunopathology
12, no. 4 (1990): 401–414.
</cite> [<a href="https://doi.org/10.1007/BF00225326" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2096471/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Springer%20Seminars%20in%20Immunopathology&amp;title=Cytokine%E2%80%90Induced%20Human%20Basophil/Mast%20Cell%20Growth%20and%20Differentiation%20In%C2%A0Vitro&amp;author=J.%20A.%20Denburg&amp;volume=12&amp;issue=4&amp;publication_year=1990&amp;pages=401-414&amp;pmid=2096471&amp;doi=10.1007/BF00225326&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0084">
<span class="label">84.</span><cite>
Denburg J. A., “Basophil and Mast Cell Lineages In Vitro and In Vivo,” Blood
79, no. 4 (1992): 846–860.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1737095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Basophil%20and%20Mast%20Cell%20Lineages%20In%C2%A0Vitro%20and%20In%C2%A0Vivo&amp;author=J.%20A.%20Denburg&amp;volume=79&amp;issue=4&amp;publication_year=1992&amp;pages=846-860&amp;pmid=1737095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0085">
<span class="label">85.</span><cite>
Clutterbuck E. J., Hirst E., and Sanderson C. J., “Human Interleukin‐5 (IL‐5) Regulates the Production of Eosinophils in Human Bone Marrow Cultures: Comparison and Interaction With IL‐1, IL‐3, IL‐6, and GMCSF,” Blood
73, no. 6 (1989): 1504–1512, 10.1182/blood.V73.6.1504.bloodjournal7361504.
</cite> [<a href="https://doi.org/10.1182/blood.V73.6.1504.bloodjournal7361504" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2653458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Human%20Interleukin%E2%80%905%20(IL%E2%80%905)%20Regulates%20the%20Production%20of%20Eosinophils%20in%20Human%20Bone%20Marrow%20Cultures:%20Comparison%20and%20Interaction%20With%20IL%E2%80%901,%20IL%E2%80%903,%20IL%E2%80%906,%20and%20GMCSF&amp;author=E.%20J.%20Clutterbuck&amp;author=E.%20Hirst&amp;author=C.%20J.%20Sanderson&amp;volume=73&amp;issue=6&amp;publication_year=1989&amp;pages=1504-1512&amp;pmid=2653458&amp;doi=10.1182/blood.V73.6.1504.bloodjournal7361504&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0086">
<span class="label">86.</span><cite>
Woolley K. L., Adelroth E., Woolley M. J., et al., “Interleukin‐3 in Bronchial Biopsies From Nonasthmatics and Patients With Mild and Allergen‐Induced Asthma,” American Journal of Respiratory and Critical Care Medicine
153, no. 1 (1996): 350–355.
</cite> [<a href="https://doi.org/10.1164/ajrccm.153.1.8542142" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8542142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Interleukin%E2%80%903%20in%20Bronchial%20Biopsies%20From%20Nonasthmatics%20and%20Patients%20With%20Mild%20and%20Allergen%E2%80%90Induced%20Asthma&amp;author=K.%20L.%20Woolley&amp;author=E.%20Adelroth&amp;author=M.%20J.%20Woolley&amp;volume=153&amp;issue=1&amp;publication_year=1996&amp;pages=350-355&amp;pmid=8542142&amp;doi=10.1164/ajrccm.153.1.8542142&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0087">
<span class="label">87.</span><cite>
Woolley K., Adelroth E., Woolley M., Ellis R., Jordana M., and O'byrne P., “Effects of Allergen Challenge on Eosinophils, Eosinophil Cationic Protein, and Granulocyte‐Macrophage Colony‐Stimulating Factor in Mild Asthma,” American Journal of Respiratory and Critical Care Medicine
151, no. 6 (1995): 1915–1924.
</cite> [<a href="https://doi.org/10.1164/ajrccm.151.6.7767540" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7767540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Effects%20of%20Allergen%20Challenge%20on%20Eosinophils,%20Eosinophil%20Cationic%20Protein,%20and%20Granulocyte%E2%80%90Macrophage%20Colony%E2%80%90Stimulating%20Factor%20in%20Mild%20Asthma&amp;author=K.%20Woolley&amp;author=E.%20Adelroth&amp;author=M.%20Woolley&amp;author=R.%20Ellis&amp;author=M.%20Jordana&amp;volume=151&amp;issue=6&amp;publication_year=1995&amp;pages=1915-1924&amp;pmid=7767540&amp;doi=10.1164/ajrccm.151.6.7767540&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0088">
<span class="label">88.</span><cite>
Gauvreau G. M., Watson R. M., and O'Byrne P. M., “Kinetics of Allergen‐Induced Airway Eosinophilic Cytokine Production and Airway Inflammation,” American Journal of Respiratory and Critical Care Medicine
160, no. 2 (1999): 640–647.
</cite> [<a href="https://doi.org/10.1164/ajrccm.160.2.9809130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10430741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Kinetics%20of%20Allergen%E2%80%90Induced%20Airway%20Eosinophilic%20Cytokine%20Production%20and%20Airway%20Inflammation&amp;author=G.%20M.%20Gauvreau&amp;author=R.%20M.%20Watson&amp;author=P.%20M.%20O'Byrne&amp;volume=160&amp;issue=2&amp;publication_year=1999&amp;pages=640-647&amp;pmid=10430741&amp;doi=10.1164/ajrccm.160.2.9809130&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0089">
<span class="label">89.</span><cite>
Gauvreau G. M., Sehmi R., FitzGerald J. M., et al., “Benralizumab for Allergic Asthma: A Randomised, Double‐Blind, Placebo‐Controlled Trial,” European Respiratory Journal
64, no. 3 (2024): 2400512, 10.1183/13993003.00512-2024.
</cite> [<a href="https://doi.org/10.1183/13993003.00512-2024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11391094/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39060015/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Respiratory%20Journal&amp;title=Benralizumab%20for%20Allergic%20Asthma:%20A%20Randomised,%20Double%E2%80%90Blind,%20Placebo%E2%80%90Controlled%20Trial&amp;author=G.%20M.%20Gauvreau&amp;author=R.%20Sehmi&amp;author=J.%20M.%20FitzGerald&amp;volume=64&amp;issue=3&amp;publication_year=2024&amp;pages=2400512&amp;pmid=39060015&amp;doi=10.1183/13993003.00512-2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0090">
<span class="label">90.</span><cite>
Sanderson C. J., Warren D. J., and Strath M., “Identification of a Lymphokine That Stimulates Eosinophil Differentiation In Vitro. Its Relationship to Interleukin 3, and Functional Properties of Eosinophils Produced in Cultures,” Journal of Experimental Medicine
162, no. 1 (1985): 60–74.
</cite> [<a href="https://doi.org/10.1084/jem.162.1.60" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2187704/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3925072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Identification%20of%20a%20Lymphokine%20That%20Stimulates%20Eosinophil%20Differentiation%20In%C2%A0Vitro.%20Its%20Relationship%20to%20Interleukin%203,%20and%20Functional%20Properties%20of%20Eosinophils%20Produced%20in%20Cultures&amp;author=C.%20J.%20Sanderson&amp;author=D.%20J.%20Warren&amp;author=M.%20Strath&amp;volume=162&amp;issue=1&amp;publication_year=1985&amp;pages=60-74&amp;pmid=3925072&amp;doi=10.1084/jem.162.1.60&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0091">
<span class="label">91.</span><cite>
Denburg J. A., Telizyn S., Belda A., Dolovich J., and Bienenstock J., “Increased Numbers of Circulating Basophil Progenitors in Atopic Patients,” Journal of Allergy and Clinical Immunology
76, no. 3 (1985): 466–472.
</cite> [<a href="https://doi.org/10.1016/0091-6749(85)90728-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/4031318/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Increased%20Numbers%20of%20Circulating%20Basophil%20Progenitors%20in%20Atopic%20Patients&amp;author=J.%20A.%20Denburg&amp;author=S.%20Telizyn&amp;author=A.%20Belda&amp;author=J.%20Dolovich&amp;author=J.%20Bienenstock&amp;volume=76&amp;issue=3&amp;publication_year=1985&amp;pages=466-472&amp;pmid=4031318&amp;doi=10.1016/0091-6749(85)90728-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0092">
<span class="label">92.</span><cite>
Otsuka H., Dolovich J., Befus A. D., Telizyn S., Bienenstock J., and Denburg J. A., “Basophilic Cell Progenitors, Nasal Metachromatic Cells, and Peripheral Blood Basophils in Ragweed‐Allergic Patients,” Journal of Allergy and Clinical Immunology
78, no. 2 (1986): 365–371.
</cite> [<a href="https://doi.org/10.1016/s0091-6749(86)80091-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3734290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Basophilic%20Cell%20Progenitors,%20Nasal%20Metachromatic%20Cells,%20and%20Peripheral%20Blood%20Basophils%20in%20Ragweed%E2%80%90Allergic%20Patients&amp;author=H.%20Otsuka&amp;author=J.%20Dolovich&amp;author=A.%20D.%20Befus&amp;author=S.%20Telizyn&amp;author=J.%20Bienenstock&amp;volume=78&amp;issue=2&amp;publication_year=1986&amp;pages=365-371&amp;pmid=3734290&amp;doi=10.1016/s0091-6749(86)80091-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0093">
<span class="label">93.</span><cite>
Linden M., Svensson C., Andersson M., et al., “Circulating Eosinophil/Basophil Progenitors and Nasal Mucosal Cytokines in Seasonal Allergic Rhinitis,” Allergy
54, no. 3 (1999): 212–219.
</cite> [<a href="https://doi.org/10.1034/j.1398-9995.1999.00756.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10321556/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Circulating%20Eosinophil/Basophil%20Progenitors%20and%20Nasal%20Mucosal%20Cytokines%20in%20Seasonal%20Allergic%20Rhinitis&amp;author=M.%20Linden&amp;author=C.%20Svensson&amp;author=M.%20Andersson&amp;volume=54&amp;issue=3&amp;publication_year=1999&amp;pages=212-219&amp;pmid=10321556&amp;doi=10.1034/j.1398-9995.1999.00756.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0094">
<span class="label">94.</span><cite>
Cyr M. M., Hayes L. M., Crawford L., Baatjes A. J., Keith P. K., and Denburg J. A., “The Effect of Desloratadine on Eosinophil/Basophil Progenitors and Other Inflammatory Markers in Seasonal Allergic Rhinitis: A Placebo‐Controlled Randomized Study,” International Archives of Allergy and Immunology
138, no. 3 (2005): 209–216.
</cite> [<a href="https://doi.org/10.1159/000088721" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16210859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Archives%20of%20Allergy%20and%20Immunology&amp;title=The%20Effect%20of%20Desloratadine%20on%20Eosinophil/Basophil%20Progenitors%20and%20Other%20Inflammatory%20Markers%20in%20Seasonal%20Allergic%20Rhinitis:%20A%20Placebo%E2%80%90Controlled%20Randomized%20Study&amp;author=M.%20M.%20Cyr&amp;author=L.%20M.%20Hayes&amp;author=L.%20Crawford&amp;author=A.%20J.%20Baatjes&amp;author=P.%20K.%20Keith&amp;volume=138&amp;issue=3&amp;publication_year=2005&amp;pages=209-216&amp;pmid=16210859&amp;doi=10.1159/000088721&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0095">
<span class="label">95.</span><cite>
Wood L. J., Inman M. D., Watson R. M., Foley R., Denburg J. A., and O'Byrne P. M., “Changes in Bone Marrow Inflammatory Cell Progenitors After Inhaled Allergen in Asthmatic Subjects,” American Journal of Respiratory and Critical Care Medicine
157, no. 1 (1998): 99–105.
</cite> [<a href="https://doi.org/10.1164/ajrccm.157.1.9704125" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9445285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Changes%20in%20Bone%20Marrow%20Inflammatory%20Cell%20Progenitors%20After%20Inhaled%20Allergen%20in%20Asthmatic%20Subjects&amp;author=L.%20J.%20Wood&amp;author=M.%20D.%20Inman&amp;author=R.%20M.%20Watson&amp;author=R.%20Foley&amp;author=J.%20A.%20Denburg&amp;volume=157&amp;issue=1&amp;publication_year=1998&amp;pages=99-105&amp;pmid=9445285&amp;doi=10.1164/ajrccm.157.1.9704125&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0096">
<span class="label">96.</span><cite>
Dorman S. C., Sehmi R., Gauvreau G. M., et al., “Kinetics of Bone Marrow Eosinophilopoiesis and Associated Cytokines After Allergen Inhalation,” American Journal of Respiratory and Critical Care Medicine
169, no. 5 (2004): 565–572, 10.1164/rccm.200307-1024OC.
</cite> [<a href="https://doi.org/10.1164/rccm.200307-1024OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14656753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Kinetics%20of%20Bone%20Marrow%20Eosinophilopoiesis%20and%20Associated%20Cytokines%20After%20Allergen%20Inhalation&amp;author=S.%20C.%20Dorman&amp;author=R.%20Sehmi&amp;author=G.%20M.%20Gauvreau&amp;volume=169&amp;issue=5&amp;publication_year=2004&amp;pages=565-572&amp;pmid=14656753&amp;doi=10.1164/rccm.200307-1024OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0097">
<span class="label">97.</span><cite>
Wood L. J., Sehmi R., Dorman S., et al., “Allergen‐Induced Increases in Bone Marrow T Lymphocytes and Interleukin‐5 Expression in Subjects With Asthma,” American Journal of Respiratory and Critical Care Medicine
166, no. 6 (2002): 883–889.
</cite> [<a href="https://doi.org/10.1164/rccm.2108015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12231502/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Allergen%E2%80%90Induced%20Increases%20in%20Bone%20Marrow%20T%20Lymphocytes%20and%20Interleukin%E2%80%905%20Expression%20in%20Subjects%20With%20Asthma&amp;author=L.%20J.%20Wood&amp;author=R.%20Sehmi&amp;author=S.%20Dorman&amp;volume=166&amp;issue=6&amp;publication_year=2002&amp;pages=883-889&amp;pmid=12231502&amp;doi=10.1164/rccm.2108015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0098">
<span class="label">98.</span><cite>
Gibson P., Dolovich J., Girgis‐Gabardo A., et al., “The Inflammatory Response in Asthma Exacerbation: Changes in Circulating Eosinophils, Basophils and Their Progenitors,” Clinical and Experimental Allergy
20, no. 6 (1990): 661–668, 10.1111/j.1365-2222.1990.tb02705.x.
</cite> [<a href="https://doi.org/10.1111/j.1365-2222.1990.tb02705.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2083406/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=The%20Inflammatory%20Response%20in%20Asthma%20Exacerbation:%20Changes%20in%20Circulating%20Eosinophils,%20Basophils%20and%20Their%20Progenitors&amp;author=P.%20Gibson&amp;author=J.%20Dolovich&amp;author=A.%20Girgis%E2%80%90Gabardo&amp;volume=20&amp;issue=6&amp;publication_year=1990&amp;pages=661-668&amp;pmid=2083406&amp;doi=10.1111/j.1365-2222.1990.tb02705.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0099">
<span class="label">99.</span><cite>
Gibson P. G., Manning P. J., O'Byrne P. M., et al., “Allergen‐Induced Asthmatic Responses: Relationship Between Increases in Airway Responsiveness and Increases in Circulating Eosinophils, Basophils, and Their Progenitors,” American Review of Respiratory Disease
143, no. 2 (1991): 331–335, 10.1164/ajrccm/143.2.331.
</cite> [<a href="https://doi.org/10.1164/ajrccm/143.2.331" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1990948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Review%20of%20Respiratory%20Disease&amp;title=Allergen%E2%80%90Induced%20Asthmatic%20Responses:%20Relationship%20Between%20Increases%20in%20Airway%20Responsiveness%20and%20Increases%20in%20Circulating%20Eosinophils,%20Basophils,%20and%20Their%20Progenitors&amp;author=P.%20G.%20Gibson&amp;author=P.%20J.%20Manning&amp;author=P.%20M.%20O'Byrne&amp;volume=143&amp;issue=2&amp;publication_year=1991&amp;pages=331-335&amp;pmid=1990948&amp;doi=10.1164/ajrccm/143.2.331&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0100">
<span class="label">100.</span><cite>
Gauvreau G. M., O'Byrne P. M., Moqbel R., et al., “Enhanced Expression of GM‐CSF in Differentiating Eosinophils of Atopic and Atopic Asthmatic Subjects,” American Journal of Respiratory Cell and Molecular Biology
19, no. 1 (1998): 55–62.
</cite> [<a href="https://doi.org/10.1165/ajrcmb.19.1.2871" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9651180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20Cell%20and%20Molecular%20Biology&amp;title=Enhanced%20Expression%20of%20GM%E2%80%90CSF%20in%20Differentiating%20Eosinophils%20of%20Atopic%20and%20Atopic%20Asthmatic%20Subjects&amp;author=G.%20M.%20Gauvreau&amp;author=P.%20M.%20O'Byrne&amp;author=R.%20Moqbel&amp;volume=19&amp;issue=1&amp;publication_year=1998&amp;pages=55-62&amp;pmid=9651180&amp;doi=10.1165/ajrcmb.19.1.2871&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0101">
<span class="label">101.</span><cite>
Wood L. J., Inman M. D., Denburg J. A., and O'Byrne P. M., “Allergen Challenge Increases Cell Traffic Between Bone Marrow and Lung,” American Journal of Respiratory Cell and Molecular Biology
18, no. 6 (1998): 759–767.
</cite> [<a href="https://doi.org/10.1165/ajrcmb.18.6.3006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9618380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20Cell%20and%20Molecular%20Biology&amp;title=Allergen%20Challenge%20Increases%20Cell%20Traffic%20Between%20Bone%20Marrow%20and%20Lung&amp;author=L.%20J.%20Wood&amp;author=M.%20D.%20Inman&amp;author=J.%20A.%20Denburg&amp;author=P.%20M.%20O'Byrne&amp;volume=18&amp;issue=6&amp;publication_year=1998&amp;pages=759-767&amp;pmid=9618380&amp;doi=10.1165/ajrcmb.18.6.3006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0102">
<span class="label">102.</span><cite>
Johansson A. K., Sergejeva S., Sjöstrand M., Lee J. J., and Lötvall J., “Allergen‐Induced Traffic of Bone Marrow Eosinophils, Neutrophils and Lymphocytes to Airways,” European Journal of Immunology
34, no. 11 (2004): 3135–3145.
</cite> [<a href="https://doi.org/10.1002/eji.200425043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15384047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Immunology&amp;title=Allergen%E2%80%90Induced%20Traffic%20of%20Bone%20Marrow%20Eosinophils,%20Neutrophils%20and%20Lymphocytes%20to%20Airways&amp;author=A.%20K.%20Johansson&amp;author=S.%20Sergejeva&amp;author=M.%20Sj%C3%B6strand&amp;author=J.%20J.%20Lee&amp;author=J.%20L%C3%B6tvall&amp;volume=34&amp;issue=11&amp;publication_year=2004&amp;pages=3135-3145&amp;pmid=15384047&amp;doi=10.1002/eji.200425043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0103">
<span class="label">103.</span><cite>
Saito H., Howie K., Wattie J., et al., “Allergen‐Induced Murine Upper Airway Inflammation: Local and Systemic Changes in Murine Experimental Allergic Rhinitis,” Immunology
104, no. 2 (2001): 226–234.
</cite> [<a href="https://doi.org/10.1046/j.0019-2805.2001.01253.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1783291/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11683963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunology&amp;title=Allergen%E2%80%90Induced%20Murine%20Upper%20Airway%20Inflammation:%20Local%20and%20Systemic%20Changes%20in%20Murine%20Experimental%20Allergic%20Rhinitis&amp;author=H.%20Saito&amp;author=K.%20Howie&amp;author=J.%20Wattie&amp;volume=104&amp;issue=2&amp;publication_year=2001&amp;pages=226-234&amp;pmid=11683963&amp;doi=10.1046/j.0019-2805.2001.01253.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0104">
<span class="label">104.</span><cite>
Li J., Saito H., Crawford L., Inman M. D., Cyr M. M., and Denburg J. A., “Haemopoietic Mechanisms in Murine Allergic Upper and Lower Airway Inflammation,” Immunology
114, no. 3 (2005): 386–396.
</cite> [<a href="https://doi.org/10.1111/j.1365-2567.2005.02109.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1782093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15720440/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunology&amp;title=Haemopoietic%20Mechanisms%20in%20Murine%20Allergic%20Upper%20and%20Lower%20Airway%20Inflammation&amp;author=J.%20Li&amp;author=H.%20Saito&amp;author=L.%20Crawford&amp;author=M.%20D.%20Inman&amp;author=M.%20M.%20Cyr&amp;volume=114&amp;issue=3&amp;publication_year=2005&amp;pages=386-396&amp;pmid=15720440&amp;doi=10.1111/j.1365-2567.2005.02109.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0105">
<span class="label">105.</span><cite>
Saito H., Matsumoto K., Denburg A. E., et al., “Pathogenesis of Murine Experimental Allergic Rhinitis: A Study of Local and Systemic Consequences of IL‐5 Deficiency,” Journal of Immunology
168, no. 6 (2002): 3017–3023.</cite> [<a href="https://doi.org/10.4049/jimmunol.168.6.3017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11884474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Pathogenesis%20of%20Murine%20Experimental%20Allergic%20Rhinitis:%20A%20Study%20of%20Local%20and%20Systemic%20Consequences%20of%20IL%E2%80%905%20Deficiency&amp;author=H.%20Saito&amp;author=K.%20Matsumoto&amp;author=A.%20E.%20Denburg&amp;volume=168&amp;issue=6&amp;publication_year=2002&amp;pages=3017-3023&amp;pmid=11884474&amp;doi=10.4049/jimmunol.168.6.3017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0106">
<span class="label">106.</span><cite>
Saito H., Morikawa H., Howie K., et al., “Effects of a Cysteinyl Leukotriene Receptor Antagonist on Eosinophil Recruitment in Experimental Allergic Rhinitis,” Immunology
113, no. 2 (2004): 246–252.
</cite> [<a href="https://doi.org/10.1111/j.1365-2567.2004.01944.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1782557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15379985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunology&amp;title=Effects%20of%20a%20Cysteinyl%20Leukotriene%20Receptor%20Antagonist%20on%20Eosinophil%20Recruitment%20in%20Experimental%20Allergic%20Rhinitis&amp;author=H.%20Saito&amp;author=H.%20Morikawa&amp;author=K.%20Howie&amp;volume=113&amp;issue=2&amp;publication_year=2004&amp;pages=246-252&amp;pmid=15379985&amp;doi=10.1111/j.1365-2567.2004.01944.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0107">
<span class="label">107.</span><cite>
Southam D. S., Widmer N., Ellis R., Hirota J. A., Inman M. D., and Sehmi R., “Increased Eosinophil‐Lineage Committed Progenitors in the Lung of Allergen‐Challenged Mice,” Journal of Allergy and Clinical Immunology
115, no. 1 (2005): 95–102.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2004.09.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15637553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Increased%20Eosinophil%E2%80%90Lineage%20Committed%20Progenitors%20in%20the%20Lung%20of%20Allergen%E2%80%90Challenged%20Mice&amp;author=D.%20S.%20Southam&amp;author=N.%20Widmer&amp;author=R.%20Ellis&amp;author=J.%20A.%20Hirota&amp;author=M.%20D.%20Inman&amp;volume=115&amp;issue=1&amp;publication_year=2005&amp;pages=95-102&amp;pmid=15637553&amp;doi=10.1016/j.jaci.2004.09.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0108">
<span class="label">108.</span><cite>
Gauvreau G. M., Newbold P., Perrett J., et al., “Kinetics of Cellular Infiltration Post Allergen Challenge in Asthma Subjects: Differences Between Bronchial Washings and Lung Tissue,” American Journal of Respiratory and Critical Care Medicine
175 (2007): A679.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Kinetics%20of%20Cellular%20Infiltration%20Post%20Allergen%20Challenge%20in%20Asthma%20Subjects:%20Differences%20Between%20Bronchial%20Washings%20and%20Lung%20Tissue&amp;author=G.%20M.%20Gauvreau&amp;author=P.%20Newbold&amp;author=J.%20Perrett&amp;volume=175&amp;publication_year=2007&amp;pages=A679&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0109">
<span class="label">109.</span><cite>
Minshall E. M., Schleimer R., Cameron L., et al., “Interleukin‐5 Expression in the Bone Marrow of Sensitized Balb/c Mice After Allergen Challenge,” American Journal of Respiratory and Critical Care Medicine
158, no. 3 (1998): 951–957, 10.1164/ajrccm.158.3.9709114.
</cite> [<a href="https://doi.org/10.1164/ajrccm.158.3.9709114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9731030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Interleukin%E2%80%905%20Expression%20in%20the%20Bone%20Marrow%20of%20Sensitized%20Balb/c%20Mice%20After%20Allergen%20Challenge&amp;author=E.%20M.%20Minshall&amp;author=R.%20Schleimer&amp;author=L.%20Cameron&amp;volume=158&amp;issue=3&amp;publication_year=1998&amp;pages=951-957&amp;pmid=9731030&amp;doi=10.1164/ajrccm.158.3.9709114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0110">
<span class="label">110.</span><cite>
Dorman S. C., Efthimiadis A., Babirad I., et al., “Sputum CD34+ IL‐5Rα+ Cells Increase After Allergen: Evidence for In Situ Eosinophilopoiesis,” American Journal of Respiratory and Critical Care Medicine
169, no. 5 (2004): 573–577, 10.1164/rccm.200307-1004OC.
</cite> [<a href="https://doi.org/10.1164/rccm.200307-1004OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14630618/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Sputum%20CD34+%20IL%E2%80%905R%CE%B1+%20Cells%20Increase%20After%20Allergen:%20Evidence%20for%20In%C2%A0Situ%20Eosinophilopoiesis&amp;author=S.%20C.%20Dorman&amp;author=A.%20Efthimiadis&amp;author=I.%20Babirad&amp;volume=169&amp;issue=5&amp;publication_year=2004&amp;pages=573-577&amp;pmid=14630618&amp;doi=10.1164/rccm.200307-1004OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0111">
<span class="label">111.</span><cite>
Whetstone C. E., Cusack R. P., Price E., et al., “Effect of Benralizumab on Inflammation in Skin After Intradermal Allergen Challenge in Patients With Moderate‐To‐Severe Atopic Dermatitis,” Journal of Allergy and Clinical Immunology: Global
3, no. 4 (2024): 100310.
</cite> [<a href="https://doi.org/10.1016/j.jacig.2024.100310" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11372810/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39234416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology:%20Global&amp;title=Effect%20of%20Benralizumab%20on%20Inflammation%20in%20Skin%20After%20Intradermal%20Allergen%20Challenge%20in%20Patients%20With%20Moderate%E2%80%90To%E2%80%90Severe%20Atopic%20Dermatitis&amp;author=C.%20E.%20Whetstone&amp;author=R.%20P.%20Cusack&amp;author=E.%20Price&amp;volume=3&amp;issue=4&amp;publication_year=2024&amp;pages=100310&amp;pmid=39234416&amp;doi=10.1016/j.jacig.2024.100310&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0112">
<span class="label">112.</span><cite>
Sehmi R., Howie K., Rerecich T., Watson R., Foley R., and O'Byrne P., “Increased Numbers of Eosinophil Progenitor Cells (CD34+ IL5Rα+) in the Bone Marrow of Atopic Asthmatic Subjects,” Journal of Allergy and Clinical Immunology
105, no. 1 (2000): S172.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Increased%20Numbers%20of%20Eosinophil%20Progenitor%20Cells%20(CD34+%20IL5R%CE%B1+)%20in%20the%20Bone%20Marrow%20of%20Atopic%20Asthmatic%20Subjects&amp;author=R.%20Sehmi&amp;author=K.%20Howie&amp;author=T.%20Rerecich&amp;author=R.%20Watson&amp;author=R.%20Foley&amp;volume=105&amp;issue=1&amp;publication_year=2000&amp;pages=S172&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0113">
<span class="label">113.</span><cite>
Sitkauskiene B., Rådinger M., Bossios A., Johansson A.‐K., Sakalauskas R., and Lötvall J., “Airway Allergen Exposure Stimulates Bone Marrow Eosinophilia Partly via IL‐9,” Respiratory Research
6 (2005): 33.
</cite> [<a href="https://doi.org/10.1186/1465-9921-6-33" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1090617/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15823208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Respiratory%20Research&amp;title=Airway%20Allergen%20Exposure%20Stimulates%20Bone%20Marrow%20Eosinophilia%20Partly%20via%20IL%E2%80%909&amp;author=B.%20Sitkauskiene&amp;author=M.%20R%C3%A5dinger&amp;author=A.%20Bossios&amp;author=A.%E2%80%90K.%20Johansson&amp;author=R.%20Sakalauskas&amp;volume=6&amp;publication_year=2005&amp;pages=33&amp;pmid=15823208&amp;doi=10.1186/1465-9921-6-33&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0114">
<span class="label">114.</span><cite>
Allakhverdi Z., Comeau M. R., Smith D. E., et al., “CD34+ Hemopoietic Progenitor Cells Are Potent Effectors of Allergic Inflammation,” Journal of Allergy and Clinical Immunology
123, no. 2 (2009): 472–478.e1.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2008.10.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19064280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=CD34+%20Hemopoietic%20Progenitor%20Cells%20Are%20Potent%20Effectors%20of%20Allergic%20Inflammation&amp;author=Z.%20Allakhverdi&amp;author=M.%20R.%20Comeau&amp;author=D.%20E.%20Smith&amp;volume=123&amp;issue=2&amp;publication_year=2009&amp;pages=472-478&amp;pmid=19064280&amp;doi=10.1016/j.jaci.2008.10.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0115">
<span class="label">115.</span><cite>
Bossios A., Sjöstrand M., Dahlborn A. K., et al., “IL‐5 Expression and Release From Human CD34 Cells In Vitro; Ex Vivo Evidence From Cases of Asthma and Churg–Strauss Syndrome,” Allergy
65, no. 7 (2010): 831–839, 10.1111/j.1398-9995.2009.02271.x.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2009.02271.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19968630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=IL%E2%80%905%20Expression%20and%20Release%20From%20Human%20CD34%20Cells%20In%C2%A0Vitro;%20Ex%C2%A0Vivo%20Evidence%20From%20Cases%20of%20Asthma%20and%20Churg%E2%80%93Strauss%20Syndrome&amp;author=A.%20Bossios&amp;author=M.%20Sj%C3%B6strand&amp;author=A.%20K.%20Dahlborn&amp;volume=65&amp;issue=7&amp;publication_year=2010&amp;pages=831-839&amp;pmid=19968630&amp;doi=10.1111/j.1398-9995.2009.02271.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0116">
<span class="label">116.</span><cite>
Konno S.‐i., Gonokami Y., Kurokawa M., et al., “Cytokine Concentrations in Sputum of Asthmatic Patients,” International Archives of Allergy and Immunology
109, no. 1 (1996): 73–78, 10.1159/000237234.
</cite> [<a href="https://doi.org/10.1159/000237234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8527954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Archives%20of%20Allergy%20and%20Immunology&amp;title=Cytokine%20Concentrations%20in%20Sputum%20of%20Asthmatic%20Patients&amp;author=S.%E2%80%90i.%20Konno&amp;author=Y.%20Gonokami&amp;author=M.%20Kurokawa&amp;volume=109&amp;issue=1&amp;publication_year=1996&amp;pages=73-78&amp;pmid=8527954&amp;doi=10.1159/000237234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0117">
<span class="label">117.</span><cite>
Hoshi H., Ohno I., Honma M., et al., “IL‐5, IL‐8 and GM‐CSF Immunostaining of Sputum Cells in Bronchial Asthma and Chronic Bronchitis,” Clinical and Experimental Allergy
25, no. 8 (1995): 720–728.
</cite> [<a href="https://doi.org/10.1111/j.1365-2222.1995.tb00009.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7584683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=IL%E2%80%905,%20IL%E2%80%908%20and%20GM%E2%80%90CSF%20Immunostaining%20of%20Sputum%20Cells%20in%20Bronchial%20Asthma%20and%20Chronic%20Bronchitis&amp;author=H.%20Hoshi&amp;author=I.%20Ohno&amp;author=M.%20Honma&amp;volume=25&amp;issue=8&amp;publication_year=1995&amp;pages=720-728&amp;pmid=7584683&amp;doi=10.1111/j.1365-2222.1995.tb00009.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0118">
<span class="label">118.</span><cite>
Chou C., Wang C., and Kuo H.‐P., “Upregulation of IL‐5 Receptor Expression on Bone Marrow‐Derived CD34+ Cells From Patients With Asthma,” Changgeng Yi Xue Za Zhi
22, no. 3 (1999): 416–422.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10584413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Changgeng%20Yi%20Xue%20Za%20Zhi&amp;title=Upregulation%20of%20IL%E2%80%905%20Receptor%20Expression%20on%20Bone%20Marrow%E2%80%90Derived%20CD34+%20Cells%20From%20Patients%20With%20Asthma&amp;author=C.%20Chou&amp;author=C.%20Wang&amp;author=H.%E2%80%90P.%20Kuo&amp;volume=22&amp;issue=3&amp;publication_year=1999&amp;pages=416-422&amp;pmid=10584413&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0119">
<span class="label">119.</span><cite>
Sehmi R., Dorman S., Baatjes A., et al., “Allergen‐Induced Fluctuation in CC Chemokine Receptor 3 Expression on Bone Marrow CD34+ Cells From Asthmatic Subjects: Significance for Mobilization of Haemopoietic Progenitor Cells in Allergic Inflammation,” Immunology
109, no. 4 (2003): 536–546.
</cite> [<a href="https://doi.org/10.1046/j.1365-2567.2003.01686.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1782995/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12871220/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunology&amp;title=Allergen%E2%80%90Induced%20Fluctuation%20in%20CC%20Chemokine%20Receptor%203%20Expression%20on%20Bone%20Marrow%20CD34+%20Cells%20From%20Asthmatic%20Subjects:%20Significance%20for%20Mobilization%20of%20Haemopoietic%20Progenitor%20Cells%20in%20Allergic%20Inflammation&amp;author=R.%20Sehmi&amp;author=S.%20Dorman&amp;author=A.%20Baatjes&amp;volume=109&amp;issue=4&amp;publication_year=2003&amp;pages=536-546&amp;pmid=12871220&amp;doi=10.1046/j.1365-2567.2003.01686.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0120">
<span class="label">120.</span><cite>
Lamkhioued B., Abdelilah S. G., Hamid Q., Mansour N., Delespesse G., and Renzi P. M., “The CCR3 Receptor Is Involved in Eosinophil Differentiation and Is Up‐Regulated by Th2 Cytokines in CD34+ Progenitor Cells,” Journal of Immunology
170, no. 1 (2003): 537–547.</cite> [<a href="https://doi.org/10.4049/jimmunol.170.1.537" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12496441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=The%20CCR3%20Receptor%20Is%20Involved%20in%20Eosinophil%20Differentiation%20and%20Is%20Up%E2%80%90Regulated%20by%20Th2%20Cytokines%20in%20CD34+%20Progenitor%20Cells&amp;author=B.%20Lamkhioued&amp;author=S.%20G.%20Abdelilah&amp;author=Q.%20Hamid&amp;author=N.%20Mansour&amp;author=G.%20Delespesse&amp;volume=170&amp;issue=1&amp;publication_year=2003&amp;pages=537-547&amp;pmid=12496441&amp;doi=10.4049/jimmunol.170.1.537&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0121">
<span class="label">121.</span><cite>
Zeibecoglou K., Ying S., Yamada T., et al., “Increased Mature and Immature CCR3 Messenger RNA+ Eosinophils in Bone Marrow From Patients With Atopic Asthma Compared With Atopic and Nonatopic Control Subjects,” Journal of Allergy and Clinical Immunology
103, no. 1 (1999): 99–106.
</cite> [<a href="https://doi.org/10.1016/s0091-6749(99)70532-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9893192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Increased%20Mature%20and%20Immature%20CCR3%20Messenger%20RNA+%20Eosinophils%20in%20Bone%20Marrow%20From%20Patients%20With%20Atopic%20Asthma%20Compared%20With%20Atopic%20and%20Nonatopic%20Control%20Subjects&amp;author=K.%20Zeibecoglou&amp;author=S.%20Ying&amp;author=T.%20Yamada&amp;volume=103&amp;issue=1&amp;publication_year=1999&amp;pages=99-106&amp;pmid=9893192&amp;doi=10.1016/s0091-6749(99)70532-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0122">
<span class="label">122.</span><cite>
Dorman S. C., Babirad I., Post J., et al., “Progenitor Egress From the Bone Marrow After Allergen Challenge: Role of Stromal Cell–Derived Factor 1α and Eotaxin,” Journal of Allergy and Clinical Immunology
115, no. 3 (2005): 501–507.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2004.11.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15753896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Progenitor%20Egress%20From%20the%20Bone%20Marrow%20After%20Allergen%20Challenge:%20Role%20of%20Stromal%20Cell%E2%80%93Derived%20Factor%201%CE%B1%20and%20Eotaxin&amp;author=S.%20C.%20Dorman&amp;author=I.%20Babirad&amp;author=J.%20Post&amp;volume=115&amp;issue=3&amp;publication_year=2005&amp;pages=501-507&amp;pmid=15753896&amp;doi=10.1016/j.jaci.2004.11.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0123">
<span class="label">123.</span><cite>
Catalli A. E., Thomson J. V., Babirad I. M., et al., “Modulation of β1‐Integrins on Hemopoietic Progenitor Cells After Allergen Challenge in Asthmatic Subjects,” Journal of Allergy and Clinical Immunology
122, no. 4 (2008): 803–810.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2008.07.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18760454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Modulation%20of%20%CE%B21%E2%80%90Integrins%20on%20Hemopoietic%20Progenitor%20Cells%20After%20Allergen%20Challenge%20in%20Asthmatic%20Subjects&amp;author=A.%20E.%20Catalli&amp;author=J.%20V.%20Thomson&amp;author=I.%20M.%20Babirad&amp;volume=122&amp;issue=4&amp;publication_year=2008&amp;pages=803-810&amp;pmid=18760454&amp;doi=10.1016/j.jaci.2008.07.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0124">
<span class="label">124.</span><cite>
Matsuzawa S., Sakashita K., Kinoshita T., Ito S., Yamashita T., and Koike K., “IL‐9 Enhances the Growth of Human Mast Cell Progenitors Under Stimulation With Stem Cell Factor,” Journal of Immunology
170, no. 7 (2003): 3461–3467.</cite> [<a href="https://doi.org/10.4049/jimmunol.170.7.3461" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12646606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=IL%E2%80%909%20Enhances%20the%20Growth%20of%20Human%20Mast%20Cell%20Progenitors%20Under%20Stimulation%20With%20Stem%20Cell%20Factor&amp;author=S.%20Matsuzawa&amp;author=K.%20Sakashita&amp;author=T.%20Kinoshita&amp;author=S.%20Ito&amp;author=T.%20Yamashita&amp;volume=170&amp;issue=7&amp;publication_year=2003&amp;pages=3461-3467&amp;pmid=12646606&amp;doi=10.4049/jimmunol.170.7.3461&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0125">
<span class="label">125.</span><cite>
Semlali A., Jacques E., Koussih L., Gounni A. S., and Chakir J., “Thymic Stromal Lymphopoietin–Induced Human Asthmatic Airway Epithelial Cell Proliferation Through an IL‐13–Dependent Pathway,” Journal of Allergy and Clinical Immunology
125, no. 4 (2010): 844–850.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2010.01.044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20236697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Thymic%20Stromal%20Lymphopoietin%E2%80%93Induced%20Human%20Asthmatic%20Airway%20Epithelial%20Cell%20Proliferation%20Through%20an%20IL%E2%80%9013%E2%80%93Dependent%20Pathway&amp;author=A.%20Semlali&amp;author=E.%20Jacques&amp;author=L.%20Koussih&amp;author=A.%20S.%20Gounni&amp;author=J.%20Chakir&amp;volume=125&amp;issue=4&amp;publication_year=2010&amp;pages=844-850&amp;pmid=20236697&amp;doi=10.1016/j.jaci.2010.01.044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0126">
<span class="label">126.</span><cite>
Préfontaine D., Nadigel J., Chouiali F., et al., “Increased IL‐33 Expression by Epithelial Cells in Bronchial Asthma,” Journal of Allergy and Clinical Immunology
125, no. 3 (2010): 752–754.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2009.12.935" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20153038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Increased%20IL%E2%80%9033%20Expression%20by%20Epithelial%20Cells%20in%20Bronchial%20Asthma&amp;author=D.%20Pr%C3%A9fontaine&amp;author=J.%20Nadigel&amp;author=F.%20Chouiali&amp;volume=125&amp;issue=3&amp;publication_year=2010&amp;pages=752-754&amp;pmid=20153038&amp;doi=10.1016/j.jaci.2009.12.935&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0127">
<span class="label">127.</span><cite>
Ying S., O'Connor B., Ratoff J., et al., “Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates With Expression of Th2‐Attracting Chemokines and Disease Severity,” Journal of Immunology
174, no. 12 (2005): 8183–8190, 10.4049/jimmunol.174.12.8183.</cite> [<a href="https://doi.org/10.4049/jimmunol.174.12.8183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15944327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Thymic%20Stromal%20Lymphopoietin%20Expression%20Is%20Increased%20in%20Asthmatic%20Airways%20and%20Correlates%20With%20Expression%20of%20Th2%E2%80%90Attracting%20Chemokines%20and%20Disease%20Severity&amp;author=S.%20Ying&amp;author=B.%20O'Connor&amp;author=J.%20Ratoff&amp;volume=174&amp;issue=12&amp;publication_year=2005&amp;pages=8183-8190&amp;pmid=15944327&amp;doi=10.4049/jimmunol.174.12.8183&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0128">
<span class="label">128.</span><cite>
Li Y., Wang W., Lv Z., et al., “Elevated Expression of IL‐33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease,” Journal of Immunology
200, no. 7 (2018): 2253–2262.</cite> [<a href="https://doi.org/10.4049/jimmunol.1701455" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29453280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Elevated%20Expression%20of%20IL%E2%80%9033%20and%20TSLP%20in%20the%20Airways%20of%20Human%20Asthmatics%20In%C2%A0Vivo:%20A%20Potential%20Biomarker%20of%20Severe%20Refractory%20Disease&amp;author=Y.%20Li&amp;author=W.%20Wang&amp;author=Z.%20Lv&amp;volume=200&amp;issue=7&amp;publication_year=2018&amp;pages=2253-2262&amp;pmid=29453280&amp;doi=10.4049/jimmunol.1701455&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0129">
<span class="label">129.</span><cite>
Al‐Sajee D., Sehmi R., Hawke T. J., et al., “Expression of IL‐33 and TSLP and Their Receptors in Asthmatic Airways After Inhaled Allergen Challenge,” American Journal of Respiratory and Critical Care Medicine
198, no. 6 (2018): 805–807.
</cite> [<a href="https://doi.org/10.1164/rccm.201712-2468LE" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29733677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Expression%20of%20IL%E2%80%9033%20and%20TSLP%20and%20Their%20Receptors%20in%20Asthmatic%20Airways%20After%20Inhaled%20Allergen%20Challenge&amp;author=D.%20Al%E2%80%90Sajee&amp;author=R.%20Sehmi&amp;author=T.%20J.%20Hawke&amp;volume=198&amp;issue=6&amp;publication_year=2018&amp;pages=805-807&amp;pmid=29733677&amp;doi=10.1164/rccm.201712-2468LE&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0130">
<span class="label">130.</span><cite>
Mitchell P. D., Salter B. M., Oliveria J. P., et al., “IL‐33 and Its Receptor ST2 After Inhaled Allergen Challenge in Allergic Asthmatics,” International Archives of Allergy and Immunology
176, no. 2 (2018): 133–142.
</cite> [<a href="https://doi.org/10.1159/000488015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29694974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Archives%20of%20Allergy%20and%20Immunology&amp;title=IL%E2%80%9033%20and%20Its%20Receptor%20ST2%20After%20Inhaled%20Allergen%20Challenge%20in%20Allergic%20Asthmatics&amp;author=P.%20D.%20Mitchell&amp;author=B.%20M.%20Salter&amp;author=J.%20P.%20Oliveria&amp;volume=176&amp;issue=2&amp;publication_year=2018&amp;pages=133-142&amp;pmid=29694974&amp;doi=10.1159/000488015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0131">
<span class="label">131.</span><cite>
Wang W., Li Y., Lv Z., et al., “Bronchial Allergen Challenge of Patients With Atopic Asthma Triggers an Alarmin (IL‐33, TSLP, and IL‐25) Response in the Airways Epithelium and Submucosa,” Journal of Immunology
201, no. 8 (2018): 2221–2231.</cite> [<a href="https://doi.org/10.4049/jimmunol.1800709" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30185520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Bronchial%20Allergen%20Challenge%20of%20Patients%20With%20Atopic%20Asthma%20Triggers%20an%20Alarmin%20(IL%E2%80%9033,%20TSLP,%20and%20IL%E2%80%9025)%20Response%20in%20the%20Airways%20Epithelium%20and%20Submucosa&amp;author=W.%20Wang&amp;author=Y.%20Li&amp;author=Z.%20Lv&amp;volume=201&amp;issue=8&amp;publication_year=2018&amp;pages=2221-2231&amp;pmid=30185520&amp;doi=10.4049/jimmunol.1800709&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0132">
<span class="label">132.</span><cite>
Whetstone C. E., Ranjbar M., Omer H., Cusack R. P., and Gauvreau G. M., “The Role of Airway Epithelial Cell Alarmins in Asthma,” Cells
11, no. 7 (2022): 1105.
</cite> [<a href="https://doi.org/10.3390/cells11071105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8997824/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35406669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=The%20Role%20of%20Airway%20Epithelial%20Cell%20Alarmins%20in%20Asthma&amp;author=C.%20E.%20Whetstone&amp;author=M.%20Ranjbar&amp;author=H.%20Omer&amp;author=R.%20P.%20Cusack&amp;author=G.%20M.%20Gauvreau&amp;volume=11&amp;issue=7&amp;publication_year=2022&amp;pages=1105&amp;pmid=35406669&amp;doi=10.3390/cells11071105&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0133">
<span class="label">133.</span><cite>
Salter B. M., Oliveria J. P., Nusca G., et al., “Thymic Stromal Lymphopoietin Activation of Basophils in Patients With Allergic Asthma Is IL‐3 Dependent,” Journal of Allergy and Clinical Immunology
136, no. 6 (2015): 1636–1644.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2015.03.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25962901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Thymic%20Stromal%20Lymphopoietin%20Activation%20of%20Basophils%20in%20Patients%20With%20Allergic%20Asthma%20Is%20IL%E2%80%903%20Dependent&amp;author=B.%20M.%20Salter&amp;author=J.%20P.%20Oliveria&amp;author=G.%20Nusca&amp;volume=136&amp;issue=6&amp;publication_year=2015&amp;pages=1636-1644&amp;pmid=25962901&amp;doi=10.1016/j.jaci.2015.03.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0134">
<span class="label">134.</span><cite>
Salter B. M., Oliveria J. P., Nusca G., et al., “IL‐25 and IL‐33 Induce Type 2 Inflammation in Basophils From Subjects With Allergic Asthma,” Respiratory Research
17 (2016): 5, 10.1186/s12931-016-0321-z.
</cite> [<a href="https://doi.org/10.1186/s12931-016-0321-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4712475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26762527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Respiratory%20Research&amp;title=IL%E2%80%9025%20and%20IL%E2%80%9033%20Induce%20Type%202%20Inflammation%20in%20Basophils%20From%20Subjects%20With%20Allergic%20Asthma&amp;author=B.%20M.%20Salter&amp;author=J.%20P.%20Oliveria&amp;author=G.%20Nusca&amp;volume=17&amp;publication_year=2016&amp;pages=5&amp;pmid=26762527&amp;doi=10.1186/s12931-016-0321-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0135">
<span class="label">135.</span><cite>
Tang W., Smith S. G., Du W., et al., “Interleukin‐25 and Eosinophils Progenitor Cell Mobilization in Allergic Asthma,” Clinical and Translational Allergy
8 (2018): 5.
</cite> [<a href="https://doi.org/10.1186/s13601-018-0190-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5809891/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29456832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Translational%20Allergy&amp;title=Interleukin%E2%80%9025%20and%20Eosinophils%20Progenitor%20Cell%20Mobilization%20in%20Allergic%20Asthma&amp;author=W.%20Tang&amp;author=S.%20G.%20Smith&amp;author=W.%20Du&amp;volume=8&amp;publication_year=2018&amp;pages=5&amp;pmid=29456832&amp;doi=10.1186/s13601-018-0190-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0136">
<span class="label">136.</span><cite>
Siracusa M. C., Saenz S. A., Hill D. A., et al., “TSLP Promotes Interleukin‐3‐Independent Basophil Haematopoiesis and Type 2 Inflammation,” Nature
477, no. 7363 (2011): 229–233.
</cite> [<a href="https://doi.org/10.1038/nature10329" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3263308/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21841801/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=TSLP%20Promotes%20Interleukin%E2%80%903%E2%80%90Independent%20Basophil%20Haematopoiesis%20and%20Type%202%20Inflammation&amp;author=M.%20C.%20Siracusa&amp;author=S.%20A.%20Saenz&amp;author=D.%20A.%20Hill&amp;volume=477&amp;issue=7363&amp;publication_year=2011&amp;pages=229-233&amp;pmid=21841801&amp;doi=10.1038/nature10329&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0137">
<span class="label">137.</span><cite>
Allakhverdi Z., Comeau M. R., Armant M., et al., “Mast Cell‐Activated Bone Marrow Mesenchymal Stromal Cells Regulate Proliferation and Lineage Commitment of CD34+ Progenitor Cells,” Frontiers in Immunology
4 (2013): 461, 10.3389/fimmu.2013.00461.
</cite> [<a href="https://doi.org/10.3389/fimmu.2013.00461" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3865761/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24381572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Immunology&amp;title=Mast%20Cell%E2%80%90Activated%20Bone%20Marrow%20Mesenchymal%20Stromal%20Cells%20Regulate%20Proliferation%20and%20Lineage%20Commitment%20of%20CD34+%20Progenitor%20Cells&amp;author=Z.%20Allakhverdi&amp;author=M.%20R.%20Comeau&amp;author=M.%20Armant&amp;volume=4&amp;publication_year=2013&amp;pages=461&amp;pmid=24381572&amp;doi=10.3389/fimmu.2013.00461&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0138">
<span class="label">138.</span><cite>
Hui C. C., Rusta‐Sallehy S., Asher I., Heroux D., and Denburg J. A., “The Effects of Thymic Stromal Lymphopoietin and IL‐3 on Human Eosinophil–Basophil Lineage Commitment: Relevance to Atopic Sensitization,” Immunity, Inflammation and Disease
2, no. 1 (2014): 44–55.
</cite> [<a href="https://doi.org/10.1002/iid3.20" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4220668/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25400924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity,%20Inflammation%20and%20Disease&amp;title=The%20Effects%20of%20Thymic%20Stromal%20Lymphopoietin%20and%20IL%E2%80%903%20on%20Human%20Eosinophil%E2%80%93Basophil%20Lineage%20Commitment:%20Relevance%20to%20Atopic%20Sensitization&amp;author=C.%20C.%20Hui&amp;author=S.%20Rusta%E2%80%90Sallehy&amp;author=I.%20Asher&amp;author=D.%20Heroux&amp;author=J.%20A.%20Denburg&amp;volume=2&amp;issue=1&amp;publication_year=2014&amp;pages=44-55&amp;pmid=25400924&amp;doi=10.1002/iid3.20&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0139">
<span class="label">139.</span><cite>
Salter B. M., Smith S. G., Mukherjee M., et al., “Human Bronchial Epithelial Cell–Derived Factors From Severe Asthmatic Subjects Stimulate Eosinophil Differentiation,” American Journal of Respiratory Cell and Molecular Biology
58, no. 1 (2018): 99–106, 10.1165/rcmb.2016-0262OC.
</cite> [<a href="https://doi.org/10.1165/rcmb.2016-0262OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28853918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20Cell%20and%20Molecular%20Biology&amp;title=Human%20Bronchial%20Epithelial%20Cell%E2%80%93Derived%20Factors%20From%20Severe%20Asthmatic%20Subjects%20Stimulate%20Eosinophil%20Differentiation&amp;author=B.%20M.%20Salter&amp;author=S.%20G.%20Smith&amp;author=M.%20Mukherjee&amp;volume=58&amp;issue=1&amp;publication_year=2018&amp;pages=99-106&amp;pmid=28853918&amp;doi=10.1165/rcmb.2016-0262OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0140">
<span class="label">140.</span><cite>
Wu C. A., Peluso J. J., Zhu L., Lingenheld E. G., Walker S. T., and Puddington L., “Bronchial Epithelial Cells Produce IL‐5: Implications for Local Immune Responses in the Airways,” Cellular Immunology
264, no. 1 (2010): 32–41.
</cite> [<a href="https://doi.org/10.1016/j.cellimm.2010.04.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2902557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20494340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20Immunology&amp;title=Bronchial%20Epithelial%20Cells%20Produce%20IL%E2%80%905:%20Implications%20for%20Local%20Immune%20Responses%20in%20the%20Airways&amp;author=C.%20A.%20Wu&amp;author=J.%20J.%20Peluso&amp;author=L.%20Zhu&amp;author=E.%20G.%20Lingenheld&amp;author=S.%20T.%20Walker&amp;volume=264&amp;issue=1&amp;publication_year=2010&amp;pages=32-41&amp;pmid=20494340&amp;doi=10.1016/j.cellimm.2010.04.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0141">
<span class="label">141.</span><cite>
Gauvreau G., Wood L., Sehmi R., et al., “The Effects of Inhaled Budesonide on Circulating Eosinophil Progenitors and Their Expression of Cytokines After Allergen Challenge in Subjects With Atopic Asthma,” American Journal of Respiratory and Critical Care Medicine
162, no. 6 (2000): 2139–2144, 10.1164/ajrccm.162.6.2001120.
</cite> [<a href="https://doi.org/10.1164/ajrccm.162.6.2001120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11112128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=The%20Effects%20of%20Inhaled%20Budesonide%20on%20Circulating%20Eosinophil%20Progenitors%20and%20Their%20Expression%20of%20Cytokines%20After%20Allergen%20Challenge%20in%20Subjects%20With%20Atopic%20Asthma&amp;author=G.%20Gauvreau&amp;author=L.%20Wood&amp;author=R.%20Sehmi&amp;volume=162&amp;issue=6&amp;publication_year=2000&amp;pages=2139-2144&amp;pmid=11112128&amp;doi=10.1164/ajrccm.162.6.2001120&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0142">
<span class="label">142.</span><cite>
Smith S. G., Chen R., Kjarsgaard M., et al., “Increased Numbers of Activated Group 2 Innate Lymphoid Cells in the Airways of Patients With Severe Asthma and Persistent Airway Eosinophilia,” Journal of Allergy and Clinical Immunology
137, no. 1 (2016): 75–86.e8.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2015.05.037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26194544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Increased%20Numbers%20of%20Activated%20Group%202%20Innate%20Lymphoid%20Cells%20in%20the%20Airways%20of%20Patients%20With%20Severe%20Asthma%20and%20Persistent%20Airway%20Eosinophilia&amp;author=S.%20G.%20Smith&amp;author=R.%20Chen&amp;author=M.%20Kjarsgaard&amp;volume=137&amp;issue=1&amp;publication_year=2016&amp;pages=75-86&amp;pmid=26194544&amp;doi=10.1016/j.jaci.2015.05.037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0143">
<span class="label">143.</span><cite>
Price E., Al‐Sajee D., Krisna S., et al., “The Effect of Steroid Treatment on Eosinophil Progenitors, Eosinophils and Basophils in the Skin of Patients With Moderate‐to‐Severe Atopic Dermatitis,” Allergy
114, no. 2 (2019): AB92.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=The%20Effect%20of%20Steroid%20Treatment%20on%20Eosinophil%20Progenitors,%20Eosinophils%20and%20Basophils%20in%20the%20Skin%20of%20Patients%20With%20Moderate%E2%80%90to%E2%80%90Severe%20Atopic%20Dermatitis&amp;author=E.%20Price&amp;author=D.%20Al%E2%80%90Sajee&amp;author=S.%20Krisna&amp;volume=114&amp;issue=2&amp;publication_year=2019&amp;pages=AB92&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0144">
<span class="label">144.</span><cite>
Sehmi R., Price E., Al‐Sajee D., et al., “Correlation of Clinical Atopic Dermatitis Scores With Levels of Eosinophil Progenitors in Skin After Intradermal Allergen Challenge,” Journal of Allergy and Clinical Immunology
143, no. 2 (2019): AB66.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Correlation%20of%20Clinical%20Atopic%20Dermatitis%20Scores%20With%20Levels%20of%20Eosinophil%20Progenitors%20in%20Skin%20After%20Intradermal%20Allergen%20Challenge&amp;author=R.%20Sehmi&amp;author=E.%20Price&amp;author=D.%20Al%E2%80%90Sajee&amp;volume=143&amp;issue=2&amp;publication_year=2019&amp;pages=AB66&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0145">
<span class="label">145.</span><cite>
Price E., Al‐Sajee D., Krisna S. S., et al., “Elevated Eosinophil Lineage‐Committed Progenitors in Skin Lesions of Patients With Moderate‐To‐Severe Atopic Dermatitis,” Journal of Allergy and Clinical Immunology
141, no. 2 (2018): AB92.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Elevated%20Eosinophil%20Lineage%E2%80%90Committed%20Progenitors%20in%20Skin%20Lesions%20of%20Patients%20With%20Moderate%E2%80%90To%E2%80%90Severe%20Atopic%20Dermatitis&amp;author=E.%20Price&amp;author=D.%20Al%E2%80%90Sajee&amp;author=S.%20S.%20Krisna&amp;volume=141&amp;issue=2&amp;publication_year=2018&amp;pages=AB92&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0146">
<span class="label">146.</span><cite>
Price E., Al‐Sajee D., Krisna S., et al., The Novel Characterization of Eosinophil Progenitors in the Skin of Atopic Dermatitis Patients Following Intradermal Allergen Challenge (CSACI, 2017).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=The%20Novel%20Characterization%20of%20Eosinophil%20Progenitors%20in%20the%20Skin%20of%20Atopic%20Dermatitis%20Patients%20Following%20Intradermal%20Allergen%20Challenge&amp;author=E.%20Price&amp;author=D.%20Al%E2%80%90Sajee&amp;author=S.%20Krisna&amp;publication_year=2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0147">
<span class="label">147.</span><cite>
Jose P., Griffiths‐Johnson D., Collins P., et al., “Eotaxin: A Potent Eosinophil Chemoattractant Cytokine Detected in a Guinea Pig Model of Allergic Airways Inflammation,” Journal of Experimental Medicine
179, no. 3 (1994): 881–887, 10.1084/jem.179.3.881.
</cite> [<a href="https://doi.org/10.1084/jem.179.3.881" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2191401/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7509365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Eotaxin:%20A%20Potent%20Eosinophil%20Chemoattractant%20Cytokine%20Detected%20in%20a%20Guinea%20Pig%20Model%20of%20Allergic%20Airways%20Inflammation&amp;author=P.%20Jose&amp;author=D.%20Griffiths%E2%80%90Johnson&amp;author=P.%20Collins&amp;volume=179&amp;issue=3&amp;publication_year=1994&amp;pages=881-887&amp;pmid=7509365&amp;doi=10.1084/jem.179.3.881&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0148">
<span class="label">148.</span><cite>
Fulkerson P. C., Fischetti C. A., McBride M. L., Hassman L. M., Hogan S. P., and Rothenberg M. E., “A Central Regulatory Role for Eosinophils and the Eotaxin/CCR3 Axis in Chronic Experimental Allergic Airway Inflammation,” Proceedings of the National Academy of Sciences of the United States of America
103, no. 44 (2006): 16418–16423.
</cite> [<a href="https://doi.org/10.1073/pnas.0607863103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1637597/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17060636/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America&amp;title=A%20Central%20Regulatory%20Role%20for%20Eosinophils%20and%20the%20Eotaxin/CCR3%20Axis%20in%20Chronic%20Experimental%20Allergic%20Airway%20Inflammation&amp;author=P.%20C.%20Fulkerson&amp;author=C.%20A.%20Fischetti&amp;author=M.%20L.%20McBride&amp;author=L.%20M.%20Hassman&amp;author=S.%20P.%20Hogan&amp;volume=103&amp;issue=44&amp;publication_year=2006&amp;pages=16418-16423&amp;pmid=17060636&amp;doi=10.1073/pnas.0607863103&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0149">
<span class="label">149.</span><cite>
Garcia‐Zepeda E. A., Rothenberg M. E., Ownbey R. T., Celestin J., Leder P., and Luster A. D., “Human Eotaxin Is a Specific Chemoattractant for Eosinophil Cells and Provides a New Mechanism to Explain Tissue Eosinophilia,” Nature Medicine
2, no. 4 (1996): 449–456.</cite> [<a href="https://doi.org/10.1038/nm0496-449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8597956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Medicine&amp;title=Human%20Eotaxin%20Is%20a%20Specific%20Chemoattractant%20for%20Eosinophil%20Cells%20and%20Provides%20a%20New%20Mechanism%20to%20Explain%20Tissue%20Eosinophilia&amp;author=E.%20A.%20Garcia%E2%80%90Zepeda&amp;author=M.%20E.%20Rothenberg&amp;author=R.%20T.%20Ownbey&amp;author=J.%20Celestin&amp;author=P.%20Leder&amp;volume=2&amp;issue=4&amp;publication_year=1996&amp;pages=449-456&amp;pmid=8597956&amp;doi=10.1038/nm0496-449&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0150">
<span class="label">150.</span><cite>
Brown J., Kleimberg J., Marini M., Sun G., Bellini A., and Mattoli S., “Kinetics of Eotaxin Expression and Its Relationship to Eosinophil Accumulation and Activation in Bronchial Biopsies and Bronchoalveolar Lavage (BAL) of Asthmatic Patients After Allergen Inhalation,” Clinical and Experimental Immunology
114, no. 2 (1998): 137–146.
</cite> [<a href="https://doi.org/10.1046/j.1365-2249.1998.00688.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1905105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9822268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Immunology&amp;title=Kinetics%20of%20Eotaxin%20Expression%20and%20Its%20Relationship%20to%20Eosinophil%20Accumulation%20and%20Activation%20in%20Bronchial%20Biopsies%20and%20Bronchoalveolar%20Lavage%20(BAL)%20of%20Asthmatic%20Patients%20After%20Allergen%20Inhalation&amp;author=J.%20Brown&amp;author=J.%20Kleimberg&amp;author=M.%20Marini&amp;author=G.%20Sun&amp;author=A.%20Bellini&amp;volume=114&amp;issue=2&amp;publication_year=1998&amp;pages=137-146&amp;pmid=9822268&amp;doi=10.1046/j.1365-2249.1998.00688.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0151">
<span class="label">151.</span><cite>
Rådinger M., Bossios A., Sjöstrand M., et al., “Local Proliferation and Mobilization of CCR3+ CD34+ Eosinophil‐Lineage‐Committed Cells in the Lung,” Immunology
132, no. 1 (2011): 144–154.
</cite> [<a href="https://doi.org/10.1111/j.1365-2567.2010.03349.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3015084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20875077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunology&amp;title=Local%20Proliferation%20and%20Mobilization%20of%20CCR3+%20CD34+%20Eosinophil%E2%80%90Lineage%E2%80%90Committed%20Cells%20in%20the%20Lung&amp;author=M.%20R%C3%A5dinger&amp;author=A.%20Bossios&amp;author=M.%20Sj%C3%B6strand&amp;volume=132&amp;issue=1&amp;publication_year=2011&amp;pages=144-154&amp;pmid=20875077&amp;doi=10.1111/j.1365-2567.2010.03349.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0152">
<span class="label">152.</span><cite>
Ye Q., Barrett N., and Balestrieri B., “Bioactive Lipids: Accessible Indicators Toward Improved Diagnosis and Treatment of Asthma,” Journal of Allergy and Clinical Immunology
150, no. 4 (2022): 790–792.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2022.08.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36029891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Bioactive%20Lipids:%20Accessible%20Indicators%20Toward%20Improved%20Diagnosis%20and%20Treatment%20of%20Asthma&amp;author=Q.%20Ye&amp;author=N.%20Barrett&amp;author=B.%20Balestrieri&amp;volume=150&amp;issue=4&amp;publication_year=2022&amp;pages=790-792&amp;pmid=36029891&amp;doi=10.1016/j.jaci.2022.08.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0153">
<span class="label">153.</span><cite>
Braccioni F., Dorman S. C., O'Byrne P. M., et al., “The Effect of Cysteinyl Leukotrienes on Growth of Eosinophil Progenitors From Peripheral Blood and Bone Marrow of Atopic Subjects,” Journal of Allergy and Clinical Immunology
110, no. 1 (2002): 96–101, 10.1067/mai.2002.125000.
</cite> [<a href="https://doi.org/10.1067/mai.2002.125000" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12110827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=The%20Effect%20of%20Cysteinyl%20Leukotrienes%20on%20Growth%20of%20Eosinophil%20Progenitors%20From%20Peripheral%20Blood%20and%20Bone%20Marrow%20of%20Atopic%20Subjects&amp;author=F.%20Braccioni&amp;author=S.%20C.%20Dorman&amp;author=P.%20M.%20O'Byrne&amp;volume=110&amp;issue=1&amp;publication_year=2002&amp;pages=96-101&amp;pmid=12110827&amp;doi=10.1067/mai.2002.125000&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0154">
<span class="label">154.</span><cite>
Gauvreau G. M., Plitt J. R., Baatjes A., and MacGlashan D. W., “Expression of Functional Cysteinyl Leukotriene Receptors by Human Basophils,” Journal of Allergy and Clinical Immunology
116, no. 1 (2005): 80–87.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2005.03.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15990778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Expression%20of%20Functional%20Cysteinyl%20Leukotriene%20Receptors%20by%20Human%20Basophils&amp;author=G.%20M.%20Gauvreau&amp;author=J.%20R.%20Plitt&amp;author=A.%20Baatjes&amp;author=D.%20W.%20MacGlashan&amp;volume=116&amp;issue=1&amp;publication_year=2005&amp;pages=80-87&amp;pmid=15990778&amp;doi=10.1016/j.jaci.2005.03.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0155">
<span class="label">155.</span><cite>
Fregonese L., Silvestri M., Sabatini F., and Rossi G., “Cysteinyl Leukotrienes Induce Human Eosinophil Locomotion and Adhesion Molecule Expression via a CysLT1 Receptor‐Mediated Mechanism,” Clinical and Experimental Allergy
32, no. 5 (2002): 745–750.
</cite> [<a href="https://doi.org/10.1046/j.1365-2222.2002.01384.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11994100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Cysteinyl%20Leukotrienes%20Induce%20Human%20Eosinophil%20Locomotion%20and%20Adhesion%20Molecule%20Expression%20via%20a%20CysLT1%20Receptor%E2%80%90Mediated%20Mechanism&amp;author=L.%20Fregonese&amp;author=M.%20Silvestri&amp;author=F.%20Sabatini&amp;author=G.%20Rossi&amp;volume=32&amp;issue=5&amp;publication_year=2002&amp;pages=745-750&amp;pmid=11994100&amp;doi=10.1046/j.1365-2222.2002.01384.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0156">
<span class="label">156.</span><cite>
Wenzel S. E., Larsen G. L., Johnston K., Voelkel N. F., and Westcott J. Y., “Elevated Levels of Leukotriene C4 in Bronchoalveolar Lavage Fluid From Atopic Asthmatics After Endobronchial Allergen Challenge,” American Review of Respiratory Disease
142, no. 1 (1990): 112–119.
</cite> [<a href="https://doi.org/10.1164/ajrccm/142.1.112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2195930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Review%20of%20Respiratory%20Disease&amp;title=Elevated%20Levels%20of%20Leukotriene%20C4%20in%20Bronchoalveolar%20Lavage%20Fluid%20From%20Atopic%20Asthmatics%20After%20Endobronchial%20Allergen%20Challenge&amp;author=S.%20E.%20Wenzel&amp;author=G.%20L.%20Larsen&amp;author=K.%20Johnston&amp;author=N.%20F.%20Voelkel&amp;author=J.%20Y.%20Westcott&amp;volume=142&amp;issue=1&amp;publication_year=1990&amp;pages=112-119&amp;pmid=2195930&amp;doi=10.1164/ajrccm/142.1.112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0157">
<span class="label">157.</span><cite>
Wenzel S. E., Westcott J. Y., and Larsen G. L., “Bronchoalveolar Lavage Fluid Mediator Levels 5 Minutes After Allergen Challenge in Atopic Subjects With Asthma: Relationship to the Development of Late Asthmatic Responses,” Journal of Allergy and Clinical Immunology
87, no. 2 (1991): 540–548.
</cite> [<a href="https://doi.org/10.1016/0091-6749(91)90013-e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1993813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Bronchoalveolar%20Lavage%20Fluid%20Mediator%20Levels%205%20Minutes%20After%20Allergen%20Challenge%20in%20Atopic%20Subjects%20With%20Asthma:%20Relationship%20to%20the%20Development%20of%20Late%20Asthmatic%20Responses&amp;author=S.%20E.%20Wenzel&amp;author=J.%20Y.%20Westcott&amp;author=G.%20L.%20Larsen&amp;volume=87&amp;issue=2&amp;publication_year=1991&amp;pages=540-548&amp;pmid=1993813&amp;doi=10.1016/0091-6749(91)90013-e&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0158">
<span class="label">158.</span><cite>
Gauvreau G. M., Parameswaran K. N., Watson R. M., and O'Byrne P. M., “Inhaled Leukotriene E4, but Not Leukotriene D4, Increased Airway Inflammatory Cells in Subjects With Atopic Asthma,” American Journal of Respiratory and Critical Care Medicine
164, no. 8 (2001): 1495–1500.
</cite> [<a href="https://doi.org/10.1164/ajrccm.164.8.2102033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11704602/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Inhaled%20Leukotriene%20E4,%20but%20Not%20Leukotriene%20D4,%20Increased%20Airway%20Inflammatory%20Cells%20in%20Subjects%20With%20Atopic%20Asthma&amp;author=G.%20M.%20Gauvreau&amp;author=K.%20N.%20Parameswaran&amp;author=R.%20M.%20Watson&amp;author=P.%20M.%20O'Byrne&amp;volume=164&amp;issue=8&amp;publication_year=2001&amp;pages=1495-1500&amp;pmid=11704602&amp;doi=10.1164/ajrccm.164.8.2102033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0159">
<span class="label">159.</span><cite>
Bautz F., Denzlinger C., Kanz L., and Möhle R., “Chemotaxis and Transendothelial Migration of CD34+ Hematopoietic Progenitor Cells Induced by the Inflammatory Mediator Leukotriene D4 Are Mediated by the 7‐Transmembrane Receptor CysLT1,” Blood
97, no. 11 (2001): 3433–3440.
</cite> [<a href="https://doi.org/10.1182/blood.v97.11.3433" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11369634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Chemotaxis%20and%20Transendothelial%20Migration%20of%20CD34+%20Hematopoietic%20Progenitor%20Cells%20Induced%20by%20the%20Inflammatory%20Mediator%20Leukotriene%20D4%20Are%20Mediated%20by%20the%207%E2%80%90Transmembrane%20Receptor%20CysLT1&amp;author=F.%20Bautz&amp;author=C.%20Denzlinger&amp;author=L.%20Kanz&amp;author=R.%20M%C3%B6hle&amp;volume=97&amp;issue=11&amp;publication_year=2001&amp;pages=3433-3440&amp;pmid=11369634&amp;doi=10.1182/blood.v97.11.3433&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0160">
<span class="label">160.</span><cite>
Parameswaran K., Watson R., Gauvreau G. M., Sehmi R., and O'Byrne P. M., “The Effect of Pranlukast on Allergen‐Induced Bone Marrow Eosinophilopoiesis in Subjects With Asthma,” American Journal of Respiratory and Critical Care Medicine
169, no. 8 (2004): 915–920.
</cite> [<a href="https://doi.org/10.1164/rccm.200312-1645OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14742305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=The%20Effect%20of%20Pranlukast%20on%20Allergen%E2%80%90Induced%20Bone%20Marrow%20Eosinophilopoiesis%20in%20Subjects%20With%20Asthma&amp;author=K.%20Parameswaran&amp;author=R.%20Watson&amp;author=G.%20M.%20Gauvreau&amp;author=R.%20Sehmi&amp;author=P.%20M.%20O'Byrne&amp;volume=169&amp;issue=8&amp;publication_year=2004&amp;pages=915-920&amp;pmid=14742305&amp;doi=10.1164/rccm.200312-1645OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0161">
<span class="label">161.</span><cite>
Weller P. F., “Eosinophils: Structure and Functions,” Current Opinion in Immunology
6, no. 1 (1994): 85–90.
</cite> [<a href="https://doi.org/10.1016/0952-7915(94)90038-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8172683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Immunology&amp;title=Eosinophils:%20Structure%20and%20Functions&amp;author=P.%20F.%20Weller&amp;volume=6&amp;issue=1&amp;publication_year=1994&amp;pages=85-90&amp;pmid=8172683&amp;doi=10.1016/0952-7915(94)90038-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0162">
<span class="label">162.</span><cite>
Rosenberg H. F., Phipps S., and Foster P. S., “Eosinophil Trafficking in Allergy and Asthma,” Journal of Allergy and Clinical Immunology
119, no. 6 (2007): 1303–1310.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2007.03.048" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17481712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Eosinophil%20Trafficking%20in%20Allergy%20and%20Asthma&amp;author=H.%20F.%20Rosenberg&amp;author=S.%20Phipps&amp;author=P.%20S.%20Foster&amp;volume=119&amp;issue=6&amp;publication_year=2007&amp;pages=1303-1310&amp;pmid=17481712&amp;doi=10.1016/j.jaci.2007.03.048&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0163">
<span class="label">163.</span><cite>
Asquith K. L., Ramshaw H. S., Hansbro P. M., Beagley K. W., Lopez A. F., and Foster P. S., “The IL‐3/IL‐5/GM‐CSF Common β Receptor Plays a Pivotal Role in the Regulation of Th2 Immunity and Allergic Airway Inflammation,” Journal of Immunology
180, no. 2 (2008): 1199–1206.</cite> [<a href="https://doi.org/10.4049/jimmunol.180.2.1199" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18178860/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=The%20IL%E2%80%903/IL%E2%80%905/GM%E2%80%90CSF%20Common%20%CE%B2%20Receptor%20Plays%20a%20Pivotal%20Role%20in%20the%20Regulation%20of%20Th2%20Immunity%20and%20Allergic%20Airway%20Inflammation&amp;author=K.%20L.%20Asquith&amp;author=H.%20S.%20Ramshaw&amp;author=P.%20M.%20Hansbro&amp;author=K.%20W.%20Beagley&amp;author=A.%20F.%20Lopez&amp;volume=180&amp;issue=2&amp;publication_year=2008&amp;pages=1199-1206&amp;pmid=18178860&amp;doi=10.4049/jimmunol.180.2.1199&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0164">
<span class="label">164.</span><cite>
Panousis C., Dhagat U., Edwards K. M., et al., “CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL‐3, GM‐CSF and IL‐5 receptors,” Monoclonal Antibodies
8, no. 3 (2016): 436–453.
</cite> [<a href="https://doi.org/10.1080/19420862.2015.1119352" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4966837/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26651396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Monoclonal%20Antibodies&amp;title=CSL311,%20a%20novel,%20potent,%20therapeutic%20monoclonal%20antibody%20for%20the%20treatment%20of%20diseases%20mediated%20by%20the%20common%20%CE%B2%20chain%20of%20the%20IL%E2%80%903,%20GM%E2%80%90CSF%20and%20IL%E2%80%905%20receptors&amp;author=C.%20Panousis&amp;author=U.%20Dhagat&amp;author=K.%20M.%20Edwards&amp;volume=8&amp;issue=3&amp;publication_year=2016&amp;pages=436-453&amp;pmid=26651396&amp;doi=10.1080/19420862.2015.1119352&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0165">
<span class="label">165.</span><cite>
Shalit M., Sekhsaria S., and Malech H. L., “Modulation of Growth and Differentiation of Eosinophils From Human Peripheral Blood CD34+ Cells by IL5 and Other Growth Factors,” Cellular Immunology
160, no. 1 (1995): 50–57.
</cite> [<a href="https://doi.org/10.1016/0008-8749(95)80008-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7531118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20Immunology&amp;title=Modulation%20of%20Growth%20and%20Differentiation%20of%20Eosinophils%20From%20Human%20Peripheral%20Blood%20CD34+%20Cells%20by%20IL5%20and%20Other%20Growth%20Factors&amp;author=M.%20Shalit&amp;author=S.%20Sekhsaria&amp;author=H.%20L.%20Malech&amp;volume=160&amp;issue=1&amp;publication_year=1995&amp;pages=50-57&amp;pmid=7531118&amp;doi=10.1016/0008-8749(95)80008-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0166">
<span class="label">166.</span><cite>
Ying S., Meng Q., Barata L. T., Robinson D. S., Durham S. R., and Kay A. B., “Associations Between IL‐13 and IL‐4 (mRNA and Protein), Vascular Cell Adhesion Molecule‐1 Expression, and the Infiltration of Eosinophils, Macrophages, and T Cells in Allergen‐Induced Late‐Phase Cutaneous Reactions in Atopic Subjects,” Journal of Immunology
158, no. 10 (1997): 5050–5057.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9144526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Associations%20Between%20IL%E2%80%9013%20and%20IL%E2%80%904%20(mRNA%20and%20Protein),%20Vascular%20Cell%20Adhesion%20Molecule%E2%80%901%20Expression,%20and%20the%20Infiltration%20of%20Eosinophils,%20Macrophages,%20and%20T%20Cells%20in%20Allergen%E2%80%90Induced%20Late%E2%80%90Phase%20Cutaneous%20Reactions%20in%20Atopic%20Subjects&amp;author=S.%20Ying&amp;author=Q.%20Meng&amp;author=L.%20T.%20Barata&amp;author=D.%20S.%20Robinson&amp;author=S.%20R.%20Durham&amp;volume=158&amp;issue=10&amp;publication_year=1997&amp;pages=5050-5057&amp;pmid=9144526&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0167">
<span class="label">167.</span><cite>
Li L., Xia Y., Nguyen A., et al., “Effects of Th2 Cytokines on Chemokine Expression in the Lung: IL‐13 Potently Induces Eotaxin Expression by Airway Epithelial Cells,” Journal of Immunology
162, no. 5 (1999): 2477–2487.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10072486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Effects%20of%20Th2%20Cytokines%20on%20Chemokine%20Expression%20in%20the%20Lung:%20IL%E2%80%9013%20Potently%20Induces%20Eotaxin%20Expression%20by%20Airway%20Epithelial%20Cells&amp;author=L.%20Li&amp;author=Y.%20Xia&amp;author=A.%20Nguyen&amp;volume=162&amp;issue=5&amp;publication_year=1999&amp;pages=2477-2487&amp;pmid=10072486&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0168">
<span class="label">168.</span><cite>
Zimmermann N., Hogan S. P., Mishra A., et al., “Murine Eotaxin‐2: A Constitutive Eosinophil Chemokine Induced by Allergen Challenge and IL‐4 Overexpression,” Journal of Immunology
165, no. 10 (2000): 5839–5846.</cite> [<a href="https://doi.org/10.4049/jimmunol.165.10.5839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11067944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Murine%20Eotaxin%E2%80%902:%20A%20Constitutive%20Eosinophil%20Chemokine%20Induced%20by%20Allergen%20Challenge%20and%20IL%E2%80%904%20Overexpression&amp;author=N.%20Zimmermann&amp;author=S.%20P.%20Hogan&amp;author=A.%20Mishra&amp;volume=165&amp;issue=10&amp;publication_year=2000&amp;pages=5839-5846&amp;pmid=11067944&amp;doi=10.4049/jimmunol.165.10.5839&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0169">
<span class="label">169.</span><cite>
Yamada H., Hirai K., Miyamasu M., et al., “Eotaxin Is a Potent Chemotaxin for Human Basophils,” Biochemical and Biophysical Research Communications
231, no. 2 (1997): 365–368.
</cite> [<a href="https://doi.org/10.1006/bbrc.1997.6100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9070280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=Eotaxin%20Is%20a%20Potent%20Chemotaxin%20for%20Human%20Basophils&amp;author=H.%20Yamada&amp;author=K.%20Hirai&amp;author=M.%20Miyamasu&amp;volume=231&amp;issue=2&amp;publication_year=1997&amp;pages=365-368&amp;pmid=9070280&amp;doi=10.1006/bbrc.1997.6100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0170">
<span class="label">170.</span><cite>
Pettipher R., “The Roles of the Prostaglandin D2 Receptors DP1 and CRTH2 in Promoting Allergic Responses,” British Journal of Pharmacology
153, no. S1 (2008): S191–S199.
</cite> [<a href="https://doi.org/10.1038/sj.bjp.0707488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2268053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17965752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=The%20Roles%20of%20the%20Prostaglandin%20D2%20Receptors%20DP1%20and%20CRTH2%20in%20Promoting%20Allergic%20Responses&amp;author=R.%20Pettipher&amp;volume=153&amp;issue=S1&amp;publication_year=2008&amp;pages=S191-S199&amp;pmid=17965752&amp;doi=10.1038/sj.bjp.0707488&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0171">
<span class="label">171.</span><cite>
Smith S. G., Hill M., Oliveria J. P., et al., “Evaluation of Peroxisome Proliferator‐Activated Receptor Agonists on Interleukin‐5‐Induced Eosinophil Differentiation,” Immunology
142, no. 3 (2014): 484–491.
</cite> [<a href="https://doi.org/10.1111/imm.12280" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4080964/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24628018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunology&amp;title=Evaluation%20of%20Peroxisome%20Proliferator%E2%80%90Activated%20Receptor%20Agonists%20on%20Interleukin%E2%80%905%E2%80%90Induced%20Eosinophil%20Differentiation&amp;author=S.%20G.%20Smith&amp;author=M.%20Hill&amp;author=J.%20P.%20Oliveria&amp;volume=142&amp;issue=3&amp;publication_year=2014&amp;pages=484-491&amp;pmid=24628018&amp;doi=10.1111/imm.12280&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0172">
<span class="label">172.</span><cite>
Saenz S. A., Taylor B. C., and Artis D., “Welcome to the Neighborhood: Epithelial Cell‐Derived Cytokines License Innate and Adaptive Immune Responses at Mucosal Sites,” Immunological Reviews
226, no. 1 (2008): 172–190.
</cite> [<a href="https://doi.org/10.1111/j.1600-065X.2008.00713.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2683382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19161424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunological%20Reviews&amp;title=Welcome%20to%20the%20Neighborhood:%20Epithelial%20Cell%E2%80%90Derived%20Cytokines%20License%20Innate%20and%20Adaptive%20Immune%20Responses%20at%20Mucosal%20Sites&amp;author=S.%20A.%20Saenz&amp;author=B.%20C.%20Taylor&amp;author=D.%20Artis&amp;volume=226&amp;issue=1&amp;publication_year=2008&amp;pages=172-190&amp;pmid=19161424&amp;doi=10.1111/j.1600-065X.2008.00713.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0173">
<span class="label">173.</span><cite>
Cheung P., Wong C., Ip W., and Lam C., “IL‐25 Regulates the Expression of Adhesion Molecules on Eosinophils: Mechanism of Eosinophilia in Allergic Inflammation,” Allergy
61, no. 7 (2006): 878–885.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2006.01102.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16792588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=IL%E2%80%9025%20Regulates%20the%20Expression%20of%20Adhesion%20Molecules%20on%20Eosinophils:%20Mechanism%20of%20Eosinophilia%20in%20Allergic%20Inflammation&amp;author=P.%20Cheung&amp;author=C.%20Wong&amp;author=W.%20Ip&amp;author=C.%20Lam&amp;volume=61&amp;issue=7&amp;publication_year=2006&amp;pages=878-885&amp;pmid=16792588&amp;doi=10.1111/j.1398-9995.2006.01102.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0174">
<span class="label">174.</span><cite>
Wong C. K., Cheung P. F., Ip W. K., and Lam C. W., “Interleukin‐25–Induced Chemokines and Interleukin‐6 Release From Eosinophils Is Mediated by p38 Mitogen‐Activated Protein Kinase, c‐Jun N‐Terminal Kinase, and Nuclear Factor‐κB,” American Journal of Respiratory Cell and Molecular Biology
33, no. 2 (2005): 186–194.
</cite> [<a href="https://doi.org/10.1165/rcmb.2005-0034OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15860795/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20Cell%20and%20Molecular%20Biology&amp;title=Interleukin%E2%80%9025%E2%80%93Induced%20Chemokines%20and%20Interleukin%E2%80%906%20Release%20From%20Eosinophils%20Is%20Mediated%20by%20p38%20Mitogen%E2%80%90Activated%20Protein%20Kinase,%20c%E2%80%90Jun%20N%E2%80%90Terminal%20Kinase,%20and%20Nuclear%20Factor%E2%80%90%CE%BAB&amp;author=C.%20K.%20Wong&amp;author=P.%20F.%20Cheung&amp;author=W.%20K.%20Ip&amp;author=C.%20W.%20Lam&amp;volume=33&amp;issue=2&amp;publication_year=2005&amp;pages=186-194&amp;pmid=15860795&amp;doi=10.1165/rcmb.2005-0034OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0175">
<span class="label">175.</span><cite>
Tang W., Smith S. G., Salter B., et al., “Allergen‐Induced Increases in Interleukin‐25 and Interleukin‐25 Receptor Expression in Mature Eosinophils From Atopic Asthmatics,” International Archives of Allergy and Immunology
170, no. 4 (2016): 234–242.
</cite> [<a href="https://doi.org/10.1159/000449248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27685606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Archives%20of%20Allergy%20and%20Immunology&amp;title=Allergen%E2%80%90Induced%20Increases%20in%20Interleukin%E2%80%9025%20and%20Interleukin%E2%80%9025%20Receptor%20Expression%20in%20Mature%20Eosinophils%20From%20Atopic%20Asthmatics&amp;author=W.%20Tang&amp;author=S.%20G.%20Smith&amp;author=B.%20Salter&amp;volume=170&amp;issue=4&amp;publication_year=2016&amp;pages=234-242&amp;pmid=27685606&amp;doi=10.1159/000449248&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0176">
<span class="label">176.</span><cite>
Sears M., Burrows B., Flannery E., Herbison G., and Holdaway M., “Atopy in Childhood. I. Gender and Allergen Related Risks for Development of Hay Fever and Asthma,” Clinical and Experimental Allergy
23, no. 11 (1993): 941–948.
</cite> [<a href="https://doi.org/10.1111/j.1365-2222.1993.tb00279.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10779282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Atopy%20in%20Childhood.%20I.%20Gender%20and%20Allergen%20Related%20Risks%20for%20Development%20of%20Hay%20Fever%20and%20Asthma&amp;author=M.%20Sears&amp;author=B.%20Burrows&amp;author=E.%20Flannery&amp;author=G.%20Herbison&amp;author=M.%20Holdaway&amp;volume=23&amp;issue=11&amp;publication_year=1993&amp;pages=941-948&amp;pmid=10779282&amp;doi=10.1111/j.1365-2222.1993.tb00279.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0177">
<span class="label">177.</span><cite>
Simpson A., Tan V. Y., Winn J., et al., “Beyond Atopy: Multiple Patterns of Sensitization in Relation to Asthma in a Birth Cohort Study,” American Journal of Respiratory and Critical Care Medicine
181, no. 11 (2010): 1200–1206.
</cite> [<a href="https://doi.org/10.1164/rccm.200907-1101OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20167852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Beyond%20Atopy:%20Multiple%20Patterns%20of%20Sensitization%20in%20Relation%20to%20Asthma%20in%20a%20Birth%20Cohort%20Study&amp;author=A.%20Simpson&amp;author=V.%20Y.%20Tan&amp;author=J.%20Winn&amp;volume=181&amp;issue=11&amp;publication_year=2010&amp;pages=1200-1206&amp;pmid=20167852&amp;doi=10.1164/rccm.200907-1101OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0178">
<span class="label">178.</span><cite>
Sears M., Herbison G., Holdaway M., Hewitt C., Flannery E. M., and Silva P., “The Relative Risks of Sensitivity to Grass Pollen, House Dust Mite and Cat Dander in the Development of Childhood Asthma,” Clinical and Experimental Allergy
19, no. 4 (1989): 419–424.
</cite> [<a href="https://doi.org/10.1111/j.1365-2222.1989.tb02408.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2758355/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=The%20Relative%20Risks%20of%20Sensitivity%20to%20Grass%20Pollen,%20House%20Dust%20Mite%20and%20Cat%20Dander%20in%20the%20Development%20of%20Childhood%20Asthma&amp;author=M.%20Sears&amp;author=G.%20Herbison&amp;author=M.%20Holdaway&amp;author=C.%20Hewitt&amp;author=E.%20M.%20Flannery&amp;volume=19&amp;issue=4&amp;publication_year=1989&amp;pages=419-424&amp;pmid=2758355&amp;doi=10.1111/j.1365-2222.1989.tb02408.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0179">
<span class="label">179.</span><cite>
Boulet L.‐P., Cartier A., Thomson N. C., Roberts R. S., Dolovich J., and Hargreave F. E., “Asthma and Increases in Nonallergic Bronchial Responsiveness From Seasonal Pollen Exposure,” Journal of Allergy and Clinical Immunology
71, no. 4 (1983): 399–406.
</cite> [<a href="https://doi.org/10.1016/0091-6749(83)90069-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6601124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Asthma%20and%20Increases%20in%20Nonallergic%20Bronchial%20Responsiveness%20From%20Seasonal%20Pollen%20Exposure&amp;author=L.%E2%80%90P.%20Boulet&amp;author=A.%20Cartier&amp;author=N.%20C.%20Thomson&amp;author=R.%20S.%20Roberts&amp;author=J.%20Dolovich&amp;volume=71&amp;issue=4&amp;publication_year=1983&amp;pages=399-406&amp;pmid=6601124&amp;doi=10.1016/0091-6749(83)90069-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0180">
<span class="label">180.</span><cite>
Antó J. M., Sunyer J., Rodriguez‐Roisin R., et al., “Community Outbreaks of Asthma Associated With Inhalation of Soybean Dust,” New England Journal of Medicine
320, no. 17 (1989): 1097–1102.
</cite> [<a href="https://doi.org/10.1056/NEJM198904273201701" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2710172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Community%20Outbreaks%20of%20Asthma%20Associated%20With%20Inhalation%20of%20Soybean%20Dust&amp;author=J.%20M.%20Ant%C3%B3&amp;author=J.%20Sunyer&amp;author=R.%20Rodriguez%E2%80%90Roisin&amp;volume=320&amp;issue=17&amp;publication_year=1989&amp;pages=1097-1102&amp;pmid=2710172&amp;doi=10.1056/NEJM198904273201701&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0181">
<span class="label">181.</span><cite>
O'hollaren M. T., Yunginger J. W., Offord K. P., et al., “Exposure to an Aeroallergen as a Possible Precipitating Factor in Respiratory Arrest in Young Patients With Asthma,” New England Journal of Medicine
324, no. 6 (1991): 359–363, 10.1056/NEJM199102073240602.
</cite> [<a href="https://doi.org/10.1056/NEJM199102073240602" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1987459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Exposure%20to%20an%20Aeroallergen%20as%20a%20Possible%20Precipitating%20Factor%20in%20Respiratory%20Arrest%20in%20Young%20Patients%20With%20Asthma&amp;author=M.%20T.%20O'hollaren&amp;author=J.%20W.%20Yunginger&amp;author=K.%20P.%20Offord&amp;volume=324&amp;issue=6&amp;publication_year=1991&amp;pages=359-363&amp;pmid=1987459&amp;doi=10.1056/NEJM199102073240602&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0182">
<span class="label">182.</span><cite>
Bellomo R., “Thunderstorm Associated Epidemics of Asthma,” Medical Journal of Australia
157, no. 5 (1992): 352–353.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1294131/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medical%20Journal%20of%20Australia&amp;title=Thunderstorm%20Associated%20Epidemics%20of%20Asthma&amp;author=R.%20Bellomo&amp;volume=157&amp;issue=5&amp;publication_year=1992&amp;pages=352-353&amp;pmid=1294131&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0183">
<span class="label">183.</span><cite>
Platts‐Mills T. E., Mitchell E. B., Nock P., Tovey E., Moszoro H., and Wilkins S., “Reduction of Bronchial Hyperreactivity During Prolonged Allergen Avoidance,” Lancet
320, no. 8300 (1982): 675–678.</cite> [<a href="https://doi.org/10.1016/s0140-6736(82)90709-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6126624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Reduction%20of%20Bronchial%20Hyperreactivity%20During%20Prolonged%20Allergen%20Avoidance&amp;author=T.%20E.%20Platts%E2%80%90Mills&amp;author=E.%20B.%20Mitchell&amp;author=P.%20Nock&amp;author=E.%20Tovey&amp;author=H.%20Moszoro&amp;volume=320&amp;issue=8300&amp;publication_year=1982&amp;pages=675-678&amp;pmid=6126624&amp;doi=10.1016/s0140-6736(82)90709-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0184">
<span class="label">184.</span><cite>
Van Velzen E., Den Van Bos J., Benckhuijsen J., Van Essel T., De Bruijn R., and Aalbers R., “Effect of Allergen Avoidance at High Altitude on Direct and Indirect Bronchial Hyperresponsiveness and Markers of Inflammation in Children With Allergic Asthma,” Thorax
51, no. 6 (1996): 582–584.
</cite> [<a href="https://doi.org/10.1136/thx.51.6.582" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1090486/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8693437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorax&amp;title=Effect%20of%20Allergen%20Avoidance%20at%20High%20Altitude%20on%20Direct%20and%20Indirect%20Bronchial%20Hyperresponsiveness%20and%20Markers%20of%20Inflammation%20in%20Children%20With%20Allergic%20Asthma&amp;author=E.%20Van%20Velzen&amp;author=J.%20Den%20Van%20Bos&amp;author=J.%20Benckhuijsen&amp;author=T.%20Van%20Essel&amp;author=R.%20De%20Bruijn&amp;volume=51&amp;issue=6&amp;publication_year=1996&amp;pages=582-584&amp;pmid=8693437&amp;doi=10.1136/thx.51.6.582&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0185">
<span class="label">185.</span><cite>
Tarlo S. M. and Lemiere C., “Occupational Asthma,” New England Journal of Medicine
370, no. 7 (2014): 640–649.
</cite> [<a href="https://doi.org/10.1056/NEJMra1301758" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24521110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Occupational%20Asthma&amp;author=S.%20M.%20Tarlo&amp;author=C.%20Lemiere&amp;volume=370&amp;issue=7&amp;publication_year=2014&amp;pages=640-649&amp;pmid=24521110&amp;doi=10.1056/NEJMra1301758&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0186">
<span class="label">186.</span><cite>
Ellis A. K., Soliman M., Steacy L., et al., “The Allergic Rhinitis–Clinical Investigator Collaborative (AR‐CIC): Nasal Allergen Challenge Protocol Optimization for Studying AR Pathophysiology and Evaluating Novel Therapies,” Allergy, Asthma and Clinical Immunology
11, no. 1 (2015): 16, 10.1186/s13223-015-0082-0.</cite> [<a href="https://doi.org/10.1186/s13223-015-0082-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4419495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25945101/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy,%20Asthma%20and%20Clinical%20Immunology&amp;title=The%20Allergic%20Rhinitis%E2%80%93Clinical%20Investigator%20Collaborative%20(AR%E2%80%90CIC):%20Nasal%20Allergen%20Challenge%20Protocol%20Optimization%20for%20Studying%20AR%20Pathophysiology%20and%20Evaluating%20Novel%20Therapies&amp;author=A.%20K.%20Ellis&amp;author=M.%20Soliman&amp;author=L.%20Steacy&amp;volume=11&amp;issue=1&amp;publication_year=2015&amp;pages=16&amp;pmid=25945101&amp;doi=10.1186/s13223-015-0082-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0187">
<span class="label">187.</span><cite>
Gauvreau G. M., Davis B. E., Scadding G., et al., “Allergen Provocation Tests in Respiratory Research: Building on 50 Years of Experience,” European Respiratory Journal
60, no. 2 (2022): 2102782.
</cite> [<a href="https://doi.org/10.1183/13993003.02782-2021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9403392/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35086834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Respiratory%20Journal&amp;title=Allergen%20Provocation%20Tests%20in%20Respiratory%20Research:%20Building%20on%2050%E2%80%89Years%20of%20Experience&amp;author=G.%20M.%20Gauvreau&amp;author=B.%20E.%20Davis&amp;author=G.%20Scadding&amp;volume=60&amp;issue=2&amp;publication_year=2022&amp;pages=2102782&amp;pmid=35086834&amp;doi=10.1183/13993003.02782-2021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0188">
<span class="label">188.</span><cite>
Bauer R. N., Xie Y., Beaudin S., et al., “Evaluation of the Reproducibility of Responses to Nasal Allergen Challenge and Effects of Inhaled Nasal Corticosteroids,” Clinical and Experimental Allergy
53, no. 11 (2023): 1187–1197.
</cite> [<a href="https://doi.org/10.1111/cea.14406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37794659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Evaluation%20of%20the%20Reproducibility%20of%20Responses%20to%20Nasal%20Allergen%20Challenge%20and%20Effects%20of%20Inhaled%20Nasal%20Corticosteroids&amp;author=R.%20N.%20Bauer&amp;author=Y.%20Xie&amp;author=S.%20Beaudin&amp;volume=53&amp;issue=11&amp;publication_year=2023&amp;pages=1187-1197&amp;pmid=37794659&amp;doi=10.1111/cea.14406&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0189">
<span class="label">189.</span><cite>
Frew A. and Kay A., “The Pattern of Human Late‐Phase Skin Reactions to Extracts of Aeroallergens,” Journal of Allergy and Clinical Immunology
81, no. 6 (1988): 1117–1121.
</cite> [<a href="https://doi.org/10.1016/0091-6749(88)90878-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3379223/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=The%20Pattern%20of%20Human%20Late%E2%80%90Phase%20Skin%20Reactions%20to%20Extracts%20of%20Aeroallergens&amp;author=A.%20Frew&amp;author=A.%20Kay&amp;volume=81&amp;issue=6&amp;publication_year=1988&amp;pages=1117-1121&amp;pmid=3379223&amp;doi=10.1016/0091-6749(88)90878-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0190">
<span class="label">190.</span><cite>
Meltzer E. O., “The Relationships of Rhinitis and Asthma,” Allergy and Asthma Proceedings
26, no. 5 (2005): 336–340.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/16450565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy%20and%20Asthma%20Proceedings&amp;title=The%20Relationships%20of%20Rhinitis%20and%20Asthma&amp;author=E.%20O.%20Meltzer&amp;volume=26&amp;issue=5&amp;publication_year=2005&amp;pages=336-340&amp;pmid=16450565&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0191">
<span class="label">191.</span><cite>
Togias A., “Rhinitis and Asthma: Evidence for Respiratory System Integration,” Journal of Allergy and Clinical Immunology
111, no. 6 (2003): 1171–1183; quiz 84.
</cite> [<a href="https://doi.org/10.1067/mai.2003.1592" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12789212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Rhinitis%20and%20Asthma:%20Evidence%20for%20Respiratory%20System%20Integration&amp;author=A.%20Togias&amp;volume=111&amp;issue=6&amp;publication_year=2003&amp;pages=1171-1183&amp;pmid=12789212&amp;doi=10.1067/mai.2003.1592&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0192">
<span class="label">192.</span><cite>
Hellings P. W. and Prokopakis E. P., “Global Airway Disease Beyond Allergy,” Current Allergy and Asthma Reports
10, no. 2 (2010): 143–149.
</cite> [<a href="https://doi.org/10.1007/s11882-010-0107-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20425506/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Allergy%20and%20Asthma%20Reports&amp;title=Global%20Airway%20Disease%20Beyond%20Allergy&amp;author=P.%20W.%20Hellings&amp;author=E.%20P.%20Prokopakis&amp;volume=10&amp;issue=2&amp;publication_year=2010&amp;pages=143-149&amp;pmid=20425506&amp;doi=10.1007/s11882-010-0107-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0193">
<span class="label">193.</span><cite>
Braunstahl G. J., Overbeek S. E., Fokkens W. J., et al., “Segmental Bronchoprovocation in Allergic Rhinitis Patients Affects Mast Cell and Basophil Numbers in Nasal and Bronchial Mucosa,” American Journal of Respiratory and Critical Care Medicine
164, no. 5 (2001): 858–865, 10.1164/ajrccm.164.5.2006082.
</cite> [<a href="https://doi.org/10.1164/ajrccm.164.5.2006082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11549546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Segmental%20Bronchoprovocation%20in%20Allergic%20Rhinitis%20Patients%20Affects%20Mast%20Cell%20and%20Basophil%20Numbers%20in%20Nasal%20and%20Bronchial%20Mucosa&amp;author=G.%20J.%20Braunstahl&amp;author=S.%20E.%20Overbeek&amp;author=W.%20J.%20Fokkens&amp;volume=164&amp;issue=5&amp;publication_year=2001&amp;pages=858-865&amp;pmid=11549546&amp;doi=10.1164/ajrccm.164.5.2006082&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0194">
<span class="label">194.</span><cite>
Beeh K. M., Beier J., Kornmann O., Meier C., Taeumer T., and Buhl R., “A Single Nasal Allergen Challenge Increases Induced Sputum Inflammatory Markers in Non‐asthmatic Subjects With Seasonal Allergic Rhinitis: Correlation With Plasma Interleukin‐5,” Clinical and Experimental Allergy
33, no. 4 (2003): 475–482.
</cite> [<a href="https://doi.org/10.1046/j.1365-2222.2003.01632.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12680863/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=A%20Single%20Nasal%20Allergen%20Challenge%20Increases%20Induced%20Sputum%20Inflammatory%20Markers%20in%20Non%E2%80%90asthmatic%20Subjects%20With%20Seasonal%20Allergic%20Rhinitis:%20Correlation%20With%20Plasma%20Interleukin%E2%80%905&amp;author=K.%20M.%20Beeh&amp;author=J.%20Beier&amp;author=O.%20Kornmann&amp;author=C.%20Meier&amp;author=T.%20Taeumer&amp;volume=33&amp;issue=4&amp;publication_year=2003&amp;pages=475-482&amp;pmid=12680863&amp;doi=10.1046/j.1365-2222.2003.01632.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0195">
<span class="label">195.</span><cite>
Braunstahl G. J., Overbeek S. E., Kleinjan A., Prins J. B., Hoogsteden H. C., and Fokkens W. J., “Nasal Allergen Provocation Induces Adhesion Molecule Expression and Tissue Eosinophilia in Upper and Lower Airways,” Journal of Allergy and Clinical Immunology
107, no. 3 (2001): 469–476.
</cite> [<a href="https://doi.org/10.1067/mai.2001.113046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11240947/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Nasal%20Allergen%20Provocation%20Induces%20Adhesion%20Molecule%20Expression%20and%20Tissue%20Eosinophilia%20in%20Upper%20and%20Lower%20Airways&amp;author=G.%20J.%20Braunstahl&amp;author=S.%20E.%20Overbeek&amp;author=A.%20Kleinjan&amp;author=J.%20B.%20Prins&amp;author=H.%20C.%20Hoogsteden&amp;volume=107&amp;issue=3&amp;publication_year=2001&amp;pages=469-476&amp;pmid=11240947&amp;doi=10.1067/mai.2001.113046&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0196">
<span class="label">196.</span><cite>
Herxheimer H., “Bronchial Obstruction Induced by Allergens, Histamine and Acetyl‐Beta‐Methylcholinechloride,” International Archives of Allergy and Immunology
2, no. 1 (1951): 27–39.</cite> [<a href="https://doi.org/10.1159/000227898" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14840917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Archives%20of%20Allergy%20and%20Immunology&amp;title=Bronchial%20Obstruction%20Induced%20by%20Allergens,%20Histamine%20and%20Acetyl%E2%80%90Beta%E2%80%90Methylcholinechloride&amp;author=H.%20Herxheimer&amp;volume=2&amp;issue=1&amp;publication_year=1951&amp;pages=27-39&amp;pmid=14840917&amp;doi=10.1159/000227898&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0197">
<span class="label">197.</span><cite>
Cockcroft D., Ruffin R., Dolovich J., and Hargreave F., “Allergen‐Induced Increase in Non‐allergic Bronchial Reactivity,” Clinical and Experimental Allergy
7, no. 6 (1977): 503–513.</cite> [<a href="https://doi.org/10.1111/j.1365-2222.1977.tb01481.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/589783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Allergen%E2%80%90Induced%20Increase%20in%20Non%E2%80%90allergic%20Bronchial%20Reactivity&amp;author=D.%20Cockcroft&amp;author=R.%20Ruffin&amp;author=J.%20Dolovich&amp;author=F.%20Hargreave&amp;volume=7&amp;issue=6&amp;publication_year=1977&amp;pages=503-513&amp;pmid=589783&amp;doi=10.1111/j.1365-2222.1977.tb01481.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0198">
<span class="label">198.</span><cite>
Gauvreau G. M., Lee J. M., Watson R. M., Irani A.‐M. A., Schwartz L. B., and O'Byrne P. M., “Increased Numbers of Both Airway Basophils and Mast Cells in Sputum After Allergen Inhalation Challenge of Atopic Asthmatics,” American Journal of Respiratory and Critical Care Medicine
161, no. 5 (2000): 1473–1478.
</cite> [<a href="https://doi.org/10.1164/ajrccm.161.5.9908090" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10806141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Increased%20Numbers%20of%20Both%20Airway%20Basophils%20and%20Mast%20Cells%20in%20Sputum%20After%20Allergen%20Inhalation%20Challenge%20of%20Atopic%20Asthmatics&amp;author=G.%20M.%20Gauvreau&amp;author=J.%20M.%20Lee&amp;author=R.%20M.%20Watson&amp;author=A.%E2%80%90M.%20A.%20Irani&amp;author=L.%20B.%20Schwartz&amp;volume=161&amp;issue=5&amp;publication_year=2000&amp;pages=1473-1478&amp;pmid=10806141&amp;doi=10.1164/ajrccm.161.5.9908090&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0199">
<span class="label">199.</span><cite>
Cartier A., Thomson N., Frith P., Roberts R., and Hargreave F., “Allergen‐Induced Increase in Bronchial Responsiveness to Histamine: Relationship to the Late Asthmatic Response and Change in Airway Caliber,” Journal of Allergy and Clinical Immunology
70, no. 3 (1982): 170–177.
</cite> [<a href="https://doi.org/10.1016/0091-6749(82)90038-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7108068/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Allergen%E2%80%90Induced%20Increase%20in%20Bronchial%20Responsiveness%20to%20Histamine:%20Relationship%20to%20the%20Late%20Asthmatic%20Response%20and%20Change%20in%20Airway%20Caliber&amp;author=A.%20Cartier&amp;author=N.%20Thomson&amp;author=P.%20Frith&amp;author=R.%20Roberts&amp;author=F.%20Hargreave&amp;volume=70&amp;issue=3&amp;publication_year=1982&amp;pages=170-177&amp;pmid=7108068&amp;doi=10.1016/0091-6749(82)90038-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0200">
<span class="label">200.</span><cite>
Iliopoulos O., Baroody F. M., Naclerio R. M., Bochner B. S., Kagey‐Sobotka A., and Lichtenstein L. M., “Histamine‐Containing Cells Obtained From the Nose Hours After Antigen Challenge Have Functional and Phenotypic Characteristics of Basophils,” Journal of Immunology
148, no. 7 (1992): 2223–2228.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1372025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Histamine%E2%80%90Containing%20Cells%20Obtained%20From%20the%20Nose%20Hours%20After%20Antigen%20Challenge%20Have%20Functional%20and%20Phenotypic%20Characteristics%20of%20Basophils&amp;author=O.%20Iliopoulos&amp;author=F.%20M.%20Baroody&amp;author=R.%20M.%20Naclerio&amp;author=B.%20S.%20Bochner&amp;author=A.%20Kagey%E2%80%90Sobotka&amp;volume=148&amp;issue=7&amp;publication_year=1992&amp;pages=2223-2228&amp;pmid=1372025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0201">
<span class="label">201.</span><cite>
Parameswaran K., Fanat A., and O'Byrne P., “Effects of Intranasal Fluticasone and Salmeterol on Allergen‐Induced Nasal Responses,” Allergy
61, no. 6 (2006): 731–736.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2005.00906.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16677243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Effects%20of%20Intranasal%20Fluticasone%20and%20Salmeterol%20on%20Allergen%E2%80%90Induced%20Nasal%20Responses&amp;author=K.%20Parameswaran&amp;author=A.%20Fanat&amp;author=P.%20O'Byrne&amp;volume=61&amp;issue=6&amp;publication_year=2006&amp;pages=731-736&amp;pmid=16677243&amp;doi=10.1111/j.1398-9995.2005.00906.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0202">
<span class="label">202.</span><cite>
Gaga M., Frew A., Varney V. A., and Kay A., “Eosinophil Activation and T Lymphocyte Infiltration in Allergen‐Induced Late Phase Skin Reactions and Classical Delayed‐Type Hypersensitivity,” Journal of Immunology
147, no. 3 (1991): 816–822.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1830598/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Eosinophil%20Activation%20and%20T%20Lymphocyte%20Infiltration%20in%20Allergen%E2%80%90Induced%20Late%20Phase%20Skin%20Reactions%20and%20Classical%20Delayed%E2%80%90Type%20Hypersensitivity&amp;author=M.%20Gaga&amp;author=A.%20Frew&amp;author=V.%20A.%20Varney&amp;author=A.%20Kay&amp;volume=147&amp;issue=3&amp;publication_year=1991&amp;pages=816-822&amp;pmid=1830598&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0203">
<span class="label">203.</span><cite>
Macfarlane A. J., Kon O. M., Smith S. J., et al., “Basophils, Eosinophils, and Mast Cells in Atopic and Nonatopic Asthma and in Late‐Phase Allergic Reactions in the Lung and Skin,” Journal of Allergy and Clinical Immunology
105, no. 1 (2000): 99–107.
</cite> [<a href="https://doi.org/10.1016/s0091-6749(00)90184-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10629459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Basophils,%20Eosinophils,%20and%20Mast%20Cells%20in%20Atopic%20and%20Nonatopic%20Asthma%20and%20in%20Late%E2%80%90Phase%20Allergic%20Reactions%20in%20the%20Lung%20and%20Skin&amp;author=A.%20J.%20Macfarlane&amp;author=O.%20M.%20Kon&amp;author=S.%20J.%20Smith&amp;volume=105&amp;issue=1&amp;publication_year=2000&amp;pages=99-107&amp;pmid=10629459&amp;doi=10.1016/s0091-6749(00)90184-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0204">
<span class="label">204.</span><cite>
Inman M., Watson R., Cockcroft D., Wong B., Hargreave F., and O'Byrne P., “Reproducibility of Allergen‐Induced Early and Late Asthmatic Responses,” Journal of Allergy and Clinical Immunology
95, no. 6 (1995): 1191–1195.
</cite> [<a href="https://doi.org/10.1016/s0091-6749(95)70075-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7797787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Reproducibility%20of%20Allergen%E2%80%90Induced%20Early%20and%20Late%20Asthmatic%20Responses&amp;author=M.%20Inman&amp;author=R.%20Watson&amp;author=D.%20Cockcroft&amp;author=B.%20Wong&amp;author=F.%20Hargreave&amp;volume=95&amp;issue=6&amp;publication_year=1995&amp;pages=1191-1195&amp;pmid=7797787&amp;doi=10.1016/s0091-6749(95)70075-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0205">
<span class="label">205.</span><cite>
Inman M. D., Hamilton A. L., Kerstjens H. A., Watson R. M., and O'Byrne P. M., “The Utility of Methacholine Airway Responsiveness Measurements in Evaluating Anti‐Asthma Drugs,” Journal of Allergy and Clinical Immunology
101, no. 3 (1998): 342–348.
</cite> [<a href="https://doi.org/10.1016/S0091-6749(98)70246-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9525450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=The%20Utility%20of%20Methacholine%20Airway%20Responsiveness%20Measurements%20in%20Evaluating%20Anti%E2%80%90Asthma%20Drugs&amp;author=M.%20D.%20Inman&amp;author=A.%20L.%20Hamilton&amp;author=H.%20A.%20Kerstjens&amp;author=R.%20M.%20Watson&amp;author=P.%20M.%20O'Byrne&amp;volume=101&amp;issue=3&amp;publication_year=1998&amp;pages=342-348&amp;pmid=9525450&amp;doi=10.1016/S0091-6749(98)70246-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0206">
<span class="label">206.</span><cite>
Gauvreau G. M., Watson R. M., Rerecich T. J., Baswick E., Inman M. D., and O'Byrne P. M., “Repeatability of Allergen‐Induced Airway Inflammation,” Journal of Allergy and Clinical Immunology
104, no. 1 (1999): 66–71.
</cite> [<a href="https://doi.org/10.1016/s0091-6749(99)70115-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10400841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Repeatability%20of%20Allergen%E2%80%90Induced%20Airway%20Inflammation&amp;author=G.%20M.%20Gauvreau&amp;author=R.%20M.%20Watson&amp;author=T.%20J.%20Rerecich&amp;author=E.%20Baswick&amp;author=M.%20D.%20Inman&amp;volume=104&amp;issue=1&amp;publication_year=1999&amp;pages=66-71&amp;pmid=10400841&amp;doi=10.1016/s0091-6749(99)70115-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0207">
<span class="label">207.</span><cite>
Boulet L. P., Gauvreau G., Boulay M. E., O'Byrne P., and Cockcroft D., “The Allergen Bronchoprovocation Model: An Important Tool for the Investigation of New Asthma Anti‐Inflammatory Therapies,” Allergy
62, no. 10 (2007): 1101–1110.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2007.01499.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17845579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=The%20Allergen%20Bronchoprovocation%20Model:%20An%20Important%20Tool%20for%20the%20Investigation%20of%20New%20Asthma%20Anti%E2%80%90Inflammatory%20Therapies&amp;author=L.%20P.%20Boulet&amp;author=G.%20Gauvreau&amp;author=M.%20E.%20Boulay&amp;author=P.%20O'Byrne&amp;author=D.%20Cockcroft&amp;volume=62&amp;issue=10&amp;publication_year=2007&amp;pages=1101-1110&amp;pmid=17845579&amp;doi=10.1111/j.1398-9995.2007.01499.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0208">
<span class="label">208.</span><cite>
Bruijnzeel P., De Monchy J., Verhagen J., and Kauffman H., “The Eosinophilic Granulocyte an Active Participant in the Late Phase Asthmatic Reaction?,” Bulletin Europeen de Physiopathologie Respiratoire
22 (1986): 54–61.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/3082393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bulletin%20Europeen%20de%20Physiopathologie%20Respiratoire&amp;title=The%20Eosinophilic%20Granulocyte%20an%20Active%20Participant%20in%20the%20Late%20Phase%20Asthmatic%20Reaction?&amp;author=P.%20Bruijnzeel&amp;author=J.%20De%20Monchy&amp;author=J.%20Verhagen&amp;author=H.%20Kauffman&amp;volume=22&amp;publication_year=1986&amp;pages=54-61&amp;pmid=3082393&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0209">
<span class="label">209.</span><cite>
Gauvreau G., Ellis A., and Denburg J., “Haemopoietic Processes in Allergic Disease: Eosinophil/Basophil Development,” Clinical and Experimental Allergy
39, no. 9 (2009): 1297–1306.
</cite> [<a href="https://doi.org/10.1111/j.1365-2222.2009.03325.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19622087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Haemopoietic%20Processes%20in%20Allergic%20Disease:%20Eosinophil/Basophil%20Development&amp;author=G.%20Gauvreau&amp;author=A.%20Ellis&amp;author=J.%20Denburg&amp;volume=39&amp;issue=9&amp;publication_year=2009&amp;pages=1297-1306&amp;pmid=19622087&amp;doi=10.1111/j.1365-2222.2009.03325.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0210">
<span class="label">210.</span><cite>
Gauvreau G. M., Doctor J., Watson R. M., Jordana M., and O'Byrne P. M., “Effects of Inhaled Budesonide on Allergen‐Induced Airway Responses and Airway Inflammation,” American Journal of Respiratory and Critical Care Medicine
154, no. 5 (1996): 1267–1271.
</cite> [<a href="https://doi.org/10.1164/ajrccm.154.5.8912734" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8912734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Effects%20of%20Inhaled%20Budesonide%20on%20Allergen%E2%80%90Induced%20Airway%20Responses%20and%20Airway%20Inflammation&amp;author=G.%20M.%20Gauvreau&amp;author=J.%20Doctor&amp;author=R.%20M.%20Watson&amp;author=M.%20Jordana&amp;author=P.%20M.%20O'Byrne&amp;volume=154&amp;issue=5&amp;publication_year=1996&amp;pages=1267-1271&amp;pmid=8912734&amp;doi=10.1164/ajrccm.154.5.8912734&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0211">
<span class="label">211.</span><cite>
Wood L. J., Sehmi R., Gauvreau G. M., et al., “An Inhaled Corticosteroid, Budesonide, Reduces Baseline but Not Allergen‐Induced Increases in Bone Marrow Inflammatory Cell Progenitors in Asthmatic Subjects,” American Journal of Respiratory and Critical Care Medicine
159, no. 5 (1999): 1457–1463, 10.1164/ajrccm.159.5.9808123.
</cite> [<a href="https://doi.org/10.1164/ajrccm.159.5.9808123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10228111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=An%20Inhaled%20Corticosteroid,%20Budesonide,%20Reduces%20Baseline%20but%20Not%20Allergen%E2%80%90Induced%20Increases%20in%20Bone%20Marrow%20Inflammatory%20Cell%20Progenitors%20in%20Asthmatic%20Subjects&amp;author=L.%20J.%20Wood&amp;author=R.%20Sehmi&amp;author=G.%20M.%20Gauvreau&amp;volume=159&amp;issue=5&amp;publication_year=1999&amp;pages=1457-1463&amp;pmid=10228111&amp;doi=10.1164/ajrccm.159.5.9808123&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0212">
<span class="label">212.</span><cite>
Inman M. D., Watson R. M., Rerecich T., et al., “Dose‐Dependent Effects of Inhaled Mometasone Furoate on Airway Function and Inflammation After Allergen Inhalation Challenge,” American Journal of Respiratory and Critical Care Medicine
164, no. 4 (2001): 569–574, 10.1164/ajrccm.164.4.2007063.
</cite> [<a href="https://doi.org/10.1164/ajrccm.164.4.2007063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11520717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Dose%E2%80%90Dependent%20Effects%20of%20Inhaled%20Mometasone%20Furoate%20on%20Airway%20Function%20and%20Inflammation%20After%20Allergen%20Inhalation%20Challenge&amp;author=M.%20D.%20Inman&amp;author=R.%20M.%20Watson&amp;author=T.%20Rerecich&amp;volume=164&amp;issue=4&amp;publication_year=2001&amp;pages=569-574&amp;pmid=11520717&amp;doi=10.1164/ajrccm.164.4.2007063&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0213">
<span class="label">213.</span><cite>
Jee Y.‐K., Gilmour J., Kelly A., et al., “Repression of Interleukin‐5 Transcription by the Glucocorticoid Receptor Targets GATA3 Signaling and Involves Histone Deacetylase Recruitment,” Journal of Biological Chemistry
280, no. 24 (2005): 23243–23250.
</cite> [<a href="https://doi.org/10.1074/jbc.M503659200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15826950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biological%20Chemistry&amp;title=Repression%20of%20Interleukin%E2%80%905%20Transcription%20by%20the%20Glucocorticoid%20Receptor%20Targets%20GATA3%20Signaling%20and%20Involves%20Histone%20Deacetylase%20Recruitment&amp;author=Y.%E2%80%90K.%20Jee&amp;author=J.%20Gilmour&amp;author=A.%20Kelly&amp;volume=280&amp;issue=24&amp;publication_year=2005&amp;pages=23243-23250&amp;pmid=15826950&amp;doi=10.1074/jbc.M503659200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0214">
<span class="label">214.</span><cite>
Khoury P., Stokes K., Gadkari M., et al., “Glucocorticoid‐Induced Eosinopenia in Humans Can Be Linked to Early Transcriptional Events,” Allergy
73, no. 10 (2018): 2076–2079.
</cite> [<a href="https://doi.org/10.1111/all.13497" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6207465/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29885264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Glucocorticoid%E2%80%90Induced%20Eosinopenia%20in%20Humans%20Can%20Be%20Linked%20to%20Early%20Transcriptional%20Events&amp;author=P.%20Khoury&amp;author=K.%20Stokes&amp;author=M.%20Gadkari&amp;volume=73&amp;issue=10&amp;publication_year=2018&amp;pages=2076-2079&amp;pmid=29885264&amp;doi=10.1111/all.13497&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0215">
<span class="label">215.</span><cite>
Hong S. G., Sato N., Legrand F., et al., “Glucocorticoid‐Induced Eosinopenia Results From CXCR4‐Dependent Bone Marrow Migration,” Blood
136, no. 23 (2020): 2667–2678.
</cite> [<a href="https://doi.org/10.1182/blood.2020005161" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7735160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32659786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Glucocorticoid%E2%80%90Induced%20Eosinopenia%20Results%20From%20CXCR4%E2%80%90Dependent%20Bone%20Marrow%20Migration&amp;author=S.%20G.%20Hong&amp;author=N.%20Sato&amp;author=F.%20Legrand&amp;volume=136&amp;issue=23&amp;publication_year=2020&amp;pages=2667-2678&amp;pmid=32659786&amp;doi=10.1182/blood.2020005161&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0216">
<span class="label">216.</span><cite>
Gauvreau G., Jordana M., Watson R., Cockcroft D., and O'Byrne P., “Effect of Regular Inhaled Albuterol on Allergen‐Induced Late Responses and Sputum Eosinophils in Asthmatic Subjects,” American Journal of Respiratory and Critical Care Medicine
156, no. 6 (1997): 1738–1745.
</cite> [<a href="https://doi.org/10.1164/ajrccm.156.6.96-08042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9412549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Effect%20of%20Regular%20Inhaled%20Albuterol%20on%20Allergen%E2%80%90Induced%20Late%20Responses%20and%20Sputum%20Eosinophils%20in%20Asthmatic%20Subjects&amp;author=G.%20Gauvreau&amp;author=M.%20Jordana&amp;author=R.%20Watson&amp;author=D.%20Cockcroft&amp;author=P.%20O'Byrne&amp;volume=156&amp;issue=6&amp;publication_year=1997&amp;pages=1738-1745&amp;pmid=9412549&amp;doi=10.1164/ajrccm.156.6.96-08042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0217">
<span class="label">217.</span><cite>
De Graaf‐in't Veld C., Garrelds I., Van Toorenenbergen A., and van Wijk R. G., “Nasal Responsiveness to Allergen and Histamine in Patients With Perennial Rhinitis With and Without a Late Phase Response,” Thorax
52, no. 2 (1997): 143–148.
</cite> [<a href="https://doi.org/10.1136/thx.52.2.143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1758482/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9059474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorax&amp;title=Nasal%20Responsiveness%20to%20Allergen%20and%20Histamine%20in%20Patients%20With%20Perennial%20Rhinitis%20With%20and%20Without%20a%20Late%20Phase%20Response&amp;author=C.%20De%20Graaf%E2%80%90in't%20Veld&amp;author=I.%20Garrelds&amp;author=A.%20Van%20Toorenenbergen&amp;author=R.%20G.%20van%20Wijk&amp;volume=52&amp;issue=2&amp;publication_year=1997&amp;pages=143-148&amp;pmid=9059474&amp;doi=10.1136/thx.52.2.143&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0218">
<span class="label">218.</span><cite>
Price E., Whetstone C., Al‐Sajee D., et al., “Prednisolone Treatment Reduces Type 2 Inflammation in Skin Lesions of Patients With Atopic Dermatitis,” Journal of Allergy and Clinical Immunology
147, no. 2 (2021): AB35.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Prednisolone%20Treatment%20Reduces%20Type%202%20Inflammation%20in%20Skin%20Lesions%20of%20Patients%20With%20Atopic%20Dermatitis&amp;author=E.%20Price&amp;author=C.%20Whetstone&amp;author=D.%20Al%E2%80%90Sajee&amp;volume=147&amp;issue=2&amp;publication_year=2021&amp;pages=AB35&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0219">
<span class="label">219.</span><cite>
Bischoff S. C., Brunner T., De Weck A. L., and Dahinden C., “Interleukin 5 Modifies Histamine Release and Leukotriene Generation by Human Basophils in Response to Diverse Agonists,” Journal of Experimental Medicine
172, no. 6 (1990): 1577–1582.
</cite> [<a href="https://doi.org/10.1084/jem.172.6.1577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2188769/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1701820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Interleukin%205%20Modifies%20Histamine%20Release%20and%20Leukotriene%20Generation%20by%20Human%20Basophils%20in%20Response%20to%20Diverse%20Agonists&amp;author=S.%20C.%20Bischoff&amp;author=T.%20Brunner&amp;author=A.%20L.%20De%20Weck&amp;author=C.%20Dahinden&amp;volume=172&amp;issue=6&amp;publication_year=1990&amp;pages=1577-1582&amp;pmid=1701820&amp;doi=10.1084/jem.172.6.1577&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0220">
<span class="label">220.</span><cite>
Price D. B., Rigazio A., Campbell J. D., et al., “Blood Eosinophil Count and Prospective Annual Asthma Disease Burden: A UK Cohort Study,” Lancet Respiratory Medicine
3, no. 11 (2015): 849–858.
</cite> [<a href="https://doi.org/10.1016/S2213-2600(15)00367-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26493938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Respiratory%20Medicine&amp;title=Blood%20Eosinophil%20Count%20and%20Prospective%20Annual%20Asthma%20Disease%20Burden:%20A%20UK%20Cohort%20Study&amp;author=D.%20B.%20Price&amp;author=A.%20Rigazio&amp;author=J.%20D.%20Campbell&amp;volume=3&amp;issue=11&amp;publication_year=2015&amp;pages=849-858&amp;pmid=26493938&amp;doi=10.1016/S2213-2600(15)00367-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0221">
<span class="label">221.</span><cite>
Bousquet J., Chanez P., Lacoste J. Y., et al., “Eosinophilic Inflammation in Asthma,” New England Journal of Medicine
323, no. 15 (1990): 1033–1039.
</cite> [<a href="https://doi.org/10.1056/NEJM199010113231505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2215562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Eosinophilic%20Inflammation%20in%20Asthma&amp;author=J.%20Bousquet&amp;author=P.%20Chanez&amp;author=J.%20Y.%20Lacoste&amp;volume=323&amp;issue=15&amp;publication_year=1990&amp;pages=1033-1039&amp;pmid=2215562&amp;doi=10.1056/NEJM199010113231505&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0222">
<span class="label">222.</span><cite>
Creticos P. S., Peters S. P., 
N. F.
Adkinson, Jr.
, et al., “Peptide Leukotriene Release After Antigen Challenge in Patients Sensitive to Ragweed,” New England Journal of Medicine
310, no. 25 (1984): 1626–1630.
</cite> [<a href="https://doi.org/10.1056/NEJM198406213102502" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6328300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Peptide%20Leukotriene%20Release%20After%20Antigen%20Challenge%20in%20Patients%20Sensitive%20to%20Ragweed&amp;author=P.%20S.%20Creticos&amp;author=S.%20P.%20Peters&amp;author=N.%20F.%20Adkinson&amp;volume=310&amp;issue=25&amp;publication_year=1984&amp;pages=1626-1630&amp;pmid=6328300&amp;doi=10.1056/NEJM198406213102502&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0223">
<span class="label">223.</span><cite>
Kay A. B., “Mediators of Hypersensitivity and Inflammatory Cells in the Pathogenesis of Bronchial Asthma,” European Journal of Respiratory Diseases Supplement
129 (1983): 1–44.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/6418559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Respiratory%20Diseases%20Supplement&amp;title=Mediators%20of%20Hypersensitivity%20and%20Inflammatory%20Cells%20in%20the%20Pathogenesis%20of%20Bronchial%20Asthma&amp;author=A.%20B.%20Kay&amp;volume=129&amp;publication_year=1983&amp;pages=1-44&amp;pmid=6418559&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0224">
<span class="label">224.</span><cite>
Mita H., Yui Y., Yasueda H., Kajita T., Saito H., and Shida T., “Allergen Induced Histamine Release and Immunoreactive‐Leukotriene C4 Generation From Leukocytes in Mite Sensitive Asthmatic Patients,” Prostaglandins
31, no. 5 (1986): 869–886.
</cite> [<a href="https://doi.org/10.1016/0090-6980(86)90020-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2425395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins&amp;title=Allergen%20Induced%20Histamine%20Release%20and%20Immunoreactive%E2%80%90Leukotriene%20C4%20Generation%20From%20Leukocytes%20in%20Mite%20Sensitive%20Asthmatic%20Patients&amp;author=H.%20Mita&amp;author=Y.%20Yui&amp;author=H.%20Yasueda&amp;author=T.%20Kajita&amp;author=H.%20Saito&amp;volume=31&amp;issue=5&amp;publication_year=1986&amp;pages=869-886&amp;pmid=2425395&amp;doi=10.1016/0090-6980(86)90020-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0225">
<span class="label">225.</span><cite>
Smith L. J., Greenberger P. A., Patterson R., Krell R. D., and Bernstein P. R., “The Effect of Inhaled Leukotriene D4 in Humans,” American Review of Respiratory Disease
131, no. 3 (1985): 368–372.
</cite> [<a href="https://doi.org/10.1164/arrd.1985.131.3.368" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3883862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Review%20of%20Respiratory%20Disease&amp;title=The%20Effect%20of%20Inhaled%20Leukotriene%20D4%20in%20Humans&amp;author=L.%20J.%20Smith&amp;author=P.%20A.%20Greenberger&amp;author=R.%20Patterson&amp;author=R.%20D.%20Krell&amp;author=P.%20R.%20Bernstein&amp;volume=131&amp;issue=3&amp;publication_year=1985&amp;pages=368-372&amp;pmid=3883862&amp;doi=10.1164/arrd.1985.131.3.368&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0226">
<span class="label">226.</span><cite>
Diamant Z., Gauvreau G. M., Cockcroft D. W., et al., “Inhaled Allergen Bronchoprovocation Tests,” Journal of Allergy and Clinical Immunology
132, no. 5 (2013): 1045–1055.e6.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2013.08.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24119772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Inhaled%20Allergen%20Bronchoprovocation%20Tests&amp;author=Z.%20Diamant&amp;author=G.%20M.%20Gauvreau&amp;author=D.%20W.%20Cockcroft&amp;volume=132&amp;issue=5&amp;publication_year=2013&amp;pages=1045-1055&amp;pmid=24119772&amp;doi=10.1016/j.jaci.2013.08.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0227">
<span class="label">227.</span><cite>
Durr S.‐M., Davis B., Gauvreau G., and Cockcroft D., “Allergen Bronchoprovocation: Correlation Between FEV1 Maximal Percent Fall and Area Under the FEV1 Curve and Impact of Allergen on Recovery,” Allergy, Asthma and Clinical Immunology
19, no. 1 (2023): 8.</cite> [<a href="https://doi.org/10.1186/s13223-023-00759-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9867859/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36681834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy,%20Asthma%20and%20Clinical%20Immunology&amp;title=Allergen%20Bronchoprovocation:%20Correlation%20Between%20FEV1%20Maximal%20Percent%20Fall%20and%20Area%20Under%20the%20FEV1%20Curve%20and%20Impact%20of%20Allergen%20on%20Recovery&amp;author=S.%E2%80%90M.%20Durr&amp;author=B.%20Davis&amp;author=G.%20Gauvreau&amp;author=D.%20Cockcroft&amp;volume=19&amp;issue=1&amp;publication_year=2023&amp;pages=8&amp;pmid=36681834&amp;doi=10.1186/s13223-023-00759-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0228">
<span class="label">228.</span><cite>
Gauvreau G. M., Bergeron C., Boulet L. P., et al., “Sounding the Alarmins—The Role of Alarmin Cytokines in Asthma,” Allergy
78, no. 2 (2023): 402–417.
</cite> [<a href="https://doi.org/10.1111/all.15609" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10108333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36463491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Sounding%20the%20Alarmins%E2%80%94The%20Role%20of%20Alarmin%20Cytokines%20in%20Asthma&amp;author=G.%20M.%20Gauvreau&amp;author=C.%20Bergeron&amp;author=L.%20P.%20Boulet&amp;volume=78&amp;issue=2&amp;publication_year=2023&amp;pages=402-417&amp;pmid=36463491&amp;doi=10.1111/all.15609&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0229">
<span class="label">229.</span><cite>
Haselden B. M., Barry Kay A., and Larché M., “Immunoglobulin E–Independent Major Histocompatibility Complex–Restricted T Cell Peptide Epitope–Induced Late Asthmatic Reactions,” Journal of Experimental Medicine
189, no. 12 (1999): 1885–1894.
</cite> [<a href="https://doi.org/10.1084/jem.189.12.1885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2192970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10377184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Immunoglobulin%20E%E2%80%93Independent%20Major%20Histocompatibility%20Complex%E2%80%93Restricted%20T%20Cell%20Peptide%20Epitope%E2%80%93Induced%20Late%20Asthmatic%20Reactions&amp;author=B.%20M.%20Haselden&amp;author=A.%20Barry%20Kay&amp;author=M.%20Larch%C3%A9&amp;volume=189&amp;issue=12&amp;publication_year=1999&amp;pages=1885-1894&amp;pmid=10377184&amp;doi=10.1084/jem.189.12.1885&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0230">
<span class="label">230.</span><cite>
Ali F. R., Oldfield W. L., Higashi N., Larché M., and Kay A. B., “Late Asthmatic Reactions Induced by Inhalation of Allergen‐Derived T Cell Peptides,” American Journal of Respiratory and Critical Care Medicine
169, no. 1 (2004): 20–26.
</cite> [<a href="https://doi.org/10.1164/rccm.200305-690OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14500264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Late%20Asthmatic%20Reactions%20Induced%20by%20Inhalation%20of%20Allergen%E2%80%90Derived%20T%20Cell%20Peptides&amp;author=F.%20R.%20Ali&amp;author=W.%20L.%20Oldfield&amp;author=N.%20Higashi&amp;author=M.%20Larch%C3%A9&amp;author=A.%20B.%20Kay&amp;volume=169&amp;issue=1&amp;publication_year=2004&amp;pages=20-26&amp;pmid=14500264&amp;doi=10.1164/rccm.200305-690OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0231">
<span class="label">231.</span><cite>
Ali F. R., Kay A. B., and Larché M., “Airway Hyperresponsiveness and Bronchial Mucosal Inflammation in T Cell Peptide‐Induced Asthmatic Reactions in Atopic Subjects,” Thorax
62, no. 9 (2007): 750–757.
</cite> [<a href="https://doi.org/10.1136/thx.2006.072041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2117301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17389757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorax&amp;title=Airway%20Hyperresponsiveness%20and%20Bronchial%20Mucosal%20Inflammation%20in%20T%20Cell%20Peptide%E2%80%90Induced%20Asthmatic%20Reactions%20in%20Atopic%20Subjects&amp;author=F.%20R.%20Ali&amp;author=A.%20B.%20Kay&amp;author=M.%20Larch%C3%A9&amp;volume=62&amp;issue=9&amp;publication_year=2007&amp;pages=750-757&amp;pmid=17389757&amp;doi=10.1136/thx.2006.072041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0232">
<span class="label">232.</span><cite>
Leckie M. J., ten Brinke A., Khan J., et al., “Effects of an Interleukin‐5 Blocking Monoclonal Antibody on Eosinophils, Airway Hyper‐Responsiveness, and the Late Asthmatic Response,” Lancet
356, no. 9248 (2000): 2144–2148, 10.1016/S0140-6736(00)03496-6.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(00)03496-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11191542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effects%20of%20an%20Interleukin%E2%80%905%20Blocking%20Monoclonal%20Antibody%20on%20Eosinophils,%20Airway%20Hyper%E2%80%90Responsiveness,%20and%20the%20Late%20Asthmatic%20Response&amp;author=M.%20J.%20Leckie&amp;author=A.%20ten%20Brinke&amp;author=J.%20Khan&amp;volume=356&amp;issue=9248&amp;publication_year=2000&amp;pages=2144-2148&amp;pmid=11191542&amp;doi=10.1016/S0140-6736(00)03496-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0233">
<span class="label">233.</span><cite>
Durham S., Carroll M., Walsh G. M., and Kay A., “Leukocyte Activation in Allergen‐Induced Late‐Phase Asthmatic Reactions,” New England Journal of Medicine
311, no. 22 (1984): 1398–1402.
</cite> [<a href="https://doi.org/10.1056/NEJM198411293112202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6387491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Leukocyte%20Activation%20in%20Allergen%E2%80%90Induced%20Late%E2%80%90Phase%20Asthmatic%20Reactions&amp;author=S.%20Durham&amp;author=M.%20Carroll&amp;author=G.%20M.%20Walsh&amp;author=A.%20Kay&amp;volume=311&amp;issue=22&amp;publication_year=1984&amp;pages=1398-1402&amp;pmid=6387491&amp;doi=10.1056/NEJM198411293112202&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0234">
<span class="label">234.</span><cite>
Boulet L. P., Roberts R., Dolovich J., and Hargreave F., “Prediction of Late Asthmatic Responses to Inhaled Allergen,” Clinical and Experimental Allergy
14, no. 4 (1984): 379–385.</cite> [<a href="https://doi.org/10.1111/j.1365-2222.1984.tb02219.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6467560/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Prediction%20of%20Late%20Asthmatic%20Responses%20to%20Inhaled%20Allergen&amp;author=L.%20P.%20Boulet&amp;author=R.%20Roberts&amp;author=J.%20Dolovich&amp;author=F.%20Hargreave&amp;volume=14&amp;issue=4&amp;publication_year=1984&amp;pages=379-385&amp;pmid=6467560&amp;doi=10.1111/j.1365-2222.1984.tb02219.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0235">
<span class="label">235.</span><cite>
Boulet L. P., Gauvreau G., Boulay M. E., O'Byrne P., and Cockcroft D. W., “Allergen‐Induced Early and Late Asthmatic Responses to Inhaled Seasonal and Perennial Allergens,” Clinical and Experimental Allergy
45, no. 11 (2015): 1647–1653.
</cite> [<a href="https://doi.org/10.1111/cea.12587" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26115509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Allergen%E2%80%90Induced%20Early%20and%20Late%20Asthmatic%20Responses%20to%20Inhaled%20Seasonal%20and%20Perennial%20Allergens&amp;author=L.%20P.%20Boulet&amp;author=G.%20Gauvreau&amp;author=M.%20E.%20Boulay&amp;author=P.%20O'Byrne&amp;author=D.%20W.%20Cockcroft&amp;volume=45&amp;issue=11&amp;publication_year=2015&amp;pages=1647-1653&amp;pmid=26115509&amp;doi=10.1111/cea.12587&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0236">
<span class="label">236.</span><cite>
Laviolette M., Gossage D. L., Gauvreau G., et al., “Effects of Benralizumab on Airway Eosinophils in Asthmatic Patients With Sputum Eosinophilia,” Journal of Allergy and Clinical Immunology
132, no. 5 (2013): 1086–1096.e5.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2013.05.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4172321/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23866823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Effects%20of%20Benralizumab%20on%20Airway%20Eosinophils%20in%20Asthmatic%20Patients%20With%20Sputum%20Eosinophilia&amp;author=M.%20Laviolette&amp;author=D.%20L.%20Gossage&amp;author=G.%20Gauvreau&amp;volume=132&amp;issue=5&amp;publication_year=2013&amp;pages=1086-1096&amp;pmid=23866823&amp;doi=10.1016/j.jaci.2013.05.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0237">
<span class="label">237.</span><cite>
Flood‐Page P. T., Menzies‐Gow A. N., Kay A. B., and Robinson D. S., “Eosinophil's Role Remains Uncertain as Anti–Interleukin‐5 Only Partially Depletes Numbers in Asthmatic Airway,” American Journal of Respiratory and Critical Care Medicine
167, no. 2 (2003): 199–204.
</cite> [<a href="https://doi.org/10.1164/rccm.200208-789OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12406833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Eosinophil's%20Role%20Remains%20Uncertain%20as%20Anti%E2%80%93Interleukin%E2%80%905%20Only%20Partially%20Depletes%20Numbers%20in%20Asthmatic%20Airway&amp;author=P.%20T.%20Flood%E2%80%90Page&amp;author=A.%20N.%20Menzies%E2%80%90Gow&amp;author=A.%20B.%20Kay&amp;author=D.%20S.%20Robinson&amp;volume=167&amp;issue=2&amp;publication_year=2003&amp;pages=199-204&amp;pmid=12406833&amp;doi=10.1164/rccm.200208-789OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0238">
<span class="label">238.</span><cite>
Davis B. E., Illamperuma C., Gauvreau G., et al., “Single‐Dose Desloratadine and Montelukast and Allergen‐Induced Late Airway Responses,” European Respiratory Journal
33, no. 6 (2009): 1302–1308, 10.1183/09031936.00169008.
</cite> [<a href="https://doi.org/10.1183/09031936.00169008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19164343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Respiratory%20Journal&amp;title=Single%E2%80%90Dose%20Desloratadine%20and%20Montelukast%20and%20Allergen%E2%80%90Induced%20Late%20Airway%20Responses&amp;author=B.%20E.%20Davis&amp;author=C.%20Illamperuma&amp;author=G.%20Gauvreau&amp;volume=33&amp;issue=6&amp;publication_year=2009&amp;pages=1302-1308&amp;pmid=19164343&amp;doi=10.1183/09031936.00169008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0239">
<span class="label">239.</span><cite>
Roquet A., Dahlén B., Kumlin M., et al., “Combined Antagonism of Leukotrienes and Histamine Produces Predominant Inhibition of Allergen‐Induced Early and Late Phase Airway Obstruction in Asthmatics,” American Journal of Respiratory and Critical Care Medicine
155, no. 6 (1997): 1856–1863.
</cite> [<a href="https://doi.org/10.1164/ajrccm.155.6.9196086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9196086/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Combined%20Antagonism%20of%20Leukotrienes%20and%20Histamine%20Produces%20Predominant%20Inhibition%20of%20Allergen%E2%80%90Induced%20Early%20and%20Late%20Phase%20Airway%20Obstruction%20in%20Asthmatics&amp;author=A.%20Roquet&amp;author=B.%20Dahl%C3%A9n&amp;author=M.%20Kumlin&amp;volume=155&amp;issue=6&amp;publication_year=1997&amp;pages=1856-1863&amp;pmid=9196086&amp;doi=10.1164/ajrccm.155.6.9196086&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0240">
<span class="label">240.</span><cite>
Kinoshita T., Baatjes A., Smith S. G., et al., “Natural Regulatory T Cells in Isolated Early Responders Compared With Dual Responders With Allergic Asthma,” Journal of Allergy and Clinical Immunology
133, no. 3 (2014): 696–703.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2013.08.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24139499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Natural%20Regulatory%20T%20Cells%20in%20Isolated%20Early%20Responders%20Compared%20With%20Dual%20Responders%20With%20Allergic%20Asthma&amp;author=T.%20Kinoshita&amp;author=A.%20Baatjes&amp;author=S.%20G.%20Smith&amp;volume=133&amp;issue=3&amp;publication_year=2014&amp;pages=696-703&amp;pmid=24139499&amp;doi=10.1016/j.jaci.2013.08.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0241">
<span class="label">241.</span><cite>
Upham J. W. and Stumbles P. A., “Why Are Dendritic Cells Important in Allergic Diseases of the Respiratory Tract?,” Pharmacology and Therapeutics
100, no. 1 (2003): 75–87.
</cite> [<a href="https://doi.org/10.1016/s0163-7258(03)00094-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14550506/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20and%20Therapeutics&amp;title=Why%20Are%20Dendritic%20Cells%20Important%20in%20Allergic%20Diseases%20of%20the%20Respiratory%20Tract?&amp;author=J.%20W.%20Upham&amp;author=P.%20A.%20Stumbles&amp;volume=100&amp;issue=1&amp;publication_year=2003&amp;pages=75-87&amp;pmid=14550506&amp;doi=10.1016/s0163-7258(03)00094-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0242">
<span class="label">242.</span><cite>
Yerkovich S. T., Roponen M., Smith M. E., et al., “Allergen‐Enhanced Thrombomodulin (Blood Dendritic Cell Antigen 3, CD141) Expression on Dendritic Cells Is Associated With a TH2‐Skewed Immune Response,” Journal of Allergy and Clinical Immunology
123, no. 1 (2009): 209–216.e4.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2008.09.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18947863/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Allergen%E2%80%90Enhanced%20Thrombomodulin%20(Blood%20Dendritic%20Cell%20Antigen%203,%20CD141)%20Expression%20on%20Dendritic%20Cells%20Is%20Associated%20With%20a%20TH2%E2%80%90Skewed%20Immune%20Response&amp;author=S.%20T.%20Yerkovich&amp;author=M.%20Roponen&amp;author=M.%20E.%20Smith&amp;volume=123&amp;issue=1&amp;publication_year=2009&amp;pages=209-216&amp;pmid=18947863&amp;doi=10.1016/j.jaci.2008.09.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0243">
<span class="label">243.</span><cite>
Farrell E., O'Connor T., Duong M., et al., “Circulating Myeloid and Plasmacytoid Dendritic Cells After Allergen Inhalation in Asthmatic Subjects,” Allergy
62, no. 10 (2007): 1139–1145, 10.1111/j.1398-9995.2007.01465.x.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2007.01465.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17845582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Circulating%20Myeloid%20and%20Plasmacytoid%20Dendritic%20Cells%20After%20Allergen%20Inhalation%20in%20Asthmatic%20Subjects&amp;author=E.%20Farrell&amp;author=T.%20O'Connor&amp;author=M.%20Duong&amp;volume=62&amp;issue=10&amp;publication_year=2007&amp;pages=1139-1145&amp;pmid=17845582&amp;doi=10.1111/j.1398-9995.2007.01465.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0244">
<span class="label">244.</span><cite>
Parameswaran K., Liang H., Fanat A., Watson R., Snider D. P., and O'Byrne P. M., “Role for Cysteinyl Leukotrienes in Allergen‐Induced Change in Circulating Dendritic Cell Number in Asthma,” Journal of Allergy and Clinical Immunology
114, no. 1 (2004): 73–79.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2004.03.054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15241347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Role%20for%20Cysteinyl%20Leukotrienes%20in%20Allergen%E2%80%90Induced%20Change%20in%20Circulating%20Dendritic%20Cell%20Number%20in%20Asthma&amp;author=K.%20Parameswaran&amp;author=H.%20Liang&amp;author=A.%20Fanat&amp;author=R.%20Watson&amp;author=D.%20P.%20Snider&amp;volume=114&amp;issue=1&amp;publication_year=2004&amp;pages=73-79&amp;pmid=15241347&amp;doi=10.1016/j.jaci.2004.03.054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0245">
<span class="label">245.</span><cite>
El‐Gammal A., Oliveria J.‐P., Howie K., et al., “Allergen‐Induced Changes in Bone Marrow and Airway Dendritic Cells in Subjects With Asthma,” American Journal of Respiratory and Critical Care Medicine
194, no. 2 (2016): 169–177.
</cite> [<a href="https://doi.org/10.1164/rccm.201508-1623OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26844926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Allergen%E2%80%90Induced%20Changes%20in%20Bone%20Marrow%20and%20Airway%20Dendritic%20Cells%20in%20Subjects%20With%20Asthma&amp;author=A.%20El%E2%80%90Gammal&amp;author=J.%E2%80%90P.%20Oliveria&amp;author=K.%20Howie&amp;volume=194&amp;issue=2&amp;publication_year=2016&amp;pages=169-177&amp;pmid=26844926&amp;doi=10.1164/rccm.201508-1623OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0246">
<span class="label">246.</span><cite>
Dua B., Watson R. M., Gauvreau G. M., and O'Byrne P. M., “Myeloid and Plasmacytoid Dendritic Cells in Induced Sputum After Allergen Inhalation in Subjects With Asthma,” Journal of Allergy and Clinical Immunology
126, no. 1 (2010): 133–139.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2010.04.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20538329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Myeloid%20and%20Plasmacytoid%20Dendritic%20Cells%20in%20Induced%20Sputum%20After%20Allergen%20Inhalation%20in%20Subjects%20With%20Asthma&amp;author=B.%20Dua&amp;author=R.%20M.%20Watson&amp;author=G.%20M.%20Gauvreau&amp;author=P.%20M.%20O'Byrne&amp;volume=126&amp;issue=1&amp;publication_year=2010&amp;pages=133-139&amp;pmid=20538329&amp;doi=10.1016/j.jaci.2010.04.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0247">
<span class="label">247.</span><cite>
Dua B., Tang W., Watson R., Gauvreau G., and O'Byrne P. M., “Myeloid Dendritic Cells Type 2 After Allergen Inhalation in Asthmatic Subjects,” Clinical and Experimental Allergy
44, no. 7 (2014): 921–929.
</cite> [<a href="https://doi.org/10.1111/cea.12297" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24575847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Myeloid%20Dendritic%20Cells%20Type%202%20After%20Allergen%20Inhalation%20in%20Asthmatic%20Subjects&amp;author=B.%20Dua&amp;author=W.%20Tang&amp;author=R.%20Watson&amp;author=G.%20Gauvreau&amp;author=P.%20M.%20O'Byrne&amp;volume=44&amp;issue=7&amp;publication_year=2014&amp;pages=921-929&amp;pmid=24575847&amp;doi=10.1111/cea.12297&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0248">
<span class="label">248.</span><cite>
Agache I., Beltran J., Akdis C., et al., “Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma. A Systematic Review for the EAACI Guidelines‐Recommendations on the Use of Biologicals in Severe Asthma,” Allergy
75, no. 5 (2020): 1023–1042.
</cite> [<a href="https://doi.org/10.1111/all.14221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32034960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Efficacy%20and%20Safety%20of%20Treatment%20With%20Biologicals%20(Benralizumab,%20Dupilumab,%20Mepolizumab,%20Omalizumab%20and%20Reslizumab)%20for%20Severe%20Eosinophilic%20Asthma.%20A%20Systematic%20Review%20for%20the%20EAACI%20Guidelines%E2%80%90Recommendations%20on%20the%20Use%20of%20Biologicals%20in%20Severe%20Asthma&amp;author=I.%20Agache&amp;author=J.%20Beltran&amp;author=C.%20Akdis&amp;volume=75&amp;issue=5&amp;publication_year=2020&amp;pages=1023-1042&amp;pmid=32034960&amp;doi=10.1111/all.14221&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0249">
<span class="label">249.</span><cite>
Singh A., Shannon C. P., Kim Y. W., et al., “Novel Blood‐Based Transcriptional Biomarker Panels Predict the Late‐Phase Asthmatic Response,” American Journal of Respiratory and Critical Care Medicine
197, no. 4 (2018): 450–462, 10.1164/rccm.201701-0110OC.
</cite> [<a href="https://doi.org/10.1164/rccm.201701-0110OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29087730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Novel%20Blood%E2%80%90Based%20Transcriptional%20Biomarker%20Panels%20Predict%20the%20Late%E2%80%90Phase%20Asthmatic%20Response&amp;author=A.%20Singh&amp;author=C.%20P.%20Shannon&amp;author=Y.%20W.%20Kim&amp;volume=197&amp;issue=4&amp;publication_year=2018&amp;pages=450-462&amp;pmid=29087730&amp;doi=10.1164/rccm.201701-0110OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0250">
<span class="label">250.</span><cite>
Wills‐Karp M., Luyimbazi J., Xu X., et al., “Interleukin‐13: Central Mediator of Allergic Asthma,” Science
282, no. 5397 (1998): 2258–2261.
</cite> [<a href="https://doi.org/10.1126/science.282.5397.2258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9856949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Interleukin%E2%80%9013:%20Central%20Mediator%20of%20Allergic%20Asthma&amp;author=M.%20Wills%E2%80%90Karp&amp;author=J.%20Luyimbazi&amp;author=X.%20Xu&amp;volume=282&amp;issue=5397&amp;publication_year=1998&amp;pages=2258-2261&amp;pmid=9856949&amp;doi=10.1126/science.282.5397.2258&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0251">
<span class="label">251.</span><cite>
Gauvreau G. M., O'Byrne P. M., Boulet L.‐P., et al., “Effects of an Anti‐TSLP Antibody on Allergen‐Induced Asthmatic Responses,” New England Journal of Medicine
370, no. 22 (2014): 2102–2110, 10.1056/NEJMoa1402895.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1402895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24846652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Effects%20of%20an%20Anti%E2%80%90TSLP%20Antibody%20on%20Allergen%E2%80%90Induced%20Asthmatic%20Responses&amp;author=G.%20M.%20Gauvreau&amp;author=P.%20M.%20O'Byrne&amp;author=L.%E2%80%90P.%20Boulet&amp;volume=370&amp;issue=22&amp;publication_year=2014&amp;pages=2102-2110&amp;pmid=24846652&amp;doi=10.1056/NEJMoa1402895&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0252">
<span class="label">252.</span><cite>
Gupta A., Espinosa V., Galusha L. E., et al., “Expression and Targeting of Lymphocyte Function‐Associated Antigen 1 (LFA‐1) on White Blood Cells for Treatment of Allergic Asthma,” Journal of Leucocyte Biology
97, no. 3 (2015): 439–446.</cite> [<a href="https://doi.org/10.1189/jlb.5HI0414-196R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4338844/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25341726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Leucocyte%20Biology&amp;title=Expression%20and%20Targeting%20of%20Lymphocyte%20Function%E2%80%90Associated%20Antigen%201%20(LFA%E2%80%901)%20on%20White%20Blood%20Cells%20for%20Treatment%20of%20Allergic%20Asthma&amp;author=A.%20Gupta&amp;author=V.%20Espinosa&amp;author=L.%20E.%20Galusha&amp;volume=97&amp;issue=3&amp;publication_year=2015&amp;pages=439-446&amp;pmid=25341726&amp;doi=10.1189/jlb.5HI0414-196R&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0253">
<span class="label">253.</span><cite>
Scheerens H., Arron J., Zheng Y., et al., “The Effects of Lebrikizumab in Patients With Mild Asthma Following Whole Lung Allergen Challenge,” Clinical and Experimental Allergy
44, no. 1 (2014): 38–46, 10.1111/cea.12220.
</cite> [<a href="https://doi.org/10.1111/cea.12220" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4204278/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24131304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=The%20Effects%20of%20Lebrikizumab%20in%20Patients%20With%20Mild%20Asthma%20Following%20Whole%20Lung%20Allergen%20Challenge&amp;author=H.%20Scheerens&amp;author=J.%20Arron&amp;author=Y.%20Zheng&amp;volume=44&amp;issue=1&amp;publication_year=2014&amp;pages=38-46&amp;pmid=24131304&amp;doi=10.1111/cea.12220&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0254">
<span class="label">254.</span><cite>
Seshasayee D., Lee W. P., Zhou M., et al., “In Vivo Blockade of OX40 Ligand Inhibits Thymic Stromal Lymphopoietin Driven Atopic Inflammation,” Journal of Clinical Investigation
117, no. 12 (2007): 3868–3878.
</cite> [<a href="https://doi.org/10.1172/JCI33559" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2096422/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18060034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=In%20Vivo%20Blockade%20of%20OX40%20Ligand%20Inhibits%20Thymic%20Stromal%20Lymphopoietin%20Driven%20Atopic%20Inflammation&amp;author=D.%20Seshasayee&amp;author=W.%20P.%20Lee&amp;author=M.%20Zhou&amp;volume=117&amp;issue=12&amp;publication_year=2007&amp;pages=3868-3878&amp;pmid=18060034&amp;doi=10.1172/JCI33559&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0255">
<span class="label">255.</span><cite>
Gauvreau G. M., Hohlfeld J. M., FitzGerald J. M., et al., “Inhaled Anti‐TSLP Antibody Fragment, Ecleralimab, Blocks Responses to Allergen in Mild Asthma,” European Respiratory Journal
61, no. 3 (2023): 2201193, 10.1183/13993003.01193-2022.
</cite> [<a href="https://doi.org/10.1183/13993003.01193-2022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9996823/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36822634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Respiratory%20Journal&amp;title=Inhaled%20Anti%E2%80%90TSLP%20Antibody%20Fragment,%20Ecleralimab,%20Blocks%20Responses%20to%20Allergen%20in%20Mild%20Asthma&amp;author=G.%20M.%20Gauvreau&amp;author=J.%20M.%20Hohlfeld&amp;author=J.%20M.%20FitzGerald&amp;volume=61&amp;issue=3&amp;publication_year=2023&amp;pages=2201193&amp;pmid=36822634&amp;doi=10.1183/13993003.01193-2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0256">
<span class="label">256.</span><cite>
Boulet L.‐P., Gauvreau G. M., Cockcroft D. W., et al., “Effects of Asm‐024, A Modulator of Acetylcholine Receptor Function, on Airway Responsiveness and Allergen‐Induced Responses in Patients With Mild Asthma,” Canadian Respiratory Journal
22, no. 4 (2015): 230–234.
</cite> [<a href="https://doi.org/10.1155/2015/832865" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4530857/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26252534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Canadian%20Respiratory%20Journal&amp;title=Effects%20of%20Asm%E2%80%90024,%20A%20Modulator%20of%20Acetylcholine%20Receptor%20Function,%20on%20Airway%20Responsiveness%20and%20Allergen%E2%80%90Induced%20Responses%20in%20Patients%20With%20Mild%20Asthma&amp;author=L.%E2%80%90P.%20Boulet&amp;author=G.%20M.%20Gauvreau&amp;author=D.%20W.%20Cockcroft&amp;volume=22&amp;issue=4&amp;publication_year=2015&amp;pages=230-234&amp;pmid=26252534&amp;doi=10.1155/2015/832865&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0257">
<span class="label">257.</span><cite>
Todd C. M., Salter B. M., Murphy D. M., et al., “The Effects of a CXCR1/CXCR2 Antagonist on Neutrophil Migration in Mild Atopic Asthmatic Subjects,” Pulmonary Pharmacology and Therapeutics
41 (2016): 34–39.
</cite> [<a href="https://doi.org/10.1016/j.pupt.2016.09.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27640067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pulmonary%20Pharmacology%20and%20Therapeutics&amp;title=The%20Effects%20of%20a%20CXCR1/CXCR2%20Antagonist%20on%20Neutrophil%20Migration%20in%20Mild%20Atopic%20Asthmatic%20Subjects&amp;author=C.%20M.%20Todd&amp;author=B.%20M.%20Salter&amp;author=D.%20M.%20Murphy&amp;volume=41&amp;publication_year=2016&amp;pages=34-39&amp;pmid=27640067&amp;doi=10.1016/j.pupt.2016.09.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0258">
<span class="label">258.</span><cite>
Gauvreau G. M., Sulakvelidze I., Watson R. M., Inman M. D., Rerecich T. J., and O'Byrne P. M., “Effects of Once Daily Dosing With Inhaled Budesonide on Airway Hyperresponsiveness and Airway Inflammation Following Repeated Low‐Dose Allergen Challenge in Atopic Asthmatics,” Clinical and Experimental Allergy
30, no. 9 (2000): 1235–1243.
</cite> [<a href="https://doi.org/10.1046/j.1365-2222.2000.00860.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10971469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Effects%20of%20Once%20Daily%20Dosing%20With%20Inhaled%20Budesonide%20on%20Airway%20Hyperresponsiveness%20and%20Airway%20Inflammation%20Following%20Repeated%20Low%E2%80%90Dose%20Allergen%20Challenge%20in%20Atopic%20Asthmatics&amp;author=G.%20M.%20Gauvreau&amp;author=I.%20Sulakvelidze&amp;author=R.%20M.%20Watson&amp;author=M.%20D.%20Inman&amp;author=T.%20J.%20Rerecich&amp;volume=30&amp;issue=9&amp;publication_year=2000&amp;pages=1235-1243&amp;pmid=10971469&amp;doi=10.1046/j.1365-2222.2000.00860.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0259">
<span class="label">259.</span><cite>
Kelly M. M., O'Connor T. M., Leigh R., et al., “Effects of Budesonide and Formoterol on Allergen‐Induced Airway Responses, Inflammation, and Airway Remodeling in Asthma,” Journal of Allergy and Clinical Immunology
125, no. 2 (2010): 349–356.e13.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2009.09.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19969339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Effects%20of%20Budesonide%20and%20Formoterol%20on%20Allergen%E2%80%90Induced%20Airway%20Responses,%20Inflammation,%20and%20Airway%20Remodeling%20in%20Asthma&amp;author=M.%20M.%20Kelly&amp;author=T.%20M.%20O'Connor&amp;author=R.%20Leigh&amp;volume=125&amp;issue=2&amp;publication_year=2010&amp;pages=349-356&amp;pmid=19969339&amp;doi=10.1016/j.jaci.2009.09.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0260">
<span class="label">260.</span><cite>
Kawayama T., O'Byrne P., Watson R., et al., “Effects of Inhaled Ciclesonide on Circulating T‐Helper Type 1/T‐Helper Type 2 Cells in Atopic Asthmatics After Allergen Challenge,” Clinical and Experimental Allergy
36, no. 11 (2006): 1417–1424, 10.1111/j.1365-2222.2006.02592.x.
</cite> [<a href="https://doi.org/10.1111/j.1365-2222.2006.02592.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17083352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=Effects%20of%20Inhaled%20Ciclesonide%20on%20Circulating%20T%E2%80%90Helper%20Type%201/T%E2%80%90Helper%20Type%202%20Cells%20in%20Atopic%20Asthmatics%20After%20Allergen%20Challenge&amp;author=T.%20Kawayama&amp;author=P.%20O'Byrne&amp;author=R.%20Watson&amp;volume=36&amp;issue=11&amp;publication_year=2006&amp;pages=1417-1424&amp;pmid=17083352&amp;doi=10.1111/j.1365-2222.2006.02592.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0261">
<span class="label">261.</span><cite>
Gauvreau G. M., Boulet L. P., Cockcroft D. W., et al., “Antisense Therapy Against CCR3 and the Common Beta Chain Attenuates Allergen‐Induced Eosinophilic Responses,” American Journal of Respiratory and Critical Care Medicine
177, no. 9 (2008): 952–958.
</cite> [<a href="https://doi.org/10.1164/rccm.200708-1251OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18244953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Antisense%20Therapy%20Against%20CCR3%20and%20the%20Common%20Beta%20Chain%20Attenuates%20Allergen%E2%80%90Induced%20Eosinophilic%20Responses&amp;author=G.%20M.%20Gauvreau&amp;author=L.%20P.%20Boulet&amp;author=D.%20W.%20Cockcroft&amp;volume=177&amp;issue=9&amp;publication_year=2008&amp;pages=952-958&amp;pmid=18244953&amp;doi=10.1164/rccm.200708-1251OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0262">
<span class="label">262.</span><cite>
Gauvreau G. M., Boulet L. P., FitzGerald J., et al., “A Dual Cys LT 1/2 Antagonist Attenuates Allergen‐Induced Airway Responses in Subjects With Mild Allergic Asthma,” Allergy
71, no. 12 (2016): 1721–1727, 10.1111/all.12987.
</cite> [<a href="https://doi.org/10.1111/all.12987" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27444660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=A%20Dual%20Cys%20LT%201/2%20Antagonist%20Attenuates%20Allergen%E2%80%90Induced%20Airway%20Responses%20in%20Subjects%20With%20Mild%20Allergic%20Asthma&amp;author=G.%20M.%20Gauvreau&amp;author=L.%20P.%20Boulet&amp;author=J.%20FitzGerald&amp;volume=71&amp;issue=12&amp;publication_year=2016&amp;pages=1721-1727&amp;pmid=27444660&amp;doi=10.1111/all.12987&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0263">
<span class="label">263.</span><cite>
Gauvreau G. M., Hessel E. M., Boulet L.‐P., Coffman R. L., and O'Byrne P. M., “Immunostimulatory Sequences Regulate Interferon‐Inducible Genes but Not Allergic Airway Responses,” American Journal of Respiratory and Critical Care Medicine
174, no. 1 (2006): 15–20.
</cite> [<a href="https://doi.org/10.1164/rccm.200601-057OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16574937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Immunostimulatory%20Sequences%20Regulate%20Interferon%E2%80%90Inducible%20Genes%20but%20Not%20Allergic%20Airway%20Responses&amp;author=G.%20M.%20Gauvreau&amp;author=E.%20M.%20Hessel&amp;author=L.%E2%80%90P.%20Boulet&amp;author=R.%20L.%20Coffman&amp;author=P.%20M.%20O'Byrne&amp;volume=174&amp;issue=1&amp;publication_year=2006&amp;pages=15-20&amp;pmid=16574937&amp;doi=10.1164/rccm.200601-057OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0264">
<span class="label">264.</span><cite>
Duong M., Cockcroft D., Boulet L. P., et al., “The Effect of IVX‐0142, a Heparin‐Derived Hypersulfated Disaccharide, on the Allergic Airway Responses in Asthma,” Allergy
63, no. 9 (2008): 1195–1201, 10.1111/j.1398-9995.2008.01707.x.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2008.01707.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18699936/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=The%20Effect%20of%20IVX%E2%80%900142,%20a%20Heparin%E2%80%90Derived%20Hypersulfated%20Disaccharide,%20on%20the%20Allergic%20Airway%20Responses%20in%20Asthma&amp;author=M.%20Duong&amp;author=D.%20Cockcroft&amp;author=L.%20P.%20Boulet&amp;volume=63&amp;issue=9&amp;publication_year=2008&amp;pages=1195-1201&amp;pmid=18699936&amp;doi=10.1111/j.1398-9995.2008.01707.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0265">
<span class="label">265.</span><cite>
Kaur D. and Brightling C., “OX40/OX40 Ligand Interactions in T‐Cell Regulation and Asthma,” Chest
141, no. 2 (2012): 494–499.
</cite> [<a href="https://doi.org/10.1378/chest.11-1730" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3277294/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22315115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=OX40/OX40%20Ligand%20Interactions%20in%20T%E2%80%90Cell%20Regulation%20and%20Asthma&amp;author=D.%20Kaur&amp;author=C.%20Brightling&amp;volume=141&amp;issue=2&amp;publication_year=2012&amp;pages=494-499&amp;pmid=22315115&amp;doi=10.1378/chest.11-1730&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0266">
<span class="label">266.</span><cite>
Singh D., Cadden P., Hunter M., et al., “Inhibition of the Asthmatic Allergen Challenge Response by the CRTH2 Antagonist OC000459,” European Respiratory Journal
41, no. 1 (2012): 46–52, 10.1183/09031936.00092111.
</cite> [<a href="https://doi.org/10.1183/09031936.00092111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22496329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Respiratory%20Journal&amp;title=Inhibition%20of%20the%20Asthmatic%20Allergen%20Challenge%20Response%20by%20the%20CRTH2%20Antagonist%20OC000459&amp;author=D.%20Singh&amp;author=P.%20Cadden&amp;author=M.%20Hunter&amp;volume=41&amp;issue=1&amp;publication_year=2012&amp;pages=46-52&amp;pmid=22496329&amp;doi=10.1183/09031936.00092111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0267">
<span class="label">267.</span><cite>
Leigh R., Vethanayagam D., Yoshida M., et al., “Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma,” American Journal of Respiratory and Critical Care Medicine
166, no. 9 (2002): 1212–1217.
</cite> [<a href="https://doi.org/10.1164/rccm.200206-509OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12403690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Effects%20of%20Montelukast%20and%20Budesonide%20on%20Airway%20Responses%20and%20Airway%20Inflammation%20in%20Asthma&amp;author=R.%20Leigh&amp;author=D.%20Vethanayagam&amp;author=M.%20Yoshida&amp;volume=166&amp;issue=9&amp;publication_year=2002&amp;pages=1212-1217&amp;pmid=12403690&amp;doi=10.1164/rccm.200206-509OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0268">
<span class="label">268.</span><cite>
Gauvreau G. M., Boulet L. P., Postma D. S., et al., “Effect of Low‐Dose Ciclesonide on Allergen‐Induced Responses in Subjects With Mild Allergic Asthma,” Journal of Allergy and Clinical Immunology
116, no. 2 (2005): 285–291.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2005.05.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16083781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Effect%20of%20Low%E2%80%90Dose%20Ciclesonide%20on%20Allergen%E2%80%90Induced%20Responses%20in%20Subjects%20With%20Mild%20Allergic%20Asthma&amp;author=G.%20M.%20Gauvreau&amp;author=L.%20P.%20Boulet&amp;author=D.%20S.%20Postma&amp;volume=116&amp;issue=2&amp;publication_year=2005&amp;pages=285-291&amp;pmid=16083781&amp;doi=10.1016/j.jaci.2005.05.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0269">
<span class="label">269.</span><cite>
Gauvreau G. M., Boulet L.‐P., Leigh R., et al., “A Nonsteroidal Glucocorticoid Receptor Agonist Inhibits Allergen‐Induced Late Asthmatic Responses,” American Journal of Respiratory and Critical Care Medicine
191, no. 2 (2015): 161–167.
</cite> [<a href="https://doi.org/10.1164/rccm.201404-0623OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25473939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=A%20Nonsteroidal%20Glucocorticoid%20Receptor%20Agonist%20Inhibits%20Allergen%E2%80%90Induced%20Late%20Asthmatic%20Responses&amp;author=G.%20M.%20Gauvreau&amp;author=L.%E2%80%90P.%20Boulet&amp;author=R.%20Leigh&amp;volume=191&amp;issue=2&amp;publication_year=2015&amp;pages=161-167&amp;pmid=25473939&amp;doi=10.1164/rccm.201404-0623OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0270">
<span class="label">270.</span><cite>
Gauvreau G. M., FitzGerald J., Boulet L. P., et al., “The Effects of a CCR 3 Inhibitor, AXP 1275, on Allergen‐Induced Airway Responses in Adults With Mild‐To‐Moderate Atopic Asthma,” Clinical and Experimental Allergy
48, no. 4 (2018): 445–451.
</cite> [<a href="https://doi.org/10.1111/cea.13114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29423947/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=The%20Effects%20of%20a%20CCR%203%20Inhibitor,%20AXP%201275,%20on%20Allergen%E2%80%90Induced%20Airway%20Responses%20in%20Adults%20With%20Mild%E2%80%90To%E2%80%90Moderate%20Atopic%20Asthma&amp;author=G.%20M.%20Gauvreau&amp;author=J.%20FitzGerald&amp;author=L.%20P.%20Boulet&amp;volume=48&amp;issue=4&amp;publication_year=2018&amp;pages=445-451&amp;pmid=29423947&amp;doi=10.1111/cea.13114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0271">
<span class="label">271.</span><cite>
Gauvreau G., Pageau R., Séguin R., et al., “Dose–Response Effects of TPI ASM8 in Asthmatics After Allergen,” Allergy
66, no. 9 (2011): 1242–1248, 10.1111/j.1398-9995.2011.02638.x.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2011.02638.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21605124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Dose%E2%80%93Response%20Effects%20of%20TPI%20ASM8%20in%20Asthmatics%20After%20Allergen&amp;author=G.%20Gauvreau&amp;author=R.%20Pageau&amp;author=R.%20S%C3%A9guin&amp;volume=66&amp;issue=9&amp;publication_year=2011&amp;pages=1242-1248&amp;pmid=21605124&amp;doi=10.1111/j.1398-9995.2011.02638.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0272">
<span class="label">272.</span><cite>
Imaoka H., Campbell H., Babirad I., et al., “TPI ASM8 Reduces Eosinophil Progenitors in Sputum After Allergen Challenge,” Clinical and Experimental Allergy
41, no. 12 (2011): 1740–1746, 10.1111/j.1365-2222.2011.03816.x.
</cite> [<a href="https://doi.org/10.1111/j.1365-2222.2011.03816.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21762225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=TPI%20ASM8%20Reduces%20Eosinophil%20Progenitors%20in%20Sputum%20After%20Allergen%20Challenge&amp;author=H.%20Imaoka&amp;author=H.%20Campbell&amp;author=I.%20Babirad&amp;volume=41&amp;issue=12&amp;publication_year=2011&amp;pages=1740-1746&amp;pmid=21762225&amp;doi=10.1111/j.1365-2222.2011.03816.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0273">
<span class="label">273.</span><cite>
Melendi G. A., Hoffman S. J., Karron R. A., et al., “C5 Modulates Airway Hyperreactivity and Pulmonary Eosinophilia During Enhanced Respiratory Syncytial Virus Disease by Decreasing C3a Receptor Expression,” Journal of Virology
81, no. 2 (2007): 991–999.
</cite> [<a href="https://doi.org/10.1128/JVI.01783-06" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1797434/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17079327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Virology&amp;title=C5%20Modulates%20Airway%20Hyperreactivity%20and%20Pulmonary%20Eosinophilia%20During%20Enhanced%20Respiratory%20Syncytial%20Virus%20Disease%20by%20Decreasing%20C3a%20Receptor%20Expression&amp;author=G.%20A.%20Melendi&amp;author=S.%20J.%20Hoffman&amp;author=R.%20A.%20Karron&amp;volume=81&amp;issue=2&amp;publication_year=2007&amp;pages=991-999&amp;pmid=17079327&amp;doi=10.1128/JVI.01783-06&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0274">
<span class="label">274.</span><cite>
Lett‐Brown M. A., Boetcher D. A., and Leonard E. J., “Chemotactic Responses of Normal Human Basophils to C5a and to Lymphocyte‐Derived Chemotactic Factor,” Journal of Immunology
117, no. 1 (1976): 246–252.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/932427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Immunology&amp;title=Chemotactic%20Responses%20of%20Normal%20Human%20Basophils%20to%20C5a%20and%20to%20Lymphocyte%E2%80%90Derived%20Chemotactic%20Factor&amp;author=M.%20A.%20Lett%E2%80%90Brown&amp;author=D.%20A.%20Boetcher&amp;author=E.%20J.%20Leonard&amp;volume=117&amp;issue=1&amp;publication_year=1976&amp;pages=246-252&amp;pmid=932427&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0275">
<span class="label">275.</span><cite>
Yanase Y., Matsuo Y., Takahagi S., et al., “Coagulation Factors Induce Human Skin Mast Cell and Basophil Degranulation via Activation of Complement 5 and the C5a Receptor,” Journal of Allergy and Clinical Immunology
147, no. 3 (2021): 1101–1104.e7.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2020.08.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32888945/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Coagulation%20Factors%20Induce%20Human%20Skin%20Mast%20Cell%20and%20Basophil%20Degranulation%20via%20Activation%20of%20Complement%205%20and%20the%20C5a%20Receptor&amp;author=Y.%20Yanase&amp;author=Y.%20Matsuo&amp;author=S.%20Takahagi&amp;volume=147&amp;issue=3&amp;publication_year=2021&amp;pages=1101-1104&amp;pmid=32888945&amp;doi=10.1016/j.jaci.2020.08.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0276">
<span class="label">276.</span><cite>
Gauvreau G., Boulet L., Severino B., et al., “The Effect of C5 Inhibition by Eculizumab on Allergen‐Induced Asthmatic Responses in Patients,” Allergy
46, no. 14 (2009): 2837–2838.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=The%20Effect%20of%20C5%20Inhibition%20by%20Eculizumab%20on%20Allergen%E2%80%90Induced%20Asthmatic%20Responses%20in%20Patients&amp;author=G.%20Gauvreau&amp;author=L.%20Boulet&amp;author=B.%20Severino&amp;volume=46&amp;issue=14&amp;publication_year=2009&amp;pages=2837-2838&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0277">
<span class="label">277.</span><cite>
Gauvreau G. M., Becker A. B., Boulet L.‐P., et al., “The Effects of an Anti‐CD11a mAb, Efalizumab, on Allergen‐Induced Airway Responses and Airway Inflammation in Subjects With Atopic Asthma,” Journal of Allergy and Clinical Immunology
112, no. 2 (2003): 331–338.
</cite> [<a href="https://doi.org/10.1067/mai.2003.1689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12897739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=The%20Effects%20of%20an%20Anti%E2%80%90CD11a%20mAb,%20Efalizumab,%20on%20Allergen%E2%80%90Induced%20Airway%20Responses%20and%20Airway%20Inflammation%20in%20Subjects%20With%20Atopic%20Asthma&amp;author=G.%20M.%20Gauvreau&amp;author=A.%20B.%20Becker&amp;author=L.%E2%80%90P.%20Boulet&amp;volume=112&amp;issue=2&amp;publication_year=2003&amp;pages=331-338&amp;pmid=12897739&amp;doi=10.1067/mai.2003.1689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0278">
<span class="label">278.</span><cite>
Gauvreau G. M., Boulet L.‐P., Cockcroft D. W., et al., “Effects of Interleukin‐13 Blockade on Allergen‐Induced Airway Responses in Mild Atopic Asthma,” American Journal of Respiratory and Critical Care Medicine
183, no. 8 (2011): 1007–1014, 10.1164/rccm.201008-1210OC.
</cite> [<a href="https://doi.org/10.1164/rccm.201008-1210OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21057005/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Effects%20of%20Interleukin%E2%80%9013%20Blockade%20on%20Allergen%E2%80%90Induced%20Airway%20Responses%20in%20Mild%20Atopic%20Asthma&amp;author=G.%20M.%20Gauvreau&amp;author=L.%E2%80%90P.%20Boulet&amp;author=D.%20W.%20Cockcroft&amp;volume=183&amp;issue=8&amp;publication_year=2011&amp;pages=1007-1014&amp;pmid=21057005&amp;doi=10.1164/rccm.201008-1210OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0279">
<span class="label">279.</span><cite>
Castro M., Corren J., Pavord I. D., et al., “Dupilumab Efficacy and Safety in Moderate‐To‐Severe Uncontrolled Asthma,” New England Journal of Medicine
378, no. 26 (2018): 2486–2496, 10.1056/NEJMoa1804092.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1804092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29782217/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Dupilumab%20Efficacy%20and%20Safety%20in%20Moderate%E2%80%90To%E2%80%90Severe%20Uncontrolled%20Asthma&amp;author=M.%20Castro&amp;author=J.%20Corren&amp;author=I.%20D.%20Pavord&amp;volume=378&amp;issue=26&amp;publication_year=2018&amp;pages=2486-2496&amp;pmid=29782217&amp;doi=10.1056/NEJMoa1804092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0280">
<span class="label">280.</span><cite>
Rabe K. F., Nair P., Brusselle G., et al., “Efficacy and Safety of Dupilumab in Glucocorticoid‐Dependent Severe Asthma,” New England Journal of Medicine
378, no. 26 (2018): 2475–2485, 10.1056/NEJMoa1804093.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1804093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29782224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Efficacy%20and%20Safety%20of%20Dupilumab%20in%20Glucocorticoid%E2%80%90Dependent%20Severe%20Asthma&amp;author=K.%20F.%20Rabe&amp;author=P.%20Nair&amp;author=G.%20Brusselle&amp;volume=378&amp;issue=26&amp;publication_year=2018&amp;pages=2475-2485&amp;pmid=29782224&amp;doi=10.1056/NEJMoa1804093&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0281">
<span class="label">281.</span><cite>
Wenzel S., Wilbraham D., Fuller R., Getz E. B., and Longphre M., “Effect of an Interleukin‐4 Variant on Late Phase Asthmatic Response to Allergen Challenge in Asthmatic Patients: Results of Two Phase 2a Studies,” Lancet
370, no. 9596 (2007): 1422–1431.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(07)61600-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17950857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effect%20of%20an%20Interleukin%E2%80%904%20Variant%20on%20Late%20Phase%20Asthmatic%20Response%20to%20Allergen%20Challenge%20in%20Asthmatic%20Patients:%20Results%20of%20Two%20Phase%202a%20Studies&amp;author=S.%20Wenzel&amp;author=D.%20Wilbraham&amp;author=R.%20Fuller&amp;author=E.%20B.%20Getz&amp;author=M.%20Longphre&amp;volume=370&amp;issue=9596&amp;publication_year=2007&amp;pages=1422-1431&amp;pmid=17950857&amp;doi=10.1016/S0140-6736(07)61600-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0282">
<span class="label">282.</span><cite>
Svenningsen S., Kjarsgaard M., Zhang K., et al., “Effect of Dupilumab on Sputum Eosinophils in Patients With Moderate‐To‐Severe Asthma,” Allergy
79, no. 2 (2024): 509–513.
</cite> [<a href="https://doi.org/10.1111/all.15901" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37750593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Effect%20of%20Dupilumab%20on%20Sputum%20Eosinophils%20in%20Patients%20With%20Moderate%E2%80%90To%E2%80%90Severe%20Asthma&amp;author=S.%20Svenningsen&amp;author=M.%20Kjarsgaard&amp;author=K.%20Zhang&amp;volume=79&amp;issue=2&amp;publication_year=2024&amp;pages=509-513&amp;pmid=37750593&amp;doi=10.1111/all.15901&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0283">
<span class="label">283.</span><cite>
Fahy J. V., Fleming H. E., Wong H. H., et al., “The Effect of an Anti‐IgE Monoclonal Antibody on the Early‐and Late‐Phase Responses to Allergen Inhalation in Asthmatic Subjects,” American Journal of Respiratory and Critical Care Medicine
155, no. 6 (1997): 1828–1834, 10.1164/ajrccm.155.6.9196082.
</cite> [<a href="https://doi.org/10.1164/ajrccm.155.6.9196082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9196082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=The%20Effect%20of%20an%20Anti%E2%80%90IgE%20Monoclonal%20Antibody%20on%20the%20Early%E2%80%90and%20Late%E2%80%90Phase%20Responses%20to%20Allergen%20Inhalation%20in%20Asthmatic%20Subjects&amp;author=J.%20V.%20Fahy&amp;author=H.%20E.%20Fleming&amp;author=H.%20H.%20Wong&amp;volume=155&amp;issue=6&amp;publication_year=1997&amp;pages=1828-1834&amp;pmid=9196082&amp;doi=10.1164/ajrccm.155.6.9196082&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0284">
<span class="label">284.</span><cite>
Fahy J. V., Cockcroft D. W., Boulet L.‐P., et al., “Effect of Aerosolized Anti‐IgE (E25) on Airway Responses to Inhaled Allergen in Asthmatic Subjects,” American Journal of Respiratory and Critical Care Medicine
160, no. 3 (1999): 1023–1027, 10.1164/ajrccm.160.3.9810012.
</cite> [<a href="https://doi.org/10.1164/ajrccm.160.3.9810012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10471635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Effect%20of%20Aerosolized%20Anti%E2%80%90IgE%20(E25)%20on%20Airway%20Responses%20to%20Inhaled%20Allergen%20in%20Asthmatic%20Subjects&amp;author=J.%20V.%20Fahy&amp;author=D.%20W.%20Cockcroft&amp;author=L.%E2%80%90P.%20Boulet&amp;volume=160&amp;issue=3&amp;publication_year=1999&amp;pages=1023-1027&amp;pmid=10471635&amp;doi=10.1164/ajrccm.160.3.9810012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0285">
<span class="label">285.</span><cite>
Van Rensen E., Evertse C., Van Schadewijk W., et al., “Eosinophils in Bronchial Mucosa of Asthmatics After Allergen Challenge: Effect of Anti‐IgE Treatment,” Allergy
64, no. 1 (2009): 72–80, 10.1111/j.1398-9995.2008.01881.x.
</cite> [<a href="https://doi.org/10.1111/j.1398-9995.2008.01881.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19076931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Eosinophils%20in%20Bronchial%20Mucosa%20of%20Asthmatics%20After%20Allergen%20Challenge:%20Effect%20of%20Anti%E2%80%90IgE%20Treatment&amp;author=E.%20Van%20Rensen&amp;author=C.%20Evertse&amp;author=W.%20Van%20Schadewijk&amp;volume=64&amp;issue=1&amp;publication_year=2009&amp;pages=72-80&amp;pmid=19076931&amp;doi=10.1111/j.1398-9995.2008.01881.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0286">
<span class="label">286.</span><cite>
Gauvreau G. M., Arm J. P., Boulet L.‐P., et al., “Efficacy and Safety of Multiple Doses of QGE031 (Ligelizumab) Versus Omalizumab and Placebo in Inhibiting Allergen‐Induced Early Asthmatic Responses,” Journal of Allergy and Clinical Immunology
138, no. 4 (2016): 1051–1059.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2016.02.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27185571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Efficacy%20and%20Safety%20of%20Multiple%20Doses%20of%20QGE031%20(Ligelizumab)%20Versus%20Omalizumab%20and%20Placebo%20in%20Inhibiting%20Allergen%E2%80%90Induced%20Early%20Asthmatic%20Responses&amp;author=G.%20M.%20Gauvreau&amp;author=J.%20P.%20Arm&amp;author=L.%E2%80%90P.%20Boulet&amp;volume=138&amp;issue=4&amp;publication_year=2016&amp;pages=1051-1059&amp;pmid=27185571&amp;doi=10.1016/j.jaci.2016.02.027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0287">
<span class="label">287.</span><cite>
Gauvreau G. M., Harris J. M., Boulet L.‐P., et al., “Targeting Membrane‐Expressed IgE B Cell Receptor With an Antibody to the M1 Prime Epitope Reduces IgE Production,” Science Translational Medicine
6 (2014): 243ra85.</cite> [<a href="https://doi.org/10.1126/scitranslmed.3008961" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24990880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science%20Translational%20Medicine&amp;title=Targeting%20Membrane%E2%80%90Expressed%20IgE%20B%20Cell%20Receptor%20With%20an%20Antibody%20to%20the%20M1%20Prime%20Epitope%20Reduces%20IgE%20Production&amp;author=G.%20M.%20Gauvreau&amp;author=J.%20M.%20Harris&amp;author=L.%E2%80%90P.%20Boulet&amp;volume=6&amp;publication_year=2014&amp;pages=243ra85&amp;pmid=24990880&amp;doi=10.1126/scitranslmed.3008961&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0288">
<span class="label">288.</span><cite>
Gauvreau G., Boulet L., Parker J., et al., “A Randomized, Double‐Blind, Placebo Controlled Multicenter Study to Evaluate the Efficacy of a Humanized Interleukin‐9 Monoclonal Antibody (MEDI‐528) on the Late Asthmatic Response in Adults with Atopic Asthma,” B92 NEW TREATMENT APPROACHES FOR ASTHMA AND ALLERGY: American Thoracic Society, 2009. p. A3639.</cite>
</li>
<li id="imr70018-bib-0289">
<span class="label">289.</span><cite>
Parker J. M., Oh C. K., LaForce C., et al., “Safety Profile and Clinical Activity of Multiple Subcutaneous Doses of MEDI‐528, a Humanized Anti‐Interleukin‐9 Monoclonal Antibody, in Two Randomized Phase 2a Studies in Subjects With Asthma,” BMC Pulmonary Medicine
11 (2011): 14.
</cite> [<a href="https://doi.org/10.1186/1471-2466-11-14" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3058114/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21356110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Pulmonary%20Medicine&amp;title=Safety%20Profile%20and%20Clinical%20Activity%20of%20Multiple%20Subcutaneous%20Doses%20of%20MEDI%E2%80%90528,%20a%20Humanized%20Anti%E2%80%90Interleukin%E2%80%909%20Monoclonal%20Antibody,%20in%20Two%20Randomized%20Phase%202a%20Studies%20in%20Subjects%20With%20Asthma&amp;author=J.%20M.%20Parker&amp;author=C.%20K.%20Oh&amp;author=C.%20LaForce&amp;volume=11&amp;publication_year=2011&amp;pages=14&amp;pmid=21356110&amp;doi=10.1186/1471-2466-11-14&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0290">
<span class="label">290.</span><cite>
“A Phase 2a, Multi‐Center, Randomized, Double‐Blind, Placebo‐Controlled, Parallel Group, Bronchial Allergen Challenge Study to Assess the Safety, Tolerability, and Efficacy of Inhaled AIR645 in Subjects With Mild Allergic Asthma [Internet],” 2009, <a href="https://clinicaltrials.gov/study/NCT00941577" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov/study/NCT00941577</a>.</cite>
</li>
<li id="imr70018-bib-0291">
<span class="label">291.</span><cite>
Revez J. A., Bain L. M., Watson R. M., et al., “Effects of Interleukin‐6 Receptor Blockade on Allergen‐Induced Airway Responses in Mild Asthmatics,” Clinical and Translational Immunology
8, no. 6 (2019): e1044.
</cite> [<a href="https://doi.org/10.1002/cti2.1044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6566140/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31223480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Translational%20Immunology&amp;title=Effects%20of%20Interleukin%E2%80%906%20Receptor%20Blockade%20on%20Allergen%E2%80%90Induced%20Airway%20Responses%20in%20Mild%20Asthmatics&amp;author=J.%20A.%20Revez&amp;author=L.%20M.%20Bain&amp;author=R.%20M.%20Watson&amp;volume=8&amp;issue=6&amp;publication_year=2019&amp;pages=e1044&amp;pmid=31223480&amp;doi=10.1002/cti2.1044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0292">
<span class="label">292.</span><cite>
Imaoka H., Punia N., Irshad A., et al., “Lung Homing of Endothelial Progenitor Cells in Humans With Asthma After Allergen Challenge,” American Journal of Respiratory and Critical Care Medicine
184, no. 7 (2011): 771–778.
</cite> [<a href="https://doi.org/10.1164/rccm.201102-0272OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21719753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Lung%20Homing%20of%20Endothelial%20Progenitor%20Cells%20in%20Humans%20With%20Asthma%20After%20Allergen%20Challenge&amp;author=H.%20Imaoka&amp;author=N.%20Punia&amp;author=A.%20Irshad&amp;volume=184&amp;issue=7&amp;publication_year=2011&amp;pages=771-778&amp;pmid=21719753&amp;doi=10.1164/rccm.201102-0272OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0293">
<span class="label">293.</span><cite>
Gauvreau G. M., Boulet L.‐P., Schmid‐Wirlitsch C., et al., “Roflumilast Attenuates Allergen‐Induced Inflammation in Mild Asthmatic Subjects,” Respiratory Research
12 (2011): 140, 10.1186/1465-9921-12-140.
</cite> [<a href="https://doi.org/10.1186/1465-9921-12-140" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3219708/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22029856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Respiratory%20Research&amp;title=Roflumilast%20Attenuates%20Allergen%E2%80%90Induced%20Inflammation%20in%20Mild%20Asthmatic%20Subjects&amp;author=G.%20M.%20Gauvreau&amp;author=L.%E2%80%90P.%20Boulet&amp;author=C.%20Schmid%E2%80%90Wirlitsch&amp;volume=12&amp;publication_year=2011&amp;pages=140&amp;pmid=22029856&amp;doi=10.1186/1465-9921-12-140&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0294">
<span class="label">294.</span><cite>
Gauvreau G. M., Watson R. M., and O'Byrne P. M., “Protective Effects of Inhaled PGE2 on Allergen‐Induced Airway Responses and Airway Inflammation,” American Journal of Respiratory and Critical Care Medicine
159, no. 1 (1999): 31–36.
</cite> [<a href="https://doi.org/10.1164/ajrccm.159.1.9804030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9872814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Protective%20Effects%20of%20Inhaled%20PGE2%20on%20Allergen%E2%80%90Induced%20Airway%20Responses%20and%20Airway%20Inflammation&amp;author=G.%20M.%20Gauvreau&amp;author=R.%20M.%20Watson&amp;author=P.%20M.%20O'Byrne&amp;volume=159&amp;issue=1&amp;publication_year=1999&amp;pages=31-36&amp;pmid=9872814&amp;doi=10.1164/ajrccm.159.1.9804030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0295">
<span class="label">295.</span><cite>
Gauvreau G., Boulet L. P., Cockcroft D., et al., “OX 40L Blockade and Allergen‐Induced Airway Responses in Subjects With Mild Asthma,” Clinical and Experimental Allergy
44, no. 1 (2014): 29–37.
</cite> [<a href="https://doi.org/10.1111/cea.12235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4253735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24224471/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Experimental%20Allergy&amp;title=OX%2040L%20Blockade%20and%20Allergen%E2%80%90Induced%20Airway%20Responses%20in%20Subjects%20With%20Mild%20Asthma&amp;author=G.%20Gauvreau&amp;author=L.%20P.%20Boulet&amp;author=D.%20Cockcroft&amp;volume=44&amp;issue=1&amp;publication_year=2014&amp;pages=29-37&amp;pmid=24224471&amp;doi=10.1111/cea.12235&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0296">
<span class="label">296.</span><cite>
Balzar S., Chu H. W., Strand M., and Wenzel S., “Relationship of Small Airway Chymase‐Positive Mast Cells and Lung Function in Severe Asthma,” American Journal of Respiratory and Critical Care Medicine
171, no. 5 (2005): 431–439.
</cite> [<a href="https://doi.org/10.1164/rccm.200407-949OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15563633/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Respiratory%20and%20Critical%20Care%20Medicine&amp;title=Relationship%20of%20Small%20Airway%20Chymase%E2%80%90Positive%20Mast%20Cells%20and%20Lung%20Function%20in%20Severe%20Asthma&amp;author=S.%20Balzar&amp;author=H.%20W.%20Chu&amp;author=M.%20Strand&amp;author=S.%20Wenzel&amp;volume=171&amp;issue=5&amp;publication_year=2005&amp;pages=431-439&amp;pmid=15563633&amp;doi=10.1164/rccm.200407-949OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0297">
<span class="label">297.</span><cite>
Fajt M. L. and Wenzel S. E., “Mast Cells, Their Subtypes, and Relation to Asthma Phenotypes,” Annals of the American Thoracic Society
10, no. Supplement (2013): S158–S164.
</cite> [<a href="https://doi.org/10.1513/AnnalsATS.201303-064AW" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24313767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20the%20American%20Thoracic%20Society&amp;title=Mast%20Cells,%20Their%20Subtypes,%20and%20Relation%20to%20Asthma%20Phenotypes&amp;author=M.%20L.%20Fajt&amp;author=S.%20E.%20Wenzel&amp;volume=10&amp;issue=Supplement&amp;publication_year=2013&amp;pages=S158-S164&amp;pmid=24313767&amp;doi=10.1513/AnnalsATS.201303-064AW&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0298">
<span class="label">298.</span><cite>
Ochi H., Hirani W. M., Yuan Q., Friend D. S., Austen K. F., and Boyce J. A., “T Helper Cell Type 2 Cytokine–Mediated Comitogenic Responses and CCR3 Expression During Differentiation of Human Mast Cells In Vitro,” Journal of Experimental Medicine
190, no. 2 (1999): 267–280.
</cite> [<a href="https://doi.org/10.1084/jem.190.2.267" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2195573/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10432289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=T%20Helper%20Cell%20Type%202%20Cytokine%E2%80%93Mediated%20Comitogenic%20Responses%20and%20CCR3%20Expression%20During%20Differentiation%20of%20Human%20Mast%20Cells%20In%C2%A0Vitro&amp;author=H.%20Ochi&amp;author=W.%20M.%20Hirani&amp;author=Q.%20Yuan&amp;author=D.%20S.%20Friend&amp;author=K.%20F.%20Austen&amp;volume=190&amp;issue=2&amp;publication_year=1999&amp;pages=267-280&amp;pmid=10432289&amp;doi=10.1084/jem.190.2.267&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0299">
<span class="label">299.</span><cite>
Dougherty R. H., Sidhu S. S., Raman K., et al., “Accumulation of Intraepithelial Mast Cells With a Unique Protease Phenotype in TH2‐High Asthma,” Journal of Allergy and Clinical Immunology
125, no. 5 (2010): 1046–1053.e8.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2010.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2918406/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20451039/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Accumulation%20of%20Intraepithelial%20Mast%20Cells%20With%20a%20Unique%20Protease%20Phenotype%20in%20TH2%E2%80%90High%20Asthma&amp;author=R.%20H.%20Dougherty&amp;author=S.%20S.%20Sidhu&amp;author=K.%20Raman&amp;volume=125&amp;issue=5&amp;publication_year=2010&amp;pages=1046-1053&amp;pmid=20451039&amp;doi=10.1016/j.jaci.2010.03.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0300">
<span class="label">300.</span><cite>
Hallstrand T. S., Wurfel M. M., Lai Y., et al., “Transglutaminase 2, a Novel Regulator of Eicosanoid Production in Asthma Revealed by Genome‐Wide Expression Profiling of Distinct Asthma Phenotypes,” PLoS One
5, no. 1 (2010): e8583.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0008583" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2797392/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20052409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Transglutaminase%202,%20a%20Novel%20Regulator%20of%20Eicosanoid%20Production%20in%20Asthma%20Revealed%20by%20Genome%E2%80%90Wide%20Expression%20Profiling%20of%20Distinct%20Asthma%20Phenotypes&amp;author=T.%20S.%20Hallstrand&amp;author=M.%20M.%20Wurfel&amp;author=Y.%20Lai&amp;volume=5&amp;issue=1&amp;publication_year=2010&amp;pages=e8583&amp;pmid=20052409&amp;doi=10.1371/journal.pone.0008583&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0301">
<span class="label">301.</span><cite>
Altman M. C., Lai Y., Nolin J. D., et al., “Airway Epithelium–Shifted Mast Cell Infiltration Regulates Asthmatic Inflammation via IL‐33 Signaling,” Journal of Clinical Investigation
129, no. 11 (2020): 4979–4991.</cite> [<a href="https://doi.org/10.1172/JCI126402" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6819127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31437129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Airway%20Epithelium%E2%80%93Shifted%20Mast%20Cell%20Infiltration%20Regulates%20Asthmatic%20Inflammation%20via%20IL%E2%80%9033%20Signaling&amp;author=M.%20C.%20Altman&amp;author=Y.%20Lai&amp;author=J.%20D.%20Nolin&amp;volume=129&amp;issue=11&amp;publication_year=2020&amp;pages=4979-4991&amp;pmid=31437129&amp;doi=10.1172/JCI126402&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0302">
<span class="label">302.</span><cite>
Gonzalez N. V., Oliveria J.‐P., Tebaykin D., et al., “Mass Cytometry Phenotyping of Human Granulocytes Reveals Novel Basophil Functional Heterogeneity,” IScience
23, no. 11 (2020): 101724, 10.1016/j.isci.2020.101724.
</cite> [<a href="https://doi.org/10.1016/j.isci.2020.101724" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7653073/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33205028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IScience&amp;title=Mass%20Cytometry%20Phenotyping%20of%20Human%20Granulocytes%20Reveals%20Novel%20Basophil%20Functional%20Heterogeneity&amp;author=N.%20V.%20Gonzalez&amp;author=J.%E2%80%90P.%20Oliveria&amp;author=D.%20Tebaykin&amp;volume=23&amp;issue=11&amp;publication_year=2020&amp;pages=101724&amp;pmid=33205028&amp;doi=10.1016/j.isci.2020.101724&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0303">
<span class="label">303.</span><cite>
Salter B. M., Nusca G., Tworek D., et al., “Expression of Activation Markers in Circulating Basophils and the Relationship to Allergen‐Induced Bronchoconstriction in Subjects With Mild Allergic Asthma,” Journal of Allergy and Clinical Immunology
137, no. 3 (2016): 936–938.e7.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2015.08.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26441227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20and%20Clinical%20Immunology&amp;title=Expression%20of%20Activation%20Markers%20in%20Circulating%20Basophils%20and%20the%20Relationship%20to%20Allergen%E2%80%90Induced%20Bronchoconstriction%20in%20Subjects%20With%20Mild%20Allergic%20Asthma&amp;author=B.%20M.%20Salter&amp;author=G.%20Nusca&amp;author=D.%20Tworek&amp;volume=137&amp;issue=3&amp;publication_year=2016&amp;pages=936-938&amp;pmid=26441227&amp;doi=10.1016/j.jaci.2015.08.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0304">
<span class="label">304.</span><cite>
Mesnil C., Raulier S., Paulissen G., et al., “Lung‐Resident Eosinophils Represent a Distinct Regulatory Eosinophil Subset,” Journal of Clinical Investigation
126, no. 9 (2016): 3279–3295.
</cite> [<a href="https://doi.org/10.1172/JCI85664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5004964/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27548519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Lung%E2%80%90Resident%20Eosinophils%20Represent%20a%20Distinct%20Regulatory%20Eosinophil%20Subset&amp;author=C.%20Mesnil&amp;author=S.%20Raulier&amp;author=G.%20Paulissen&amp;volume=126&amp;issue=9&amp;publication_year=2016&amp;pages=3279-3295&amp;pmid=27548519&amp;doi=10.1172/JCI85664&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0305">
<span class="label">305.</span><cite>
Abdala Valencia H., Loffredo L., Misharin A., and Berdnikovs S., “Phenotypic Plasticity and Targeting of S Iglec‐F High CD 11clow Eosinophils to the Airway in a Murine Model of Asthma,” Allergy
71, no. 2 (2016): 267–271.
</cite> [<a href="https://doi.org/10.1111/all.12776" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26414117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Phenotypic%20Plasticity%20and%20Targeting%20of%20S%20Iglec%E2%80%90F%20High%20CD%2011clow%20Eosinophils%20to%20the%20Airway%20in%20a%20Murine%20Model%20of%20Asthma&amp;author=H.%20Abdala%20Valencia&amp;author=L.%20Loffredo&amp;author=A.%20Misharin&amp;author=S.%20Berdnikovs&amp;volume=71&amp;issue=2&amp;publication_year=2016&amp;pages=267-271&amp;pmid=26414117&amp;doi=10.1111/all.12776&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0306">
<span class="label">306.</span><cite>
Whetstone C., Satia I., Oliveria J.‐P., et al., “Higher Inflammatory Eosinophil Levels in Eosinophilic Bronchitis Compared to Mild Allergic Asthma,” European Respiratory Society
64, no. S68 (2024): PA4013.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Respiratory%20Society&amp;title=Higher%20Inflammatory%20Eosinophil%20Levels%20in%20Eosinophilic%20Bronchitis%20Compared%20to%20Mild%20Allergic%20Asthma&amp;author=C.%20Whetstone&amp;author=I.%20Satia&amp;author=J.%E2%80%90P.%20Oliveria&amp;volume=64&amp;issue=S68&amp;publication_year=2024&amp;pages=PA4013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="imr70018-bib-0307">
<span class="label">307.</span><cite>
Whetstone C., Oliveria J.‐P., Howie K., et al., “Eosinophil Phenotypes in Circulation and Airways of Asthmatics After Inhaled Allergen Challenge,” European Respiratory Society
62, no. S67 (2023): PA1932.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Respiratory%20Society&amp;title=Eosinophil%20Phenotypes%20in%20Circulation%20and%20Airways%20of%20Asthmatics%20After%20Inhaled%20Allergen%20Challenge&amp;author=C.%20Whetstone&amp;author=J.%E2%80%90P.%20Oliveria&amp;author=K.%20Howie&amp;volume=62&amp;issue=S67&amp;publication_year=2023&amp;pages=PA1932&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The authors have nothing to report.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Immunological Reviews are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/imr.70018"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/IMR-331-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (5.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12001016/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12001016/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12001016%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12001016/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12001016/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12001016/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40235366/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12001016/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40235366/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12001016/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12001016/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="GwDIsakGKFWbBPKJvWwar3fwY8F6FR8f8PyfaOjfj7vRHuymBEpykwr5FS8Rr3NT">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
